0001140361-13-031524.txt : 20130809 0001140361-13-031524.hdr.sgml : 20130809 20130809171045 ACCESSION NUMBER: 0001140361-13-031524 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20130630 FILED AS OF DATE: 20130809 DATE AS OF CHANGE: 20130809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VirnetX Holding Corp CENTRAL INDEX KEY: 0001082324 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 770390628 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33852 FILM NUMBER: 131027577 BUSINESS ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 BUSINESS PHONE: (831) 438-8200 MAIL ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 FORMER COMPANY: FORMER CONFORMED NAME: PASW INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC SOFTWORKS INC DATE OF NAME CHANGE: 19990322 10-Q 1 form10q.htm VIRNETX HOLDING CORPORATION 10-Q 6-30-2013

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2013
or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-33852


VirnetX Holding Corporation
(Exact name of registrant as specified in its charter)

Delaware
 
77-0390628
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification Number)

308 Dorla Court, Suite 206
 
 
Zephyr Cove, Nevada
 
89448
(Address of principal executive offices)
 
(Zip Code))

Registrant’s telephone number, including area code: (775) 548-1785

Former name, former address and former fiscal year, if changed since last report:

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):
 
Large accelerated filer x
Accelerated filer o
Non-accelerated filer o
Smaller reporting company o
 
 
(Do not check if a smaller reporting company)
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x

The number of shares outstanding of the Registrant’s Common Stock as of August 3, 2013, was 51,203,141.


VIRNETX HOLDING CORPORATION
INDEX

 
 
Page
PART I — FINANCIAL INFORMATION
1
 
1
 
1
 
2
 
2
 
3
 
4
 
12
 
17
 
17
PART II — OTHER INFORMATION
18
 
18
 
20
 
  20
 
26
27
29
 
PART I — FINANCIAL INFORMATION

ITEM 1. - FINANCIAL STATEMENTS.

VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except  share amounts)


 
 
June 30, 2013
   
December 31, 2012
 
 
 
(Unaudited)
   
 
ASSETS
 
   
 
Current assets:
 
   
 
Cash and cash equivalents
 
$
32,878
   
$
19,661
 
Investments available for sale
   
13,382
     
26,493
 
Prepaid taxes
   
     
14,963
 
Prepaid expense and other current assets
   
601
     
114
 
Total current assets
   
46,861
     
61,231
 
Property and equipment, net
   
65
     
70
 
Intangible and other assets
   
     
12
 
Total assets
 
$
46,926
   
$
61,313
 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
Current liabilities:
               
Accounts payable and accrued liabilities
 
$
1,861
   
$
3,197
 
Derivative liability
   
2,686
     
4,172
 
Total current liabilities
   
4,547
     
7,369
 
Stockholders' equity:
               
Preferred stock, par value $0.0001 per share
               
Authorized: 10,000,000 shares at June 30, 2013, and December 31, 2012, Issued and outstanding:  none
   
     
 
Common stock, par value $0.0001 per share
               
Authorized: 100,000,000 shares at June 30, 2013 and December 31, 2012, Issued and outstanding: 51,203,141 shares at June 30, 2013, and 51,150,242 shares at December 31, 2012
   
5
     
5
 
Additional paid in capital
   
120,229
     
116,856
 
Accumulated deficit
   
(77,847
)
   
(62,925
)
Accumulated other comprehensive income (loss)
   
(8
)
   
8
 
Total stockholders' equity
   
42,379
     
53,944
 
Total liabilities and stockholders' equity
 
$
46,926
   
$
61,313
 

See accompanying notes to condensed consolidated financial statements.
1

VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in thousands, except per share amounts)

 
 
Three Months Ended
   
Six Months Ended
 
 
 
June 30, 2013
   
June 30, 2012
   
June 30, 2013
   
June 30, 2012
 
Revenue
 
$
6
   
$
36
   
$
300
   
$
36
 
Operating expense:
                               
Research and development
   
382
     
274
     
686
     
530
 
General, selling and administrative
   
6,202
     
11,496
     
15,722
     
18,463
 
Total operating expense
   
6,584
     
11,770
     
16,408
     
18,993
 
Loss from operations
   
(6,578
)
   
(11,734
)
   
(16,108
)
   
(18,957
)
Gain (loss) on change in value of derivative liability
   
(120
)
   
(2,248
)
   
1,486
     
(1,979
)
Interest income, net
   
23
     
128
     
56
     
202
 
Loss before taxes
   
(6,675
)
   
(13,854
)
   
(14,566
)
   
(20,734
)
Income tax (expense) benefit
   
(354
)
   
3,590
     
(356
)
   
5,763
 
Net loss
 
$
(7,029
)
 
$
(10,264
)
 
$
(14,922
)
 
$
(14,971
)
Basic and diluted loss per share:
 
$
(0.14
)
 
$
(0.20
)
 
$
(0.29
)
 
$
(0.29
)
Weighted average shares outstanding basic and diluted
   
51,179
     
50,874
     
51,165
     
50,766
 
 
VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)
(in thousands)

 
 
Three Months Ended
   
Six Months Ended
 
 
 
June 30, 2013
   
June 30, 2012
   
June 30, 2013
   
June 30, 2012
 
Net loss
 
$
(7,029
)
 
$
(10,264
)
 
$
(14,922
)
 
$
(14,971
)
Other comprehensive income (loss):
                               
Change in equity adjustment from Foreign currency translation, net of tax
(12 )
(12 )
Change in unrealized gain (loss) on investments, net of tax
   
4
     
1
     
(4
)
   
(17
)
 
    (8)       1       (16    
(17
)
Comprehensive loss
 
$
(7,037
)
 
$
(10,263
)
 
$
(14,938
)
 
$
(14,988
)

See accompanying notes to condensed consolidated financial statements.
2

VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in thousands)

 
 
Six Months
Ended
June 30,
2013
   
Six Months
Ended
June 30,
2012
 
Cash flows from operating activities:
 
   
 
Net loss
 
$
(14,922
)
 
$
(14,971
)
Adjustments to reconcile net loss to net cash used in operating activities:
               
Depreciation and amortization
   
23
     
36
 
Stock-based compensation
   
3,344
     
2,340
 
Net change in deferred taxes
   
     
204
 
Change in value of derivative liability
   
(1,486
)
   
1,979
 
Changes in assets and liabilities:
               
Prepaid taxes
   
14,963
     
5,192
 
Prepaid expenses and other current assets
   
(487
   
(259
)
Accounts payable and accrued liabilities
   
(1,336
)
   
4,032
 
Net cash provided by (used in) operating activities
    99
 
   
(1,447
)
Cash flows from investing activities:
               
Purchase of property and equipment
   
(7
)
   
(26
)
Purchase of investments
   
(13,000
)
   
(33,599
)
Proceeds from sale or maturity of investments
   
26,094
     
22,208
 
Net cash provided by (used in) investing activities
   
13,087
     
(11,417
)
Cash flows from financing activities:
               
Proceeds from exercise of stock options
   
31
     
1,175
 
Proceeds from exercise of warrants
   
     
156
 
Net cash provided by financing activities
   
31
     
1,331
 
Net increase (decrease) in cash and cash equivalents
   
13,217
     
(11,533
)
Cash and cash equivalents, beginning of period
   
19,661
     
49,482
 
Cash and cash equivalents, end of period
 
$
32,878
   
$
37,949
 

See accompanying notes to condensed consolidated financial statements.
3

VIRNETX HOLDING CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 (Unaudited)

Note 1 — Business Description and Basis of Presentation

VirnetX, Inc. (“we”, “our”, “us” or “VirnetX”) develops software and technology solutions for securing real-time communications over the Internet.  Our patented GABRIEL Connection Technology™ combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks.

Our portfolio of intellectual property is the foundation of our business model.  We currently own 21 patents in the United States and 41 foreign patents, as well as several pending U.S. and foreign patent applications.  Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry.  Our patented methods also have additional applications in operating systems and network security.

Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer and remote desktop.  Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.

We have executed licenses and intend to seek further licensees for our technology, including our GABRIEL Connection Technology™ to original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.

During interim periods, we follow the accounting policies set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012 and apply appropriate interim financial reporting standards for a fair statement of our operating results and financial position in conformity with accounting principles generally accepted in the United States of America, as codified by the Financial Accounting Standards Board (FASB) in the Accounting Standards Codification (ASC) (referred to herein as U.S. GAAP), as indicated below.  Users of financial information produced for interim periods are encouraged to read this Quarterly Report on Form 10-Q in conjunction with our consolidated financial statements and notes thereto filed with the Securities and Exchange Commission (SEC) in our 2012 Annual Report on Form 10-K.

Interim financial reporting standards require us to make estimates that are based on assumptions regarding the outcome of future events and circumstances not known at that time, including the use of estimated effective tax rates.  Inevitably, some assumptions will not materialize, unanticipated events or circumstances may occur which vary from those estimates and such variations may significantly affect our future results. Our financial results have varied significantly from period to period.  Additionally, interim results may not be indicative of our results for future interim periods or our annual results.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC’s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and six month periods ended June 30, 2013 and 2012; (ii) the condensed consolidated statements of comprehensive loss for the three and six month periods ended June 30, 2013 and 2012; (iii) the condensed consolidated balance sheets at June 30, 2013 and December 31, 2012; and (iv) the condensed consolidated statements of cash flows for the six month periods ended June 30, 2013 and 2012. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by U.S. GAAP.  The condensed consolidated balance sheet, included in this report, as of December 31, 2012 was derived from our 2012 audited financial statements, but does not include all disclosures required by U.S. GAAP.
4

Note 2 – Summary of Significant Accounting Policies

Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements can be complex and may or may not include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the FASB revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue arrangements with multiple deliverables and the guidance for revenue recognition. Under our patent license agreements, we typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

· Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.

· Current Royalty Payments: These are ongoing royalty payments covering a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe Current Royalty Payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.

For the three and six months ended June 30, 2013, we recognized royalty revenue of $6 and $300 respectively, compared to $36 for the three and six months ended June 30, 2012, as part of license agreements entered into with customers during the patent infringement actions (see “Legal Proceedings”).  In accordance with our revenue recognition policy related to a licensee’s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.  In the patent infringement actions we did not request, nor receive any amounts allocable to settlement fees, expense reimbursement, damages or any other amount unrelated to historical sales.  Revenue from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.

Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.  During the six months ended June 30, 2013 we had, at times, funds which were uninsured.   We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.

Derivative Instruments

Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock.  The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.
5

Impairment of Long-Lived Assets

On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Certificate of deposits: Fair value measured at face value plus accrued interest.

Corporate bonds:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.

Series I Warrants: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for June 30, 2013, included a warrant exercise price of $3.59 per share, a common share price of $19.99, a discount rate of 1.41%, and a volatility of 93%. The assumptions used for December 31, 2012, were a warrant exercise price of $3.59 per share, a common share price of $29.28, a discount rate of 0.72%, and a volatility of 94%.

The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.

 
 
June 30, 2013
 
Level 1:
 
Adjusted Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair Value
 
Certificates of deposit
 
$
351
   
$
   
$
   
$
351
 
 
                               
Corporate Bonds:
                               
AA
   
13,027
     
4
     
     
13,031
 
Total Corporate Bonds
   
13,027
     
4
     
     
13,031
 
 
                               
Total Investments at Fair Value
 
$
13,378
   
$
4
   
$
   
$
13,382
 

 
December 31, 2012
 
Level 1:
 
Adjusted Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair Value
 
Certificates of deposit
 
$
17,836
   
$
   
$
   
$
17,836
 
                               
Corporate bonds:
                               
AA
   
4,099
     
     
     
4,099
 
A
   
4,039
     
8
     
     
4,047
 
BAA
   
511
     
     
     
511
 
Total corporate bonds
   
8,649
     
8
     
     
8,657
 
                                 
Total investments at fair value
 
$
26,485
   
$
8
   
$
   
$
26,493
 
6

The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.

   
June 30, 2013
   
Quoted
Prices in
Active
Markets for
Identical
Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
   
(Level 1)
 
(Level 2)
 
(Level 3)
 
Total
Series l Warrants
  $
    $
    $
2,686
    $
2,686
 

   
December 31, 2012
   
Quoted
Prices in
Active
Markets
for
Identical
Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
   
(Level 1)
 
(Level 2)
 
(Level 3)
 
Total
Series l Warrants
 
$
   
$
   
$
4,172
   
$
4,172
 

The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012
.

 
 
Six Months Ended
June 30, 2013
 
 
 
Six Months Ended
June 30, 2012
 
 
 
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
 
 
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
Balance December 31, 2012
 
$
4,172
 
Balance December 31, 2011
 
$
4,699
 
Gain on derivative liability included in net loss
   
(1,486
)
Loss on derivative liability included in net loss
   
1,979
 
Settlements
   
 
Settlements
   
(1,415
)
Balance June 30, 2013
 
$
2,686
 
Balance June 30, 2012
 
$
5,263
 

New Accounting Pronouncement

In July 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ASU No. 2013-11 is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The new standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The new standard becomes effective for us on January 1, 2014 and will be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted. We are currently assessing the impacts of this new standard.
7

In February 2013, the FASB issued final guidance on the presentation of reclassifications out of other comprehensive income. The amendments require an entity to provide information about the amounts reclassified out of other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in a footnote, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, only if the amount reclassified is required by GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide detail about those amounts. This amendment was effective for interim and fiscal years beginning after December 15, 2012. The amended standard did not impact our financial position or results of operations.

Note 3 — Patent Portfolio

As of June 30, 2013, we own 21 issued U.S. and 41 issued foreign patents, in addition to several pending U.S. and foreign patent applications.  Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.  Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation, or SAIC, in 2006 and we are required to make payments to SAIC based on cash or certain other values generated from those patents.  The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, SAIC is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX or from the settlement of certain patent infringement claims of ours. Capitalized patent costs, net of amortization, are included in intangible and other assets in the accompanying Condensed Consolidated Balance Sheet at December 31, 2012, and were fully amortized at June 30, 2013.

Note 4 - Income Taxes

The income tax expense for the three months ended June 30, 2013 was $354, which was a negative effective income tax rate of 5 percent. The income tax expense for the six months ended June 30, 2013 was $356, which was a negative effective income tax rate of 2.5 percent. As a result of net operating losses during the periods the provision reflects only minimum tax payments and prior year tax true-up.  The tax expense was calculated using the statutory U.S. federal rate primarily as a result of the change of the valuation allowance of $5,695, stock based compensation expense and non-deductible derivative loss. We have valuation allowances covering our deferred tax assets including net operating loss carry-forwards.

The income tax benefit for the three months ended June 30, 2012 was $3,590, which was an effective income tax rate of 26 percent. The income tax benefit for the six months ended June 30, 2012 was $5,763, which was an effective income tax rate of 28 percent.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2013 will not be fully realizable. Accordingly, management has maintained a valuation allowance against our net deferred tax assets at June 30, 2013. The valuation allowance carried against our net deferred tax assets was $11,423 and $6,970 at June 30, 2013 and December 31, 2012, respectively.

At June 30, 2013, we have federal and state net operating loss carry-forwards of approximately $15,527 and $52,756 respectively, expiring beginning in 2027 and 2016, respectively.

Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.

Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2013, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.
8

Note 5 — Commitments

On October 30, 2011, we entered into a new lease agreement for our corporate headquarters. The lease commencement date was October 30, 2011 and includes monthly payments of $5 until the lease term expires in October 2013

We entered into a non-cancelable agreement for corporate promotional and marketing purposes for a period of ten years at a cost of $4,000. Initial payments of $250 have been prepaid and are included in prepaid expenses and other current assets on our Condensed Consolidated Balance Sheet. The remaining balance is due on March 1 of the year the facility will become available for use, which the lessor anticipates will be in 2014 or 2015, at which time we will begin amortizing the agreement over the contract period.  The lease terms include certain refunds, deductions, etc. in the event construction is delayed or not completed within specified time-frames.

Note 6 — Stock-Based Compensation

On May 22, 2013, our stockholders approved the VirnetX Holding Corporation 2013 Equity Incentive Plan (the "Plan) at our 2013 annual stockholders' meeting.  The Plan provides for the issuance of up to 2,500,000 shares of our common stock. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the Plan. The Plan provides for the granting of stock options and restricted stock purchase rights (RSU) to our employees and consultants. Stock options granted under the Plan may be incentive stock options or nonqualified stock options. Incentive stock options ("ISO") may only be granted to our employees (including officers and directors). Nonqualified stock options ("NSO") and stock purchase rights may be granted to our employees and consultants.

The Plan will expire 10 years after it was approved by our Board of Directors. Options may be granted under the Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the fair market value at the date of grant in the case of an NSO, the exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant. Stock options granted under the Plan typically vest over four years and have a 10 year term. All RSUs are considered to be granted at the fair value of our stock on the date of grant because they have no exercise price. RSUs typically vest over four years.

We had 5,009,849 and 4,776,224 options outstanding at June 30, 2013 and December 31, 2012, respectively, with a weighted-average exercise price of $7.87 and $6.94, respectively. At June 30, 2013 and December 31, 2012, we had 248,915 and 151,665 RSU’s outstanding with a weighted-average grant-date fair value of $24.10 and $25.60, respectively.

During the six months ended June 30, 2013 and 2012, we granted options for a total of 274,625 and 277,500 shares respectively. The weighted average fair values at the grant dates for options issued during the six months ending June 30, 2013 and 2012 were $19.24 and $22.26 per option, respectively. The fair value of options at the grant date was estimated utilizing the Black-Scholes valuation model with following weighted average assumptions for the six months ending June 30, 2013 and 2012, respectively: (i) dividend yield on our common stock of 0 percent and 0 percent; (ii) expected stock price volatility of 93 percent and 115 percent; (iii) a risk-free interest rate of 2.06 percent and 1.92 percent; and (iv) an expected option term of 6 and 7 years.

During the six months ended June 30, 2013 and 2012, we also granted RSUs totaling 156,415 and 151,665 units, respectively, that vest ratably over one to four years. The weighted-average fair values of each issued RSU on the dates of grant were $23.72 and $25.60, respectively. RSUs, which are subject to forfeiture if employment terminates prior to the shares vesting, are expensed ratably over the vesting period.

Stock-based compensation expense is measured at grant date, based on the fair value of the award, and is recognized over the employees’ requisite service period. Stock-based compensation expense included in general and administrative expense was $1,759 and $3,344 for the three and six months ended June 30, 2013, respectively, and $1,466 and $2,340 for the three and six months ended June 30, 2012, respectively.

As of June 30, 2013 and 2012, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $15,372 and $5,372, respectively, which will be amortized over an estimated weighted average vesting amortization period of approximately 2.72 and 3.21 years, respectively.
9

Note 7 — Warrants
 
Information about warrants outstanding during the six months ended June 30, 2013 follows:


 
Original
Number of
Warrants
Issued
Exercise
Price per
Common
Share
Exercisable at
December 31,
2012
Became
Exercisable
Exercised
Terminated /
Cancelled /
Expired
Exercisable
at June 30,
2013
Expiration
Date
 
  
2,619,036
 
(1
)
 
$
3.59
     
159,967
     
     
     
     
159,967
 
March 2015
Total
               
159,967
             
     
      159,967  
   

 
(1)
Referred to as our Series I Warrants.

Note 8 — Litigation

We have five intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints. We have one complaint with the United States International Trade Commission (ITC) alleging that Apple, Inc. has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.’s infringement through the district courts.  The ITC case has been terminated.
 
VirnetX Inc. et al., v. Microsoft Corporation
On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274.  We seek damages and injunctive relief.  No hearing or trial dates have been set.

VirnetX Inc. v. Cisco Systems, Inc. et al and VirnetX Inc. v. Apple Inc. (Severed Case)
On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief. On February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we again amended our complaint against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to include Apple’s iPad 2 in the list of Apple products that are accused of infringing our patents. We also asserted our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC have signed license agreements with us and we have agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to postpone the trial against Cisco to March 4, 2013 and just try the case against Apple. On November 6, 2012, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368,000 in a verdict against Apple Corporation for infringing four of our patents. A post-trial hearing in the case against Apple was held on December 20, 2012. On February 26, 2013, the United States District Court for the Eastern District of Texas, Tyler Division issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict. The Court denied Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict. Additionally, the Court granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. Specifically, the Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction. In doing so, the Court ordered the parties to mediate over a license in the following 45 days for Apple’s future infringing use not covered by the Court’s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court’s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are “not colorably different” with regards to the accused functionality. However, the judgment may be appealed and no assurances can be given as to when or if we will receive any proceeds in connection with these matters, and accordingly there has been no recognition of the jury awards or royalties in our accompanying financial statements. Under our agreements with Science Applications International Corporation (SAIC), we would pay to SAIC 25% of the proceeds obtained by us in this lawsuit against Apple after reduction for attorneys’ fees and costs incurred in litigating those claims. We are awaiting the Court’s decision in this matter.  On July 1, 2013, the Court entered an Order setting a hearing on VirnetX’s motion for an ongoing royalty for August 15, 2013.  On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit.
10

The jury trial against Cisco was held on March 4, 2013. At the end of the trial, the jury came back with a verdict of non-infringement in the trial. The same jury also found that all our patents-in-suit were valid and enforceable. On April 3, 2013, we filed a request for a new trial regarding Cisco’s infringement of four of our patents based primarily on our allegations of Cisco’s inappropriate conduct and arguments during the jury trial that concluded on March 14, 2013. In addition to the request for a new trial, we filed a motion for a judgment as a matter of law on Cisco’s infringement of the ‘759 patent. On April 11, 2013, in response to our motion, Cisco filed its renewed motion to dismiss as moot its invalidity counterclaims against the claims in our patents that were not asserted in the lawsuit as well as a conditional motion for a new trial on certain limited claims and defenses. We are awaiting the Court’s decision in this matter.  A hearing on VirnetX’s motion for new trial and Cisco’s renewed motion to dismiss as moot its invalidity counterclaims and conditional motion for a new trial was held on June 17, 2013.  We are awaiting the Court’s ruling on these motions.

VirnetX Inc. v. Mitel Networks Corporation et al
On January 12, 2011, we initiated a lawsuit by filing a complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these companies infringe three of our patents. We seek damages and injunctive relief. On April 12, 2011 we again amended our complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, to add Avaya Inc. as a defendant. On July 11, 2012, Mitel Network Corporation signed a license agreement with us and we dismissed the patent infringement case against them. On July 12, 2012 we had a claims construction hearing in this case and a Markman order was issued on August 1, 2012. On January 29, 2013 Siemens signed a license agreement with us and we dismissed the patent infringement case against them. On April 9, 2013, the Court issued a new docket control order in our lawsuit against the remaining defendant Avaya Inc. According to this new order, jury selection is set for September 3, 2013 followed by a jury trial on September 9, 2013. A pretrial conference has been scheduled for August 22, 2013.

VirnetX Inc. v. Apple, Inc.
On November 1, 2011, we initiated a lawsuit against Apple in the United States District Court, Tyler Division, pursuant to which we allege that Apple infringes one or more claims of our U.S. Patent No. 8,051,181. We seek damages and injunctive relief. No hearing or trial dates have been set.  On June 17, 2013 the Court granted VirnetX’s unopposed motion to lift the stay ordered by the Court on December 15, 2011.  On June 18, 2013 the Court granted the parties unopposed motion to consolidate this case with Civil Action No. 6:12-cv-00855-LED.

VirnetX Inc. v. Apple, Inc.
On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013.  On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED.

ITC Investigation No. 337-TA-858
On July 18, 2012, the Administrative Law Judge (ALJ) assigned to investigate our complaint against Apple Inc., identified a procedural discrepancy with our complaint and dismissed it. On September 14, 2012, we re-filed our complaint with the ITC jointly with Science Applications International Corporation (SAIC) [NYSE: SAI] to remove a procedural standing issue that was identified as the reason for dismissal of our previous complaint. On October 16, 2012, the United States International Trade Commission (ITC) accepted our complaint and instituted an investigation against Apple and assigned ALJ E. James Gildea to preside over this investigation. Subsequently on October 23, 2012, ALJ Gildea issued an order setting up February 21, 2014 as the target date for completion of this investigation. The hearing in-front of ALJ Gildea was scheduled for May 20, 2013. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.’s infringement through the district courts.  The ITC case has been terminated.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.

Note 9 — Subsequent Events
 
On August 7, 2013, we signed a Patent License Agreement (the “Agreement”) with Avaya Inc. Under the terms of the Agreement, VirnetX has agreed to license certain of its patents to Avaya, in exchange for multiple payments to VirnetX and an ongoing reasonable royalty for future sales through the expiration of the licensed patents as outlined in the Agreement with respect to certain current and future IP-encrypted products. In further consideration, Avaya has agreed to license certain of its patents to VirnetX for its ongoing Gabriel technology product development.

Under the terms of the Agreement, the Parties have also agreed to dismiss the patent infringement case brought by VirnetX before the U.S. District Court for the Eastern District of Texas. All other aspects of the agreement were not disclosed.

11

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Note About Forward-Looking Statements

Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: “Management’s Discussion and Analysis,” and “Risk Factors.” These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part II, Item 1A of this Form 10-Q). We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.

Company Overview

We develop software and technology solutions for securing real-time communications over the Internet.  Our patented GABRIEL Connection Technology™ combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks. We are currently beta testing our GABRIEL Connection Technology™ as part of our Secure Domain Name Initiative, or (SDNI), on various platforms including PCs, smart phones and tablets. We also intend to establish the exclusive secure domain name registry in the United States and other key markets around the world.

Our portfolio of intellectual property is the foundation of our business model.  We currently own 21 patents in the United States and 41 foreign patents, as well as several pending U.S. and foreign patent applications.  Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry.  Our patented methods also have additional applications in operating systems and network security.   We have submitted  a declaration with the 3rd Generation Partnership Project, or 3GPP, identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3GPP LTE, System Architecture Evolution (SAE) project. We have agreed to make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us. We believe that we are positioned to license our essential security patents to 3GPP members as they move into 4G.

We have an ongoing Gabriel Licensing Program under which we offer licenses to our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. Our Gabriel Connection TechnologyTM License is offered to OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products.  We have developed GABRIEL Connection Technology™ Software Development Kit (SDK) to assist with rapid integration of these techniques into existing software implementations with minimal code changes and include object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement our technology. Customers who want to develop their own implementation of the VirnetX patented techniques for supporting secure domain names, or other techniques that are covered by our patent portfolio for establishing secure communication links, can purchase a patent license. The number of patents licensed, and therefore the cost of the patent license to the customer, will depend upon which of the patents are used in a particular product or service. These licenses will typically include an initial license fee, as well as an ongoing royalty.

We intend to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators.  We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE wireless networks. We also believe that all 4G mobile devices will require unique secure domain names and become part of a secure domain name registry.

In connection with the settlement of our lawsuit against Microsoft Corporation in 2010, Microsoft became our first licensee.  Pursuant to the Settlement and License Agreement between us and Microsoft, Microsoft paid us $200 million, which was recognized as gain on settlement and Microsoft was granted a worldwide, irrevocable, nonexclusive, non-sublicenseable fully paid up license for our patents for Microsoft products. We have Patent License Agreements with Aastra USA, Inc. Mitel Networks Corporation, NEC Corporation and NEC Corporation of America, to license certain of our US patents, for a one-time payment to VirnetX and an ongoing royalty for all future sales through the expiration of the licensed patents with respect to certain current and future IP-encrypted products. We intend to seek further license of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.
12

We have five intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Apple, Inc., Cisco Systems, Inc., and Avaya Inc. infringe on certain of our patents. We seek damages and injunctive relief in all the complaints. We have one complaint pending with the United States International Trade Commission (ITC) against Apple, Inc. On October 31, 2012, a jury trial began regarding our Compliant against Apple. On November 6, 2012, jurors found that Apple infringed four of our patents. (see Legal Proceedings). The jury trial against Cisco was held on March 4, 2013. At the end of the trial, the jury came back with a verdict of non-infringement in the trial. The same jury also found that all our patents-in-suit were valid and enforceable.  We have a motion pending in the court requesting a new trial (see Legal Proceedings). The trial against Avaya is now scheduled for jury selection on September 3, 2013. On February 27, 2013 we filed a motion to withdraw our complaint against Apple in the ITC. On April 22, 2013, the ALJ assigned to investigate our complaint against Apple at the ITC, issued an order with the initial determination granting our motion to terminate the investigation against Apple and denying Apple’s motion for sanctions against us.

Our employees include the core development team behind our patent portfolio, technology and software.  This team has worked together for over ten years and is the same team that invented and developed this technology while working at Science Application International Corporation, or SAIC.  SAIC is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at SAIC and expanded the set of patents we acquired in 2006 from SAIC into a larger portfolio with 62 issued U.S. and foreign patents and numerous pending U.S. and foreign patent applications. This portfolio now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.

We intend to grow our licensing business by offering incentives to early licensing targets or asserting our rights for use of our patents.  We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers, and others) and build our secure domain name registry.

Recent Developments
 
In August 2013 we were granted two new patents by the U.S. Patent and Trademark Office. U.S. Patent No. 8,504,696 (696 Patent) and No. 8,504,697 (697 Patent) System and Method Employing an Agile Network Protocol for Secure Communications Using Secure Domain Names and filed papers with the U.S. District Court for the Eastern District of Texas seeking to add allegations that Apple Inc. defendant in its currently-pending patent infringement lawsuit, VirnetX Inc. et al v. Apple Inc., (Case 6:12-cv-00855-LED) infringes the new '697 patent.

13

Competition

We believe our technology and solutions will compete primarily against various proprietary security solutions.  We group these solutions into three main categories:

Proprietary or home-grown application specific security solutions have been developed by vendors and integrated directly into their products for our target markets including IP-telephony, mobility, fixed-mobile convergence, and unified communications.  These proprietary solutions have been developed due to the lack of standardized approaches to securing real-time communications.  This approach has led to corporate networks that are isolated and, as a result, restrict enterprises to using these next-generation networks within the boundaries of their private network.  These solutions generally do not provide security for communications over the Internet or require network administrators to manually exchange keys and other security parameters with each destination network outside their corporate network boundary.  The cost-savings and other benefits of IP-based real-time communications are significantly limited by this approach to securing real-time communications.

A session border controller, or SBC, is a device used in networks to exert control over the signaling and media streams involved in establishing, conducting and terminating VoIP calls.  A traditional firewall or network address translation, or NAT, device typically block information like endpoint IP addresses and port numbers required by signaling protocols, such as SIP and XMPP, to reach and communicate with their intended destination.  SBCs are used in physical networks to address these limitations and enable real-time session traffic to cross the boundaries created by firewalls and other NAT devices and enable VoIP calls to be established successfully.  However, SBCs must decrypt and analyze every single data packet for the information to be transmitted successfully, thereby preventing end-to-end encryption.  This network design results in SBCs becoming a single point of congestion on the network, as well as a single point of failure.  SBCs are also limited to the physical network they secure.

SIP firewalls, or SIP-aware firewalls, and application layer gateways, manage and protect the traffic, flow and quality of VoIP and other SIP-related communications.  They perform real-time network address translation, dynamic firewall functions; support multiple signaling protocols, and media functionality, allowing secure interconnection and the flow of IP media streams across multiple networks.  While SIP firewalls assist in analyzing SIP traffic transmitted over the corporate network to filter out various threats, they do not necessarily encrypt the traffic.  As a result, this traffic is not entirely secure from end-to-end nor is it protected against threats like man-in-middle and eavesdropping.

New Accounting Pronouncements

In July 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ASU No. 2013-11 is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The new standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The new standard becomes effective for us on January 1, 2014 and will be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted. We are currently assessing the impacts of this new standard.

In February 2013, the FASB issued final guidance on the presentation of reclassifications out of other comprehensive income. The amendments require an entity to provide information about the amounts reclassified out of other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in a footnote, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, only if the amount reclassified is required by GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide detail about those amounts. This amendment was effective for interim and fiscal years beginning after December 15, 2012. The amended standard did not impact our financial position or results of operations.
14

Results of Operation
 
Three and Six Months Ended June 30, 2013
Compared with Three and Six Months Ended June 30, 2012
(in thousands, except per share amounts)

Revenue

We had $6 and $300, in revenue for the three and six months ended June 30, 2013, respectively, and $36, for the three and six months ended June 30, 2012.

For the three and six months ended June 30, 2013, we recognized royalty revenue, as part of settlement agreements entered into with customers during our patent infringement actions (see “Legal Proceedings”).  In accordance with our revenue recognition policy related to a licensee’s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured. In the patent infringement actions, we did not request or receive any amounts allocable to settlement fees, expense reimbursement, damages or any other amount unrelated to historical sales.  Revenue to be earned from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.

Research and Development Expenses

Research and development expenses were $382 and $274 for the three months ended June 30, 2013 and 2012, respectively, representing an increase of $108. Research and development expenses were $686 and $530 for the six months ended June 30, 2013 and 2012, respectively, representing an increase of $156. The increases were primarily due to increased wage and medical costs and share-based compensation expense to our employees.

Selling, General and Administrative Expenses

Selling, general and administrative expenses include management and administrative personnel, as well as outside legal, accounting, and consulting services.

Our selling, general and administrative expenses decreased by $5,294 to $6,202 for the three months ended June 30, 2013, from $11,496 for the three months ended June 30, 2012, and by $2,741 to $15,722 for the six months ended June 30, 2013, from $18,463 for the comparable period in 2012. This decrease is primarily due to a decrease in legal fees of $5,587, for the three months ending June 30, 2013 and $3,839 for the six months ending June 30, 2013, compared to the three months and six months ended June 30, 2012 respectively as a result of the decrease in legal fees associated with our patent infringement actions.  We expect to incur the same levels or increased legal fees over the next two quarters as we enter the final phases in these infringement actions and expect to report losses from operations as a result. See Note 8 of the financial statements for additional information regarding these infringement actions. Management believes our legal expenses will decrease materially after our current court schedule is complete.

 Other Income and Expenses

For the three months ended June 30, 2013, the non-cash loss related to the periodic revaluation of our Series I Warrants liability was $120, which compares to a non-cash loss of $2,248 for the three months ended June 30, 2012, and for the six months ended June 30, 2013, the non-cash gain was $1,486 as compared to the non-cash loss of $1,979 for the six months ended June 30, 2012. The liability for the Series I Warrants decreased to $2,686 at June 30, 2013, from $4,172 at December 31, 2012. The gain from the revaluations of the warrant liability in the six months ended June 30, 2013 was primarily the result of decreases in our common share price during the period.

Interest income decreased by $105 to $23 for the three months ended June 30, 2013, from $128 for the comparable 2012 period, and decreased by $146 to $56 for the six months ended June 30, 2013, from $202 for the six months ended June 30, 2012.
15

Liquidity and Capital Resources

As of June 30, 2013, our cash and cash equivalents totaled approximately $32,878 and our short-term investments totaled approximately $13,382, compared to cash equivalents of approximately $19,661 and short-term investments of approximately $26,493 at December 31, 2012. Working capital was $42,314 at June 30, 2013 and $53,862 at December 31, 2012. The decrease in cash and investments during the periods reported are primarily attributed to costs incurred for legal expenses in defense of our patent infringement actions, and losses incurred during the periods reported.
 
We expect that our cash and cash equivalents and short-term investments as of June 30, 2013, will be sufficient to fund our operations and provide working capital for general corporate purposes and legal expenses for at least the next several years. Over the long term, we expect to derive the majority of our future revenue from license fees and royalties associated with our patent portfolio, technology, software and secure domain name registry in the United States and other markets around the world.

Income Taxes

The income tax expense for the three months ended June 30, 2013 was $354, which was a negative effective income tax rate of 5 percent. The income tax expense for the six months ended June 30, 2013 was $356, which was a negative effective income tax rate of 2.5 percent. As a result of net operating losses during the periods the provision reflects only minimum tax payments and prior year tax true-up.  The tax expense was calculated using the statutory U.S. federal rate primarily as a result of the change of the valuation allowance of $5,695, stock based compensation expense and non-deductible derivative loss. We have valuation allowances covering our deferred tax assets including net operating loss carry-forwards.

The income tax benefit for the three months ended June 30, 2012 was $3,590, which was an effective income tax rate of 26 percent. The income tax benefit for the six months ended June 30, 2012 was $5,763, which was an effective income tax rate of 28 percent.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2013 will not be fully realizable. Accordingly, management has maintained a valuation allowance against our net deferred tax assets at June 30, 2013. The valuation allowance carried against our net deferred tax assets was $11,423 and $6,970 at June 30, 2013 and December 31, 2012, respectively.

At June 30, 2013, we have federal and state net operating loss carry-forwards of approximately $15,527and $52,756 respectively, expiring beginning in 2027 and 2016, respectively.

Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.

Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2013, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.

Contractual Obligations

There have been no material changes to the contractual obligations disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

Off-Balance Sheet Arrangements

None.
16

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Interest Rate Risk

We invest our excess cash primarily in highly liquid instruments including time deposits, money market, and corporate debt securities. We seek to limit the amount of our credit exposure to any one issuer.

Investments in fixed rate instruments carry a degree of interest rate risk. Fixed rate securities may have their fair market value adversely impacted due to a rise in interest rates. Due in part to these factors, our income from investments may decrease in the future.

We considered the historical volatility of short-term interest rates and determined that it was reasonably possible that an adverse change of 100 basis points could be experienced in the near term but would have an immaterial impact in the fair value of our marketable securities, which generally mature within six months of June 30, 2013.

Other Market Risks

We have no obligation to settle our Series I Warrant obligations in cash. However, these derivative instruments are accounted for as liabilities on our consolidated balance sheets and are marked-to-market each period based on their estimated fair value. The non-cash gains or losses from the decreases and increases in the estimated fair value of the warrant liability are recognized in earnings each period. The estimated fair value is determined in large part by reference to our assumptions and estimates of various factors. Our liability will increase by approximately $200 and we may recognize significant non-cash losses, all other factors being constant if the market price of our common shares increases by $1.  Conversely, our liability will decrease by approximately $200 and we may recognize significant non-cash gains, if all other factors being constant, if the market price of our common shares decreases by $1.

We considered the historical volatility of our stock prices and determined that it was reasonably possible that the fair market value of our stock price could increase or decrease substantially in the near term and could have a material impact to our consolidated balance sheets and statement of operations.

 ITEM 4 — CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of June 30, 2013.

The purpose of this evaluation was to determine whether as of June 30, 2013 our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in our filings with the SEC, (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of June 30, 2013, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended June 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
17

PART II — OTHER INFORMATION

ITEM 1 — LEGAL PROCEEDINGS

We have five intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints. We have one complaint with the United States International Trade Commission (ITC) alleging that Apple, Inc. has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.’s infringement through the district courts.  The ITC case has been terminated.
 
VirnetX Inc. et al., v. Microsoft Corporation
On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274.  We seek damages and injunctive relief.  No hearing or trial dates have been set.

VirnetX Inc. v. Cisco Systems, Inc. et al and VirnetX Inc. v. Apple Inc. (Severed Case)
On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief. On February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we again amended our complaint against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to include Apple’s iPad 2 in the list of Apple products that are accused of infringing our patents. We also asserted our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC have signed license agreements with us and we have agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to postpone the trial against Cisco to March 4, 2013 and just try the case against Apple. On November 6, 2012, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368,000 in a verdict against Apple Corporation for infringing four of our patents. A post-trial hearing in the case against Apple was held on December 20, 2012. On February 26, 2013, the United States District Court for the Eastern District of Texas, Tyler Division issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict. The Court denied Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict. Additionally, the Court granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. Specifically, the Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction. In doing so, the Court ordered the parties to mediate over a license in the following 45 days for Apple’s future infringing use not covered by the Court’s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court’s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are “not colorably different” with regards to the accused functionality. However, the judgment may be appealed and no assurances can be given as to when or if we will receive any proceeds in connection with these matters, and accordingly there has been no recognition of the jury awards or royalties in our accompanying financial statements. Under our agreements with Science Applications International Corporation (SAIC), we would pay to SAIC 25% of the proceeds obtained by us in this lawsuit against Apple after reduction for attorneys’ fees and costs incurred in litigating those claims. We are awaiting the Court’s decision in this matter.  On July 1, 2013, the Court entered an Order setting a hearing on VirnetX’s motion for an ongoing royalty for August 15, 2013.  On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit.

The jury trial against Cisco was held on March 4, 2013. At the end of the trial, the jury came back with a verdict of non-infringement in the trial. The same jury also found that all our patents-in-suit were valid and enforceable. On April 3, 2013, we filed a request for a new trial regarding Cisco’s infringement of four of our patents based primarily on our allegations of Cisco’s inappropriate conduct and arguments during the jury trial that concluded on March 14, 2013. In addition to the request for a new trial, we filed a motion for a judgment as a matter of law on Cisco’s infringement of the ‘759 patent. On April 11, 2013, in response to our motion, Cisco filed its renewed motion to dismiss as moot its invalidity counterclaims against the claims in our patents that were not asserted in the lawsuit as well as a conditional motion for a new trial on certain limited claims and defenses. We are awaiting the Court’s decision in this matter.  A hearing on VirnetX’s motion for new trial and Cisco’s renewed motion to dismiss as moot its invalidity counterclaims and conditional motion for a new trial was held on June 17, 2013.  We are awaiting the Court’s ruling on these motions.
18

VirnetX Inc. v. Mitel Networks Corporation et al
On January 12, 2011, we initiated a lawsuit by filing a complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these companies infringe three of our patents. We seek damages and injunctive relief. On April 12, 2011 we again amended our complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, to add Avaya Inc. as a defendant. On July 11, 2012, Mitel Network Corporation signed a license agreement with us and we dismissed the patent infringement case against them. On July 12, 2012 we had a claims construction hearing in this case and a Markman order was issued on August 1, 2012. On January 29, 2013 Siemens signed a license agreement with us and we dismissed the patent infringement case against them. On April 9, 2013, the Court issued a new docket control order in our lawsuit against the remaining defendant Avaya Inc. According to this new order, jury selection is set for September 3, 2013 followed by a jury trial on September 9, 2013. A pretrial conference has been scheduled for August 22, 2013.

VirnetX Inc. v. Apple, Inc.
On November 1, 2011, we initiated a lawsuit against Apple in the United States District Court, Tyler Division, pursuant to which we allege that Apple infringes one or more claims of our U.S. Patent No. 8,051,181. We seek damages and injunctive relief. No hearing or trial dates have been set.  On June 17, 2013 the Court granted VirnetX’s unopposed motion to lift the stay ordered by the Court on December 15, 2011.  On June 18, 2013 the Court granted the parties unopposed motion to consolidate this case with Civil Action No. 6:12-cv-00855-LED.

VirnetX Inc. v. Apple, Inc.
On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013.  On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED.

ITC Investigation No. 337-TA-858
On July 18, 2012, the Administrative Law Judge (ALJ) assigned to investigate our complaint against Apple Inc., identified a procedural discrepancy with our complaint and dismissed it. On September 14, 2012, we re-filed our complaint with the ITC jointly with Science Applications International Corporation (SAIC) [NYSE: SAI] to remove a procedural standing issue that was identified as the reason for dismissal of our previous complaint. On October 16, 2012, the United States International Trade Commission (ITC) accepted our complaint and instituted an investigation against Apple and assigned ALJ E. James Gildea to preside over this investigation. Subsequently on October 23, 2012, ALJ Gildea issued an order setting up February 21, 2014 as the target date for completion of this investigation. The hearing in-front of ALJ Gildea was scheduled for May 20, 2013. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.’s infringement through the district courts.  The ITC case has been terminated.
 
One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.
19

ITEM 1A — RISK FACTORS

You should carefully consider the following material risks in addition to the other information set forth in this Quarterly Report on Form 10-Q, as well as our Annual Form 10-K filed March 1, 2013 before making any investment in our common stock.  The risks and uncertainties described below are not the only ones we face.  Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business.  If any of these risk factors occurs, you could lose substantial value or your entire investment in our shares.

Risks Related to Our Business and Our Financial Reporting

We may not be able to capitalize on market opportunities related to our licensing strategy or our patent portfolio.

Our business strategy includes licensing our patents and technology to other companies in order to reach a larger end-user base than we could reach through direct sales and marketing efforts; as such, our business strategy and revenues will depend on intellectual property licensing fees and royalties for the majority of our revenues.  We currently derive minimal revenue from licensing activities and we cannot assure you that we will successfully capitalize on our market opportunities or that our current business strategy will succeed.  Factors that may affect our ability to execute our current business strategy including, but are not limited to:

Although we have to date entered into a limited number of settlement and license agreements, we may not be successful in entering into further licensing relationships and existing settlement and license agreements may not generate the financial results we expect;

Third parties may challenge the validity of our patents;

The pendency of our various litigations may cause potential licensees not to do business with us;

We face, and we expect to continue to face, intense competition from new and established competitors who may have superior products and services or better marketing, financial or other capacities than we do; and

It is possible that one or more of our potential customers or licensees develops or otherwise sources products or technologies similar to, competitive with or superior to ours.

If we are not able to adequately protect our patent rights, our business would be negatively impacted.

We believe our patents are valid, enforceable and valuable.  Notwithstanding this belief, third parties may make claims of infringement or invalidity claims with respect to our patents and such claims could give rise to material cost for defense or settlement or both, jeopardize or substantially delay a successful outcome of litigation we are or may become involved in, divert resources away from our other activities, limit or cease our revenues related to such patents, or otherwise materially and adversely affect our business.  Similar challenges could also prevent us from obtaining additional patents in the future.  Even if we are successful in enforcing our rights, our patents may not ultimately provide us with any competitive advantages and may be less valuable than we currently expect.  These risks may be heightened in countries other than the United States where laws regarding patent protection are less developed, and may be negatively affected by the fact that legal standards in the United States and elsewhere for protection of intellectual property rights in Internet-related businesses are uncertain and still evolving.  In addition, there are a significant number of United States and foreign patents and patent applications in our areas of interest, and we expect that significant litigation in these areas will continue, and will add uncertainty to the value of certain patents and other intellectual property rights in our areas of interest.  If we are unable to protect our intellectual property rights or otherwise realize value from them, our business would be negatively affected.

We are involved and will continue to be involved in numerous litigation matters defending our patent portfolio, which can be time-consuming and costly and we cannot anticipate the results.

We spend a significant amount of our financial and management resources to pursue our current litigation matters.  We believe that these litigation matters and others that we may in the future determine to pursue could continue for years and continue to consume significant financial and management resources.  The counterparties to our litigation are all large, well-financed companies with substantially greater resources than us.  We cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us.  In addition, even if we obtain favorable interim rulings or verdicts in particular litigation matters, they may not be predictive of the ultimate resolution of the dispute. Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend.  Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse effects, which could encumber our ability to develop and commercialize products.
20

We can provide no assurances that the licensing of our essential security patents under FRAND will be successful.

At the request of the European Telecommunications Standards Institute (ETSI), and the Alliance for Telecommunications Industry Solutions (ATIS), we agreed to update our licensing declaration to ETSI and ATIS under their respective Intellectual Property Rights (IRP) policies.  This was in response to our Statement of Patent Holder identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3rd Generation Partnership Project (3GPP) Long Term Evolution (LTE), Systems Architecture Evolution (SAE) project.  We will make available a non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms and conditions, with compensation) for the patents identified by VirnetX that are or become essential, to applicants desiring to implement the Technical Specifications identified by VirnetX, as set forth in the updated licensing declaration under the ATIS and ETSI IPR policies. Our licensing declarations under the ATIS and ETSI IPR policies may limit our flexibility in determining royalties and license terms for certain of our patents.  Consequently, we cannot assure you that the licensing of the essential security patents will be successful or that third parties will be willing to enter into licenses with VirnetX on reasonable terms or at all, which could have an adverse effect on our business and harm our competitive position.

Because our business is conducted or expected to be conducted in an environment that is subject to rapid change, we may be subject to various developments in regulation, law and consumer preferences to which we may not be able to adapt successfully.

The current regulatory environment for our products and services remains unclear.  We can give no assurance that our planned product offerings will be in compliance with laws and regulations of local, state, United States federal or foreign authorities.  Further, we can give no assurance that we will not unintentionally violate such laws or regulations or that such laws or regulations will not be modified, or that new laws or regulations will be enacted in the future which would cause us to be in violation of such laws or regulations.  For example, Voice-over-Internet Protocol (or VoIP) services are not currently subject to all of the same regulations that apply to traditional telephony, but it is possible that similar regulations may be applied to VoIP in the future and that these could result in substantial costs which adversely affect the marketability of our products and planned products related to VoIP.  For further example, the use of the Internet and private Internet Protocol (IP) networks for communication is largely unregulated within the United States, but may become regulated in the future; also several foreign governments have enacted measures that could restrict or prohibit voice communications services over the Internet or private IP networks.

Our business depends on the growth of instant messaging, VoIP, mobile services, streaming video, file transfer and remote desktop and other next-generation Internet-based applications which are relatively new.  A decline in the use of these applications due to complexity or cost of these applications relative to alternate traditional or newly developed communications channels, or development of alternative technologies, could cause a material decline in the number of users in these areas.

More aggressive domestic or international regulation of the Internet in general, and Internet telephony providers and services specifically or a lack of growth in acceptance of the Internet as a long term viable marketplace for communications services may materially and adversely affect our business, financial condition, operating results and future prospects.

Our exposure to outside influences beyond our control, including new legislation, court rulings or actions by the United States Patent and Trademark Office, could adversely affect our licensing and enforcement activities and results of operations.

Our licensing and enforcement activities are subject to numerous risks from outside influences, including the following:

New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue. For instance, the United States Supreme Court has recently modified some tests used by the United States Patent and Trademark Office (USPTO) in granting patents during the past 20 years which may decrease the likelihood that we will be able to obtain patents and increase the likelihood of challenge of any patents we obtain or license.  In addition, the United States recently enacted sweeping changes to the United States patent system under the Leahy-Smith America Invents Act (“AIA”), including changes that transition the United States from a “first-to-invent” system to a “first to file” system and alter the processes for challenging issued patents.

More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.

Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.

As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.
21

If we experience security breaches, we could be exposed to liability and our reputation and business could suffer.

We expect to retain certain confidential customer information in our secure data centers and secure domain name registry.  It will be critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure.  Our secure domain name registry operations will also depend on our ability to maintain our computer and telecommunications equipment in effective working order and to reasonably protect our systems against interruption, and potentially depend on protection by other registrars in the shared registration system.  The secure domain name servers that we will operate will be critical hardware to our registry services operations.  Therefore, we expect to have to expend significant time and money to maintain or increase the security of our facilities and infrastructure. Security technologies are constantly being tested by computer professionals, academics and “hackers.” Advances in the techniques for attacking security solutions could make some or all of our products obsolete or unmarketable.  Likewise, if any of our products are found to have significant security vulnerabilities, then we may need to dedicate engineering and other resources to eliminate the vulnerabilities and to repair or replace products already sold or licensed to our customers.  Despite our security measures, our infrastructure may be vulnerable to physical break-ins, computer viruses, attacks by hackers or similar disruptive problems.  It is possible that we may have to expend additional financial and other resources to address such problems.  Any physical or electronic break-in or other security breach or compromise of the information stored at our secure data centers and domain name registration systems may jeopardize the security of information stored on our premises or in the computer systems and networks of our customers.  In such an event, we could face significant liability and customers could be reluctant to use our services.  Such an occurrence could also result in adverse publicity and therefore adversely affect the market’s perception of the security of electronic commerce and communications over IP networks as well as the security or reliability of our services.

A security breach could require a substantial amount of expense to rectify and could result in a product liability claim that causes us to incur substantial liability and related legal and other costs.  A security breach may also harm our reputation and make it more difficult or impossible for us to successfully market to others.  These matters could harm our operating results and financial condition.

We expect that we will experience long and unpredictable sales cycles, which may impact our operating results.

We expect that our sales cycles will be long and unpredictable due to a number of uncertainties such as:

The need to educate potential customers about our patent rights and our product and service capabilities;

Customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;

Customers’ budgetary constraints;

The timing of customers’ budget cycles; and

Delays caused by customers’ internal review processes.

Long sales cycles may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.

We expect that we will be substantially dependent on a concentrated number of customers.  If we are unable to establish, maintain or replace our relationships with customers and develop a diversified customer base, our revenues may fluctuate and our growth may be limited.

We expect that in the future, a significant portion of our revenues will be generated from a limited number of customers. There can be no guarantee that we will be able to obtain additional customers, or if we do so, to sustain our revenue levels from these prospective customers.  If we are not able to establish, maintain or replace the limited group of prospective customers that we anticipate may generate a substantial majority of our revenues in the future, or if they do not generate revenues at the levels or at the times that we anticipate, our ability to maintain or grow our revenues will be adversely affected.

Our products are highly technical and may contain undetected errors, which could cause harm to our reputation and adversely affect our business.

Our products are highly technical and complex and, when deployed, may contain errors or defects.  Despite testing, some errors in our products may only be discovered after a product has been installed and used by customers.  Any errors or defects discovered in our products after commercial release could result in failure to achieve market acceptance, loss of revenue or delay in revenue recognition, loss of customers and increased service and warranty cost, any of which could adversely affect our business, operating results and financial condition.  In addition, we could face claims for product liability, tort or breach of warranty, including claims relating to changes to our products made by our channel partners.  The performance of our products could have unforeseen or unknown adverse effects on the networks over which they are delivered as well as on third-party applications and services that utilize our services, which could result in legal claims against us, harming our business.  Furthermore, we expect to provide implementation, consulting and other technical services in connection with the implementation and ongoing maintenance of our products, which typically involves working with sophisticated software, computing and communications systems.  We expect that our contracts with customers will contain provisions relating to warranty disclaimers and liability limitations, which may not be upheld.  Defending a lawsuit, regardless of its merit, is costly and may divert management’s attention and adversely affect the market’s perception of us and our products.  In addition, if our business liability insurance coverage proves inadequate or future coverage is unavailable on acceptable terms or at all, our business, operating results and financial condition could be adversely impacted.
22

Malfunctions of third-party communications infrastructure, hardware and software expose us to a variety of risks we cannot control.

Our business will depend upon, among other things, the capacity, reliability and security of the infrastructure owned by third parties that we will use to deploy our offerings.  We have no control over the operation, quality or maintenance of a significant portion of that infrastructure or whether or not those third parties will upgrade or improve their equipment.  We depend on these companies to maintain the operational integrity of our connections.  If one or more of these companies is unable or unwilling to supply or expand its levels of service to us in the future, our operations could be severely interrupted.  Also, to the extent the number of users of networks utilizing our future products suddenly increases, the technology platform and secure hosting services which will be required to accommodate a higher volume of traffic may result in slower response times or service interruptions.  System interruptions or increases in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users.  In addition, users depend on real-time communications; outages caused by increased traffic could result in delays and system failures.  These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

System failure or interruption or our failure to meet increasing demands on our systems could harm our business.

The success of our license and service offerings will depend on the uninterrupted operation of various systems, secure data centers and other computer and communication networks that we establish.  To the extent the number of users of networks utilizing our future products suddenly increases, the technology platform and hosting services which will be required to accommodate a higher volume of traffic may result in slower response times, service interruptions or delays or system failures.  Our systems and operations will also be vulnerable to damage or interruption from:

power loss, transmission cable cuts and other telecommunications failures;

damage or interruption caused by fire, earthquake, and other natural disasters;

computer viruses or software defects; and

physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.

System interruptions or failures and increases or delays in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users.  These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

Any significant problem with our systems or operations could result in lost revenue, customer dissatisfaction or lawsuits against us.  A failure in the operation of our secure domain name registration system could result in the inability of one or more registrars to register and maintain secure domain names for a period of time.  A failure in the operation or update of the master directory that we plan to maintain could result in deletion or discontinuation of assigned secure domain names for a period of time.  The inability of the registrar systems we establish, including our back office billing and collections infrastructure, and telecommunications systems to meet the demands of an increasing number of secure domain name requests could result in substantial degradation in our customer support service and our ability to process registration requests in a timely manner.

Our ability to sell our solutions will be dependent on the quality of our technical support, and our failure to deliver high-quality technical support services could have a material adverse effect on our sales and results of operations.

If we do not effectively assist our customers in deploying our products, succeed in helping our customers quickly resolve post-deployment issues and provide effective ongoing support, or if potential customers perceive that we may not be able achieve to the foregoing, our ability to sell our products would be adversely affected, and our reputation with potential customers could be harmed.  In addition, as we expand our operations internationally, our technical support team will face additional challenges, including those associated with delivering support, training and documentation in languages other than English.  Our failure to deliver and maintain high-quality technical support services to our customers could result in customers choosing to use our competitors’ products instead of ours in the future.
23

Telephone carriers have petitioned governmental agencies to enforce regulatory tariffs, which, if granted, would increase the cost of online communication, and such increase in cost may impede the growth of online communication and adversely affect our business.

Use of the Internet has over-burdened existing telecommunications infrastructures, and many high traffic areas have begun to experience interruptions in service.  As a result, certain local telephone carriers have petitioned governmental agencies to enforce regulatory tariffs on IP telephony traffic that crosses over their traditional telephone networks.  If the relief sought in these petitions is granted, the costs of communicating via online could increase substantially, potentially adversely affecting the growth in the use of online secure communications.  Any of these developments could have an adverse effect on our business.

The departure of Kendall Larsen, our Chief Executive Officer and President, and/or other key personnel could compromise our ability to execute our strategic plan and may result in additional severance costs to us.

Our success largely depends on the skills, experience and efforts of our key personnel, including Kendall Larsen, our Chief Executive Officer and President.  We have no employment agreements with any of our key executives that prevent them from leaving us at any time.  In addition, we do not maintain key person life insurance for any of our officers or key employees.  The loss of Mr. Larsen, or our failure to retain other key personnel, would jeopardize our ability to execute our strategic plan and materially harm our business.

We will need to recruit and retain additional qualified personnel to successfully grow our business.

Our future success will depend in part on our ability to attract and retain qualified operations, marketing and sales personnel as well as engineers.  Inability to attract and retain such personnel could adversely affect our business.  Competition for engineering, sales, marketing and executive personnel is intense, particularly in the technology and Internet sectors and in the regions where our facilities are located.  We can provide no assurance that we will attract or retain such personnel.

The fair value of accounting for our Series I Warrants as derivative liabilities may materially impact our results of our operations in future periods.

We record the Series I Warrants as a derivative liability in accordance with ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity.”  These derivative liabilities are reported at fair value each reporting period with changes in the fair value recognized as gain or loss during each reporting period.  An increase in our share price or measure of our share price volatility, for example, will generally result in an increase in the fair value of our warrant liability and a non-cash charge during the period of such increase, which could materially and negatively impact our results of operations in future periods.

We may identify future material internal control weaknesses which may result in late filings, increased costs or declines in our share price.

Although we believe that we currently maintain effective control over our disclosures and procedures and internal control over financial reporting, we may in the future identify deficiencies regarding the design and effectiveness of our system of internal control over financial reporting.   If we experience any material weaknesses in our internal control over financial reporting the future or are unable to provide unqualified management or attestation reports about our internal controls, we may be unable to meet financial and other reporting deadlines and may incur costs associated with remediation, and any of which could cause our share price to decline.

Risks Related to Our Stock

We do not currently pay dividends on our common stock and thus stockholders must look to appreciation of our common stock to realize a gain on their investments.

Although we paid a special cash dividend to holders of our common stock with a record date of July 1, 2010, we do not currently pay regular dividends on our common stock and instead, retain future earnings to fund our business plan.  Our future dividend policy is within the discretion of our Board of Directors and will depend upon various factors, including our business, financial condition, results of operations, capital requirements, and investment opportunities.  We therefore can’t assure you that our Board of Directors will determine to pay regular or special dividends in the future. Accordingly, unless our Board of Directors determines to pay dividends, stockholders will be required to look to appreciation of our common stock to realize a gain on their investment.  This appreciation may not occur.

The exercise of our outstanding stock options would result in a dilution of our current stockholders' voting power and an increase in the number of shares eligible for future resale in the public market which may negatively impact the market price of our stock.

The exercise of our outstanding vested stock options would dilute the ownership interests of our existing stockholders. As of June 30, 2013, we had outstanding options to purchase an aggregate of 5,009,849 shares of common stock representing 9.8% of our total shares outstanding as of June 30, 2013, of which 4,262,724 are vested and therefore exercisable. To the extent outstanding stock options are exercised, additional shares of common stock will be issued, and such issuance would dilute non-exercising stockholders' percentage voting interests and increase the number of shares eligible for resale in the public market.
24

Trading in our common shares is limited and the price of our common shares may be subject to substantial volatility, particularly in light of the instability in the financial and capital markets.

Our common stock is listed on NYSE MKT.  Over the past years the market price of our common stock has experienced significant fluctuations.  Between July 1, 2012, and June 30, 2013, the reported last sale price on NYSE MKT for our common stock ranged between $16.45 and $40.47 per share.  The price of our common stock may continue to be volatile as a result of a number of factors, some of which are beyond our control. These factors include, but not limited to, the following:

 
developments in any then-outstanding litigation;

 
quarterly variations in our operating results;

 
large purchases or sales of common stock or derivative transactions related to our stock;

 
actual or anticipated announcements of new products or services by us or competitors;

 
general conditions in the markets in which we compete; and

 
general economic and financial conditions.

In addition, we believe there has been and may continue to be substantial off-market transactions in derivatives of our stock, including short selling activity or related similar activities, which are beyond our control and which may be beyond the full control of the SEC and Financial Institutions Regulatory Authority ("FINRA"). While SEC and FINRA rules prohibit some forms of short selling and other activities that may result in stock price manipulation, such activity may nonetheless occur without detection or enforcement. We have held conversations with regulators concerning trading activity in our stock; however, there can be no assurance that should there be any illegal manipulation in the trading of our stock it will be detected, prosecuted or successfully eradicated. Significant short selling or other types of market manipulation could cause our stock trading price to decline, to become more volatile, or both.

The market price of our common stock may decline because our operating results may not be consistent and may be difficult to predict.

Our reported net income has fluctuated in the past due to several factors. We expect that our future operating results may also fluctuate due to the same or similar factors.  We had net income of $41.4 million for the year ended December 31, 2010, a net loss of $17.3 million for the year ended December 31, 2011, a net loss $26.9 million for the year ended December 31, 2012 and a net loss $14.9 million for the six months ended June 30, 2013 with an accumulated deficit of $77.8 million. The following include some of the factors that may cause our operating results to fluctuate:

· the outcome of actions to enforce our intellectual property rights currently in progress or that we may undertake in the future, and the timing thereof;

· the amount and timing of receipt of license fees from potential infringers, licensees or customers;

· the rate of adoption of our patented technologies;

· the number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations, expiration date etc;

· the success of a licensee in selling products that use our patented technologies; and

· the amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual property rights.
25

These fluctuations may make our business particularly difficult to manage, adversely affect our business and operating results, make our operating results difficult for investors to predict and, further, cause our results to fall below investor’s expectations and adversely affect the market price of our common stock.

Because ownership of our common stock is concentrated, investors may have limited influence on stockholder decisions.

As of June 30, 2013, our executive officers and directors beneficially owned approximately 20% of our then outstanding common stock.  In addition, a group of stockholders that, as of December 31, 2007, held 4,766,666 shares, or approximately 12%, of our then outstanding common stock, have entered into a voting agreement with us that requires them to vote all of their shares of our voting stock in favor of the director nominees approved by our Board of Directors at each director election going forward, and in a manner that is proportional to the votes cast by all other voting shares as to any other matters submitted to the stockholders for a vote.  However, we cannot be certain how many shares of our common stock this group of stockholders currently owns.  Because of their beneficial ownership interest, our officers and directors could significantly influence stockholder actions of which you disapprove or that are contrary to your interests.  This ability to exercise significant influence could prevent or significantly delay another company from acquiring or merging with us.

Our protective provisions could make it difficult for a third party to successfully acquire us even if you would like to sell your stock to them.

We have a number of protective provisions that could delay, discourage or prevent a third party from acquiring control of us without the approval of our Board of Directors.  Our protective provisions include:

A staggered Board of Directors: This means that only one or two directors (since we have a five-person Board of Directors) will be up for election at any given annual meeting.  This has the effect of delaying the ability of stockholders to effect a change in control of us because it would take two annual meetings to effectively replace a majority of the Board of Directors.

Blank check preferred stock: Our Board of Directors has the authority to establish the rights, preferences and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock.  Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to you.  In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors.  We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without stockholder approval.

Advance notice requirements for director nominations and for new business to be brought up at stockholder meetings : Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form in order to have the matter voted on at a stockholder meeting.  This has the effect of giving our Board of Directors and management more time to react to stockholder proposals generally and could also have the effect of disregarding a stockholder proposal or deferring it to a subsequent meeting to the extent such proposal is not raised properly.

No stockholder actions by written consent: No stockholder or group of stockholders may take actions rapidly and without prior notice to our Board of Directors and management or to the minority stockholders.  Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions.

Super majority requirement for stockholder amendments to the By-laws: Stockholder proposals to alter or amend our By-laws or to adopt new By-laws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.

No ability of stockholders to call a special meeting of the stockholders: Only the Board of Directors or management can call special meetings of the stockholders.  This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.

In addition, the provisions of Section 203 of the Delaware General Corporate Law govern us.  These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.

These and other provisions in our amended and restated certificate of incorporation, our By-laws and under Delaware law could discourage potential takeover attempts, reduce the price that investors might be willing to pay for shares of our common stock in the future and result in the market price being lower than it would be without these provisions.

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Not applicable
26

ITEM 6 — E XHIBITS.

Exhibit Number
Description
 
 
31.1
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
31.2
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
32.1*
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
32.2*
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
101**
Interactive Data Files
 

* This exhibit is furnished herewith, but not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. Such certifications will not be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except to the extent that we explicitly incorporate them by reference.
27

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
VIRNETX HOLDING CORPORATION
 
 
 
 
 
By:
/s/ Kendall Larsen
 
 
Name
Kendall Larsen
 
 
 
 
 
 
Title
Chief Executive Officer (Principal Executive Officer)
 
 
 
 
 
By:
/s/ Richard Nance
 
 
Name
Richard H. Nance
 
 
 
 
 
 
Title
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
 
 
 
 
Date: August 09, 2013
 
 
 

28

EXHIBIT INDEX

Exhibit  Number
Description
 
 
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
101**
Interactive Data Files
 

* This exhibit is furnished herewith, but not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. Such certifications will not be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except to the extent that we explicitly incorporate them by reference.
 
 
29

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

EXHIBIT 31.1
 
CERTIFICATIONS

I, Kendall Larsen, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of VirnetX Holding Corporation for the quarter ended June 30, 2013;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
 
(Principal Executive Officer)

Date: August 9, 2013
 
 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Richard H. Nance, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of VirnetX Holding Corporation for the quarter ended June 30, 2013;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
/s/ Richard H. Nance
 
Richard H. Nance
 
Chief Financial Officer
 
(Principal Financial Officer and Principal Accounting Officer)

Date: August 9, 2013
 
 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of VirnetX Holding Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2013 as filed with the Securities and Exchange Commission on August 9, 2012 (the “Report”), I, Kendall Larsen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
 
(Principal Executive Officer)

Date: August 9, 2013
 
 

EX-32.2 5 ex32_2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of VirnetX Holding Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2013 as filed with the Securities and Exchange Commission on August 9, 2012 (the “Report”), I, Richard H. Nance, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 
/s/ Richard H. Nance
 
Richard H. Nance
 
Chief Financial Officer
 
(Principal Financial Officer and Principal Accounting Officer)

Date: August 9, 2013
 
 

GRAPHIC 6 image0.jpg begin 644 image0.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`*2FLX7J:C+NV=JX]S42FD%B;-,:1%ZL!]:C\EW^_(?H*06FG.3+#W'<5D\7B*#_`'T;KNA\D9?"S;'2CBH;>X2X MB$B'@BG[J]"-2,XJ4=4S)^[HQQ(`R2!CUI%E1CA75CZ`TDT2SQ-%(NY'&&'J M*\D\-6J>#_C+?Z1/+,;;48/-L#+(6"^JC-:@>O$X&2<"FB1'X5U;Z&H[MXH[ M.:2X($*H3)GIM`YKA_AIHB6]C>ZW^]#:C.[PI(Y81Q9^4`&@#O=HSG'-*!6- MX>_MT6MQ_;Q@\_SV\GR.GEY^7/O6SFE9`+1244P%HI,\T9H`6F&6,$@R(".Q M:H(]0M9K^:QCG1KF%0TD8/*`],UP/Q1\#R:WHTNIZ1)/%JMM^\VQR$"=1U4@ M&@#T;<,9R,>M1DQRY4.K<=`$?ZO&X#TK1V^PJ M../$KN>IJ7FN;#TO9PY2I.[N133I`H9SP2`,=S7GGQ>TNX.B6?B2P3_3M%G$ M^1U,>?F%=!K^I_9_%.@V+MMCG=V^K`<5T%W;17UG/:S*&BF0HX/H1BNJX.-D MGW.+U_7(_$GA;2+/3Y<2:\54%3]V/JY_I78&Q2#2?L5LY@1(?+C9.J8&`17G M?PP\$ZCX?U#4'U4LT5I*\.FJW(6(G)(^M>EW+F.VD=49R%)"KU/'04$GFOPG M>^U/PMK<-UJ5S).+^6(7#-EP!T(K!\!^'=3\56>J&\\3:DGV'576)HWY;:?X MO4'TKH_AE9:OX?T_5[74M(N(7FN9;J(Y!#`]%^M.^%UAJ^B+JMMJFDSVWVR] MDN8Y"05"MV/O0!F7%CJ3?&I=+.O7QLI;`R-'OZ>P]/K5F_@N/`OQ!T!-/O[J M73M7D:">UGD+A6`R&4GI4]U;:POQ?37ET6Y?38[7[*95(R3GJ!Z5-X_T_5KW MQ/X8O=.TN:ZBTZ<$^E>O1QQ6-FJ;]L,*J^&?B/KNI?V5<7 MMEJJ1F*2WP=C+V8?UJ;QC>>(=6AM=+M-"NA93.O]H2HXW>7W5?7WH`X"22#P M[\08?&B:=CPO>W1B'/"2=/.V]`">AKWZ*1)8ED1@R.`RL.X-8>LZ%8:GX/GT MF2RW6IM]J0*.5P/EQ[US/PPD\3Z9I2:)XATR=$@R+:Z9@]`'HM%':BF M!Q/Q&T&ZU/2H+_3<_P!H:>_G0@=3CJ*;X.^(-AK]LMM=N+74D^62&3@D^U=J MPR.E<5XF^&FDZ_*UW%NL[[.1-#QD^XK.2:?-$ZZ52G*'LZOR9VP8'H:7->41 MZ+\1O#IVV&H0ZE;IT67KCTJR/'/B^R`74?"L))GIU'XU MYXGQ(OBOS^$]5!]DJS#X\U*Y&(?"FI;CTW@+5$&XU"TM%[K#'N./J:.8ETK;M'3LZH"S,%'J35&75[ M-3A)?.?IMB^8U1C\,Q/@WUWT@M8PL$*1J.RC%/4AJ*\R. M.2ZFY,8A3_:Y:K8Z48I:9(8HHHH`.U%%%`"4444`%%%%`!^%%%%`!1110`44 144`%%%%`!1110`4M%%`'_]D_ ` end EX-101.INS 7 vhc-20130630.xml XBRL INSTANCE DOCUMENT 0001082324 2013-01-01 2013-06-30 0001082324 2013-08-03 0001082324 2013-06-30 0001082324 2012-06-30 0001082324 2012-12-31 0001082324 2011-12-31 0001082324 2013-04-01 2013-06-30 0001082324 2012-04-01 2012-06-30 0001082324 2012-01-01 2012-06-30 0001082324 us-gaap:WarrantMember vhc:SeriesIWarrantsMember 2013-06-30 0001082324 2012-01-01 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:PortionAtFairValueFairValueDisclosureMember 2013-06-30 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember us-gaap:CertificatesOfDepositMember 2013-06-30 0001082324 vhc:UnrealizedGainsMember us-gaap:FairValueInputsLevel1Member 2013-06-30 0001082324 vhc:UnrealizedLossesMember us-gaap:FairValueInputsLevel1Member 2013-06-30 0001082324 us-gaap:CertificatesOfDepositMember vhc:UnrealizedLossesMember us-gaap:FairValueInputsLevel1Member 2013-06-30 0001082324 us-gaap:FairValueInputsLevel1Member vhc:UnrealizedGainsMember us-gaap:CertificatesOfDepositMember 2013-06-30 0001082324 us-gaap:FairValueInputsLevel1Member vhc:CorporateDebtSecuritiesRatedaaMember us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2013-06-30 0001082324 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member us-gaap:PortionAtFairValueFairValueDisclosureMember 2013-06-30 0001082324 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2013-06-30 0001082324 us-gaap:FairValueInputsLevel1Member vhc:UnrealizedGainsMember us-gaap:CertificatesOfDepositMember 2012-12-31 0001082324 vhc:CorporateBondsRatedbaaMember vhc:UnrealizedGainsMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 vhc:CorporateBondsRatedbaaMember us-gaap:PortionAtFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member vhc:CorporateDebtSecuritiesRatedaaMember vhc:UnrealizedGainsMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member vhc:UnrealizedLossesMember vhc:CorporateDebtSecuritiesRatedaaMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2012-12-31 0001082324 us-gaap:PortionAtFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 vhc:UnrealizedLossesMember us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember vhc:UnrealizedLossesMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:PortionAtFairValueFairValueDisclosureMember vhc:CorporateDebtSecuritiesRatedaaMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member vhc:UnrealizedLossesMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:PortionAtFairValueFairValueDisclosureMember us-gaap:CorporateBondSecuritiesMember 2012-12-31 0001082324 vhc:CorporateBondsRatedbaaMember us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 vhc:CorporateBondsRatedbaaMember us-gaap:FairValueInputsLevel1Member vhc:UnrealizedLossesMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:PortionAtFairValueFairValueDisclosureMember vhc:CorporateDebtSecuritiesRatedSingleaMember 2012-12-31 0001082324 vhc:UnrealizedGainsMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember vhc:CorporateDebtSecuritiesRatedSingleaMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember us-gaap:PortionAtFairValueFairValueDisclosureMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel1Member vhc:CorporateDebtSecuritiesRatedSingleaMember vhc:UnrealizedLossesMember 2012-12-31 0001082324 vhc:UnrealizedGainsMember vhc:CorporateDebtSecuritiesRatedSingleaMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 vhc:UnrealizedGainsMember us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateBondSecuritiesMember 2012-12-31 0001082324 us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member vhc:CorporateDebtSecuritiesRatedaaMember 2012-12-31 0001082324 vhc:UnrealizedGainsMember vhc:CorporateDebtSecuritiesRatedaaMember us-gaap:FairValueInputsLevel1Member 2013-06-30 0001082324 us-gaap:FairValueInputsLevel1Member vhc:CorporateDebtSecuritiesRatedaaMember us-gaap:PortionAtFairValueFairValueDisclosureMember 2013-06-30 0001082324 vhc:UnrealizedLossesMember vhc:CorporateDebtSecuritiesRatedaaMember us-gaap:FairValueInputsLevel1Member 2013-06-30 0001082324 us-gaap:CorporateBondSecuritiesMember vhc:UnrealizedGainsMember us-gaap:FairValueInputsLevel1Member 2013-06-30 0001082324 vhc:UnrealizedLossesMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateBondSecuritiesMember 2013-06-30 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateBondSecuritiesMember us-gaap:PortionAtFairValueFairValueDisclosureMember 2013-06-30 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember us-gaap:CorporateBondSecuritiesMember 2013-06-30 0001082324 vhc:SeriesIWarrantsMember 2013-06-30 0001082324 vhc:SeriesIWarrantsMember us-gaap:FairValueInputsLevel3Member 2013-06-30 0001082324 us-gaap:FairValueInputsLevel2Member vhc:SeriesIWarrantsMember 2013-06-30 0001082324 vhc:SeriesIWarrantsMember us-gaap:FairValueInputsLevel1Member 2013-06-30 0001082324 vhc:SeriesIWarrantsMember 2012-12-31 0001082324 us-gaap:FairValueInputsLevel3Member vhc:SeriesIWarrantsMember 2012-12-31 0001082324 vhc:SeriesIWarrantsMember us-gaap:FairValueInputsLevel2Member 2012-12-31 0001082324 vhc:SeriesIWarrantsMember us-gaap:FairValueInputsLevel1Member 2012-12-31 0001082324 us-gaap:StateAndLocalJurisdictionMember 2013-06-30 0001082324 us-gaap:InternalRevenueServiceIRSMember 2013-06-30 0001082324 us-gaap:StateAndLocalJurisdictionMember 2013-01-01 2013-06-30 0001082324 us-gaap:InternalRevenueServiceIRSMember 2013-01-01 2013-06-30 0001082324 us-gaap:RestrictedStockMember 2013-01-01 2013-06-30 0001082324 us-gaap:StockOptionsMember 2013-01-01 2013-06-30 0001082324 us-gaap:RestrictedStockMember 2013-06-30 0001082324 us-gaap:RestrictedStockMember 2012-12-31 0001082324 us-gaap:StockOptionsMember 2012-01-01 2012-06-30 0001082324 us-gaap:RestrictedStockMember 2012-01-01 2012-06-30 0001082324 us-gaap:RestrictedStockMember us-gaap:MaximumMember 2013-01-01 2013-06-30 0001082324 us-gaap:MinimumMember us-gaap:RestrictedStockMember 2013-01-01 2013-06-30 0001082324 us-gaap:StockOptionsMember 2013-06-30 0001082324 us-gaap:StockOptionsMember 2013-04-01 2013-06-30 0001082324 us-gaap:RestrictedStockMember 2013-04-01 2013-06-30 0001082324 us-gaap:WarrantMember 2012-12-31 0001082324 us-gaap:WarrantMember vhc:SeriesIWarrantsMember 2012-12-31 0001082324 us-gaap:WarrantMember 2013-06-30 0001082324 us-gaap:WarrantMember vhc:SeriesIWarrantsMember 2013-01-01 2013-06-30 0001082324 us-gaap:WarrantMember 2013-01-01 2013-06-30 0001082324 2011-01-12 0001082324 2010-08-11 0001082324 2012-11-06 0001082324 2013-02-25 2013-02-26 xbrli:shares iso4217:USD iso4217:USD xbrli:shares vhc:Patent vhc:FinancialInstitution xbrli:pure vhc:Lawsuit vhc:Complaint false --12-31 2013-06-30 Yes No Yes Large Accelerated Filer VirnetX Holding Corp 0001082324 51203141 2013 Q2 10-Q 1861000 3197000 -8000 8000 120229000 116856000 3344000 1759000 1466000 2340000 46861000 61231000 46926000 61313000 13382000 26493000 13382000 351000 4000 0 0 0 13027000 351000 13378000 0 0 511000 0 0 26485000 26493000 0 0 4099000 17836000 0 8657000 511000 0 4047000 8000 4039000 17836000 0 8000 8000 8649000 4099000 4000 13031000 0 4000 0 13031000 13027000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-weight: bold;">Note 2 &#8211; Summary of Significant Accounting Policies</div><div><br /></div><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Revenue Recognition</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements can be complex and may or may not include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the FASB revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Patent License Agreements</font>: Upon signing a patent license agreement, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue arrangements with multiple deliverables and the guidance for revenue recognition. Under our patent license agreements, we typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:</div><div style="text-align: justify;"><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18pt; font-family: symbol, serif; font-size: 10pt; vertical-align: top; align: right;">&#183;</td><td style="text-align: left; width: auto; font-family: ''times new roman'', times, serif; font-size: 10pt; vertical-align: top;"><font style="font-style: italic; font-family: ''times new roman'', times, serif; font-size: 10pt;">Consideration for Past Sales:</font> Consideration related to a licensee&#8217;s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.</td></tr></table></div><div><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18pt; font-family: symbol, serif; font-size: 10pt; vertical-align: top; align: right;">&#183;</td><td style="text-align: left; width: auto; font-family: ''times new roman'', times, serif; font-size: 10pt; vertical-align: top;"><font style="font-style: italic; font-family: ''times new roman'', times, serif; font-size: 10pt;">Current Royalty Payments</font>: These are ongoing royalty payments covering a licensee&#8217;s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe Current Royalty Payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees&#8217; underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees&#8217; sales is limited.</td></tr></table></div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">For the three and six months ended June 30, 2013, we recognized royalty revenue of $6 and $300 respectively, compared to $36 for the three and six months ended June 30, 2012, as part of license agreements entered into with customers during the patent infringement actions (see &#8220;Legal Proceedings&#8221;). &#160;In accordance with our revenue recognition policy related to a licensee&#8217;s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured. &#160;In the patent infringement actions we did not request, nor receive any amounts allocable to settlement fees, expense reimbursement, damages or any other amount unrelated to historical sales. &#160;Revenue from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.</div><div style="text-align: left;"><br /></div><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Earnings Per Share</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. &#160;Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued<font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">.</font></div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. &#160;During the six months ended June 30, 2013 we had, at times, funds which were uninsured. &#160; We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.</div><div style="text-align: left;"><br /></div><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Derivative Instruments</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock. &#160;The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.</div><div style="font-style: italic; font-weight: bold;">&#160;</div><div style="font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable. &#160;Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets&#8217; carrying value. &#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. &#160;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). &#160;Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our financial instruments are stated at amounts that equal, or approximate, fair value. &#160;When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. &#160;We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div><div style="text-align: justify;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Certificate of deposits</font>: Fair value measured at face value plus accrued interest.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Corporate bonds</font>: &#160;Fair value measured at the closing price reported on the active market on which the individual securities are traded.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Series I Warrants</font>: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for June 30, 2013, included a warrant exercise price of $3.59 per share, a common share price of $19.99, a discount rate of 1.41%, and a volatility of 93%. The assumptions used for December 31, 2012, were a warrant exercise price of $3.59 per share, a common share price of $29.28, a discount rate of 0.72%, and a volatility of 94%.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.</div><div style="text-align: left;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9.9pt; font-family: ''times new roman'', times, serif; margin-left: 9.9pt; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 18px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 156px; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Corporate Bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 27pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Corporate Bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Investments at Fair Value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,378</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,382</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: center;"><br />&#160;</div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Corporate bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 52%; vertical-align: bottom;"><div style="text-indent: -9pt; margin-left: 9pt;">A</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,039</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,047</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">BAA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total corporate bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,649</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,657</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total investments at fair value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,485</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,493</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div>&#160;</div><div>The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: left;"><br /></div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012</div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 13px;"><td bgcolor="#cceeff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance December 31, 2012</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance December 31, 2011</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,699</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Gain on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,486</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Loss on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">1,979</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,415</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance June 30, 2013</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance June 30, 2012</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">5,263</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">New Accounting Pronouncement</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">In July 2013, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2013-11 &#8220;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.&#8221; ASU No. 2013-11 is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The new standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The new standard becomes effective for us on January 1, 2014 and&#160;will be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted.&#160;We are&#160;currently assessing the impacts of this new standard.</div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;">In February 2013, the FASB issued final guidance on the presentation of reclassifications out of other comprehensive income. The amendments require an entity to provide information about the amounts reclassified out of other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in a footnote, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, only if the amount reclassified is required by GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide detail about those amounts. This amendment was effective for interim and fiscal years beginning after December 15, 2012. The amended standard did not impact our financial position or results of operations.</div></div> 32878000 37949000 19661000 49482000 13217000 -11533000 3.59 3.59 3.59 2619036 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-weight: bold;">Note 5 &#8212; Commitments</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On October 30, 2011, we entered into a new lease agreement for our corporate headquarters. The lease commencement date was October 30, 2011 and includes monthly payments of $5 until the lease term expires in October 2013</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We entered into a non-cancelable agreement for corporate promotional and marketing purposes for a period of ten years at a cost of $4,000. Initial payments of $250 have been prepaid and are included in prepaid expenses and other current assets on our Condensed Consolidated Balance Sheet. The remaining balance is due on March 1 of the year the facility will become available for use, which the lessor anticipates will be in 2014 or 2015, at which time we will begin amortizing the agreement over the contract period. &#160;The lease terms include certain refunds, deductions, etc. in the event construction is delayed or not completed within specified time-frames.</div></div> 51203141 51150242 5000 5000 51203141 51150242 0.0001 0.0001 100000000 100000000 -7037000 -10263000 -14938000 -14988000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. &#160;During the six months ended June 30, 2013 we had, at times, funds which were uninsured. &#160; We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.</div></div> 11423000 6970000 23000 36000 2686000 4172000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Derivative Instruments</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock. &#160;The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 6 &#8212; Stock-Based Compensation</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On May 22, 2013, our stockholders approved the VirnetX Holding Corporation 2013 Equity Incentive Plan (the "Plan) at our 2013 annual stockholders' meeting. &#160;The Plan provides for the issuance of up to 2,500,000 shares of our common stock. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the Plan. The Plan provides for the granting of stock options and restricted stock purchase rights (RSU) to our employees and consultants. Stock options granted under the Plan may be incentive stock options or nonqualified stock options. Incentive stock options ("ISO") may only be granted to our employees (including officers and directors). Nonqualified stock options ("NSO") and stock purchase rights may be granted to our employees and consultants.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The Plan will expire 10 years after it was approved by our Board of Directors. Options may be granted under the Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the fair market value at the date of grant in the case of an NSO, the exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant. Stock options granted under the Plan typically vest over four years and have a 10 year term. All RSUs are considered to be granted at the fair value of our stock on the date of grant because they have no exercise price. RSUs typically vest over four years.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We had 5,009,849 and 4,776,224 options outstanding at June 30, 2013 and December 31, 2012, respectively, with a weighted-average exercise price of $7.87 and $6.94, respectively. At June 30, 2013 and December 31, 2012, we had 248,915 and 151,665 RSU&#8217;s outstanding with a weighted-average grant-date fair value of $24.10 and $25.60, respectively.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">During the six months ended June 30, 2013 and 2012, we granted options for a total of 274,625 and 277,500 shares respectively. The weighted average fair values at the grant dates for options issued during the six months ending June 30, 2013 and 2012 were $19.24 and $22.26 per option, respectively. The fair value of options at the grant date was estimated utilizing the Black-Scholes valuation model with following weighted average assumptions for the six months ending June 30, 2013 and 2012, respectively: (i) dividend yield on our common stock of 0 percent and 0 percent; (ii) expected stock price volatility of 93 percent and 115 percent; (iii) a risk-free interest rate of 2.06 percent and 1.92 percent; and (iv) an expected option term of 6 and 7 years.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">During the six months ended June 30, 2013 and 2012, we also granted RSUs totaling 156,415 and 151,665 units, respectively, that vest ratably over one to four years. The weighted-average fair values of each issued RSU on the dates of grant were $23.72 and $25.60, respectively. RSUs, which are subject to forfeiture if employment terminates prior to the shares vesting, are expensed ratably over the vesting period.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Stock-based compensation expense is measured at grant date, based on the fair value of the award, and is recognized over the employees&#8217; requisite service period. Stock-based compensation expense included in general and administrative expense was $1,759 and $3,344 for the three and six months ended June 30, 2013, respectively, and $1,466 and $2,340 for the three and six months ended June 30, 2012, respectively.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">As of June 30, 2013 and 2012, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $15,372 and $5,372, respectively, which will be amortized over an estimated weighted average vesting amortization period of approximately 2.72 and 3.21 years, respectively.</div></div> -0.14 -0.20 -0.29 -0.29 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Earnings Per Share</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. &#160;Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued<font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">.</font></div></div> -0.05 -0.025 0.26 0.28 P2Y8M19D P3Y2M16D 15372000 5372000 0.93 0.9415 0.0141 0.0072 2686000 5263000 4172000 4699000 1415000 0 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012</div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 13px;"><td bgcolor="#cceeff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance December 31, 2012</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance December 31, 2011</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,699</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Gain on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,486</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Loss on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">1,979</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,415</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance June 30, 2013</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance June 30, 2012</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">5,263</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.</div><div style="text-align: left;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9.9pt; font-family: ''times new roman'', times, serif; margin-left: 9.9pt; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 18px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 156px; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Corporate Bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 27pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Corporate Bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Investments at Fair Value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,378</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,382</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="text-align: center;"><br />&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Corporate bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 52%; vertical-align: bottom;"><div style="text-indent: -9pt; margin-left: 9pt;">A</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,039</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,047</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">BAA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total corporate bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,649</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,657</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total investments at fair value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,485</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,493</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. &#160;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). &#160;Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our financial instruments are stated at amounts that equal, or approximate, fair value. &#160;When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. &#160;We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Certificate of deposits</font>: Fair value measured at face value plus accrued interest.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Corporate bonds</font>: &#160;Fair value measured at the closing price reported on the active market on which the individual securities are traded.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Series I Warrants</font>: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for June 30, 2013, included a warrant exercise price of $3.59 per share, a common share price of $19.99, a discount rate of 1.41%, and a volatility of 93%. The assumptions used for December 31, 2012, were a warrant exercise price of $3.59 per share, a common share price of $29.28, a discount rate of 0.72%, and a volatility of 94%.</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.</div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9.9pt; font-family: ''times new roman'', times, serif; margin-left: 9.9pt; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 18px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 156px; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Corporate Bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 27pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Corporate Bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Investments at Fair Value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,378</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,382</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br />&#160;</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Corporate bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 52%; vertical-align: bottom;"><div style="text-indent: -9pt; margin-left: 9pt;">A</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,039</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,047</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">BAA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total corporate bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,649</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,657</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total investments at fair value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,485</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,493</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.</div></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012</div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 13px;"><td bgcolor="#cceeff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance December 31, 2012</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance December 31, 2011</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,699</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Gain on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,486</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Loss on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">1,979</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,415</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance June 30, 2013</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance June 30, 2012</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">5,263</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: left;"><br /></div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div></div> -1486000 1979000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable. &#160;Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets&#8217; carrying value. &#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 4 - Income Taxes</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The income tax expense for the three months ended June 30, 2013 was $354, which was a negative effective income tax rate of 5 percent. The income tax expense for the six months ended June 30, 2013 was $356, which was a negative effective income tax rate of 2.5 percent. As a result of net operating losses during the periods the provision reflects only minimum tax payments and prior year tax true-up. &#160;The tax expense was calculated using the statutory U.S. federal rate primarily as a result of the change of the valuation allowance of $5,695, stock based compensation expense and non-deductible derivative loss. We have valuation allowances covering our deferred tax assets including net operating loss carry-forwards.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The income tax benefit for the three months ended June 30, 2012 was $3,590, which was an effective income tax rate of 26 percent. The income tax benefit for the six months ended June 30, 2012 was $5,763, which was an effective income tax rate of 28 percent.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2013 will not be fully realizable. Accordingly, management has maintained a valuation allowance against&#160;our net deferred tax assets at June 30, 2013. The valuation allowance carried against our net deferred tax assets was $11,423 and $6,970 at June 30, 2013 and December 31, 2012, respectively.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">At June 30, 2013, we have federal and state net operating loss carry-forwards of approximately $15,527 and $52,756 respectively, expiring beginning in 2027 and 2016, respectively.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.</div><div style="text-align: justify;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2013, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.</div></div> -6675000 -13854000 -14566000 -20734000 354000 -3590000 356000 -5763000 354000 3590000 356000 5763000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2013, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.</div></div> 0 -204000 -14963000 -5192000 -1336000 4032000 250000 487000 259000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 3 &#8212; Patent Portfolio</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">As of June 30, 2013, we own 21 issued U.S. and 41 issued foreign patents, in addition to several pending U.S. and foreign patent applications. &#160;Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. &#160;Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation, or SAIC, in 2006 and we are required to make payments to SAIC based on cash or certain other values generated from those patents. &#160;The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, SAIC is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX or from the settlement of certain patent infringement claims of ours. Capitalized patent costs, net of amortization, are included in intangible and other assets in the accompanying Condensed Consolidated Balance Sheet at December 31, 2012, and were fully amortized at June 30, 2013.</div></div> 23000 128000 56000 202000 2013-10-31 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 8 &#8212; Litigation</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We have five intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints. We have one complaint with the United States International Trade Commission (ITC) alleging that Apple, Inc. has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.&#8217;s infringement through the district courts. &#160;The ITC case has been terminated.</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. et al., v. Microsoft Corporation</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274. &#160;We seek damages and injunctive relief. &#160;No hearing or trial dates have been set.</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Cisco Systems, Inc. et al and VirnetX Inc. v. Apple Inc. (Severed Case)</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief. On February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we again amended our complaint against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to include Apple&#8217;s iPad 2 in the list of Apple products that are accused of infringing our patents. We also asserted our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC have signed license agreements with us and we have agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to postpone the trial against Cisco to March 4, 2013 and just try the case against Apple. On November 6, 2012, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368,000 in a verdict against Apple Corporation for infringing four of our patents. A post-trial hearing in the case against Apple was held on December 20, 2012. On February 26, 2013, the United States District Court for the Eastern District of Texas, Tyler Division issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict. The Court denied Apple&#8217;s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple&#8217;s request for a new trial on the liability and damages portions of the verdict. Additionally, the Court granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. Specifically, the Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction. In doing so, the Court ordered the parties to mediate over a license in the following 45 days for Apple&#8217;s future infringing use not covered by the Court&#8217;s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court&#8217;s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are &#8220;not colorably different&#8221; with regards to the accused functionality. However, the judgment may be appealed and no assurances can be given as to when or if we will receive any proceeds in connection with these matters, and accordingly there has been no recognition of the jury awards or royalties in our accompanying financial statements. Under our agreements with Science Applications International Corporation (SAIC), we would pay to SAIC 25% of the proceeds obtained by us in this lawsuit against Apple after reduction for attorneys&#8217; fees and costs incurred in litigating those claims.&#160;We are awaiting the Court&#8217;s decision in this matter. &#160;On July 1, 2013, the Court entered an Order setting a hearing on VirnetX&#8217;s motion for an ongoing royalty for August 15, 2013. &#160;On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple&#8217;s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit.</div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;">The jury trial against Cisco was held on March 4, 2013. At the end of the trial, the jury came back with a verdict of non-infringement in the trial. The same jury also found that all our patents-in-suit were valid and enforceable. On April 3, 2013, we filed a request for a new trial regarding Cisco&#8217;s infringement of four of our patents based primarily on our allegations of Cisco&#8217;s inappropriate conduct and arguments during the jury trial that concluded on March 14, 2013. In addition to the request for a new trial, we filed a motion for a judgment as a matter of law on Cisco&#8217;s infringement of the &#8216;759 patent. On April 11, 2013, in response to our motion, Cisco filed its renewed motion to dismiss as moot its invalidity counterclaims against the claims in our patents that were not asserted in the lawsuit as well as a conditional motion for a new trial on certain limited claims and defenses. We are awaiting the Court&#8217;s decision in this matter. &#160;A hearing on VirnetX&#8217;s motion for new trial and Cisco&#8217;s renewed motion to dismiss as moot its invalidity counterclaims and conditional motion for a new trial was held on June 17, 2013. &#160;We are awaiting the Court&#8217;s ruling on these motions.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Mitel Networks Corporation et al</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On January 12, 2011, we initiated a lawsuit by filing a complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these companies infringe three of our patents. We seek damages and injunctive relief. On April 12, 2011 we again amended our complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, to add Avaya Inc. as a defendant. On July 11, 2012, Mitel Network Corporation signed a license agreement with us and we dismissed the patent infringement case against them. On July 12, 2012 we had a claims construction hearing in this case and a Markman order was issued on August 1, 2012. On January 29, 2013 Siemens signed a license agreement with us and we dismissed the patent infringement case against them. On April 9, 2013, the Court issued a new docket control order in our lawsuit against the remaining defendant Avaya Inc. According to this new order, jury selection is set for September 3, 2013 followed by a jury trial on September 9, 2013. A pretrial conference has been scheduled for August 22, 2013.</div><div style="text-align: left;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Apple, Inc.</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On November 1, 2011, we initiated a lawsuit against Apple in the United States District Court, Tyler Division, pursuant to which we allege that Apple infringes one or more claims of our U.S. Patent No. 8,051,181. We seek damages and injunctive relief. No hearing or trial dates have been set. &#160;On June 17, 2013 the Court granted VirnetX&#8217;s unopposed motion to lift the stay ordered by the Court on December 15, 2011. &#160;On June 18, 2013 the Court granted the parties unopposed motion to consolidate this case with Civil Action No. 6:12-cv-00855-LED.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Apple, Inc.</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. &#160;On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">ITC Investigation No. 337-TA-858</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On July 18, 2012, the Administrative Law Judge (ALJ) assigned to investigate our complaint against Apple Inc., identified a procedural discrepancy with our complaint and dismissed it. On September 14, 2012, we re-filed our complaint with the ITC jointly with Science Applications International Corporation (SAIC) [NYSE: SAI] to remove a procedural standing issue that was identified as the reason for dismissal of our previous complaint. On October 16, 2012, the United States International Trade Commission (ITC) accepted our complaint and instituted an investigation against Apple and assigned ALJ E. James Gildea to preside over this investigation. Subsequently on October 23, 2012, ALJ Gildea issued an order setting up February 21, 2014 as the target date for completion of this investigation. The hearing in-front of ALJ Gildea was scheduled for May 20, 2013. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.&#8217;s infringement through the district courts. &#160;The ITC case has been terminated.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.</div></div> 4547000 7369000 46926000 61313000 5 368000000 13087000 -11417000 31000 1331000 -7029000 -10264000 -14922000 -14971000 99000 -1447000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">New Accounting Pronouncement</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">In July 2013, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2013-11 &#8220;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.&#8221; ASU No. 2013-11 is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The new standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The new standard becomes effective for us on January 1, 2014 and&#160;will be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted.&#160;We are&#160;currently assessing the impacts of this new standard.</div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;">In February 2013, the FASB issued final guidance on the presentation of reclassifications out of other comprehensive income. The amendments require an entity to provide information about the amounts reclassified out of other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in a footnote, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, only if the amount reclassified is required by GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide detail about those amounts. This amendment was effective for interim and fiscal years beginning after December 15, 2012. The amended standard did not impact our financial position or results of operations.</div></div> December 31, 2016 December 31, 2027 6584000 11770000 16408000 18993000 52756000 15527000 -6578000 -11734000 -16108000 -18957000 4000000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 1 &#8212; Business Description and Basis of Presentation</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">VirnetX, Inc. (&#8220;we&#8221;, &#8220;our&#8221;, &#8220;us&#8221; or &#8220;VirnetX&#8221;) develops software and technology solutions for securing real-time communications over the Internet. &#160;Our patented GABRIEL Connection Technology&#8482; combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our portfolio of intellectual property is the foundation of our business model. &#160;We currently own 21 patents in the United States and 41 foreign patents, as well as several pending U.S. and foreign patent applications. &#160;Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. &#160;Our patented methods also have additional applications in operating systems and network security.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer and remote desktop. &#160;Our technology generates secure connections on a &#8220;zero-click&#8221; or &#8220;single-click&#8221; basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We have executed licenses and intend to seek further licensees for our technology, including our GABRIEL Connection Technology&#8482; to original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">During interim periods, we follow the accounting policies set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012 and apply appropriate interim financial reporting standards for a fair statement of our operating results and financial position in conformity with accounting principles generally accepted in the United States of America, as codified by the Financial Accounting Standards Board (FASB) in the Accounting Standards Codification (ASC) (referred to herein as U.S. GAAP), as indicated below. &#160;Users of financial information produced for interim periods are encouraged to read this Quarterly Report on Form 10-Q in conjunction with our consolidated financial statements and notes thereto filed with the Securities and Exchange Commission (SEC) in our 2012 Annual Report on Form 10-K.</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Interim financial reporting standards require us to make estimates that are based on assumptions regarding the outcome of future events and circumstances not known at that time, including the use of estimated effective tax rates. &#160;Inevitably, some assumptions will not materialize, unanticipated events or circumstances may occur which vary from those estimates and such variations may significantly affect our future results. Our financial results have varied significantly from period to period. &#160;Additionally, interim results may not be indicative of our results for future interim periods or our annual results.</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC&#8217;s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and six month periods ended June 30, 2013 and 2012; (ii) the condensed consolidated statements of comprehensive loss for the three and six month periods ended June 30, 2013 and 2012; (iii) the condensed consolidated balance sheets at June 30, 2013 and December 31, 2012; and (iv) the condensed consolidated statements of cash flows for the six month periods ended June 30, 2013 and 2012. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by U.S. GAAP. &#160;The condensed consolidated balance sheet, included in this report, as of December 31, 2012 was derived from our 2012 audited financial statements, but does not include all disclosures required by U.S. GAAP.</div></div> 2686000 2686000 0 0 4172000 4172000 0 0 -8000 1000 -16000 -17000 0 0 -12000 -12000 4000 1000 -4000 -17000 7000 26000 13000000 33599000 0 0 10000000 10000000 0 0 0.0001 0.0001 0 0 0 14963000 601000 114000 0 156000 26094000 22208000 65000 70000 382000 274000 686000 530000 -77847000 -62925000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Revenue Recognition</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements can be complex and may or may not include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the FASB revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Patent License Agreements</font>: Upon signing a patent license agreement, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue arrangements with multiple deliverables and the guidance for revenue recognition. Under our patent license agreements, we typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:</div><div style="text-align: justify;"><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18pt; font-family: symbol, serif; font-size: 10pt; vertical-align: top; align: right;">&#183;</td><td style="text-align: left; width: auto; font-family: ''times new roman'', times, serif; font-size: 10pt; vertical-align: top;"><font style="font-style: italic; font-family: ''times new roman'', times, serif; font-size: 10pt;">Consideration for Past Sales:</font> Consideration related to a licensee&#8217;s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.</td></tr></table></div><div><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18pt; font-family: symbol, serif; font-size: 10pt; vertical-align: top; align: right;">&#183;</td><td style="text-align: left; width: auto; font-family: ''times new roman'', times, serif; font-size: 10pt; vertical-align: top;"><font style="font-style: italic; font-family: ''times new roman'', times, serif; font-size: 10pt;">Current Royalty Payments</font>: These are ongoing royalty payments covering a licensee&#8217;s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe Current Royalty Payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees&#8217; underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees&#8217; sales is limited.</td></tr></table></div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">For the three and six months ended June 30, 2013, we recognized royalty revenue of $6 and $300 respectively, compared to $36 for the three and six months ended June 30, 2012, as part of license agreements entered into with customers during the patent infringement actions (see &#8220;Legal Proceedings&#8221;). &#160;In accordance with our revenue recognition policy related to a licensee&#8217;s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured. &#160;In the patent infringement actions we did not request, nor receive any amounts allocable to settlement fees, expense reimbursement, damages or any other amount unrelated to historical sales. &#160;Revenue from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.</div></div> 6000 36000 300000 36000 P6Y P7Y P4Y P1Y <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Information about warrants outstanding during the six months ended June 30, 2013 follows:</div><div style="text-align: left;"><br /></div><div style="text-align: left;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Original </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Number of</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Warrants </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Issued</div></td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercise</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Price per </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Common</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Share</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable at</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31,</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Became</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercised</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Terminated /</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Cancelled /</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Expired</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">at June 30, </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 15%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Expiration</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Date</div></td></tr><tr><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 15%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,619,036</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">3.59</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">159,967</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div>159,967</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 15%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt;">March 2015</div></td></tr><tr style="height: 20px;"><td bgcolor="#ffffff" colspan="2" valign="bottom" style="padding-bottom: 4px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">159,967</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;">159,967</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 15%; vertical-align: bottom;"><div style="text-align: left;">&#160;&#160;&#160;</div></td></tr></table></div><div><br /></div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr style="vertical-align: top;"><td style="width: 18pt;">&#160;</td><td style="width: 18pt; vertical-align: top; align: right;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">(1)</div></td><td style="width: auto; vertical-align: top; align: left;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Referred to as our Series I Warrants.</div></td></tr></table></div></div> 6202000 11496000 15722000 18463000 159967 159967 159967 159967 3344000 2340000 0 0 23.72 25.60 25.60 24.10 0 0 P4Y P4Y 277500 274625 248915 151665 0 19.99 29.28 22.26 19.24 156415 151665 0.0192 0.0206 0 0 0.93 1.15 2500000 7.87 6.94 5009849 4776224 42379000 53944000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 9 &#8212; Subsequent Events</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: normal;">On August 7, 2013, we signed a Patent License Agreement (the &#8220;Agreement&#8221;) with Avaya Inc. Under the terms of the Agreement, VirnetX has agreed to license certain of its patents to Avaya, in exchange for multiple payments to VirnetX and an ongoing reasonable royalty for future sales through the expiration of the licensed patents as outlined in the Agreement with respect to certain current and future IP-encrypted products. In further consideration, Avaya has agreed to license certain of its patents to VirnetX for its ongoing Gabriel technology product development.</div><div style="font-weight: normal;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: normal;">Under the terms of the Agreement, the Parties have also agreed to dismiss the patent infringement case brought by VirnetX before the U.S. District Court for the Eastern District of Texas. All other aspects of the agreement were not disclosed.</div></div></div> -120000 -2248000 1486000 -1979000 5695000 51179000 50874000 51165000 50766000 P10Y P10Y 1.1 1 0.85 1 31000 1175000 1 March 2015 34000 21 0 12000 3 4 4 41 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-weight: bold;">Note 7 &#8212; Warrants</div><div>&#160;</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Information about warrants outstanding during the six months ended June 30, 2013 follows:</div><div style="text-align: left;"><br /></div><div style="text-align: left;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Original </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Number of</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Warrants </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Issued</div></td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercise</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Price per </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Common</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Share</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable at</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31,</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Became</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercised</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Terminated /</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Cancelled /</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Expired</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">at June 30, </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 15%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Expiration</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Date</div></td></tr><tr><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 15%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,619,036</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">3.59</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">159,967</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div>159,967</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 15%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt;">March 2015</div></td></tr><tr style="height: 20px;"><td bgcolor="#ffffff" colspan="2" valign="bottom" style="padding-bottom: 4px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">159,967</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;">159,967</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 15%; vertical-align: bottom;"><div style="text-align: left;">&#160;&#160;&#160;</div></td></tr></table><div><br /></div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr style="vertical-align: top;"><td style="width: 18pt;">&#160;</td><td style="width: 18pt; vertical-align: top; align: right;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">(1)</div></td><td style="width: auto; vertical-align: top; align: left;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Referred to as our Series I Warrants.</div></td></tr></table></div></div> 0.25 P45D 330000 5000 2 Referred to as our Series I Warrants. EX-101.SCH 8 vhc-20130630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Business Description and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Patent Portfolio link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 070400 - Disclosure - Income Taxes (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Business Description and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Patent Portfolio (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - Litigation (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 vhc-20130630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 vhc-20130630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 vhc-20130630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Award Type [Axis] Summary of Significant Accounting Policies [Abstract] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Additional paid in capital Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation expense Allocated Share-based Compensation Expense Current assets: ASSETS Assets [Abstract] Total current assets Assets, Current Total assets Assets Investments available for sale Available-for-sale Securities, Debt Securities, Current Investments available for sale Summary of Significant Accounting Policies Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash and Cash Equivalents, at Carrying Value Net (increase) decrease in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Certificates of Deposit [Member] Warrants [Table] Warrants [Line Items] Schedule of warrants by expiration date [Domain] Warrants by expiration date [Axis] Warrant exercise price (in dollars per share) Exercise price per common share (in dollars per share) Original number of warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Commitments Commitments Disclosure [Text Block] Commitments [Abstract] Common stock, outstanding (in shares) Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at June 30, 2013 and December 31, 2012, Issued and outstanding: 51,203,141 shares at June 30, 2013, and 51,150,242 shares at December 31, 2012 Common stock, issued (in shares) Common stock, par value (in dollars per share) Common stock, authorized (in shares) CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) [Abstract] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Concentration of Credit Risk and Other Risks and Uncertainties Total Corporate Bonds [Member] Valuation allowance carried against net deferred tax assets Deferred Tax Assets, Valuation Allowance Depreciation and amortization Derivative liability Derivative Instruments Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation [Abstract] Basic and diluted loss per share: (in dollars per share) Earnings Per Share, Basic and Diluted Earnings Per Share Effective tax rate (in hundredths) Weighted average vesting amortization period Unrecognized stock based compensation expense Expected volatility rate (in hundredths) Fair Value, Hierarchy [Axis] Liability Class [Axis] Discount rate (in hundredths) Fair value of securities on the basis of investment category [Abstract] Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract] Ending Balance Beginning Balance Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair value of liabilities [Abstract] Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis, Alternative [Abstract] Fair Value by Liability Class [Domain] Fair Value Assumptions [Abstract] Fair Value, Measurements, Fair Value Hierarchy [Domain] Level 3 financial liability Fair Value of Financial Instruments [Line Items] Fair value, assets Fair Value, Assets Measured on Recurring Basis [Table Text Block] Fair Value of Financial Instruments Fair Value, Disclosure Item Amounts [Domain] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis] Fair value, liabilities Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Significant Unobservable Inputs (Level 3) [Member] Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Gain on derivative liability included in net loss Changes in fair value of Level 3 liabilities [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Patent Portfolio [Abstract] Impairment of Long-Lived Assets CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract] Income Taxes Income Tax Disclosure [Text Block] Income Taxes [Abstract] Income Tax Authority [Axis] Income Tax Authority [Domain] Loss before taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax (expense) benefit Income Tax Expense (Benefit) Income tax benefit Income Tax Expense (Benefit), Continuing Operations Income tax uncertainties Income Tax Uncertainties, Policy [Policy Text Block] Net change in deferred taxes Increase (Decrease) in Deferred Income Taxes Prepaid taxes Increase (Decrease) in Prepaid Taxes Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Changes in assets and liabilities: Prepayments of promotional and marketing commitments Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense Patent Portfolio Intangible Assets Disclosure [Text Block] Interest income, net Federal [Member] Investment Type Categorization [Domain] Investment Type [Axis] Corporate headquarters, lease expiration date Lease Expiration Date Litigation Legal Matters and Contingencies [Text Block] Total current liabilities Liabilities, Current Current liabilities: LIABILITIES AND STOCKHOLDERS' EQUITY Total liabilities and stockholders' equity Liabilities and Equity Number of intellectual property infringement lawsuits pending Loss Contingency, Pending Claims, Number Amount of damages awarded in patent infringement case Loss Contingency, Damages Awarded, Value Maximum [Member] Minimum [Member] Cash flows from financing activities: Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Cash flows from investing activities: Cash flows from operating activities: Net loss Net loss Net Income (Loss) Attributable to Parent Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities New Accounting Pronouncements Operating expense: Operating loss carryforwards, expiration dates Total operating expense Operating Expenses Operating Loss Carryforwards [Table] Operating loss carryforwards Loss from operations Operating Loss Carryforwards [Line Items] Lease commitments, promotional and marketing Operating Leases, Future Minimum Payments Due Business Description and Basis of Presentation [Abstract] Business Description and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Series 1 Warrants Other Comprehensive Income (Loss), Tax Other Comprehensive Income, Other, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Other comprehensive income (loss): Change in unrealized gain (loss) on investments, net of tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Purchase of investments Payments to Acquire Available-for-sale Securities Fair Value [Member] Adjusted Cost [Member] Preferred stock, par value $0.0001 per share Authorized: 100,000,000 shares at June 30, 2013 and December 31,2012, Issued and outstanding: none Preferred Stock, Value, Issued Preferred stock, authorized (in shares) Preferred stock, issued (in shares) Preferred stock, par value (in dollars per share) Preferred stock, outstanding (in shares) Prepaid taxes Prepaid expense and other current assets Proceeds from exercise of warrants Proceeds from Issuance of Warrants Proceeds from sale or maturity of investments Property and equipment, net Range [Axis] Range [Domain] Research and development Research and Development Expense Restricted Stock [Member] Accumulated deficit Revenue Recognition [Abstract] Revenue Recognition Concentration of Credit Risk and Others Risks and Uncertainties [Abstract] Revenue Royalty Revenue Expected option term Vesting period of restricted share units Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Information about warrants outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] General, selling and administrative Selling, General and Administrative Expense Exercisable (in shares) Exercisable at beginning of year (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Stock-based compensation Terminated/cancelled/expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Weighted average grant date fair value of RSU's granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value of RSU's outstanding (in dollars per share) Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised Vesting period Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] RSU's outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Became exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Common share price (in dollars per share) Options granted, weighted average fair values (in dollars per share) RSUs granted (in shares) Risk-free interest rate (in hundredths) Dividend yield (in hundredths) Expected stock price volatility (in hundredths) Shares authorized for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Average exercise price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock options outstanding (in shares) Award Type [Domain] State [Member] CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)] [Abstract] CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) [Abstract] Stock Options [Member] Stockholders' equity: Total stockholders' equity Stockholders' Equity Attributable to Parent Subsequent Events Subsequent Events [Abstract] Change in value of derivative liability Gain (loss) on change in value of derivative liability Change of the valuation allowance Warrants [Member] Warrants [Abstract] Weighted average shares outstanding basic and diluted (in shares) Period of equity-based compensation awards that have actual or potential impact upon the company's financial statements. Share Based Compensation Arrangement By Share Based Payment Award Term Of Award Term of Plan Term of the lessee's leasing arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Lessee Leasing Arrangements, Operating Leases, Term of Contract Lease term Minimum exercise price of options granted to 10% percentage shareholder's as percentage of fair market value at the date of grant. Minimum Exercise Price Of Options Granted To 10% Shareholders Minimum exercise price of options granted to 10% shareholders (in hundredths) Minimum exercise price of options granted to named executive officers as percentage of fair market value at the date of grant. Minimum exercise price of options granted to Named Executive Officers Minimum exercise price of options granted to named executive officers (in hundredths) Minimum exercise price of NSO granted to any employee as percentage of fair market value at the date of grant. Minimum Exercise Price Of NSO Granted Minimum exercise price of NSO granted (in hundredths) Minimum exercise price of ISO granted to any employee as percentage of fair market value at the date of grant. Minimum exercise price of ISO granted Minimum exercise price of ISO granted (in hundredths) The cash inflow associated with the amount received from holders exercising their stock options and restricted stock. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately. Proceeds From Stock Options and Restricted stock Exercised Proceeds from exercise of stock options Number of complaints filed with the United States International Trade Commission. Number of unfair trade practices complaints filed Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment. Corporate Debt Securities RatedAA [Member] AA [Member] Date the warrant is to expire, in CCYY-MM-DD format. Expiration date for Warrants Expiration date Change between the Adjusted cost of the investment at fair value and Fair value of the investment. Unrealized Gains [Member] For an amount of damages awarded to the plaintiff in the legal matter, the daily interest payment awarded the plaintiff up to final payment of awarded damages. Loss Contingency, Damages Awarded, Value Daily Interest Amount of interest payment awarded up to final judgment, per day Represents number of domestic patents owned. Number of Domestic Patents Owned Number of U.S. patents owned Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. And, aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). Intangible And Other Assets Intangible and other assets Change between the Adjusted cost of the investment at fair value and Fair value of the investment. Unrealized Losses [Member] Represents warrants designated as Series I Warrants. Series I Warrants [Member] Series I Warrants [Member] Number of patents allegedly infringed upon by Apple, Inc. Number of patents allegedly infringed upon by Apple, Inc. Litigation [Abstract] Represents number of foreign patents owned. Number of Foreign Patents Owned Number of foreign patents owned Number of foreign patents owned The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants [Text Block] Warrants Percentage of proceeds to be paid after deducting attorneys' fees and costs incurred in litigating the claims. Percentage of proceeds to be paid after deducting fees and costs incurred in litigating the claim Percentage of proceeds to be paid after deducting and legal fees (in hundredths) Document and Entity Information [Abstract] Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment. Corporate Debt Securities Rated SingleA [Member] A [Member] Court order period in a litigation setting for interval for parties to find resolution before petitioning the court for further action. Interval in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Court Order Mediation Interval Court order mediation interval For an amount of damages awarded to the plaintiff in the legal matter, the daily payments awarded for damage infringement to the plaintiff up to final payment of awarded damages. Loss Contingency, Damages Awarded, Value Daily Payment Amount of damage infringement payment awarded up to final judgment, per day Amount of periodic rental payment required to pay monthly till the lease expiry term. Operating Leases periodic rental expenses Corporate headquarters, periodic monthly rental expenses Number of financial institutions holding the company's cash and cash equivalents. Concentration Risk, Number of Financial Institutions Number of financial institutions holding company's cash Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment. Corporate Bonds RatedBAA [Member] BAA [Member] EX-101.PRE 12 vhc-20130630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R8.xml IDEA: Summary of Significant Accounting Policies 2.4.0.8060200 - Disclosure - Summary of Significant Accounting Policiestruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-weight: bold;">Note 2 &#8211; Summary of Significant Accounting Policies</div><div><br /></div><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Revenue Recognition</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements can be complex and may or may not include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the FASB revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Patent License Agreements</font>: Upon signing a patent license agreement, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue arrangements with multiple deliverables and the guidance for revenue recognition. Under our patent license agreements, we typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:</div><div style="text-align: justify;"><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18pt; font-family: symbol, serif; font-size: 10pt; vertical-align: top; align: right;">&#183;</td><td style="text-align: left; width: auto; font-family: ''times new roman'', times, serif; font-size: 10pt; vertical-align: top;"><font style="font-style: italic; font-family: ''times new roman'', times, serif; font-size: 10pt;">Consideration for Past Sales:</font> Consideration related to a licensee&#8217;s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.</td></tr></table></div><div><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18pt; font-family: symbol, serif; font-size: 10pt; vertical-align: top; align: right;">&#183;</td><td style="text-align: left; width: auto; font-family: ''times new roman'', times, serif; font-size: 10pt; vertical-align: top;"><font style="font-style: italic; font-family: ''times new roman'', times, serif; font-size: 10pt;">Current Royalty Payments</font>: These are ongoing royalty payments covering a licensee&#8217;s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe Current Royalty Payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees&#8217; underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees&#8217; sales is limited.</td></tr></table></div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">For the three and six months ended June 30, 2013, we recognized royalty revenue of $6 and $300 respectively, compared to $36 for the three and six months ended June 30, 2012, as part of license agreements entered into with customers during the patent infringement actions (see &#8220;Legal Proceedings&#8221;). &#160;In accordance with our revenue recognition policy related to a licensee&#8217;s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured. &#160;In the patent infringement actions we did not request, nor receive any amounts allocable to settlement fees, expense reimbursement, damages or any other amount unrelated to historical sales. &#160;Revenue from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.</div><div style="text-align: left;"><br /></div><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Earnings Per Share</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. &#160;Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued<font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">.</font></div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. &#160;During the six months ended June 30, 2013 we had, at times, funds which were uninsured. &#160; We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.</div><div style="text-align: left;"><br /></div><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Derivative Instruments</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock. &#160;The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.</div><div style="font-style: italic; font-weight: bold;">&#160;</div><div style="font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable. &#160;Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets&#8217; carrying value. &#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. &#160;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). &#160;Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our financial instruments are stated at amounts that equal, or approximate, fair value. &#160;When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. &#160;We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div><div style="text-align: justify;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Certificate of deposits</font>: Fair value measured at face value plus accrued interest.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Corporate bonds</font>: &#160;Fair value measured at the closing price reported on the active market on which the individual securities are traded.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Series I Warrants</font>: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for June 30, 2013, included a warrant exercise price of $3.59 per share, a common share price of $19.99, a discount rate of 1.41%, and a volatility of 93%. The assumptions used for December 31, 2012, were a warrant exercise price of $3.59 per share, a common share price of $29.28, a discount rate of 0.72%, and a volatility of 94%.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.</div><div style="text-align: left;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9.9pt; font-family: ''times new roman'', times, serif; margin-left: 9.9pt; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 18px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 156px; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Corporate Bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 27pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Corporate Bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Investments at Fair Value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,378</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,382</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: center;"><br />&#160;</div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Corporate bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 52%; vertical-align: bottom;"><div style="text-indent: -9pt; margin-left: 9pt;">A</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,039</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,047</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">BAA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total corporate bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,649</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,657</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total investments at fair value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,485</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,493</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div>&#160;</div><div>The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: left;"><br /></div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012</div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 13px;"><td bgcolor="#cceeff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance December 31, 2012</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance December 31, 2011</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,699</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Gain on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,486</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Loss on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">1,979</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,415</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance June 30, 2013</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance June 30, 2012</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">5,263</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">New Accounting Pronouncement</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">In July 2013, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2013-11 &#8220;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.&#8221; ASU No. 2013-11 is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The new standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The new standard becomes effective for us on January 1, 2014 and&#160;will be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted.&#160;We are&#160;currently assessing the impacts of this new standard.</div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;">In February 2013, the FASB issued final guidance on the presentation of reclassifications out of other comprehensive income. The amendments require an entity to provide information about the amounts reclassified out of other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in a footnote, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, only if the amount reclassified is required by GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide detail about those amounts. This amendment was effective for interim and fiscal years beginning after December 15, 2012. The amended standard did not impact our financial position or results of operations.</div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.No definition available.false0falseSummary of Significant Accounting PoliciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/SummaryOfSignificantAccountingPolicies12 XML 14 R6.xml IDEA: CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) 2.4.0.8040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$c20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$c20120101to20120630http://www.sec.gov/CIK0001082324duration2012-01-01T00:00:002012-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-14922000-14922USD$falsetruefalse2truefalsefalse-14971000-14971USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false23true 3us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 4us-gaap_DepreciationDepletionAndAmortizationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse2300023falsefalsefalse2truefalsefalse3600036falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false25false 4us-gaap_ShareBasedCompensationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse33440003344falsefalsefalse2truefalsefalse23400002340falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false26false 4us-gaap_IncreaseDecreaseInDeferredIncomeTaxesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse00falsefalsefalse2truefalsefalse204000204falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false27false 4us-gaap_UnrealizedGainLossOnDerivativesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1486000-1486falsefalsefalse2truefalsefalse19790001979falsefalsefalsexbrli:monetaryItemTypemonetaryThe net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false28true 3us-gaap_IncreaseDecreaseInOperatingCapitalAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse09false 4us-gaap_IncreaseDecreaseInPrepaidTaxesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse1496300014963falsefalsefalse2truefalsefalse51920005192falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the amount of payments made in advance for income and other taxes, which will be charged against earnings in future periods.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false210false 4us-gaap_IncreaseDecreaseInPrepaidExpenseus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-487000-487falsefalsefalse2truefalsefalse-259000-259falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false211false 4us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-1336000-1336falsefalsefalse2truefalsefalse40320004032falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false212false 3us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse9900099falsefalsefalse2truefalsefalse-1447000-1447falsefalsefalsexbrli:monetaryItemTypemonetaryThe net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 true213true 2us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse014false 3us-gaap_PaymentsToAcquirePropertyPlantAndEquipmentus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-7000-7falsefalsefalse2truefalsefalse-26000-26falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 17 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false215false 3us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-13000000-13000falsefalsefalse2truefalsefalse-33599000-33599falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 17 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 17 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26853-111562 false216false 3us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecuritiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse2609400026094falsefalsefalse2truefalsefalse2220800022208falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 16 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26853-111562 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 16 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585 false217false 3us-gaap_NetCashProvidedByUsedInInvestingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1308700013087falsefalsefalse2truefalsefalse-11417000-11417falsefalsefalsexbrli:monetaryItemTypemonetaryThe net cash inflow or outflow from investing activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. true218true 2us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse019false 3vhc_ProceedsFromStockOptionsAndRestrictedStockExercisedvhc_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse3100031falsefalsefalse2truefalsefalse11750001175falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow associated with the amount received from holders exercising their stock options and restricted stock. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.No definition available.false220false 3us-gaap_ProceedsFromIssuanceOfWarrantsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00falsefalsefalse2truefalsefalse156000156falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 19 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false221false 3us-gaap_NetCashProvidedByUsedInFinancingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse3100031falsefalsefalse2truefalsefalse13310001331falsefalsefalsexbrli:monetaryItemTypemonetaryThe net cash inflow or outflow from financing activity for the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. true222false 2us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1321700013217falsefalsefalse2truefalsefalse-11533000-11533falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. true223false 2us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse1966100019661falsefalsefalse2truefalsefalse4948200049482falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false224false 2us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse3287800032878USD$falsetruefalse2truefalsefalse3794900037949USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false2falseCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited224 XML 15 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Policies)
6 Months Ended
Jun. 30, 2013
Income Taxes [Abstract]  
Income tax uncertainties
Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2013, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.
XML 16 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]        
Revenue $ 6 $ 36 $ 300 $ 36
Operating expense:        
Research and development 382 274 686 530
General, selling and administrative 6,202 11,496 15,722 18,463
Total operating expense 6,584 11,770 16,408 18,993
Loss from operations (6,578) (11,734) (16,108) (18,957)
Gain (loss) on change in value of derivative liability (120) (2,248) 1,486 (1,979)
Interest income, net 23 128 56 202
Loss before taxes (6,675) (13,854) (14,566) (20,734)
Income tax (expense) benefit (354) 3,590 (356) 5,763
Net loss $ (7,029) $ (10,264) $ (14,922) $ (14,971)
Basic and diluted loss per share: (in dollars per share) $ (0.14) $ (0.20) $ (0.29) $ (0.29)
Weighted average shares outstanding basic and diluted (in shares) 51,179 50,874 51,165 50,766
XML 17 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
6 Months Ended
Jun. 30, 2013
Income Taxes [Abstract]  
Income Taxes
Note 4 - Income Taxes

The income tax expense for the three months ended June 30, 2013 was $354, which was a negative effective income tax rate of 5 percent. The income tax expense for the six months ended June 30, 2013 was $356, which was a negative effective income tax rate of 2.5 percent. As a result of net operating losses during the periods the provision reflects only minimum tax payments and prior year tax true-up.  The tax expense was calculated using the statutory U.S. federal rate primarily as a result of the change of the valuation allowance of $5,695, stock based compensation expense and non-deductible derivative loss. We have valuation allowances covering our deferred tax assets including net operating loss carry-forwards.

The income tax benefit for the three months ended June 30, 2012 was $3,590, which was an effective income tax rate of 26 percent. The income tax benefit for the six months ended June 30, 2012 was $5,763, which was an effective income tax rate of 28 percent.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2013 will not be fully realizable. Accordingly, management has maintained a valuation allowance against our net deferred tax assets at June 30, 2013. The valuation allowance carried against our net deferred tax assets was $11,423 and $6,970 at June 30, 2013 and December 31, 2012, respectively.

At June 30, 2013, we have federal and state net operating loss carry-forwards of approximately $15,527 and $52,756 respectively, expiring beginning in 2027 and 2016, respectively.

Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.

Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2013, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.
XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 19 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Commitments [Abstract]  
Corporate headquarters, periodic monthly rental expenses $ 5
Corporate headquarters, lease expiration date Oct. 31, 2013
Lease term 10 years
Lease commitments, promotional and marketing 4,000
Prepayments of promotional and marketing commitments $ 250
XML 20 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2013
Summary of Significant Accounting Policies [Abstract]  
Fair value, assets
The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.

 
 
June 30, 2013
 
Level 1:
 
Adjusted Cost
  
Unrealized
Gains
  
Unrealized
Losses
  
Fair Value
 
Certificates of deposit
 
$
351
  
$
  
$
  
$
351
 
 
                
Corporate Bonds:
                
AA
  
13,027
   
4
   
   
13,031
 
Total Corporate Bonds
  
13,027
   
4
   
   
13,031
 
 
                
Total Investments at Fair Value
 
$
13,378
  
$
4
  
$
  
$
13,382
 

 
  
December 31, 2012
 
Level 1:
 
Adjusted Cost
  
Unrealized
Gains
  
Unrealized
Losses
  
Fair Value
 
Certificates of deposit
 
$
17,836
  
$
  
$
  
$
17,836
 
                 
Corporate bonds:
                
AA
  
4,099
   
   
   
4,099
 
A
  
4,039
   
8
   
   
4,047
 
BAA
  
511
   
   
   
511
 
Total corporate bonds
  
8,649
   
8
   
   
8,657
 
                 
Total investments at fair value
 
$
26,485
  
$
8
  
$
  
$
26,493
 
Fair value, liabilities
The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.
 
   
June 30, 2013
 
   
Quoted
Prices in
Active
Markets for
Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant
Unobservable
Inputs
     
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
Series l Warrants
  
   
   
2,686
   
2,686
 

   
December 31, 2012
 
   
Quoted
Prices in
Active
Markets
for
Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant
Unobservable
Inputs
     
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
Series l Warrants
 
$
  
$
  
$
4,172
  
$
4,172
 
Level 3 financial liability
The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012
 
 
 
Six Months Ended
June 30, 2013
 
 
 
Six Months Ended
June 30, 2012
 
 
 
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
 
 
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
Balance December 31, 2012
 
$
4,172
 
Balance December 31, 2011
 
$
4,699
 
Gain on derivative liability included in net loss
  
(1,486
)
Loss on derivative liability included in net loss
  
1,979
 
Settlements
  
 
Settlements
  
(1,415
)
Balance June 30, 2013
 
$
2,686
 
Balance June 30, 2012
 
$
5,263
 
XML 21 R25.xml IDEA: Stock-Based Compensation (Details) 2.4.0.8090600 - Disclosure - Stock-Based Compensation (Details)truefalseIn Thousands, except Share data, unless otherwise specifiedfalse1false USDfalsefalse$c20130401to20130630http://www.sec.gov/CIK0001082324duration2013-04-01T00:00:002013-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$c20120401to20120630http://www.sec.gov/CIK0001082324duration2012-04-01T00:00:002012-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$c20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00U006Standardhttp://www.xbrl.org/2003/instancepurexbrli0U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$c20120101to20120630http://www.sec.gov/CIK0001082324duration2012-01-01T00:00:002012-06-30T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$c20121231http://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse25000002500000falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse25000002500000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false13false 4vhc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAwardvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse0010 yearsfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaPeriod of equity-based compensation awards that have actual or potential impact upon the company's financial statements.No definition available.false04false 4vhc_MinimumExercisePriceOfIsoGrantedvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse11falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepureMinimum exercise price of ISO granted to any employee as percentage of fair market value at the date of grant.No definition available.false05false 4vhc_MinimumExercisePriceOfNsoGrantedvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse0.850.85falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepureMinimum exercise price of NSO granted to any employee as percentage of fair market value at the date of grant.No definition available.false06false 4vhc_MinimumExercisePriceOfOptionsGrantedToNamedExecutiveOfficersvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse11falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepureMinimum exercise price of options granted to named executive officers as percentage of fair market value at the date of grant.No definition available.false07false 4vhc_MinimumExercisePriceOfOptionsGrantedTo10Shareholdersvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse1.11.1falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepureMinimum exercise price of options granted to 10% percentage shareholder's as percentage of fair market value at the date of grant.No definition available.false08false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse50098495009849falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse50098495009849falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse47762244776224falsefalsefalsexbrli:sharesItemTypesharesThe number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(1)(a) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(1)(b) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false19false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse7.877.87USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse7.877.87USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse6.946.94USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(1)(a) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false310false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse274625274625falsefalsefalse4truefalsefalse277500277500falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesGross number of share options (or share units) granted during the period.No definition available.false111false 4us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse19.2419.24USD$falsetruefalse4truefalsefalse22.2622.26USD$falsetruefalse5falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalWeighted average price at which grantees can acquire the shares reserved for issuance on stock options awarded.No definition available.false312false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse17590001759USD$falsetruefalse2truefalsefalse14660001466USD$falsetruefalse3truefalsefalse33440003344USD$falsetruefalse4truefalsefalse23400002340USD$falsetruefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 64 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=6793087&loc=d3e301413-122809 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph g(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false213false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6false USDtruefalsec20130401to20130630_AwardTypeAxis_StockOptionsMemberhttp://www.sec.gov/CIK0001082324duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseStock Options [Member]us-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_StockOptionsMemberus-gaap_AwardTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse014true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse015false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse004 yearsfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaPeriod which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false016false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse00falsefalsefalse4truetruefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepureThe estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph e(2)(c) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false017false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse0.930.93falsefalsefalse4truetruefalse1.151.15falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepureThe range of expected volatilities used and the weighted-average expected volatility for an entity using a valuation technique with different volatilities during the contractual term.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph e(2)(b) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false018false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse0.02060.0206falsefalsefalse4truetruefalse0.01920.0192falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepureThe risk-free interest rate assumption that is used in valuing an option on its own shares.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph e(2)(d) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false019false 4us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse006 yearsfalsefalsefalse4falsefalsefalse007 yearsfalsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaExpected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.D.2) -URI http://asc.fasb.org/extlink&oid=6793087&loc=d3e301413-122809 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section D -Subsection 2 false020false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1537200015372USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1537200015372USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAs of the balance sheet date, the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to vest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph h -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false221false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse002 years 8 months 19 daysfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false022false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse9false USDtruefalsec20130401to20130630_AwardTypeAxis_RestrictedStockMemberhttp://www.sec.gov/CIK0001082324duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseRestricted Stock [Member]us-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RestrictedStockMemberus-gaap_AwardTypeAxisexplicitMemberU001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse023true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse024false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse004 yearsfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaPeriod which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false025false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse248915248915falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse248915248915falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse151665151665falsefalsefalsexbrli:sharesItemTypesharesThe number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(2)(b) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(2)(a) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false126false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse24.1024.10USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse24.1024.10USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse25.6025.60USD$falsetruefalsenum:perShareItemTypedecimalThe weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(2)(b) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(2)(a) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false327false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse156415156415falsefalsefalse4truefalsefalse151665151665falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThe number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(2)(c) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false128false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValueus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse23.7223.72USD$falsetruefalse4truefalsefalse25.6025.60USD$falsetruefalse5falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalThe weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph c(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(2)(c) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false329false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse53720005372USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse53720005372USD$falsetruefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAs of the balance sheet date, the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to vest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph h -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false230false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse003 years 2 months 16 daysfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false031false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse13false truefalsec20130101to20130630_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMemberhttp://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseRestricted Stock [Member]us-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RestrictedStockMemberus-gaap_AwardTypeAxisexplicitMemberfalsefalseMinimum [Member]us-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MinimumMemberus-gaap_RangeAxisexplicitMembernanafalse032true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse033false 4us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse001 yearfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average remaining contractual term for fully vested and expected to vest options that are exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false034false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse14false truefalsec20130101to20130630_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMemberhttp://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseRestricted Stock [Member]us-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RestrictedStockMemberus-gaap_AwardTypeAxisexplicitMemberfalsefalseMaximum [Member]us-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MaximumMemberus-gaap_RangeAxisexplicitMembernanafalse035true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse036false 4us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse004 yearsfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average remaining contractual term for fully vested and expected to vest options that are exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0falseStock-Based Compensation (Details) (USD $)ThousandsNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://virnetx.com/role/StockbasedCompensationDetails536 XML 22 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Litigation (Details) (USD $)
In Thousands, unless otherwise specified
0 Months Ended 6 Months Ended
Feb. 26, 2013
Jun. 30, 2013
Lawsuit
Complaint
Nov. 06, 2012
Patent
Jan. 12, 2011
Patent
Aug. 11, 2010
Patent
Litigation [Abstract]          
Number of intellectual property infringement lawsuits pending   5      
Number of unfair trade practices complaints filed   1      
Amount of damages awarded in patent infringement case   $ 368,000      
Number of patents allegedly infringed upon by Apple, Inc.     4 3 4
Amount of interest payment awarded up to final judgment, per day   34      
Amount of damage infringement payment awarded up to final judgment, per day   $ 330      
Court order mediation interval 45 days        
Percentage of proceeds to be paid after deducting and legal fees (in hundredths)   25.00%      
XML 23 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details) (USD $)
6 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Jun. 30, 2013
Warrants [Member]
Jun. 30, 2013
Warrants [Member]
Series I Warrants [Member]
Warrants [Line Items]        
Original number of warrants issued (in shares)       2,619,036 [1]
Exercise price per common share (in dollars per share) $ 3.59 $ 3.59   $ 3.59
Exercisable at beginning of year (in shares)     159,967 159,967
Became exercisable (in shares)       0
Exercised (in shares)     0 0
Terminated/cancelled/expired (in shares)     0 0
Exercisable (in shares)     159,967 159,967
Expiration date       March 2015
[1] Referred to as our Series I Warrants.
XML 24 R19.xml IDEA: Warrants (Tables) 2.4.0.8080700 - Disclosure - Warrants (Tables)truefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_WarrantsAndRightsNoteDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Information about warrants outstanding during the six months ended June 30, 2013 follows:</div><div style="text-align: left;"><br /></div><div style="text-align: left;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Original </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Number of</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Warrants </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Issued</div></td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercise</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Price per </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Common</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Share</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable at</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31,</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Became</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercised</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Terminated /</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Cancelled /</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Expired</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">at June 30, </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 15%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Expiration</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Date</div></td></tr><tr><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 15%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,619,036</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">3.59</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">159,967</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div>159,967</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 15%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt;">March 2015</div></td></tr><tr style="height: 20px;"><td bgcolor="#ffffff" colspan="2" valign="bottom" style="padding-bottom: 4px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">159,967</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;">159,967</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 15%; vertical-align: bottom;"><div style="text-align: left;">&#160;&#160;&#160;</div></td></tr></table></div><div><br /></div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr style="vertical-align: top;"><td style="width: 18pt;">&#160;</td><td style="width: 18pt; vertical-align: top; align: right;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">(1)</div></td><td style="width: auto; vertical-align: top; align: left;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Referred to as our Series I Warrants.</div></td></tr></table></div></div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Article 4 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 28 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number D-98 -Paragraph 2 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseWarrants (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/WarrantsTables12 XML 25 R9.xml IDEA: Patent Portfolio 2.4.0.8060300 - Disclosure - Patent Portfoliotruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_IntangibleAssetsDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 3 &#8212; Patent Portfolio</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">As of June 30, 2013, we own 21 issued U.S. and 41 issued foreign patents, in addition to several pending U.S. and foreign patent applications. &#160;Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. &#160;Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation, or SAIC, in 2006 and we are required to make payments to SAIC based on cash or certain other values generated from those patents. &#160;The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, SAIC is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX or from the settlement of certain patent infringement claims of ours. Capitalized patent costs, net of amortization, are included in intangible and other assets in the accompanying Condensed Consolidated Balance Sheet at December 31, 2012, and were fully amortized at June 30, 2013.</div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for all or part of the information related to intangible assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7658586&loc=d3e16323-109275 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7658586&loc=d3e16373-109275 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7658586&loc=d3e16265-109275 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 44, 45, 46 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falsePatent PortfolioUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/PatentPortfolio12 XML 26 R12.xml IDEA: Stock-Based Compensation 2.4.0.8060600 - Disclosure - Stock-Based Compensationtruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 6 &#8212; Stock-Based Compensation</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On May 22, 2013, our stockholders approved the VirnetX Holding Corporation 2013 Equity Incentive Plan (the "Plan) at our 2013 annual stockholders' meeting. &#160;The Plan provides for the issuance of up to 2,500,000 shares of our common stock. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the Plan. The Plan provides for the granting of stock options and restricted stock purchase rights (RSU) to our employees and consultants. Stock options granted under the Plan may be incentive stock options or nonqualified stock options. Incentive stock options ("ISO") may only be granted to our employees (including officers and directors). Nonqualified stock options ("NSO") and stock purchase rights may be granted to our employees and consultants.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The Plan will expire 10 years after it was approved by our Board of Directors. Options may be granted under the Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the fair market value at the date of grant in the case of an NSO, the exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant. Stock options granted under the Plan typically vest over four years and have a 10 year term. All RSUs are considered to be granted at the fair value of our stock on the date of grant because they have no exercise price. RSUs typically vest over four years.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We had 5,009,849 and 4,776,224 options outstanding at June 30, 2013 and December 31, 2012, respectively, with a weighted-average exercise price of $7.87 and $6.94, respectively. At June 30, 2013 and December 31, 2012, we had 248,915 and 151,665 RSU&#8217;s outstanding with a weighted-average grant-date fair value of $24.10 and $25.60, respectively.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">During the six months ended June 30, 2013 and 2012, we granted options for a total of 274,625 and 277,500 shares respectively. The weighted average fair values at the grant dates for options issued during the six months ending June 30, 2013 and 2012 were $19.24 and $22.26 per option, respectively. The fair value of options at the grant date was estimated utilizing the Black-Scholes valuation model with following weighted average assumptions for the six months ending June 30, 2013 and 2012, respectively: (i) dividend yield on our common stock of 0 percent and 0 percent; (ii) expected stock price volatility of 93 percent and 115 percent; (iii) a risk-free interest rate of 2.06 percent and 1.92 percent; and (iv) an expected option term of 6 and 7 years.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">During the six months ended June 30, 2013 and 2012, we also granted RSUs totaling 156,415 and 151,665 units, respectively, that vest ratably over one to four years. The weighted-average fair values of each issued RSU on the dates of grant were $23.72 and $25.60, respectively. RSUs, which are subject to forfeiture if employment terminates prior to the shares vesting, are expensed ratably over the vesting period.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Stock-based compensation expense is measured at grant date, based on the fair value of the award, and is recognized over the employees&#8217; requisite service period. Stock-based compensation expense included in general and administrative expense was $1,759 and $3,344 for the three and six months ended June 30, 2013, respectively, and $1,466 and $2,340 for the three and six months ended June 30, 2012, respectively.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">As of June 30, 2013 and 2012, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $15,372 and $5,372, respectively, which will be amortized over an estimated weighted average vesting amortization period of approximately 2.72 and 3.21 years, respectively.</div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 64, 65, A240 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 93-6 -Paragraph 53 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseStock-Based CompensationUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/StockbasedCompensation12 XML 27 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares authorized for issuance (in shares) 2,500,000   2,500,000    
Term of Plan     10 years    
Minimum exercise price of ISO granted (in hundredths)     100.00%    
Minimum exercise price of NSO granted (in hundredths)     85.00%    
Minimum exercise price of options granted to named executive officers (in hundredths)     100.00%    
Minimum exercise price of options granted to 10% shareholders (in hundredths)     110.00%    
Stock options outstanding (in shares) 5,009,849   5,009,849   4,776,224
Average exercise price (in dollars per share) $ 7.87   $ 7.87   $ 6.94
Options granted (in shares)     274,625 277,500  
Options granted, weighted average fair values (in dollars per share)     $ 19.24 $ 22.26  
Stock-based compensation expense $ 1,759 $ 1,466 $ 3,344 $ 2,340  
Stock Options [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
Dividend yield (in hundredths)     0.00% 0.00%  
Expected stock price volatility (in hundredths)     93.00% 115.00%  
Risk-free interest rate (in hundredths)     2.06% 1.92%  
Expected option term     6 years 7 years  
Unrecognized stock based compensation expense 15,372   15,372    
Weighted average vesting amortization period 2 years 8 months 19 days        
Restricted Stock [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
RSU's outstanding (in shares) 248,915   248,915   151,665
Weighted average grant date fair value of RSU's outstanding (in dollars per share) $ 24.10   $ 24.10   $ 25.60
RSUs granted (in shares)     156,415 151,665  
Weighted average grant date fair value of RSU's granted (in dollars per share)     $ 23.72 $ 25.60  
Unrecognized stock based compensation expense $ 5,372   $ 5,372    
Weighted average vesting amortization period 3 years 2 months 16 days        
Restricted Stock [Member] | Minimum [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period of restricted share units     1 year    
Restricted Stock [Member] | Maximum [Member]
         
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period of restricted share units     4 years    
XML 28 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities:    
Net loss $ (14,922) $ (14,971)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 23 36
Stock-based compensation 3,344 2,340
Net change in deferred taxes 0 204
Change in value of derivative liability (1,486) 1,979
Changes in assets and liabilities:    
Prepaid taxes 14,963 5,192
Prepaid expenses and other current assets (487) (259)
Accounts payable and accrued liabilities (1,336) 4,032
Net cash provided by (used in) operating activities 99 (1,447)
Cash flows from investing activities:    
Purchase of property and equipment (7) (26)
Purchase of investments (13,000) (33,599)
Proceeds from sale or maturity of investments 26,094 22,208
Net cash provided by (used in) investing activities 13,087 (11,417)
Cash flows from financing activities:    
Proceeds from exercise of stock options 31 1,175
Proceeds from exercise of warrants 0 156
Net cash provided by financing activities 31 1,331
Net (increase) decrease in cash and cash equivalents 13,217 (11,533)
Cash and cash equivalents, beginning of period 19,661 49,482
Cash and cash equivalents, end of period $ 32,878 $ 37,949
XML 29 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2013
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2 – Summary of Significant Accounting Policies

Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements can be complex and may or may not include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the FASB revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue arrangements with multiple deliverables and the guidance for revenue recognition. Under our patent license agreements, we typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

 ·Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.

 ·Current Royalty Payments: These are ongoing royalty payments covering a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe Current Royalty Payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.

For the three and six months ended June 30, 2013, we recognized royalty revenue of $6 and $300 respectively, compared to $36 for the three and six months ended June 30, 2012, as part of license agreements entered into with customers during the patent infringement actions (see “Legal Proceedings”).  In accordance with our revenue recognition policy related to a licensee’s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.  In the patent infringement actions we did not request, nor receive any amounts allocable to settlement fees, expense reimbursement, damages or any other amount unrelated to historical sales.  Revenue from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.

Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.  During the six months ended June 30, 2013 we had, at times, funds which were uninsured.   We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.

Derivative Instruments

Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock.  The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.
 
Impairment of Long-Lived Assets

On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Certificate of deposits: Fair value measured at face value plus accrued interest.

Corporate bonds:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.

Series I Warrants: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for June 30, 2013, included a warrant exercise price of $3.59 per share, a common share price of $19.99, a discount rate of 1.41%, and a volatility of 93%. The assumptions used for December 31, 2012, were a warrant exercise price of $3.59 per share, a common share price of $29.28, a discount rate of 0.72%, and a volatility of 94%.

The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.

 
 
June 30, 2013
 
Level 1:
 
Adjusted Cost
  
Unrealized
Gains
  
Unrealized
Losses
  
Fair Value
 
Certificates of deposit
 
$
351
  
$
  
$
  
$
351
 
 
                
Corporate Bonds:
                
AA
  
13,027
   
4
   
   
13,031
 
Total Corporate Bonds
  
13,027
   
4
   
   
13,031
 
 
                
Total Investments at Fair Value
 
$
13,378
  
$
4
  
$
  
$
13,382
 

 
  
December 31, 2012
 
Level 1:
 
Adjusted Cost
  
Unrealized
Gains
  
Unrealized
Losses
  
Fair Value
 
Certificates of deposit
 
$
17,836
  
$
  
$
  
$
17,836
 
                 
Corporate bonds:
                
AA
  
4,099
   
   
   
4,099
 
A
  
4,039
   
8
   
   
4,047
 
BAA
  
511
   
   
   
511
 
Total corporate bonds
  
8,649
   
8
   
   
8,657
 
                 
Total investments at fair value
 
$
26,485
  
$
8
  
$
  
$
26,493
 
 
The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.
 
   
June 30, 2013
 
   
Quoted
Prices in
Active
Markets for
Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant
Unobservable
Inputs
     
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
Series l Warrants
  
   
   
2,686
   
2,686
 

   
December 31, 2012
 
   
Quoted
Prices in
Active
Markets
for
Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant
Unobservable
Inputs
     
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
Series l Warrants
 
$
  
$
  
$
4,172
  
$
4,172
 

The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012
 
 
 
Six Months Ended
June 30, 2013
 
 
 
Six Months Ended
June 30, 2012
 
 
 
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
 
 
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
Balance December 31, 2012
 
$
4,172
 
Balance December 31, 2011
 
$
4,699
 
Gain on derivative liability included in net loss
  
(1,486
)
Loss on derivative liability included in net loss
  
1,979
 
Settlements
  
 
Settlements
  
(1,415
)
Balance June 30, 2013
 
$
2,686
 
Balance June 30, 2012
 
$
5,263
 

New Accounting Pronouncement

In July 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ASU No. 2013-11 is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The new standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The new standard becomes effective for us on January 1, 2014 and will be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted. We are currently assessing the impacts of this new standard.
 
In February 2013, the FASB issued final guidance on the presentation of reclassifications out of other comprehensive income. The amendments require an entity to provide information about the amounts reclassified out of other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in a footnote, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, only if the amount reclassified is required by GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide detail about those amounts. This amendment was effective for interim and fiscal years beginning after December 15, 2012. The amended standard did not impact our financial position or results of operations.
XML 30 R11.xml IDEA: Commitments 2.4.0.8060500 - Disclosure - Commitmentstruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_CommitmentsAndContingenciesDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_CommitmentsDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-weight: bold;">Note 5 &#8212; Commitments</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On October 30, 2011, we entered into a new lease agreement for our corporate headquarters. The lease commencement date was October 30, 2011 and includes monthly payments of $5 until the lease term expires in October 2013</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We entered into a non-cancelable agreement for corporate promotional and marketing purposes for a period of ten years at a cost of $4,000. Initial payments of $250 have been prepaid and are included in prepaid expenses and other current assets on our Condensed Consolidated Balance Sheet. The remaining balance is due on March 1 of the year the facility will become available for use, which the lessor anticipates will be in 2014 or 2015, at which time we will begin amortizing the agreement over the contract period. &#160;The lease terms include certain refunds, deductions, etc. in the event construction is delayed or not completed within specified time-frames.</div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 25 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 17 -Article 9 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.17) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.(a)(19)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 false0falseCommitmentsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/Commitments12 XML 31 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments
6 Months Ended
Jun. 30, 2013
Commitments [Abstract]  
Commitments
Note 5 — Commitments

On October 30, 2011, we entered into a new lease agreement for our corporate headquarters. The lease commencement date was October 30, 2011 and includes monthly payments of $5 until the lease term expires in October 2013

We entered into a non-cancelable agreement for corporate promotional and marketing purposes for a period of ten years at a cost of $4,000. Initial payments of $250 have been prepaid and are included in prepaid expenses and other current assets on our Condensed Consolidated Balance Sheet. The remaining balance is due on March 1 of the year the facility will become available for use, which the lessor anticipates will be in 2014 or 2015, at which time we will begin amortizing the agreement over the contract period.  The lease terms include certain refunds, deductions, etc. in the event construction is delayed or not completed within specified time-frames.
XML 32 R14.xml IDEA: Litigation 2.4.0.8060800 - Disclosure - Litigationtruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1vhc_LitigationAbstractvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_LegalMattersAndContingenciesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 8 &#8212; Litigation</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We have five intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints. We have one complaint with the United States International Trade Commission (ITC) alleging that Apple, Inc. has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.&#8217;s infringement through the district courts. &#160;The ITC case has been terminated.</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. et al., v. Microsoft Corporation</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274. &#160;We seek damages and injunctive relief. &#160;No hearing or trial dates have been set.</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Cisco Systems, Inc. et al and VirnetX Inc. v. Apple Inc. (Severed Case)</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief. On February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we again amended our complaint against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to include Apple&#8217;s iPad 2 in the list of Apple products that are accused of infringing our patents. We also asserted our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC have signed license agreements with us and we have agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to postpone the trial against Cisco to March 4, 2013 and just try the case against Apple. On November 6, 2012, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368,000 in a verdict against Apple Corporation for infringing four of our patents. A post-trial hearing in the case against Apple was held on December 20, 2012. On February 26, 2013, the United States District Court for the Eastern District of Texas, Tyler Division issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict. The Court denied Apple&#8217;s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple&#8217;s request for a new trial on the liability and damages portions of the verdict. Additionally, the Court granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. Specifically, the Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction. In doing so, the Court ordered the parties to mediate over a license in the following 45 days for Apple&#8217;s future infringing use not covered by the Court&#8217;s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court&#8217;s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are &#8220;not colorably different&#8221; with regards to the accused functionality. However, the judgment may be appealed and no assurances can be given as to when or if we will receive any proceeds in connection with these matters, and accordingly there has been no recognition of the jury awards or royalties in our accompanying financial statements. Under our agreements with Science Applications International Corporation (SAIC), we would pay to SAIC 25% of the proceeds obtained by us in this lawsuit against Apple after reduction for attorneys&#8217; fees and costs incurred in litigating those claims.&#160;We are awaiting the Court&#8217;s decision in this matter. &#160;On July 1, 2013, the Court entered an Order setting a hearing on VirnetX&#8217;s motion for an ongoing royalty for August 15, 2013. &#160;On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple&#8217;s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit.</div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;">The jury trial against Cisco was held on March 4, 2013. At the end of the trial, the jury came back with a verdict of non-infringement in the trial. The same jury also found that all our patents-in-suit were valid and enforceable. On April 3, 2013, we filed a request for a new trial regarding Cisco&#8217;s infringement of four of our patents based primarily on our allegations of Cisco&#8217;s inappropriate conduct and arguments during the jury trial that concluded on March 14, 2013. In addition to the request for a new trial, we filed a motion for a judgment as a matter of law on Cisco&#8217;s infringement of the &#8216;759 patent. On April 11, 2013, in response to our motion, Cisco filed its renewed motion to dismiss as moot its invalidity counterclaims against the claims in our patents that were not asserted in the lawsuit as well as a conditional motion for a new trial on certain limited claims and defenses. We are awaiting the Court&#8217;s decision in this matter. &#160;A hearing on VirnetX&#8217;s motion for new trial and Cisco&#8217;s renewed motion to dismiss as moot its invalidity counterclaims and conditional motion for a new trial was held on June 17, 2013. &#160;We are awaiting the Court&#8217;s ruling on these motions.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Mitel Networks Corporation et al</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On January 12, 2011, we initiated a lawsuit by filing a complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these companies infringe three of our patents. We seek damages and injunctive relief. On April 12, 2011 we again amended our complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, to add Avaya Inc. as a defendant. On July 11, 2012, Mitel Network Corporation signed a license agreement with us and we dismissed the patent infringement case against them. On July 12, 2012 we had a claims construction hearing in this case and a Markman order was issued on August 1, 2012. On January 29, 2013 Siemens signed a license agreement with us and we dismissed the patent infringement case against them. On April 9, 2013, the Court issued a new docket control order in our lawsuit against the remaining defendant Avaya Inc. According to this new order, jury selection is set for September 3, 2013 followed by a jury trial on September 9, 2013. A pretrial conference has been scheduled for August 22, 2013.</div><div style="text-align: left;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Apple, Inc.</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On November 1, 2011, we initiated a lawsuit against Apple in the United States District Court, Tyler Division, pursuant to which we allege that Apple infringes one or more claims of our U.S. Patent No. 8,051,181. We seek damages and injunctive relief. No hearing or trial dates have been set. &#160;On June 17, 2013 the Court granted VirnetX&#8217;s unopposed motion to lift the stay ordered by the Court on December 15, 2011. &#160;On June 18, 2013 the Court granted the parties unopposed motion to consolidate this case with Civil Action No. 6:12-cv-00855-LED.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Apple, Inc.</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. &#160;On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">ITC Investigation No. 337-TA-858</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On July 18, 2012, the Administrative Law Judge (ALJ) assigned to investigate our complaint against Apple Inc., identified a procedural discrepancy with our complaint and dismissed it. On September 14, 2012, we re-filed our complaint with the ITC jointly with Science Applications International Corporation (SAIC) [NYSE: SAI] to remove a procedural standing issue that was identified as the reason for dismissal of our previous complaint. On October 16, 2012, the United States International Trade Commission (ITC) accepted our complaint and instituted an investigation against Apple and assigned ALJ E. James Gildea to preside over this investigation. Subsequently on October 23, 2012, ALJ Gildea issued an order setting up February 21, 2014 as the target date for completion of this investigation. The hearing in-front of ALJ Gildea was scheduled for May 20, 2013. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.&#8217;s infringement through the district courts. &#160;The ITC case has been terminated.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.</div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.No definition available.false0falseLitigationUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/Litigation12 XML 33 R2.xml IDEA: CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) 2.4.0.8010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$c20130630http://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$c20121231http://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_AssetsCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse3287800032878USD$falsetruefalse2truefalsefalse1966100019661USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false23false 4us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1338200013382falsefalsefalse2truefalsefalse2649300026493falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of debt securities categorized neither as held-to-maturity nor trading which are intended be sold or mature within one year from the balance sheet date or the normal operating cycle, whichever is longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS115-1/124-1 -Paragraph 15C -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 16 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 22 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS115-1/124-1 -Paragraph 15D -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26626-111562 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Section A -Paragraph 4, 5 -Chapter 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 13, 17 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS115-1/124-1 -Paragraph 15E -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false24false 4us-gaap_PrepaidTaxesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00falsefalsefalse2truefalsefalse1496300014963falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date of payments made in advance for income and other taxes, which will be charged against earnings within one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Section A -Paragraph 4 -Chapter 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Assets -URI http://asc.fasb.org/extlink&oid=6509628 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6787-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5865-108316 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (g)(4) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 false25false 4us-gaap_PrepaidExpenseAndOtherAssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse601000601falsefalsefalse2truefalsefalse114000114falsefalsefalsexbrli:monetaryItemTypemonetaryThe total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Section A -Paragraph 4 -Chapter 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false26false 4us-gaap_AssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse4686100046861falsefalsefalse2truefalsefalse6123100061231falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.9) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 true27false 3us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse6500065falsefalsefalse2truefalsefalse7000070falsefalsefalsexbrli:monetaryItemTypemonetaryAmount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 12 -Paragraph 5 -Subparagraph b, c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false28false 3vhc_IntangibleAndOtherAssetsvhc_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00falsefalsefalse2truefalsefalse1200012falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. And, aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).No definition available.false29false 3us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse4692600046926falsefalsefalse2truefalsefalse6131300061313falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. true210true 3us-gaap_LiabilitiesCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse011false 4us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse18610001861falsefalsefalse2truefalsefalse31970003197falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Article 5 false212false 4us-gaap_DerivativeLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse26860002686falsefalsefalse2truefalsefalse41720004172falsefalsefalsexbrli:monetaryItemTypemonetaryFair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Liabilities -URI http://asc.fasb.org/extlink&oid=6509677 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Section A -Paragraph 7 -Chapter 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13495-108611 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FIN39-1 -Paragraph 10A, 10B -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 4, 17 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false213false 4us-gaap_LiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse45470004547falsefalsefalse2truefalsefalse73690007369falsefalsefalsexbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 true214true 3us-gaap_StockholdersEquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse015false 4us-gaap_PreferredStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false216false 4us-gaap_CommonStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse50005falsefalsefalse2truefalsefalse50005falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false217false 4us-gaap_AdditionalPaidInCapitalus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse120229000120229falsefalsefalse2truefalsefalse116856000116856falsefalsefalsexbrli:monetaryItemTypemonetaryExcess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false218false 4us-gaap_RetainedEarningsAccumulatedDeficitus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse-77847000-77847falsefalsefalse2truefalsefalse-62925000-62925falsefalsefalsexbrli:monetaryItemTypemonetaryThe cumulative amount of the reporting entity's undistributed earnings or deficit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false219false 4us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-8000-8falsefalsefalse2truefalsefalse80008falsefalsefalsexbrli:monetaryItemTypemonetaryAccumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e681-108580 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669686-108580 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS115-1/124-1 -Paragraph 15D -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 false220false 4us-gaap_StockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse4237900042379falsefalsefalse2truefalsefalse5394400053944falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 true221false 3us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse4692600046926USD$falsetruefalse2truefalsefalse6131300061313USD$falsetruefalsexbrli:monetaryItemTypemonetaryTotal of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 true2falseCONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/CondensedConsolidatedBalanceSheetsUnaudited221 XML 34 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Patent Portfolio
6 Months Ended
Jun. 30, 2013
Patent Portfolio [Abstract]  
Patent Portfolio
Note 3 — Patent Portfolio

As of June 30, 2013, we own 21 issued U.S. and 41 issued foreign patents, in addition to several pending U.S. and foreign patent applications.  Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.  Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation, or SAIC, in 2006 and we are required to make payments to SAIC based on cash or certain other values generated from those patents.  The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, SAIC is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX or from the settlement of certain patent infringement claims of ours. Capitalized patent costs, net of amortization, are included in intangible and other assets in the accompanying Condensed Consolidated Balance Sheet at December 31, 2012, and were fully amortized at June 30, 2013.
XML 35 R24.xml IDEA: Commitments (Details) 2.4.0.8090500 - Disclosure - Commitments (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$c20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_CommitmentsAndContingenciesDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2vhc_OperatingLeasesPeriodicRentalExpensesvhc_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse50005USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of periodic rental payment required to pay monthly till the lease expiry term.No definition available.false23false 2us-gaap_LeaseExpirationDate1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002013-10-31falsefalsetruexbrli:dateItemTypedateDate which lease or group of leases is set to expire, in CCYY-MM-DD format.No definition available.false04false 2vhc_LesseeLeasingArrangementsOperatingLeasesTermOfContractvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse0010 yearsfalsefalsefalsexbrli:durationItemTypenaTerm of the lessee's leasing arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.No definition available.false05false 2us-gaap_OperatingLeasesFutureMinimumPaymentsDueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse40000004000falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 13 -Paragraph 122 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 13 -Paragraph 16 -Subparagraph b(i) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false26false 2us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse250000250USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false2falseCommitments (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/CommitmentsDetails16 XML 36 R10.xml IDEA: Income Taxes 2.4.0.8060400 - Disclosure - Income Taxestruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_IncomeTaxDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_IncomeTaxDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 4 - Income Taxes</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The income tax expense for the three months ended June 30, 2013 was $354, which was a negative effective income tax rate of 5 percent. The income tax expense for the six months ended June 30, 2013 was $356, which was a negative effective income tax rate of 2.5 percent. As a result of net operating losses during the periods the provision reflects only minimum tax payments and prior year tax true-up. &#160;The tax expense was calculated using the statutory U.S. federal rate primarily as a result of the change of the valuation allowance of $5,695, stock based compensation expense and non-deductible derivative loss. We have valuation allowances covering our deferred tax assets including net operating loss carry-forwards.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The income tax benefit for the three months ended June 30, 2012 was $3,590, which was an effective income tax rate of 26 percent. The income tax benefit for the six months ended June 30, 2012 was $5,763, which was an effective income tax rate of 28 percent.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2013 will not be fully realizable. Accordingly, management has maintained a valuation allowance against&#160;our net deferred tax assets at June 30, 2013. The valuation allowance carried against our net deferred tax assets was $11,423 and $6,970 at June 30, 2013 and December 31, 2012, respectively.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">At June 30, 2013, we have federal and state net operating loss carry-forwards of approximately $15,527 and $52,756 respectively, expiring beginning in 2027 and 2016, respectively.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.</div><div style="text-align: justify;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2013, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.</div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 136, 172 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 43, 44, 45, 46, 47, 48, 49 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseIncome TaxesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/IncomeTaxes12 XML 37 R5.xml IDEA: CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) 2.4.0.8030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$c20130401to20130630http://www.sec.gov/CIK0001082324duration2013-04-01T00:00:002013-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$c20120401to20120630http://www.sec.gov/CIK0001082324duration2012-04-01T00:00:002012-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$c20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$c20120101to20120630http://www.sec.gov/CIK0001082324duration2012-01-01T00:00:002012-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_ComprehensiveIncomeNetOfTaxAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-7029000-7029USD$falsetruefalse2truefalsefalse-10264000-10264USD$falsetruefalse3truefalsefalse-14922000-14922USD$falsetruefalse4truefalsefalse-14971000-14971USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false23true 2us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 3us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTaxus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse-12000-12falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse-12000-12falsefalsefalse4truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after tax, before reclassification adjustments, resulting from the process of expressing in the reporting currency of the reporting entity those amounts that are denominated or measured in a different currency, and from transactions whose terms are denominated in a currency other than the entity's functional currency.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 52 -Paragraph 13, 20, 31 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32022-110900 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 45 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32157-110900 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 17 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 10A -Subparagraph (a-c) -URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669646-108580 false25false 3us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse40004falsefalsefalse2truefalsefalse10001falsefalsefalse3truefalsefalse-4000-4falsefalsefalse4truefalsefalse-17000-17falsefalsefalsexbrli:monetaryItemTypemonetaryNet of tax amount of unrealized holding gain (loss) before reclassification adjustments and transfers on available-for-sale securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 13 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 10A -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669646-108580 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 24 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 17, 22 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false26false 2us-gaap_OtherComprehensiveIncomeOtherNetOfTaxus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-8000-8falsefalsefalse2truefalsefalse10001falsefalsefalse3truefalsefalse-16000-16falsefalsefalse4truefalsefalse-17000-17falsefalsefalsexbrli:monetaryItemTypemonetaryThe change in other comprehensive income during the reporting period, net of tax, for an item that is not separately disclosed.No definition available.true27false 2us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-7037000-7037USD$falsetruefalse2truefalsefalse-10263000-10263USD$falsetruefalse3truefalsefalse-14938000-14938USD$falsetruefalse4truefalsefalse-14988000-14988USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A5 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591552-111686 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. true2falseCONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited47 EXCEL 38 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F7S0R,C%?8C`U,%]F,38T M,#AC964Q9&4B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI M=&UE;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M#I7;W)K M#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DQI=&EG871I;VX\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U M;6UA#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7T1E=&%I;',\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV M95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!&:6QE'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^3&%R9V4@06-C96QE M2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^9F%L'0^2G5N(#,P+`T*"0DR,#$S/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X M-3-F7S0R,C%?8C`U,%]F,38T,#AC964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,&9A-34Q931?.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E M,61E+U=O'0O:'1M;#L@8VAA&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F5D.B`Q,#`L,#`P+#`P,"!S:&%R97,@870@ M2G5N92`S,"P@,C`Q,R!A;F0@1&5C96UB97(@,S$L,C`Q,BP@27-S=65D(&%N M9"!O=71S=&%N9&EN9SH@;F]N93PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F7S0R,C%?8C`U,%]F,38T,#AC M964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&9A-34Q931? M.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E,61E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N M;&5S'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XV+#4X-#QS<&%N/CPO"`H97AP96YS92D@8F5N969I=#PO=&0^#0H@("`@("`@(#QT M9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F M7S0R,C%?8C`U,%]F,38T,#AC964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,&9A-34Q931?.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E,61E M+U=O'0O M:'1M;#L@8VAA2!4#PO=&0^#0H@("`@("`@(#QT9"!C;&%S M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879AF%T:6]N M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,SQS<&%N/CPO3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PY-C,\'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M/B@W*3QS<&%N/CPO&5R8VES92!O9B!W87)R86YT3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F7S0R,C%?8C`U,%]F,38T M,#AC964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&9A-34Q M931?.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E,61E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA M;B3H@)R=4:6UEF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^3F]T92`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`L(#(P,3,@86YD(#(P,3([("AI:6DI('1H M92!C;VYD96YS960@8V]N7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`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`G)U1I;65S M($YE=R!2;VUA;B6QE/3-$)W1E M>'0M86QI9VXZ(&IU6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E M;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI M;'DZ("=4:6UE6QE/3-$ M)V9O;G0M6%L='D@9F]R('!A6%L='D@&5C=71I;VX@;V8@=&AE(&QI8V5N2!H87,@;V-C M=7)R960L('=E(')E8V]R9"!T:&4@8V]N2!A MF4Z(#$P<'0[)SX\='(^/'1D('-T>6QE/3-$)W=I M9'1H.B`Q.'!T.R<^)B,Q-C`[/"]T9#X\=&0@6UB;VPL('-EF4Z(#$P M<'0[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B!A M=71O.R!F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[('9E6QE.B!I=&%L:6,[(&9O;G0M9F%M M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B2!087EM96YT6%L='D@<&%Y;65N=',@8V]V97)I;F<@ M82!L:6-E;G-E928C.#(Q-SMS(&]B;&EG871I;VYS('1O('5S(')E;&%T960@ M=&\@:71S('-A;&5S(&]F(&-O=F5R960@<')O9'5C=',@:6X@=&AE(&-U2!087EM96YT2!R97!O2!O M8FQI9V%T:6]N2!R97!OF4@3H@)R=4:6UEF4Z(#$P<'0[)SY&;W(@=&AE('1H M2!R979E;G5E(&]F("0V(&%N9"`D,S`P(')E2P@8V]M<&%R960@=&\@)#,V(&9O"!M;VYT:',@96YD960@2G5N92`S,"P@,C`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`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W1E>'0M M86QI9VXZ(&IU6QE/3-$)W1E M>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M3H@)R=4:6UEF4Z(#$P<'0[)SX\9F]N="!S M='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`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`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^061J=7-T960@ M0V]S=#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)V)OF5D M(#PO9&EV/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1V%I;G,\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED M=&@Z(#$X<'@[('9E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^56YR96%L:7IE9"`\+V1I M=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W=I9'1H M.B`U,B4[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A M;6EL>3H@)R=T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)W=I9'1H.B`Q+C$T)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(] M,T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[ M('9E3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^ M/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H.B`U,B4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V9F9F9F9B!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=W:61T:#H@,2XQ-"4[('9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQOF4Z(#$P<'0[)SY#;W)P;W)A=&4@0F]N9',Z M/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E M969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E M969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E M969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F M;VYT+69A;6EL>3H@)R=T:6UE6QE/3-$)V)O3H@ M)R=T:6UEF4Z M(#$P<'0[)SXQ,RPP,C<\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V9F9F9F M9B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C M;VQO6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F'0M M86QI9VXZ(&QE9G0[('!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E M'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG M;CH@F4Z(#$P<'0[)SY4;W1A;"!#;W)P;W)A=&4@0F]N M9',\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!V86QI9VX],T1B M;W1T;VT@6QE/3-$)W=I9'1H.B`Q+C$T M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G M8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V9F9F9F M9B!V86QI9VX],T1B;W1T;VT@"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O#L@=VED=&@Z(#$N,30E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O M;3H@,G!X.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@"!D;W5B;&4[('1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG M+6)O='1O;3H@-'!X.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)W1I;65S(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXT/"]D:78^/"]T9#X\=&0@8F=C;VQO#L@=VED=&@Z(#$N,30E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I M=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)V)O#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T M:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXQ,RPS.#(\ M+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0Q-"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF5D(#PO9&EV/CQD M:78@3H@ M)R=T:6UEF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3&]S6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M,24[('9E3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D M:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@,24[('9E3H@)R=T:6UEF4Z(#$P<'0[)SXD M/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V9O;G0M9F%M:6QY.B`G M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L M;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L M;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W=I9'1H.B`U,B4[ M('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@ M)R=T:6UEF4Z(#$P<'0[)SY!03PO9&EV/CPO=&0^/'1D(&)G M8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G M8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXT+#`Y M.3PO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C M;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T M:6UEF4Z(#$P M<'0[)SXX/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O M;3H@,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P M(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T M:#H@,24[('9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)R=T:6UEF4Z M(#$P<'0[)SXX+#8T.3PO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\ M=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O M;3H@,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P M(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W M:61T:#H@,24[('9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI M9#L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[ M('9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA M;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G M8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SY4 M;W1A;"!I;G9E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@ M,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXR-BPT.#4\+V1I M=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@ M,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D M:78^/"]T9#X\=&0@8F=C;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=CXF(S$V,#L\+V1I=CX\9&EV/E1H M92!F;VQL;W=I;F<@=&%B;&5S('-E="!F;W)T:"!B>2!L979E;"!W:71H:6X@ M=&AE(&9A:7(@=F%L=64@:&EE6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B#L@=VED M=&@Z(#4R)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D(&-O;'-P86X],T0Q,R!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)W!A9&1I;F"!S;VQI9#L@=&5X M="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T M:6UEF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^06-T:79E/"]D:78^/&1I=B!S='EL M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G)W1I;65S M(&YE=R!R;VUA;B3H@)R=T:6UE MF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^261E;G1I8V%L/"]D:78^/&1I=B!S='EL M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M4VEG;FEF:6-A;G0\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=T:6UE MF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^4VEG;FEF:6-A;G0\+V1I=CX\9&EV('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T M:6UEF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^26YP=71S/"]D:78^/"]T9#X\=&0@ M;F]W#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$QE=F5L M(#(I/"]D:78^/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)W!A9&1I;F"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C;VQO#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X M="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z M(#$P<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@-3(E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W!A9&1I;F"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L"!S M;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M1&5C96UB97(@,S$L(#(P,3(\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^06-T:79E/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT M97([(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^07-S971S/"]D:78^ M/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^3V)S97)V86)L93PO9&EV/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^26YP=71S/"]D:78^/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W!A9&1I;F"!S;VQI9#L@=&5X M="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)V)O6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z M(#4R)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA M;B'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@"!S;VQI9#L@ M=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T:6UE MF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T M:6UEF4Z(#$P M<'0[)SXT+#$W,CPO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)W!A9&1I;F"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T M:6UEF4Z(#$P M<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@ M)R=T:6UEF4Z M(#$P<'0[)SXT+#$W,CPO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W!A9&1I M;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`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`S*3PO M9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)W=I9'1H.B`R-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^57-I;F<\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]T3H@)R=T:6UE MF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;BF4Z(#$P<'0[)SY"86QA;F-E($1E8V5M8F5R(#,Q+"`R,#$Q M/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!W:61T:#H@,24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T2!I;F-L=61E9"!I;B!N970@;&]S M6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W=I M9'1H.B`R-24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT M+69A;6EL>3H@)R=T:6UE2!I;F-L=61E9"!I;B!N970@;&]S6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#4Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$ M)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\ M=&0@8F=C;VQO#L@=VED=&@Z(#(U M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@F4Z(#$P<'0[)SY3971T;&5M96YT'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@ M6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE M=R!R;VUA;B#L@=VED M=&@Z(#4Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA M;B3H@)R=T:6UEF4Z(#$P<'0[)SXR+#8X M-CPO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T M.R!F;VYT+69A;6EL>3H@)R=T:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@"!D;W5B M;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IUF5D(%1A>"!"96YE9FET(%=H96X@82!.970@3W!E2!R96QA=&5D('1O(&%N('5N"!L;W-S(&]R(&$@=&%X M(&-R961I="!C87)R>69O"!P;W-I=&EO;B!IF5D('1A>"!B96YE9FET2!A2!T;R!P2!T;R!N970@:6YC;VUE+"!A;B!E;G1I M='D@:7,@65A'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P M<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU2!O=7(@<')I;F-I<&%L(&]P97)A=&EN M9R!S=6)S:61I87)Y+"!6:7)N9718+"!);F,N+"!F6UE;G1S M('1O(%-!24,@8F%S960@;VX@8V%S:"!O7!E(&]F M('9A;'5E(&=E;F5R871E9"P@86YD(&-E6UE;G0@F5D('!A=&5N="!C;W-TF5D(&%T($IU;F4@,S`L(#(P,3,N/"]D M:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\P9F$U-3%E-%\X-3-F7S0R,C%?8C`U,%]F,38T,#AC964Q9&4-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&9A-34Q931?.#4S9E\T,C(Q M7V(P-3!?9C$V-#`X8V5E,61E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F]T92`T M("T@26YC;VUE(%1A>&5S/"]D:78^/&1I=CX\8G(@+SX\+V1I=CX\9&EV('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&IU2!A3LG/CQB3L@9F]N="UF86UI;'DZ(""!R871E(&]F(#(V('!E3L@9F]N="UF86UI;'DZ("2!D:69F97)E;F-E"!A2X\+V1I=CX\9&EV M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU&EM871E;'D@)#$U+#4R-R!A;F0@)#4R+#3H@)R=4:6UEF4Z(#$P<'0[)SY%9F9E8W1I=F4@2F%N=6%R M>2`Q+"`R,#`Y+"!W92!A9&]P=&5D(&%C8V]U;G1I;F<@9W5I9&%N8V4@9F]R M(&EN8V]M92!T87AE2!I;B!I;F-O;64@=&%X97,@"!P;W-I=&EO;B!T M86ME;B!O'!E8W1E9"!T;R!B92!T86ME;B!I;B!A('1A>"!R971U3LG/CQB"!A=71H;W)I=&EE65A65A3H@)R=4:6UEF4Z(#$P<'0[)SY/=7(@<&]L:6-Y(&ES('1O(')E8V]G;FEZ M92!I;G1E"!E>'!E;G-E+B!!'1087)T7S!F834U,64T7S@U,V9?-#(R,5]B,#4P7V8Q-C0P.&-E93%D90T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P9F$U-3%E-%\X-3-F7S0R M,C%?8C`U,%]F,38T,#AC964Q9&4O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R<^ M3F]T92`U("8C.#(Q,CL@0V]M;6ET;65N=',\+V1I=CX\9&EV/CQB3L@9F]N="UF M86UI;'DZ("2!P87EM M96YT'!I3LG/CQB3L@9F]N="UF86UI;'DZ("65A65D(&]R(&YO="!C;VUP;&5T960@=VET:&EN('-P M96-I9FEE9"!T:6UE+69R86UE'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU2`R,BP@,C`Q,RP@;W5R M('-T;V-K:&]L9&5R'!I&5R8VES86)L92!O2!O;FQY M(&)E(&=R86YT960@=&\@;W5R(&5M<&QO>65E65E6QE/3-$)W1E>'0M86QI9VXZ(&IU M2!O=7(@0F]A M2!B92!G2!O=7(@0F]A65E('-H86QL(&)E(&YO="!L97-S('1H86X@,3`P)2!O9B!T:&4@ M9F%I65A65A6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$ M)W1E>'0M86QI9VXZ(&IU2X@5&AE(&9A:7(@=F%L=64@;V8@ M;W!T:6]NFEN9R!T:&4@0FQA8VLM4V-H;VQE"!M;VYT:',@96YD:6YG($IU;F4@,S`L(#(P,3,@86YD(#(P,3(L(')E M3H@*&DI(&1I=FED96YD('EI96QD(&]N(&]U2!O9B`Y,R!P97)C96YT(&%N9"`Q M,34@<&5R8V5N=#L@*&EI:2D@82!R:7-K+69R964@:6YT97)E3L@9F]N="UF86UI;'DZ("2P@=&AA="!V97-T(')A=&%B;'D@;W9E6QE/3-$)W1E>'0M86QI9VXZ(&IU'!E;G-E(&ES(&UE87-U'!E;G-E M(&EN8VQU9&5D(&EN(&=E;F5R86P@86YD(&%D;6EN:7-T"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,RP@6QE/3-$)W1E>'0M86QI9VXZ(&IU MF%T:6]N M('!E65A2X\+V1I=CX\+V1I=CX\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$)V9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD.R<^3F]T92`W("8C.#(Q,CL@5V%R3L@9F]N M="UF86UI;'DZ("6QE/3-$)W=I9'1H.B`Q M,#`E.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^5V%R6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E"!S;VQI9#L@=&5X M="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)V)O&5R8VES86)L92!A=#PO M9&EV/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(@,S$L M/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)O&5R8VES960\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^0V%N8V5L;&5D M("\\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=T:6UEF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^17AE6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UE MF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`Q,SPO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)O'!I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@ M,G!X.R!W:61T:#H@,24[('9E#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T M:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W M#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W M:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M;F]W#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$U)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/"]T#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[)SXS+C4Y/"]D:78^/"]T9#X\=&0@8F=C;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXQ M-3DL.38W/"]D:78^/"]T9#X\=&0@8F=C;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)V)O M3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^ M/"]T9#X\=&0@8F=C;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C M;VQO6QE/3-$)V)O3H@ M)R=T:6UEF4Z M(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C;VQO#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@ M,24[('9E3H@)R=T:6UEF4Z(#$P<'0[)SXQ M-3DL.38W/"]D:78^/"]T9#X\=&0@8F=C;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#1P>"!D;W5B;&4[('1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O6QE/3-$)V)O#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O M='1O;3H@-'!X.R!W:61T:#H@,24[('9E3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C;VQO M#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXH,2D\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@875T;SL@=F5R=&EC86PM M86QI9VXZ('1O<#L@86QI9VXZ(&QE9G0[)SX\9&EV('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&IU2`R-RP@,C`Q,RP@=V4@86YN;W5N8V5D(&]U6QE/3-$)W1E>'0M86QI9VXZ(&IU3L@ M9F]N="UF86UI;'DZ("6QE/3-$)W1E>'0M M86QI9VXZ(&IU2!F:6QI;F<@ M82!C;VUP;&%I;G0@86=A:6YS="!!87-T&%S+"!4 M>6QE2UI2!I;B!T:&4@56YI=&5D(%-T871E2!T:&4@:G5R>2!F;W(@<&%S="!I;F9R M:6YG96UE;G0N(%1H92!#;W5R="!F=7)T:&5R(&1E;FEE9"!!<'!L928C.#(Q M-SMS(')E<75E2P@=&AE($-O=7)T(&=R86YT960@;W5R(&UO=&EO;G,@9F]R('!R92UJ M=61G;65N="!I;G1E2P@ M=&AE($-O=7)T(&]R9&5R960@=&AA="!!<'!L92!P87D@)#,T(&EN(&1A:6QY M(&EN=&5R97-T('5P('1O(&9I;F%L(&IU9&=M96YT(&%N9"`D,S,P(&EN(&1A M:6QY(&1A;6%G97,@9F]R(&EN9G)I;F=E;65N="!U<"!T;R!F:6YA;"!J=61G M;65N="!F;W(@8V5R=&%I;B!!<'!L92!D979I8V5S(&EN8VQU9&5D(&EN('1H M92!V97)D:6-T+B!4:&4@0V]U2!R871E(&9O2!T:&4@0V]U6%L='D@2!!<'!L92!T:&%T(&%R M92`F(S@R,C`[;F]T(&-O;&]R86)L>2!D:69F97)E;G0F(S@R,C$[('=I=&@@ M2!T;R!3 M04E#(#(U)2!O9B!T:&4@<')O8V5E9',@;V)T86EN960@8GD@=7,@:6X@=&AI M2`Q+"`R,#$S+"!T:&4@0V]U6%L='D@9F]R($%U9W5S="`Q-2P@,C`Q,RX@ M)B,Q-C`[3VX@2G5L>2`S+"`R,#$S+"!!<'!L92!F:6QE9"!A;B!A<'!E86P@ M;V8@=&AE(&IU9&=M96YT(&1A=&5D($9E8G)U87)Y(#(W+"`R,#$S(&%N9"!O M6EN9R!!<'!L928C.#(Q-SMS M(&UO=&EO;B!T;R!A;'1E2!C86UE(&)A8VL@=VET:"!A('9E2!O;B!O=7(@86QL96=A=&EO;G,@;V8@0VES8V\F(S@R,3<[ M6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU&%S+"!4 M>6QE6$@26YC+B!A M2`Q,2P@,C`Q,BP@36ET96P@3F5T=V]R M:R!#;W)P;W)A=&EO;B!S:6=N960@82!L:6-E;G-E(&%G2!A(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU3L@9F]N M="UF86UI;'DZ("3L@9F]N="UF86UI;'DZ("&%S+"!4>6QE2!V97)D:6-T(&]N($YO=F5M8F5R(#8L(#(P,3(@=&AA="!W M87,@2!T:&4@56YI=&5D(%-T871E2`R-BP@,C`Q,RX@)B,Q M-C`[3VX@2G5L>2`Q+"`R,#$S+"!W92!F:6QE9"!A(&-O;G-O;&ED871E9"!A M;F0@86UE;F1E9"!C;VUP;&%I;G0@=&\@:6YC;'5D92!5+E,N(%!A=&5N="!. M;RX@."PP-3$L,3@Q(&%N9"!C;VYS;VQI9&%T92!#:79I;"!!8W1I;VX@3F\N M(#8Z,3$M8W8M,#`U-C,M3$5$+CPO9&EV/CQD:78^/&)R("\^/"]D:78^/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!F;VYT+69A;6EL>3H@ M)R=4:6UEF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^251#($EN=F5S=&EG871I;VX@ M3F\N(#,S-RU402TX-3@\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&IU2`R M,2P@,C`Q-"!A2`R,"P@,C`Q,RX@3VX@ M1F5B6QE/3-$)W1E>'0M86QI9VXZ(&IU M2!S=6-H(&-L86EM2!L96%D('1O('!O M=&5N=&EA;"!C;W5N=&5R8VQA:6US('=H:6-H(&UA>2!P2!T;R!C;VUM97)C:6%L:7IE(&]U2!T;R!A;GD@;W1H97(@<&5N9&EN9R!L M96=A;"!P2!A;GD@9V]V97)N;65N=&%L(&%U=&AO2!O2X\+V1I=CX\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&IU3L@ M9F]N="UF86UI;'DZ("3L@9F]N M="UF86UI;'DZ("3L@9F]N="UF86UI;'DZ("6$L(&EN M(&5X8VAA;F=E(&9O2!F;W(@9G5T=7)E('-A M;&5S('1H2!P M3L@9F]N="UF86UI;'DZ("&%S+B!!;&P@;W1H97(@87-P96-T'1087)T M7S!F834U,64T7S@U,V9?-#(R,5]B,#4P7V8Q-C0P.&-E93%D90T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P9F$U-3%E-%\X-3-F7S0R,C%?8C`U M,%]F,38T,#AC964Q9&4O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`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`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W1E>'0M86QI9VXZ M(&IU6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG M/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ("=4:6UE M6QE/3-$)V9O;G0M6%L='D@ M9F]R('!A6%L='D@&5C=71I;VX@;V8@=&AE(&QI8V5N2!H87,@;V-C=7)R960L('=E M(')E8V]R9"!T:&4@8V]N2!AF4Z(#$P<'0[)SX\='(^/'1D('-T>6QE/3-$)W=I9'1H.B`Q.'!T M.R<^)B,Q-C`[/"]T9#X\=&0@6UB;VPL('-EF4Z(#$P<'0[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B!A=71O.R!F;VYT M+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[('9E6%L='D@<&%Y;65N=',@8V]V97)I;F<@82!L:6-E;G-E M928C.#(Q-SMS(&]B;&EG871I;VYS('1O('5S(')E;&%T960@=&\@:71S('-A M;&5S(&]F(&-O=F5R960@<')O9'5C=',@:6X@=&AE(&-U2!087EM96YT2!R M97!O2!O8FQI9V%T:6]N M2!R M97!OF4@3H@)R=4:6UEF4Z(#$P<'0[)SY&;W(@=&AE('1H2!R979E;G5E(&]F("0V(&%N9"`D,S`P(')E2P@ M8V]M<&%R960@=&\@)#,V(&9O"!M;VYT:',@ M96YD960@2G5N92`S,"P@,C`Q,BP@87,@<&%R="!O9B!L:6-E;G-E(&%G2!P2!A&5D M(&%N9"!D971E6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M3L@9F]N="UF86UI;'DZ("2!D:79I9&EN9R!E87)N:6YG2!T:&4@=V5I9VAT960@ M879E6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B3L@9F]N="US='EL93H@ M:71A;&EC.R!F;VYT+69A;6EL>3H@)R=4:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^0V]N8V5N=')A=&EO;B!O9B!#6QE/3-$)W1E>'0M M86QI9VXZ(&IU6QE/3-$)W1E M>'0M86QI9VXZ(&IU'!E'0^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B3H@)R=4:6UEF4Z(#$P<'0[)SY/=7(@4V5R:65S($D@5V%R&5D('1O(&]U M6QE/3-$ M)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&IU2!A;F0@2!T:&4@86UO M=6YT(&)Y('=H:6-H('1H92!C87)R>6EN9R!A;6]U;G0@;V8@=&AE(&%S&-E961S('1H92!P6QE/3-$)V9O;G0M M9F%M:6QY.B`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`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M3L@9F]N="UF86UI;'DZ("=4:6UE3L@9F]N="UF86UI;'DZ("F4Z(#$P<'0[)SY#;W)P;W)A=&4@8F]N9',\+V9O;G0^.B`F(S$V M,#M&86ER('9A;'5E(&UE87-U6QE M/3-$)W1E>'0M86QI9VXZ(&IUF4Z(#$P<'0[)SX\ M8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!O9B`Y,R4N(%1H92!A2!O9B`Y-"4N/"]D:78^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UEF4Z(#$P<'0[)SY4:&4@9F]L M;&]W:6YG('1A8FQEF5D(&=A:6YS+"!GF5D(&QO2!S:6=N:69I8V%N="!I M;G9EF4Z(#$P<'0[)SX\='(^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<^)B,Q-C`[/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M.2XY<'0[(&9O;G0M9F%M:6QY.B`G)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^56YR96%L:7IE9"`\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1F%I#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@,24[('9E3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@,24[('9E3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G M8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,2XQ-"4[('9E3H@)R=T:6UE MF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E M969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[)SXS-3$\+V1I=CX\+W1D/CQT9"!B9V-O;&]R M/3-$(V-C965F9B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE M/3-$)W=I9'1H.B`U,B4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T M.R!F;VYT+69A;6EL>3H@)R=T:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE/3-$)W=I9'1H.B`Q+C$T)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!W:61T:#H@ M,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D M:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C M9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V)O3H@ M)R=T:6UEF4Z M(#$P<'0[)SXT/"]D:78^/"]T9#X\=&0@8F=C;VQO#L@=VED=&@Z(#$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I M;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$ M)W=I9'1H.B`U,B4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F M;VYT+69A;6EL>3H@)R=T:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=W:61T:#H@,2XQ-"4[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXQ M,RPP,S$\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[ M('9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA M;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G M8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)V)O#L@=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@F4Z M(#$P<'0[)SY4;W1A;"!);G9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X M.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXQ M,RPS-S@\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F"!D;W5B M;&4[('1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UE MF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT M+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8V]L3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^1&5C96UB97(@,S$L(#(P,3(\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^56YR96%L:7IE9"`\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1F%I#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[)SXQ-RPX,S8\+V1I M=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[ M('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C M9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C M9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED M=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T:6UE MF4Z(#$P<'0[ M)SXT+#`Y.3PO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`U,B4[('9E6QE/3-$ M)W1E>'0M:6YD96YT.B`M.7!T.R!M87)G:6XM;&5F=#H@.7!T.R<^03PO9&EV M/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)R=T:6UEF4Z M(#$P<'0[)SXT+#`S.3PO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\ M=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]T6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@ M,24[('9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X M="UA;&EG;CH@"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\ M=&0@8F=C;VQO"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C;VQO"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UE MF4Z(#$P<'0[ M)SXU,3$\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V9F9F9F9B!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)R=T:6UEF4Z M(#$P<'0[)SXX+#8U-SPO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O#L@=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@"!D;W5B M;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I M;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@,24[('9E M6QE M/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;BF4Z(#$P<'0[)SXX/"]D:78^/"]T9#X\=&0@ M8F=C;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@"!D;W5B M;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C M;VQO6QE/3-$)V)O6QE M/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[)SX\9&EV/E1H92!F;VQL;W=I;F<@=&%B M;&5S('-E="!F;W)T:"!B>2!L979E;"!W:71H:6X@=&AE(&9A:7(@=F%L=64@ M:&EE3H@)U1I;65S M($YE=R!2;VUA;B3H@)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SX\='(^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!W M:61T:#H@-3(E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8V]L"!S;VQI9#L@=&5X="UA;&EG;CH@ M3H@ M)R=T:6UEF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^2G5N92`S,"P@,C`Q,SPO9&EV M/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\+W1R/CQT6QE/3-$)W!A9&1I M;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@ M)R=T:6UEF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4')I8V5S(&EN/"]D:78^/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^3W1H97(\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I M;F"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O3H@)R=T M:6UEF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^56YO8G-E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P M(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=T M:6UEF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$QE=F5L(#,I/"]D:78^/"]T9#X\ M=&0@;F]W#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E#L@=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD M:78@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G M8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXR M+#8X-CPO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXR+#8X-CPO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E M969F(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R M/CPO=&%B;&4^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@-3(E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W!A9&1I;F"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L"!S;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^1&5C96UB97(@,S$L(#(P,3(\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^06-T:79E/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C M96YT97([(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^07-S971S/"]D M:78^/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^3V)S97)V86)L93PO9&EV/CQD:78@#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W!A9&1I;F"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^*$QE=F5L(#,I/"]D:78^/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M#L@=VED M=&@Z(#4R)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE M=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@"!S;VQI M9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`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`[/"]T9#X\+W1R M/CPO=&%B;&4^/"]D:78^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I M;65S($YE=R!2;VUA;B3H@)R=4:6UEF4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A8FQE('-E M=',@9F]R=&@@82!S=6UM87)Y(&]F(&-H86YG97,@:6X@=&AE(&9A:7(@=F%L M=64@;V8@;W5R($QE=F5L(#,@;&EA8FEL:71Y('-T871E9"!A="!F86ER('9A M;'5E(&9O3H@)R=4:6UEF4Z(#$P<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\=&%B;&4@8F]R9&5R/3-$,"!C96QL<&%D M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B#L@=VED=&@Z(#4Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4VEX($UO;G1H3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^2G5N92`S M,"P@,C`Q,SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@'0M86QI9VXZ(&QE9G0[('!A9&1I;F"!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=VED M=&@Z(#(U)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@"!S;VQI9#L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([ M(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^56YO8G-E M3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^1F%I3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^365A3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^4VEG;FEF:6-A;G0\+V1I=CX\9&EV('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^26YP=71S("A,979E;"`S*3PO9&EV/CPO=&0^/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`U,24[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UE MF4Z(#$P<'0[)SY"86QA;F-E($1E8V5M8F5R(#,Q+"`R,#$R M/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!W:61T:#H@,24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G M8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T M:#H@,C4E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@+3EP=#L@9F]N="UF M86UI;'DZ("6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@)R=T:6UEF4Z(#$P<'0[)SXT M+#8Y.3PO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`U,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SY'86EN(&]N(&1E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C M9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE M=R!R;VUA;BF4Z(#$P M<'0[)SY,;W-S(&]N(&1E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!W M:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/"]T6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UE MF4Z(#$P<'0[ M)SXH,2PT,34\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78@"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#(U)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@F4Z(#$P<'0[)SY"86QA;F-E($IU;F4@,S`L(#(P,3(\+V1I=CX\+W1D/CQT M9"!B9V-O;&]R/3-$(V9F9F9F9B!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`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`R,#$S+"!T:&4@1D%30B!I2!T:&4@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P M<'0[)SY/=7(@<&]L:6-Y(&ES('1O(')E8V]G;FEZ92!I;G1E"!E>'!E;G-E+B!! M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O9B!3:6=N:69I8V%N="!! M8V-O=6YT:6YG(%!O;&EC:65S("A486)L97,I/&)R/CPO2!O9B!3:6=N M:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T6QE/3-$)V9O;G0M9F%M:6QY.B`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`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M061J=7-T960@0V]S=#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8V]L6QE/3-$ M)V)OF5D(#PO9&EV/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M1V%I;G,\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$X<'@[('9E#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^56YR96%L M:7IE9"`\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L M6QE/3-$)V)O6QE M/3-$)W=I9'1H.B`U,B4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T M.R!F;VYT+69A;6EL>3H@)R=T:6UE6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H.B`Q M+C$T)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE M=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@,24[('9E3H@)R=T:6UE MF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H.B`U,B4[ M('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$ M(V9F9F9F9B!V86QI9VX],T1B;W1T;VT@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,2XQ-"4[('9E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQOF4Z(#$P<'0[)SY#;W)P;W)A M=&4@0F]N9',Z/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L M;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L M;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L M;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UE"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXQ,RPP,C<\+V1I=CX\+W1D/CQT9"!B9V-O;&]R M/3-$(V9F9F9F9B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T M:#H@,24[('9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=&5X="UA;&EG;CH@F4Z(#$P<'0[)SY4;W1A;"!#;W)P M;W)A=&4@0F]N9',\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W=I M9'1H.B`Q+C$T)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!B9V-O;&]R M/3-$(V9F9F9F9B!V86QI9VX],T1B;W1T;VT@"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O#L@=VED=&@Z M(#$N,30E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!P861D M:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXT/"]D:78^/"]T9#X\=&0@8F=C;VQO#L@=VED=&@Z(#$N,30E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D M:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@ M-'!X.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE M=R!R;VUA;B3H@)R=T:6UE MF4Z(#$P<'0[ M)SXQ,RPS.#(\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SX\ M='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O M;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]T3H@)R=T M:6UEF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3&5V96P@,3H\+V1I=CX\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^061J=7-T960@0V]S M=#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L M6QE/3-$)V)OF5D(#PO M9&EV/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1V%I;G,\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@)R=T M:6UEF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^56YR96%L:7IE9"`\+V1I=CX\9&EV M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W=I9'1H.B`U,B4[ M('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@ M)R=T:6UEF4Z(#$P<'0[)SY#97)T:69I8V%T97,@;V8@9&5P M;W-I=#PO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C M;VQO6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@ M)R=T:6UEF4Z M(#$P<'0[)SXQ-RPX,S8\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F M9B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S M(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@,24[('9E3H@)R=T M:6UEF4Z(#$P M<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W=I9'1H M.B`U,B4[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[ M('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C M9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C M9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W=I9'1H.B`U,B4[('9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UE MF4Z(#$P<'0[)SY#;W)P;W)A=&4@8F]N9',Z/"]D:78^/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z M(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)R=T M:6UEF4Z(#$P M<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA M;B6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED M=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXT+#`T-SPO9&EV/CPO=&0^/'1D(&)G M8V]L;W(],T0C8V-E969F(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SY"04$\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V9F9F9F M9B!V86QI9VX],T1B;W1T;VT@"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXU,3$\+V1I=CX\+W1D/CQT9"!B M9V-O;&]R/3-$(V9F9F9F9B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)V)O M'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE M=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W=I9'1H.B`U,B4[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SY4;W1A;"!C;W)P;W)A=&4@8F]N9',\+V1I=CX\ M+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C M;VQO6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXX/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA M;B#L@=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@<&%D9&EN9RUB;W1T;VTZ M(#)P>#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C M;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)V)O M"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/CQD:78@"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C M;VQO6QE/3-$)V)OF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)V)O M#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D M:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXR-BPT.3,\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$ M(V-C965F9B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@-3(E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W!A9&1I;F"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^2G5N92`S,"P@,C`Q,SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^4')I8V5S(&EN/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!C96YT97([(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A M9&1I;F"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O M3H@ M)R=T:6UEF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3W1H97(\+V1I=CX\9&EV('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^56YO8G-E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\+W1R/CQT6QE/3-$ M)W!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^*$QE=F5L(#,I/"]D:78^/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#4R)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C M;VQO6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)W!A M9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXR+#8X-CPO9&EV/CPO=&0^/'1D(&)G M8V]L;W(],T0C8V-E969F(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXR+#8X-CPO9&EV M/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=B!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&)R("\^/"]D:78^/&1I=CX\ M=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS M1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ("=4:6UE6QE/3-$)W!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)V)O M#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\+W1R/CQT6QE/3-$)W!A M9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4')I8V5S(&EN/"]D:78^ M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY M.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^261E;G1I8V%L/"]D:78^/&1I=B!S='EL93TS1"=T M97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4VEG;FEF M:6-A;G0\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^4VEG;FEF:6-A;G0\+V1I=CX\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^26YP=71S/"]D:78^/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W#L@=VED=&@Z(#4R)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@ M3H@ M)R=T:6UEF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$QE=F5L(#$I/"]D:78^/"]T M9#X\=&0@;F]W#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M('9E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W!A9&1I;F"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=T:6UE MF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^5&]T86P\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F3H@)R=T:6UEF4Z(#$P<'0[)SY397)I97,@;"!787)R86YT'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO M6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXF(S@R,3([/"]D:78^/"]T9#X\ M=&0@8F=C;VQO#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C M;VQO6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8F=C;VQO6QE/3-$)V)O M6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B3PO=&0^#0H@("`@("`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`[/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ M(#)P>#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4VEX($UO M;G1H3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M2G5N92`S,"P@,C`Q,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W=I9'1H.B`U,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^57-I;F<\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,C4E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R<^)B,Q-C`[/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G)W1I;65S M(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^56YO8G-E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[)SXT+#$W,CPO9&EV M/CPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@6QE/3-$ M)W=I9'1H.B`R-24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F M;VYT+69A;6EL>3H@)R=T:6UE3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SXH,2PT.#8\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$ M(V9F9F9F9B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)R=T:6UEF4Z M(#$P<'0[)SXQ+#DW.3PO9&EV/CPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T M.R!F;VYT+69A;6EL>3H@)R=T:6UEF4Z(#$P<'0[)SY3971T M;&5M96YT'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UE#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)W1I;65S(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I M;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UEF4Z M(#$P<'0[)SY"86QA;F-E($IU;F4@,S`L(#(P,3,\+V1I=CX\+W1D/CQT9"!B M9V-O;&]R/3-$(V9F9F9F9B!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O3H@)R=T:6UEF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O M;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B3H@)R=T:6UEF4Z(#$P<'0[)SXU+#(V,SPO9&EV/CPO=&0^/'1D(&)G M8V]L;W(],T0C9F9F9F9F(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F7S0R M,C%?8C`U,%]F,38T,#AC964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,&9A-34Q931?.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E,61E+U=O M'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UEF4Z(#$P<'0[)SY);F9O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9EF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^3W)I9VEN86P@/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C M96YT97([(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M27-S=65D/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z M(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O&5R8VES93PO9&EV/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^4')I8V4@<&5R(#PO9&EV/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^0V]M;6]N/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C M96YT97([(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@ M,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M17AE6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E3H@)R=T:6UEF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^,C`Q,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T M:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^0F5C86UE/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT M97([(&9O;G0M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B&5R8VES86)L93PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T M:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^17AE"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E'!I#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`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`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[ M('9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#DE.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@;F]W#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W!A9&1I;F3H@)R=T:6UEF4Z(#$P<'0[)SXR M+#8Q.2PP,S8\+V1I=CX\+W1D/CQT9"!B9V-O;&]R/3-$(V-C965F9B!V86QI M9VX],T1B;W1T;VT@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE M=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M M9F%M:6QY.B`G)W1I;65S(&YE=R!R;VUA;B#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O M='1O;3H@,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W M:61T:#H@,24[('9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI M9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E M'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D(&)G8V]L;W(],T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P M861D:6YG+6)O='1O;3H@,G!X.R!W:61T:#H@,24[('9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&)G8V]L;W(] M,T0C8V-E969F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)V)O#L@=VED=&@Z(#$U)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/CQD:78@3H@)R=T:6UEF4Z(#$P<'0[)SY-87)C:"`R,#$U/"]D:78^/"]T9#X\+W1R M/CQT6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!F;VYT+69A;6EL>3H@)R=T:6UE MF4Z(#$P<'0[)SY4;W1A;#PO9&EV/CPO=&0^/'1D(&)G8V]L M;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@,24[('9E M#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W M:61T:#H@,24[('9E#L@=VED M=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8F=C;VQO6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T M:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O6QE/3-$)V)O#L@ M=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8F=C;VQO6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@-'!X.R!W M:61T:#H@,24[('9E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&)G8V]L;W(],T0C9F9F9F9F('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#1P>"!D;W5B;&4[('1E M>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)W1I;65S(&YE M=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F#L@=VED=&@Z(#$E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)V)O6QE/3-$)V)O M#L@=VED=&@Z(#$E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8F=C;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!P M861D:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@.24[('9E#L@=VED=&@Z(#$U)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@6QE/3-$)W=I9'1H.B`Q.'!T.R<^)B,Q-C`[/"]T9#X\=&0@3H@)R=T:6UEF4Z(#$P<'0[)SY2969E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X M-3-F7S0R,C%?8C`U,%]F,38T,#AC964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,&9A-34Q931?.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E M,61E+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&-E<'0@4&5R(%-H87)E(&1A M=&$L('5N;&5S6%L='D@4F5V96YU93PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D($=A:6YS(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!; M06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%SF5D($=A:6YS(%M-96UB97)=('P@5&]T86P@ M0V]R<&]R871E($)O;F1S(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%SF5D($QO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!;06)S M=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%SF5D($QO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D($QO'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F7S0R,C%?8C`U,%]F,38T M,#AC964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&9A-34Q M931?.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E,61E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R&5S("A$971A:6QS*2`H55-$("0I/&)R/DEN(%1H;W5S M86YD'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!R M871E("AI;B!H=6YD'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S69O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$69O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P M9F$U-3%E-%\X-3-F7S0R,C%?8C`U,%]F,38T,#AC964Q9&4-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&9A-34Q931?.#4S9E\T,C(Q7V(P-3!? M9C$V-#`X8V5E,61E+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E'!I'0^,3`@>65A'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA&-E<'0@4VAA M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,3`@>65A M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5C=71I=F4@;V9F:6-E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!3:&%R92UB87-E9"!087EM M96YT($%W87)D(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^-"!Y96%R6EE;&0@ M*&EN(&AU;F1R961T:',I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'!E8W1E9"!S=&]C:R!P'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E8W1E9"!O<'1I;VX@=&5R;3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^-B!Y96%R65A'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N('!E'0^,B!Y96%R'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%SF5D('-T M;V-K(&)A'!E;G-E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XD(#4L,S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F7S0R M,C%?8C`U,%]F,38T,#AC964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,&9A-34Q931?.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E,61E+U=O M'0O:'1M M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S&5R8VES86)L92!A="!B96=I;FYI;F<@;V8@>65A'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5R8VES86)L92`H:6X@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F7S0R,C%?8C`U,%]F,38T,#AC M964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&9A-34Q931? M.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E,61E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!I;F9R:6YG960@=7!O;B!B>2!!<'!L92P@26YC+CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P9F$U-3%E-%\X-3-F7S0R,C%?8C`U M,%]F,38T,#AC964Q9&4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M,&9A-34Q931?.#4S9E\T,C(Q7V(P-3!?9C$V-#`X8V5E,61E+U=O'0O:'1M;#L@8VAA M&UL;G,Z;STS1")U'1087)T7S!F834U,64T7S@U,V9?-#(R 7,5]B,#4P7V8Q-C0P.&-E93%D92TM#0H` ` end XML 39 R4.xml IDEA: CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) 2.4.0.8020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)truefalseIn Thousands, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$c20130401to20130630http://www.sec.gov/CIK0001082324duration2013-04-01T00:00:002013-06-30T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$c20120401to20120630http://www.sec.gov/CIK0001082324duration2012-04-01T00:00:002012-06-30T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$c20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$c20120101to20120630http://www.sec.gov/CIK0001082324duration2012-01-01T00:00:002012-06-30T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_IncomeStatementAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_RoyaltyRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse60006USD$falsetruefalse2truefalsefalse3600036USD$falsetruefalse3truefalsefalse300000300USD$falsetruefalse4truefalsefalse3600036USD$falsetruefalsexbrli:monetaryItemTypemonetaryRevenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false23true 2us-gaap_OperatingExpensesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 3us-gaap_ResearchAndDevelopmentExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse382000382falsefalsefalse2truefalsefalse274000274falsefalsefalse3truefalsefalse686000686falsefalsefalse4truefalsefalse530000530falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 2 -Paragraph 12, 13 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 51 -Subparagraph g -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 86 -Paragraph 11, 12 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false25false 3us-gaap_SellingGeneralAndAdministrativeExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse62020006202falsefalsefalse2truefalsefalse1149600011496falsefalsefalse3truefalsefalse1572200015722falsefalsefalse4truefalsefalse1846300018463falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 4 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6386349&loc=d3e3636-108311 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Paragraph 5A -Chapter 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false26false 3us-gaap_OperatingExpensesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse65840006584falsefalsefalse2truefalsefalse1177000011770falsefalsefalse3truefalsefalse1640800016408falsefalsefalse4truefalsefalse1899300018993falsefalsefalsexbrli:monetaryItemTypemonetaryGenerally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.No definition available.true27false 2us-gaap_OperatingIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse-6578000-6578falsefalsefalse2truefalsefalse-11734000-11734falsefalsefalse3truefalsefalse-16108000-16108falsefalsefalse4truefalsefalse-18957000-18957falsefalsefalsexbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No definition available.false28false 2us-gaap_UnrealizedGainLossOnDerivativesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse-120000-120falsefalsefalse2truefalsefalse-2248000-2248falsefalsefalse3truefalsefalse14860001486falsefalsefalse4truefalsefalse-1979000-1979falsefalsefalsexbrli:monetaryItemTypemonetaryThe net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 false29false 2us-gaap_InterestAndOtherIncomeus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse2300023falsefalsefalse2truefalsefalse128000128falsefalsefalse3truefalsefalse5600056falsefalsefalse4truefalsefalse202000202falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).No definition available.false210false 2us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-6675000-6675falsefalsefalse2truefalsefalse-13854000-13854falsefalsefalse3truefalsefalse-14566000-14566falsefalsefalse4truefalsefalse-20734000-20734falsefalsefalsexbrli:monetaryItemTypemonetarySum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Subparagraph 1(i) -Article 4 true211false 2us-gaap_IncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-354000-354falsefalsefalse2truefalsefalse35900003590falsefalsefalse3truefalsefalse-356000-356falsefalsefalse4truefalsefalse57630005763falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph a, b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false212false 2us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-7029000-7029USD$falsetruefalse2truefalsefalse-10264000-10264USD$falsetruefalse3truefalsefalse-14922000-14922USD$falsetruefalse4truefalsefalse-14971000-14971USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. true213false 2us-gaap_EarningsPerShareBasicAndDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-0.14-0.14USD$falsetruefalse2truefalsefalse-0.20-0.20USD$falsetruefalse3truefalsefalse-0.29-0.29USD$falsetruefalse4truefalsefalse-0.29-0.29USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.No definition available.false314false 2us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse5117900051179falsefalsefalse2truefalsefalse5087400050874falsefalsefalse3truefalsefalse5116500051165falsefalsefalse4truefalsefalse5076600050766falsefalsefalsexbrli:sharesItemTypesharesAverage number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).No definition available.false1falseCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)ThousandsThousandsNoRoundingUnKnowntruefalsefalseSheethttp://virnetx.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited414 XML 40 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 HtmlAndXml 83 151 1 true 21 0 false 8 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://virnetx.com/role/DocumentAndEntityInformation Document and Entity Information R1.xml true false R2.htm 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) R2.xml false false R3.htm 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://virnetx.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) R3.xml false false R4.htm 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) R4.xml false false R5.htm 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) R5.xml false false R6.htm 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) R6.xml false false R7.htm 060100 - Disclosure - Business Description and Basis of Presentation Sheet http://virnetx.com/role/BusinessDescriptionAndBasisOfPresentation Business Description and Basis of Presentation R7.xml false false R8.htm 060200 - Disclosure - Summary of Significant Accounting Policies Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies R8.xml false false R9.htm 060300 - Disclosure - Patent Portfolio Sheet http://virnetx.com/role/PatentPortfolio Patent Portfolio R9.xml false false R10.htm 060400 - Disclosure - Income Taxes Sheet http://virnetx.com/role/IncomeTaxes Income Taxes R10.xml false false R11.htm 060500 - Disclosure - Commitments Sheet http://virnetx.com/role/Commitments Commitments R11.xml false false R12.htm 060600 - Disclosure - Stock-Based Compensation Sheet http://virnetx.com/role/StockbasedCompensation Stock-Based Compensation R12.xml false false R13.htm 060700 - Disclosure - Warrants Sheet http://virnetx.com/role/Warrants Warrants R13.xml false false R14.htm 060800 - Disclosure - Litigation Sheet http://virnetx.com/role/Litigation Litigation R14.xml false false R15.htm 060900 - Disclosure - Subsequent Events Sheet http://virnetx.com/role/SubsequentEvents Subsequent Events R15.xml false false R16.htm 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) R16.xml false false R17.htm 070400 - Disclosure - Income Taxes (Policies) Sheet http://virnetx.com/role/IncomeTaxesPolicies Income Taxes (Policies) R17.xml false false R18.htm 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) R18.xml false false R19.htm 080700 - Disclosure - Warrants (Tables) Sheet http://virnetx.com/role/WarrantsTables Warrants (Tables) R19.xml false false R20.htm 090100 - Disclosure - Business Description and Basis of Presentation (Details) Sheet http://virnetx.com/role/BusinessDescriptionAndBasisOfPresentationDetails Business Description and Basis of Presentation (Details) R20.xml false false R21.htm 090200 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) R21.xml false false R22.htm 090300 - Disclosure - Patent Portfolio (Details) Sheet http://virnetx.com/role/PatentPortfolioDetails Patent Portfolio (Details) R22.xml false false R23.htm 090400 - Disclosure - Income Taxes (Details) Sheet http://virnetx.com/role/IncomeTaxesDetails Income Taxes (Details) R23.xml false false R24.htm 090500 - Disclosure - Commitments (Details) Sheet http://virnetx.com/role/CommitmentsDetails Commitments (Details) R24.xml false false R25.htm 090600 - Disclosure - Stock-Based Compensation (Details) Sheet http://virnetx.com/role/StockbasedCompensationDetails Stock-Based Compensation (Details) R25.xml false false R26.htm 090700 - Disclosure - Warrants (Details) Sheet http://virnetx.com/role/WarrantsDetails Warrants (Details) R26.xml false false R27.htm 090800 - Disclosure - Litigation (Details) Sheet http://virnetx.com/role/LitigationDetails Litigation (Details) R27.xml false false All Reports Book All Reports Element us-gaap_EffectiveIncomeTaxRateContinuingOperations had a mix of decimals attribute values: 2 3. Process Flow-Through: 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Process Flow-Through: 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Process Flow-Through: 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) Process Flow-Through: 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) vhc-20130630.xml vhc-20130630.xsd vhc-20130630_cal.xml vhc-20130630_def.xml vhc-20130630_lab.xml vhc-20130630_pre.xml true true XML 41 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, authorized (in shares) 10,000,000 10,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized (in shares) 100,000,000 100,000,000
Common stock, issued (in shares) 51,203,141 51,150,242
Common stock, outstanding (in shares) 51,203,141 51,150,242
XML 42 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Litigation
6 Months Ended
Jun. 30, 2013
Litigation [Abstract]  
Litigation
Note 8 — Litigation

We have five intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints. We have one complaint with the United States International Trade Commission (ITC) alleging that Apple, Inc. has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.’s infringement through the district courts.  The ITC case has been terminated.
 
VirnetX Inc. et al., v. Microsoft Corporation
On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274.  We seek damages and injunctive relief.  No hearing or trial dates have been set.

VirnetX Inc. v. Cisco Systems, Inc. et al and VirnetX Inc. v. Apple Inc. (Severed Case)
On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief. On February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we again amended our complaint against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to include Apple’s iPad 2 in the list of Apple products that are accused of infringing our patents. We also asserted our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC have signed license agreements with us and we have agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to postpone the trial against Cisco to March 4, 2013 and just try the case against Apple. On November 6, 2012, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368,000 in a verdict against Apple Corporation for infringing four of our patents. A post-trial hearing in the case against Apple was held on December 20, 2012. On February 26, 2013, the United States District Court for the Eastern District of Texas, Tyler Division issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict. The Court denied Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict. Additionally, the Court granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. Specifically, the Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction. In doing so, the Court ordered the parties to mediate over a license in the following 45 days for Apple’s future infringing use not covered by the Court’s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court’s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are “not colorably different” with regards to the accused functionality. However, the judgment may be appealed and no assurances can be given as to when or if we will receive any proceeds in connection with these matters, and accordingly there has been no recognition of the jury awards or royalties in our accompanying financial statements. Under our agreements with Science Applications International Corporation (SAIC), we would pay to SAIC 25% of the proceeds obtained by us in this lawsuit against Apple after reduction for attorneys’ fees and costs incurred in litigating those claims. We are awaiting the Court’s decision in this matter.  On July 1, 2013, the Court entered an Order setting a hearing on VirnetX’s motion for an ongoing royalty for August 15, 2013.  On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit.
 
The jury trial against Cisco was held on March 4, 2013. At the end of the trial, the jury came back with a verdict of non-infringement in the trial. The same jury also found that all our patents-in-suit were valid and enforceable. On April 3, 2013, we filed a request for a new trial regarding Cisco’s infringement of four of our patents based primarily on our allegations of Cisco’s inappropriate conduct and arguments during the jury trial that concluded on March 14, 2013. In addition to the request for a new trial, we filed a motion for a judgment as a matter of law on Cisco’s infringement of the ‘759 patent. On April 11, 2013, in response to our motion, Cisco filed its renewed motion to dismiss as moot its invalidity counterclaims against the claims in our patents that were not asserted in the lawsuit as well as a conditional motion for a new trial on certain limited claims and defenses. We are awaiting the Court’s decision in this matter.  A hearing on VirnetX’s motion for new trial and Cisco’s renewed motion to dismiss as moot its invalidity counterclaims and conditional motion for a new trial was held on June 17, 2013.  We are awaiting the Court’s ruling on these motions.

VirnetX Inc. v. Mitel Networks Corporation et al
On January 12, 2011, we initiated a lawsuit by filing a complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these companies infringe three of our patents. We seek damages and injunctive relief. On April 12, 2011 we again amended our complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, to add Avaya Inc. as a defendant. On July 11, 2012, Mitel Network Corporation signed a license agreement with us and we dismissed the patent infringement case against them. On July 12, 2012 we had a claims construction hearing in this case and a Markman order was issued on August 1, 2012. On January 29, 2013 Siemens signed a license agreement with us and we dismissed the patent infringement case against them. On April 9, 2013, the Court issued a new docket control order in our lawsuit against the remaining defendant Avaya Inc. According to this new order, jury selection is set for September 3, 2013 followed by a jury trial on September 9, 2013. A pretrial conference has been scheduled for August 22, 2013.

VirnetX Inc. v. Apple, Inc.
On November 1, 2011, we initiated a lawsuit against Apple in the United States District Court, Tyler Division, pursuant to which we allege that Apple infringes one or more claims of our U.S. Patent No. 8,051,181. We seek damages and injunctive relief. No hearing or trial dates have been set.  On June 17, 2013 the Court granted VirnetX’s unopposed motion to lift the stay ordered by the Court on December 15, 2011.  On June 18, 2013 the Court granted the parties unopposed motion to consolidate this case with Civil Action No. 6:12-cv-00855-LED.

VirnetX Inc. v. Apple, Inc.
On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013.  On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED.

ITC Investigation No. 337-TA-858
On July 18, 2012, the Administrative Law Judge (ALJ) assigned to investigate our complaint against Apple Inc., identified a procedural discrepancy with our complaint and dismissed it. On September 14, 2012, we re-filed our complaint with the ITC jointly with Science Applications International Corporation (SAIC) [NYSE: SAI] to remove a procedural standing issue that was identified as the reason for dismissal of our previous complaint. On October 16, 2012, the United States International Trade Commission (ITC) accepted our complaint and instituted an investigation against Apple and assigned ALJ E. James Gildea to preside over this investigation. Subsequently on October 23, 2012, ALJ Gildea issued an order setting up February 21, 2014 as the target date for completion of this investigation. The hearing in-front of ALJ Gildea was scheduled for May 20, 2013. On February 27, 2013, we announced our intent to withdraw our complaint with the ITC and pursue comprehensive relief from Apple Inc.’s infringement through the district courts.  The ITC case has been terminated.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.
XML 43 R20.xml IDEA: Business Description and Basis of Presentation (Details) 2.4.0.8090100 - Disclosure - Business Description and Basis of Presentation (Details)truefalsefalse1false falsefalsec20130630http://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00U004Standardhttp://virnetx.com/20130630Patentvhc01true 1us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2vhc_NumberOfDomesticPatentsOwnedvhc_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2121falsefalsefalsexbrli:integerItemTypeintegerRepresents number of domestic patents owned.No definition available.false2563false 2vhc_NumberOfForeignPatentsOwnedvhc_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse4141falsefalsefalsexbrli:integerItemTypeintegerRepresents number of foreign patents owned.No definition available.false256falseBusiness Description and Basis of Presentation (Details)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/BusinessDescriptionAndBasisOfPresentationDetails13 XML 44 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) [Abstract]        
Net loss $ (7,029) $ (10,264) $ (14,922) $ (14,971)
Other comprehensive income (loss):        
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax (12) 0 (12) 0
Change in unrealized gain (loss) on investments, net of tax 4 1 (4) (17)
Other Comprehensive Income (Loss), Tax (8) 1 (16) (17)
Comprehensive loss $ (7,037) $ (10,263) $ (14,938) $ (14,988)
XML 45 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 32,878 $ 19,661
Investments available for sale 13,382 26,493
Prepaid taxes 0 14,963
Prepaid expense and other current assets 601 114
Total current assets 46,861 61,231
Property and equipment, net 65 70
Intangible and other assets 0 12
Total assets 46,926 61,313
Current liabilities:    
Accounts payable and accrued liabilities 1,861 3,197
Derivative liability 2,686 4,172
Total current liabilities 4,547 7,369
Stockholders' equity:    
Preferred stock, par value $0.0001 per share Authorized: 100,000,000 shares at June 30, 2013 and December 31,2012, Issued and outstanding: none 0 0
Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at June 30, 2013 and December 31, 2012, Issued and outstanding: 51,203,141 shares at June 30, 2013, and 51,150,242 shares at December 31, 2012 5 5
Additional paid in capital 120,229 116,856
Accumulated deficit (77,847) (62,925)
Accumulated other comprehensive income (loss) (8) 8
Total stockholders' equity 42,379 53,944
Total liabilities and stockholders' equity $ 46,926 $ 61,313
XML 46 R7.xml IDEA: Business Description and Basis of Presentation 2.4.0.8060100 - Disclosure - Business Description and Basis of Presentationtruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 1 &#8212; Business Description and Basis of Presentation</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">VirnetX, Inc. (&#8220;we&#8221;, &#8220;our&#8221;, &#8220;us&#8221; or &#8220;VirnetX&#8221;) develops software and technology solutions for securing real-time communications over the Internet. &#160;Our patented GABRIEL Connection Technology&#8482; combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our portfolio of intellectual property is the foundation of our business model. &#160;We currently own 21 patents in the United States and 41 foreign patents, as well as several pending U.S. and foreign patent applications. &#160;Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. &#160;Our patented methods also have additional applications in operating systems and network security.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer and remote desktop. &#160;Our technology generates secure connections on a &#8220;zero-click&#8221; or &#8220;single-click&#8221; basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We have executed licenses and intend to seek further licensees for our technology, including our GABRIEL Connection Technology&#8482; to original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">During interim periods, we follow the accounting policies set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012 and apply appropriate interim financial reporting standards for a fair statement of our operating results and financial position in conformity with accounting principles generally accepted in the United States of America, as codified by the Financial Accounting Standards Board (FASB) in the Accounting Standards Codification (ASC) (referred to herein as U.S. GAAP), as indicated below. &#160;Users of financial information produced for interim periods are encouraged to read this Quarterly Report on Form 10-Q in conjunction with our consolidated financial statements and notes thereto filed with the Securities and Exchange Commission (SEC) in our 2012 Annual Report on Form 10-K.</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Interim financial reporting standards require us to make estimates that are based on assumptions regarding the outcome of future events and circumstances not known at that time, including the use of estimated effective tax rates. &#160;Inevitably, some assumptions will not materialize, unanticipated events or circumstances may occur which vary from those estimates and such variations may significantly affect our future results. Our financial results have varied significantly from period to period. &#160;Additionally, interim results may not be indicative of our results for future interim periods or our annual results.</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC&#8217;s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and six month periods ended June 30, 2013 and 2012; (ii) the condensed consolidated statements of comprehensive loss for the three and six month periods ended June 30, 2013 and 2012; (iii) the condensed consolidated balance sheets at June 30, 2013 and December 31, 2012; and (iv) the condensed consolidated statements of cash flows for the six month periods ended June 30, 2013 and 2012. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by U.S. GAAP. &#160;The condensed consolidated balance sheet, included in this report, as of December 31, 2012 was derived from our 2012 audited financial statements, but does not include all disclosures required by U.S. GAAP.</div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 46R -Paragraph 4, 14, 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2134480 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS140-4/FIN46(R)-8 -Paragraph 8, C1, C7 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2122150 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 720 -SubTopic 15 -URI http://asc.fasb.org/subtopic&trid=2122524 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6228881-111685 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7668296&loc=d3e288-107754 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2197480 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 2-6 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 915 -SubTopic 235 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2209116 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 272 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 94-6 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseBusiness Description and Basis of PresentationUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/BusinessDescriptionAndBasisOfPresentation12 XML 47 R17.xml IDEA: Income Taxes (Policies) 2.4.0.8070400 - Disclosure - Income Taxes (Policies)truefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_IncomeTaxDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_IncomeTaxUncertaintiesPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2013, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.</div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for tax positions taken in the Company's tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities (i.e., uncertain tax positions) and other types of contingencies related to income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 48 -Paragraph 21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2144681 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 48 -Paragraph 20 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 48 -Paragraph 19 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseIncome Taxes (Policies)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/IncomeTaxesPolicies12 XML 48 R16.xml IDEA: Summary of Significant Accounting Policies (Policies) 2.4.0.8070200 - Disclosure - Summary of Significant Accounting Policies (Policies)truefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_RevenueRecognitionPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Revenue Recognition</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements can be complex and may or may not include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the FASB revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Patent License Agreements</font>: Upon signing a patent license agreement, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue arrangements with multiple deliverables and the guidance for revenue recognition. Under our patent license agreements, we typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:</div><div style="text-align: justify;"><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18pt; font-family: symbol, serif; font-size: 10pt; vertical-align: top; align: right;">&#183;</td><td style="text-align: left; width: auto; font-family: ''times new roman'', times, serif; font-size: 10pt; vertical-align: top;"><font style="font-style: italic; font-family: ''times new roman'', times, serif; font-size: 10pt;">Consideration for Past Sales:</font> Consideration related to a licensee&#8217;s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.</td></tr></table></div><div><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td style="width: 18pt;">&#160;</td><td style="width: 18pt; font-family: symbol, serif; font-size: 10pt; vertical-align: top; align: right;">&#183;</td><td style="text-align: left; width: auto; font-family: ''times new roman'', times, serif; font-size: 10pt; vertical-align: top;"><font style="font-style: italic; font-family: ''times new roman'', times, serif; font-size: 10pt;">Current Royalty Payments</font>: These are ongoing royalty payments covering a licensee&#8217;s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe Current Royalty Payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees&#8217; underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees&#8217; sales is limited.</td></tr></table></div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">For the three and six months ended June 30, 2013, we recognized royalty revenue of $6 and $300 respectively, compared to $36 for the three and six months ended June 30, 2012, as part of license agreements entered into with customers during the patent infringement actions (see &#8220;Legal Proceedings&#8221;). &#160;In accordance with our revenue recognition policy related to a licensee&#8217;s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured. &#160;In the patent infringement actions we did not request, nor receive any amounts allocable to settlement fees, expense reimbursement, damages or any other amount unrelated to historical sales. &#160;Revenue from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.</div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section B -Paragraph Question 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.B.Q1) -URI http://asc.fasb.org/extlink&oid=6600647&loc=d3e214044-122780 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 22 -Paragraph 8, 12, 13 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18823-107790 false03false 2us-gaap_EarningsPerSharePolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Earnings Per Share</div><div style="text-align: left;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. &#160;Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued<font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">.</font></div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2144384 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 6, 8-16, 60 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false04false 2us-gaap_ConcentrationRiskCreditRiskus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. &#160;During the six months ended June 30, 2013 we had, at times, funds which were uninsured. &#160; We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.</div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for credit risk.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 55 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6875567&loc=d3e14537-108613 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number SOP94-6-1 -Paragraph 7, 11 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 107 -Paragraph 15A -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 825 -Section 55 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6487554&loc=d3e32600-158583 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13531-108611 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 825 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6480020&loc=d3e61082-112788 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 825 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6480020&loc=d3e61044-112788 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 01-6 -Paragraph 14 -Subparagraph m -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 55 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6875567&loc=d3e14489-108613 false05false 2us-gaap_DerivativesPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Derivative Instruments</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock. &#160;The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.</div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for its derivative instruments and hedging activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph n -Article 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(n)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 44 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41675-113959 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 39 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false06false 2us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets</div><div><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable. &#160;Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets&#8217; carrying value. &#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section CC -Subsection 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2155824 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 7-15, 26, 30-37 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false07false 2us-gaap_FairValueOfFinancialInstrumentsPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. &#160;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). &#160;Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Our financial instruments are stated at amounts that equal, or approximate, fair value. &#160;When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. &#160;We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Certificate of deposits</font>: Fair value measured at face value plus accrued interest.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Corporate bonds</font>: &#160;Fair value measured at the closing price reported on the active market on which the individual securities are traded.</div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Series I Warrants</font>: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for June 30, 2013, included a warrant exercise price of $3.59 per share, a common share price of $19.99, a discount rate of 1.41%, and a volatility of 93%. The assumptions used for December 31, 2012, were a warrant exercise price of $3.59 per share, a common share price of $29.28, a discount rate of 0.72%, and a volatility of 94%.</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.</div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9.9pt; font-family: ''times new roman'', times, serif; margin-left: 9.9pt; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 18px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 156px; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Corporate Bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 27pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Corporate Bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Investments at Fair Value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,378</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,382</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br />&#160;</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Corporate bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 52%; vertical-align: bottom;"><div style="text-indent: -9pt; margin-left: 9pt;">A</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,039</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,047</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">BAA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total corporate bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,649</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,657</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total investments at fair value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,485</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,493</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.</div></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012</div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 13px;"><td bgcolor="#cceeff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance December 31, 2012</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance December 31, 2011</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,699</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Gain on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,486</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Loss on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">1,979</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,415</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance June 30, 2013</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance June 30, 2012</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">5,263</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for determining the fair value of financial instruments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2155942 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 107 -Paragraph 8, 10, 12, 13, 14 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false08false 2us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">New Accounting Pronouncement</div><div style="text-align: justify;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">In July 2013, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2013-11 &#8220;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.&#8221; ASU No. 2013-11 is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The new standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The new standard becomes effective for us on January 1, 2014 and&#160;will be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted.&#160;We are&#160;currently assessing the impacts of this new standard.</div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;">In February 2013, the FASB issued final guidance on the presentation of reclassifications out of other comprehensive income. The amendments require an entity to provide information about the amounts reclassified out of other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in a footnote, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, only if the amount reclassified is required by GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide detail about those amounts. This amendment was effective for interim and fiscal years beginning after December 15, 2012. The amended standard did not impact our financial position or results of operations.</div></div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting.No definition available.false0falseSummary of Significant Accounting Policies (Policies)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies18 XML 49 R27.xml IDEA: Litigation (Details) 2.4.0.8090800 - Disclosure - Litigation (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false falsefalsec20130225to20130226http://www.sec.gov/CIK0001082324duration2013-02-25T00:00:002013-02-26T00:00:002false USDfalsefalse$c20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170U006Standardhttp://www.xbrl.org/2003/instancepurexbrli0U007Standardhttp://virnetx.com/20130630Lawsuitvhc0U008Standardhttp://virnetx.com/20130630Complaintvhc0USDUSD$3false falsefalsec20121106http://www.sec.gov/CIK0001082324instant2012-11-06T00:00:000001-01-01T00:00:00U004Standardhttp://virnetx.com/20130630Patentvhc04false falsefalsec20110112http://www.sec.gov/CIK0001082324instant2011-01-12T00:00:000001-01-01T00:00:00U004Standardhttp://virnetx.com/20130630Patentvhc05false falsefalsec20100811http://www.sec.gov/CIK0001082324instant2010-08-11T00:00:000001-01-01T00:00:00U004Standardhttp://virnetx.com/20130630Patentvhc01true 1vhc_LitigationAbstractvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_LossContingencyPendingClaimsNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse55falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerThe total amount of pending claims pertaining to a loss contingency accrual as of the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 9, 10, 11, 12 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false2563false 2vhc_NumberOfUnfairTradePracticesComplaintsFiledvhc_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2truefalsefalse11falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerNumber of complaints filed with the United States International Trade Commission.No definition available.false2564false 2us-gaap_LossContingencyDamagesAwardedValueus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse368000000368000USD$falsetruefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of damages awarded to the plaintiff in the legal matter.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14326-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14557-108349 false25false 2vhc_NumberOfPatentsAllegedlyInfringedUponByAppleIncvhc_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse44falsefalsefalse4truefalsefalse33falsefalsefalse5truefalsefalse44falsefalsefalsexbrli:integerItemTypeintegerNumber of patents allegedly infringed upon by Apple, Inc.No definition available.false2566false 2vhc_LossContingencyDamagesAwardedValueDailyInterestvhc_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse3400034falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryFor an amount of damages awarded to the plaintiff in the legal matter, the daily interest payment awarded the plaintiff up to final payment of awarded damages.No definition available.false27false 2vhc_LossContingencyDamagesAwardedValueDailyPaymentvhc_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse330000330USD$falsetruefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryFor an amount of damages awarded to the plaintiff in the legal matter, the daily payments awarded for damage infringement to the plaintiff up to final payment of awarded damages.No definition available.false28false 2vhc_CourtOrderMediationIntervalvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse0045 daysfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaCourt order period in a litigation setting for interval for parties to find resolution before petitioning the court for further action. Interval in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.No definition available.false09false 2vhc_PercentageOfProceedsToBePaidAfterDeductingFeesAndCostsIncurredInLitigatingClaimvhc_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsetruefalse00falsefalsefalse2truetruefalse0.250.25falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5falsetruefalse00falsefalsefalsenum:percentItemTypepurePercentage of proceeds to be paid after deducting attorneys' fees and costs incurred in litigating the claims.No definition available.false0falseLitigation (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/LitigationDetails59 XML 50 R18.xml IDEA: Summary of Significant Accounting Policies (Tables) 2.4.0.8080200 - Disclosure - Summary of Significant Accounting Policies (Tables)truefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.</div><div style="text-align: left;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9.9pt; font-family: ''times new roman'', times, serif; margin-left: 9.9pt; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 18px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 156px; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">351</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Corporate Bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 27pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Corporate Bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,027</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,031</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; padding-bottom: 2px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Total Investments at Fair Value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,378</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 1.14%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">13,382</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div style="text-align: center;"><br />&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="14" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Level 1:</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Adjusted Cost</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unrealized </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Certificates of deposit</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">17,836</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Corporate bonds:</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">AA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,099</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 52%; vertical-align: bottom;"><div style="text-indent: -9pt; margin-left: 9pt;">A</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,039</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,047</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">BAA</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">511</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total corporate bonds</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,649</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8,657</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total investments at fair value</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,485</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">8</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">26,493</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 32 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19190-110258 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 6 -Footnote 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false03false 2us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.</div><div>&#160;</div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div><div style="text-align: left;"><br /></div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="13" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Quoted</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Prices in</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Active</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Markets</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">for</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Identical</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Other</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Observable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Total</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 52%; vertical-align: bottom;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Series l Warrants</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div></div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 32 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19190-110258 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 6 -Footnote 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false04false 2us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012</div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Six Months Ended</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">June 30, 2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Fair Value</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Measurements</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Using</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Significant</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Unobservable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr style="height: 13px;"><td bgcolor="#cceeff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance December 31, 2012</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,172</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance December 31, 2011</div></td><td bgcolor="#cceeff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">4,699</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Gain on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,486</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Loss on derivative liability included in net loss</div></td><td bgcolor="#ffffff" valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">1,979</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Settlements</div></td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1,415</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td></tr><tr><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 51%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Balance June 30, 2013</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,686</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 25%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 18pt; font-size: 10pt;">Balance June 30, 2012</div></td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">5,263</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div></div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19279-110258 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 32 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseSummary of Significant Accounting Policies (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/SummaryOfSignificantAccountingPoliciesTables14 XML 51 R3.xml IDEA: CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) 2.4.0.8010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)truefalsefalse1false USDfalsefalse$c20130630http://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$c20121231http://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1true 2us-gaap_StockholdersEquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_PreferredStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse0.00010.0001USD$falsetruefalse2truefalsefalse0.00010.0001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false33false 3us-gaap_PreferredStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1000000010000000falsefalsefalse2truefalsefalse1000000010000000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false14false 3us-gaap_PreferredStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesTotal number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false15false 3us-gaap_PreferredStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesAggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false16false 3us-gaap_CommonStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse0.00010.0001USD$falsetruefalse2truefalsefalse0.00010.0001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value of common stock per share; generally not indicative of the fair market value per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false37false 3us-gaap_CommonStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse100000000100000000falsefalsefalse2truefalsefalse100000000100000000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false18false 3us-gaap_CommonStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse5120314151203141falsefalsefalse2truefalsefalse5115024251150242falsefalsefalsexbrli:sharesItemTypesharesTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false19false 3us-gaap_CommonStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse5120314151203141falsefalsefalse2truefalsefalse5115024251150242falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1falseCONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)UnKnownNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://virnetx.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical29 XML 52 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Income Taxes [Abstract]          
Change of the valuation allowance     $ 5,695    
Income tax benefit 354 3,590 356 5,763  
Effective tax rate (in hundredths) (5.00%) 26.00% (2.50%) 28.00%  
Valuation allowance carried against net deferred tax assets 11,423   11,423   6,970
Federal [Member]
         
Operating Loss Carryforwards [Line Items]          
Operating loss carryforwards 15,527   15,527    
Operating loss carryforwards, expiration dates     December 31, 2027    
State [Member]
         
Operating Loss Carryforwards [Line Items]          
Operating loss carryforwards $ 52,756   $ 52,756    
Operating loss carryforwards, expiration dates     December 31, 2016    
XML 53 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants
6 Months Ended
Jun. 30, 2013
Warrants [Abstract]  
Warrants
Note 7 — Warrants
 
Information about warrants outstanding during the six months ended June 30, 2013 follows:


 
Original
Number of
Warrants
Issued
     
Exercise
Price per
Common
Share
   
Exercisable at
December 31,
2012
   
Became
Exercisable
   
Exercised
   
Terminated /
Cancelled /
Expired
   
Exercisable
at June 30,
2013
 
Expiration
Date
                              
  
2,619,036
 
(1
)
 
$
3.59
   
159,967
   
   
   
   
159,967
 
March 2015
Total
         
159,967
       
   
   159,967 
   

 
(1)
Referred to as our Series I Warrants.
XML 54 R21.xml IDEA: Summary of Significant Accounting Policies (Details) 2.4.0.8090200 - Disclosure - Summary of Significant Accounting Policies (Details)truefalseIn Thousands, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$c20130401to20130630http://www.sec.gov/CIK0001082324duration2013-04-01T00:00:002013-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$c20120401to20120630http://www.sec.gov/CIK0001082324duration2012-04-01T00:00:002012-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$c20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00U006Standardhttp://www.xbrl.org/2003/instancepurexbrli0U005Standardhttp://virnetx.com/20130630FinancialInstitutionvhc0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4false USDfalsefalse$c20120101to20120630http://www.sec.gov/CIK0001082324duration2012-01-01T00:00:002012-06-30T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalsec20120101to20121231http://www.sec.gov/CIK0001082324duration2012-01-01T00:00:002012-12-31T00:00:00U006Standardhttp://www.xbrl.org/2003/instancepurexbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170$1true 2us-gaap_RevenueRecognitionAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 3us-gaap_RoyaltyRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse60006USD$falsetruefalse2truefalsefalse3600036USD$falsetruefalse3truefalsefalse300000300USD$falsetruefalse4truefalsefalse3600036USD$falsetruefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRevenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false23true 2us-gaap_RisksAndUncertaintiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse04false 3vhc_ConcentrationRiskNumberOfFinancialInstitutionsvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse22falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerNumber of financial institutions holding the company's cash and cash equivalents.No definition available.false2565true 4us-gaap_FairValueInputsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse06false 5us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse3.593.59USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse3.593.59USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse3.593.59USD$falsetruefalseus-types:perUnitItemTypedecimalThe exercise price of each class of warrants or rights outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 4 -Article 4 false37false 5us-gaap_SharePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse19.9919.99USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse19.9919.99USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse29.2829.28USD$falsetruefalsenum:perShareItemTypedecimalPrice of a single share of a number of saleable stocks of a company.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 false38false 5us-gaap_FairValueInputsDiscountRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse0.01410.0141falsefalsefalse4falsefalsefalse00falsefalsefalse5truetruefalse0.00720.0072falsefalsefalsenum:percentItemTypepureInterest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 false09false 5us-gaap_FairValueAssumptionsExpectedVolatilityRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse0.930.93falsefalsefalse4falsefalsefalse00falsefalsefalse5truetruefalse0.94150.9415falsefalsefalsenum:percentItemTypepureMeasure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 false010true 4us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForwardus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse011false 5us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse41720004172USD$falsefalsefalse4truefalsefalse46990004699USD$falsefalsefalse5truefalsefalse46990004699USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents a liability measured at fair value using significant unobservable inputs (Level 3) which is required for reconciliation purposes of beginning and ending balances.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 false212false 5us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse-1486000-1486USD$falsefalsefalse4truefalsefalse19790001979USD$falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of gain (loss) recognized in earnings, arising from liabilities measured at fair value on a recurring basis using unobservable inputs (level 3).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 32 -Subparagraph c(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false213false 5us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlementsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00USD$falsefalsefalse4truefalsefalse-1415000-1415USD$falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetarySettlements that have taken place during the period in relation to liabilities measured at fair value and categorized within Level 3 of the fair value hierarchy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 false214false 5us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse26860002686USD$falsefalsefalse2truefalsefalse52630005263USD$falsefalsefalse3truefalsefalse26860002686USD$falsefalsefalse4truefalsefalse52630005263USD$falsefalsefalse5truefalsefalse41720004172USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents a liability measured at fair value using significant unobservable inputs (Level 3) which is required for reconciliation purposes of beginning and ending balances.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258 false215false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6false USDtruefalse$c20130630_FairValueByLiabilityClassAxis_SeriesIWarrantsMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseSeries I Warrants [Member]us-gaap_FairValueByLiabilityClassAxisxbrldihttp://xbrl.org/2006/xbrldivhc_SeriesIWarrantsMemberus-gaap_FairValueByLiabilityClassAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse016true 4us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse017false 5us-gaap_OtherLiabilitiesFairValueDisclosureus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse26860002686USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse26860002686USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse41720004172USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This element represents the fair value of liabilities categorized as other which are not in and of themselves material enough to require separate disclosure.No definition available.false218false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse8false USDtruefalse$c20130630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_SeriesIWarrantsMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseSeries I Warrants [Member]us-gaap_FairValueByLiabilityClassAxisxbrldihttp://xbrl.org/2006/xbrldivhc_SeriesIWarrantsMemberus-gaap_FairValueByLiabilityClassAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse019true 4us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse020false 5us-gaap_OtherLiabilitiesFairValueDisclosureus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This element represents the fair value of liabilities categorized as other which are not in and of themselves material enough to require separate disclosure.No definition available.false221false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse10false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtOtherThanFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Memberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseAdjusted Cost [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtOtherThanFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse022true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse023false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1337800013378USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1337800013378USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse2648500026485USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false224false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse12false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtOtherThanFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CertificatesOfDepositMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseAdjusted Cost [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtOtherThanFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseCertificates of Deposit [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CertificatesOfDepositMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse025true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse026false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse351000351USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse351000351USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse1783600017836USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false227false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse14false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtOtherThanFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateDebtSecuritiesRatedaaMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseAdjusted Cost [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtOtherThanFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseAA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateDebtSecuritiesRatedaaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse028true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse029false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1302700013027USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1302700013027USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse40990004099USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false230false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse16false USDtruefalse$c20121231_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtOtherThanFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateDebtSecuritiesRatedSingleaMemberhttp://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseAdjusted Cost [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtOtherThanFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateDebtSecuritiesRatedSingleaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse031true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse032false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse40390004039USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false233false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse17false USDtruefalse$c20121231_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtOtherThanFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateBondsRatedbaaMemberhttp://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseAdjusted Cost [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtOtherThanFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseBAA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateBondsRatedbaaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse034true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse035false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse511000511USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false236false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse18false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtOtherThanFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateBondSecuritiesMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseAdjusted Cost [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtOtherThanFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseTotal Corporate Bonds [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CorporateBondSecuritiesMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse037true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse038false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1302700013027USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1302700013027USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse86490008649USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false239false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse20false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedGainsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Memberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Gains [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedGainsMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse040true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse041false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse40004USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse40004USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse80008USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false242false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse22false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedGainsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CertificatesOfDepositMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Gains [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedGainsMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseCertificates of Deposit [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CertificatesOfDepositMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse043true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse044false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false245false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse24false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedGainsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateDebtSecuritiesRatedaaMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Gains [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedGainsMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseAA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateDebtSecuritiesRatedaaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse046true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse047false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse40004USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse40004USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false248false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse26false USDtruefalse$c20121231_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedGainsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateDebtSecuritiesRatedSingleaMemberhttp://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Gains [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedGainsMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateDebtSecuritiesRatedSingleaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse049true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse050false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse80008USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false251false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse27false USDtruefalse$c20121231_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedGainsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateBondsRatedbaaMemberhttp://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Gains [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedGainsMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseBAA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateBondsRatedbaaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse052true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse053false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false254false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse28false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedGainsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateBondSecuritiesMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Gains [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedGainsMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseTotal Corporate Bonds [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CorporateBondSecuritiesMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse055true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse056false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse40004USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse40004USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse80008USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false257false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse30false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedLossesMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Memberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Losses [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedLossesMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse058true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse059false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false260false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse32false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedLossesMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CertificatesOfDepositMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Losses [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedLossesMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseCertificates of Deposit [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CertificatesOfDepositMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse061true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse062false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false263false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse34false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedLossesMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateDebtSecuritiesRatedaaMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Losses [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedLossesMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseAA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateDebtSecuritiesRatedaaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse064true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse065false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false266false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse36false USDtruefalse$c20121231_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedLossesMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateDebtSecuritiesRatedSingleaMemberhttp://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Losses [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedLossesMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateDebtSecuritiesRatedSingleaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse067true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse068false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false269false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse37false USDtruefalse$c20121231_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedLossesMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateBondsRatedbaaMemberhttp://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Losses [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedLossesMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseBAA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateBondsRatedbaaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse070true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse071false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false272false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse38false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_UnrealizedLossesMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateBondSecuritiesMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseUnrealized Losses [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldivhc_UnrealizedLossesMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseTotal Corporate Bonds [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CorporateBondSecuritiesMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse073true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse074false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false275false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse40false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Memberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseFair Value [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse076true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse077false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1338200013382USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1338200013382USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse2649300026493USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false278false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse42false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CertificatesOfDepositMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseFair Value [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseCertificates of Deposit [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CertificatesOfDepositMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse079true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse080false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse351000351USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse351000351USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse1783600017836USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false281false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse44false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateDebtSecuritiesRatedaaMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseFair Value [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseAA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateDebtSecuritiesRatedaaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse082true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse083false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1303100013031USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1303100013031USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse40990004099USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false284false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse46false USDtruefalse$c20121231_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateDebtSecuritiesRatedSingleaMemberhttp://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseFair Value [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateDebtSecuritiesRatedSingleaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse085true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse086false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse40470004047USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false287false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse47false USDtruefalse$c20121231_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateBondsRatedbaaMemberhttp://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseFair Value [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseBAA [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldivhc_CorporateBondsRatedbaaMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse088true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse089false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse511000511USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false290false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse48false USDtruefalse$c20130630_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_PortionAtFairValueFairValueDisclosureMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_InvestmentTypeAxis_CorporateBondSecuritiesMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseQuoted Prices in Active Markets for Identical Assets (Level 1) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseFair Value [Member]us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PortionAtFairValueFairValueDisclosureMemberus-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxisexplicitMemberfalsefalseTotal Corporate Bonds [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CorporateBondSecuritiesMemberus-gaap_InvestmentTypeAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse091true 4us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse092false 5us-gaap_AvailableForSaleSecuritiesFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1303100013031USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1303100013031USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse86570008657USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7534914&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Available-for-Sale Securities -URI http://asc.fasb.org/extlink&oid=6505594 false293false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse50false USDtruefalse$c20130630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_SeriesIWarrantsMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseSignificant Other Observable Inputs (Level 2) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel2Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseSeries I Warrants [Member]us-gaap_FairValueByLiabilityClassAxisxbrldihttp://xbrl.org/2006/xbrldivhc_SeriesIWarrantsMemberus-gaap_FairValueByLiabilityClassAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse094true 4us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse095false 5us-gaap_OtherLiabilitiesFairValueDisclosureus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This element represents the fair value of liabilities categorized as other which are not in and of themselves material enough to require separate disclosure.No definition available.false296false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse52false USDtruefalse$c20130630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_SeriesIWarrantsMemberhttp://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseSignificant Unobservable Inputs (Level 3) [Member]us-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel3Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseSeries I Warrants [Member]us-gaap_FairValueByLiabilityClassAxisxbrldihttp://xbrl.org/2006/xbrldivhc_SeriesIWarrantsMemberus-gaap_FairValueByLiabilityClassAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse097true 4us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAlternativeAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse098false 5us-gaap_OtherLiabilitiesFairValueDisclosureus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse26860002686USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse26860002686USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse41720004172USD$falsetruefalsexbrli:monetaryItemTypemonetaryThis element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This element represents the fair value of liabilities categorized as other which are not in and of themselves material enough to require separate disclosure.No definition available.false2falseSummary of Significant Accounting Policies (Details) (USD $)ThousandsUnKnownNoRoundingUnKnowntruefalsefalseSheethttp://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails598 XML 55 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2013
Summary of Significant Accounting Policies [Abstract]  
Revenue Recognition
Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements can be complex and may or may not include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the FASB revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue arrangements with multiple deliverables and the guidance for revenue recognition. Under our patent license agreements, we typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

 ·Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.

 ·Current Royalty Payments: These are ongoing royalty payments covering a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe Current Royalty Payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.

For the three and six months ended June 30, 2013, we recognized royalty revenue of $6 and $300 respectively, compared to $36 for the three and six months ended June 30, 2012, as part of license agreements entered into with customers during the patent infringement actions (see “Legal Proceedings”).  In accordance with our revenue recognition policy related to a licensee’s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.  In the patent infringement actions we did not request, nor receive any amounts allocable to settlement fees, expense reimbursement, damages or any other amount unrelated to historical sales.  Revenue from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.
Earnings Per Share
Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.
Concentration of Credit Risk and Other Risks and Uncertainties
Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.  During the six months ended June 30, 2013 we had, at times, funds which were uninsured.   We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.
Derivative Instruments
Derivative Instruments

Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock.  The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets

On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.
Fair Value of Financial Instruments
Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Certificate of deposits: Fair value measured at face value plus accrued interest.

Corporate bonds:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.

Series I Warrants: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for June 30, 2013, included a warrant exercise price of $3.59 per share, a common share price of $19.99, a discount rate of 1.41%, and a volatility of 93%. The assumptions used for December 31, 2012, were a warrant exercise price of $3.59 per share, a common share price of $29.28, a discount rate of 0.72%, and a volatility of 94%.

The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2013 and December 31, 2012.

 
 
June 30, 2013
 
Level 1:
 
Adjusted Cost
  
Unrealized
Gains
  
Unrealized
Losses
  
Fair Value
 
Certificates of deposit
 
$
351
  
$
  
$
  
$
351
 
 
                
Corporate Bonds:
                
AA
  
13,027
   
4
   
   
13,031
 
Total Corporate Bonds
  
13,027
   
4
   
   
13,031
 
 
                
Total Investments at Fair Value
 
$
13,378
  
$
4
  
$
  
$
13,382
 

 
  
December 31, 2012
 
Level 1:
 
Adjusted Cost
  
Unrealized
Gains
  
Unrealized
Losses
  
Fair Value
 
Certificates of deposit
 
$
17,836
  
$
  
$
  
$
17,836
 
                 
Corporate bonds:
                
AA
  
4,099
   
   
   
4,099
 
A
  
4,039
   
8
   
   
4,047
 
BAA
  
511
   
   
   
511
 
Total corporate bonds
  
8,649
   
8
   
   
8,657
 
                 
Total investments at fair value
 
$
26,485
  
$
8
  
$
  
$
26,493
 
 
The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of June 30, 2013 and December 31, 2012.
 
   
June 30, 2013
 
   
Quoted
Prices in
Active
Markets for
Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant
Unobservable
Inputs
     
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
Series l Warrants
  
   
   
2,686
   
2,686
 

   
December 31, 2012
 
   
Quoted
Prices in
Active
Markets
for
Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant
Unobservable
Inputs
     
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
Series l Warrants
 
$
  
$
  
$
4,172
  
$
4,172
 

The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the six months ended June 30, 2013 and 2012
 
 
 
Six Months Ended
June 30, 2013
 
 
 
Six Months Ended
June 30, 2012
 
 
 
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
 
 
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
Balance December 31, 2012
 
$
4,172
 
Balance December 31, 2011
 
$
4,699
 
Gain on derivative liability included in net loss
  
(1,486
)
Loss on derivative liability included in net loss
  
1,979
 
Settlements
  
 
Settlements
  
(1,415
)
Balance June 30, 2013
 
$
2,686
 
Balance June 30, 2012
 
$
5,263
 
New Accounting Pronouncements
New Accounting Pronouncement

In July 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ASU No. 2013-11 is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The new standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The new standard becomes effective for us on January 1, 2014 and will be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted. We are currently assessing the impacts of this new standard.
 
In February 2013, the FASB issued final guidance on the presentation of reclassifications out of other comprehensive income. The amendments require an entity to provide information about the amounts reclassified out of other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in a footnote, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, only if the amount reclassified is required by GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide detail about those amounts. This amendment was effective for interim and fiscal years beginning after December 15, 2012. The amended standard did not impact our financial position or results of operations.
XML 56 R22.xml IDEA: Patent Portfolio (Details) 2.4.0.8090300 - Disclosure - Patent Portfolio (Details)truefalsefalse1false falsefalsec20130630http://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00U004Standardhttp://virnetx.com/20130630Patentvhc01true 1us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2vhc_NumberOfDomesticPatentsOwnedvhc_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2121falsefalsefalsexbrli:integerItemTypeintegerRepresents number of domestic patents owned.No definition available.false2563false 2vhc_NumberOfForeignPatentsOwnedvhc_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse4141falsefalsefalsexbrli:integerItemTypeintegerRepresents number of foreign patents owned.No definition available.false256falsePatent Portfolio (Details)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/PatentPortfolioDetails13 XML 57 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
6 Months Ended
Jun. 30, 2013
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
Note 6 — Stock-Based Compensation

On May 22, 2013, our stockholders approved the VirnetX Holding Corporation 2013 Equity Incentive Plan (the "Plan) at our 2013 annual stockholders' meeting.  The Plan provides for the issuance of up to 2,500,000 shares of our common stock. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the Plan. The Plan provides for the granting of stock options and restricted stock purchase rights (RSU) to our employees and consultants. Stock options granted under the Plan may be incentive stock options or nonqualified stock options. Incentive stock options ("ISO") may only be granted to our employees (including officers and directors). Nonqualified stock options ("NSO") and stock purchase rights may be granted to our employees and consultants.

The Plan will expire 10 years after it was approved by our Board of Directors. Options may be granted under the Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the fair market value at the date of grant in the case of an NSO, the exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant. Stock options granted under the Plan typically vest over four years and have a 10 year term. All RSUs are considered to be granted at the fair value of our stock on the date of grant because they have no exercise price. RSUs typically vest over four years.

We had 5,009,849 and 4,776,224 options outstanding at June 30, 2013 and December 31, 2012, respectively, with a weighted-average exercise price of $7.87 and $6.94, respectively. At June 30, 2013 and December 31, 2012, we had 248,915 and 151,665 RSU’s outstanding with a weighted-average grant-date fair value of $24.10 and $25.60, respectively.

During the six months ended June 30, 2013 and 2012, we granted options for a total of 274,625 and 277,500 shares respectively. The weighted average fair values at the grant dates for options issued during the six months ending June 30, 2013 and 2012 were $19.24 and $22.26 per option, respectively. The fair value of options at the grant date was estimated utilizing the Black-Scholes valuation model with following weighted average assumptions for the six months ending June 30, 2013 and 2012, respectively: (i) dividend yield on our common stock of 0 percent and 0 percent; (ii) expected stock price volatility of 93 percent and 115 percent; (iii) a risk-free interest rate of 2.06 percent and 1.92 percent; and (iv) an expected option term of 6 and 7 years.

During the six months ended June 30, 2013 and 2012, we also granted RSUs totaling 156,415 and 151,665 units, respectively, that vest ratably over one to four years. The weighted-average fair values of each issued RSU on the dates of grant were $23.72 and $25.60, respectively. RSUs, which are subject to forfeiture if employment terminates prior to the shares vesting, are expensed ratably over the vesting period.

Stock-based compensation expense is measured at grant date, based on the fair value of the award, and is recognized over the employees’ requisite service period. Stock-based compensation expense included in general and administrative expense was $1,759 and $3,344 for the three and six months ended June 30, 2013, respectively, and $1,466 and $2,340 for the three and six months ended June 30, 2012, respectively.

As of June 30, 2013 and 2012, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $15,372 and $5,372, respectively, which will be amortized over an estimated weighted average vesting amortization period of approximately 2.72 and 3.21 years, respectively.
XML 58 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Basis of Presentation
6 Months Ended
Jun. 30, 2013
Business Description and Basis of Presentation [Abstract]  
Business Description and Basis of Presentation
Note 1 — Business Description and Basis of Presentation

VirnetX, Inc. (“we”, “our”, “us” or “VirnetX”) develops software and technology solutions for securing real-time communications over the Internet.  Our patented GABRIEL Connection Technology™ combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks.

Our portfolio of intellectual property is the foundation of our business model.  We currently own 21 patents in the United States and 41 foreign patents, as well as several pending U.S. and foreign patent applications.  Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry.  Our patented methods also have additional applications in operating systems and network security.

Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer and remote desktop.  Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.

We have executed licenses and intend to seek further licensees for our technology, including our GABRIEL Connection Technology™ to original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.

During interim periods, we follow the accounting policies set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012 and apply appropriate interim financial reporting standards for a fair statement of our operating results and financial position in conformity with accounting principles generally accepted in the United States of America, as codified by the Financial Accounting Standards Board (FASB) in the Accounting Standards Codification (ASC) (referred to herein as U.S. GAAP), as indicated below.  Users of financial information produced for interim periods are encouraged to read this Quarterly Report on Form 10-Q in conjunction with our consolidated financial statements and notes thereto filed with the Securities and Exchange Commission (SEC) in our 2012 Annual Report on Form 10-K.

Interim financial reporting standards require us to make estimates that are based on assumptions regarding the outcome of future events and circumstances not known at that time, including the use of estimated effective tax rates.  Inevitably, some assumptions will not materialize, unanticipated events or circumstances may occur which vary from those estimates and such variations may significantly affect our future results. Our financial results have varied significantly from period to period.  Additionally, interim results may not be indicative of our results for future interim periods or our annual results.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC’s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and six month periods ended June 30, 2013 and 2012; (ii) the condensed consolidated statements of comprehensive loss for the three and six month periods ended June 30, 2013 and 2012; (iii) the condensed consolidated balance sheets at June 30, 2013 and December 31, 2012; and (iv) the condensed consolidated statements of cash flows for the six month periods ended June 30, 2013 and 2012. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by U.S. GAAP.  The condensed consolidated balance sheet, included in this report, as of December 31, 2012 was derived from our 2012 audited financial statements, but does not include all disclosures required by U.S. GAAP.
ZIP 59 0001140361-13-031524-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-13-031524-xbrl.zip M4$L#!!0````(`%V)"4,L*?HR\)0``)H]"``0`!P`=FAC+3(P,3,P-C,P+GAM M;%54"0`#XEH%4N):!5)U>`L``00E#@``!#D!``#L77MSV[BU___.]#N@OGNW MFQG+%BG'<9Q-.HZ3;-W-QJF=[+9SYTX&(B$)NQ2A`J!MW4_?-?'_H!N6-2<1&^/G".F@>$A9[P>=A]?1"I!E4>YP=_ M??.G__KQSXW&3RQDDFKFD_:0O./*"X2*)".W(H@TS*#(YYOK#U>QX)('9&+(""FNR*2 M*2;OF'_4:.#J#VT9$"`V5.?X)W]]T--Z<'Y\?']_?X1/CH3L'KO-9NN8ATK3 MT&,'];IC?LX.6Q:4V[*E[4$:9UCO_YR\=;K\?Z MM#%.#R[O9P/SU)P>V\:D*U?BQ'5>S-JL[9$.".^8TJ-S*^8==<7=L6V#88[; M:#J-EI,,`CEW*1VDHSI4M4QM"8=PZA?W-'7 M\E@/!^P8>C#)O72`"!<8(\+&V#A/1*&6P^)-Q(T%&_$B*<%`IHV+6PL&AI1[ MJGB4:<(ASN@0Q;WB`=!0U%T/Y)3^T%(P@#UXO>(!V%*PA[M>1M`=ER'3#T>> MZ&//5O.TU8S[+6*:8-*$_(BV=*Z,E=RP#C&V=8X2>WV@>'\0H,F89SW).J\/ M8/U&LM;1@_(/R+&=QR`"B#34[$$3[K\^\$P_I^EHD5)G^J:]6:BY'L;/TJ?< MQ^<=SB0Q=+&1S23\N;SZ^>!-$ZR\>>:VW),?C\<')TL=%ZP5KS0`;13^^/K` M'JG?`<2^0;*1_4TGF25K&QO$0C\WY+31:F8+^[D!R=/SV7G6;%6" MB5;+=,R/LT:SE4X>MZR''U51JE%^Y/5CG?QPJ\@/=X/\<%R`SLKQ`_YK.9O@ MAU-%?CB;XT>K>5)Y]W12'O?DINRL#A"-L--=GIWN)MGI5)Z=RP9/&V2G,?%O M%_=4^E\@OKUXX.K;;U1*`)-?6+_-Y+?+@"IUW8D?7LL;3(--OUM8D:FKN$79 M_D\@D(S/K-MG*0JF#3Z0\3`(N,?C/1&?0S];6HA3R?,1%AR\21Z/\.+'X\+I M5EIO*EL/WD`Z<5[(VWGKISHUPH?RQF6I)5?&`S_>DD?<]OHM^0/E\E<:1.SM M\"T-,*6][3&F?Y(B&O"PF]7&KC3K7_2QGJ",,7\6$BME%SJ=(?TC&Q1#0FZ1 M],^_`5NI]'K#C^R.!6;*M.TJ'$1:F0:GVBBQV,XS^)C!@G6"R:I2SPA=0OR[ MA4+K,IMKW6/R2X^&6[&?;U>F9HK\3=WV)9.H\!X`"CB6=VP@5"*;VMS*:FY+ MJ,TZ=S"I/AEM,_2H-OVG6IOM4H=R>6.[.I6E;"4CK'&RW MRB]"#@2^A/B.M?4M\R+)-6?J!E]+I+0V\`T8>)$%H>DN(HIR`,TFZT'["01U M^757(_(R(4]]X/+DAKY=CU]5$RZG:RHI`E3+D,Q;$W7.^_2&M1N.JV2BU?:WY37;$F2HM3&7R)@WD`C69O[T M9OXDWKDN.=KI0K7T3&.60&KSKF M6Z(#E[JN4\%$<;OQ=UWPJ7;!I_;GM3^O2U0[&JS7UEH24ZE#WZJ%OCM:B=H- MZ@JW6U46WJ98ODG_C!=!G:]-5N.8K+QF7YICLAVR M\,I\1:CVW[MHR'4MO5QEH1U*`FKCW24OO$O66W;W6Z$$H*RU\/*:;XERYQVU MZ;VPF3ICKI2QE^C@J[;ZC5M]]0_B:E]?;/X?.6WS`&B\#*BR-GX+,S-U]1N5 M$I;='8.:W*J-?POWN^-B7Q:'6Y-07FO.:IJS;7?0JA6Z@"ON7BOTRLKD;E3' M:X1^?*2\GPI=:83>R:+PQ!N6M3:6!L>V^6)M'6F6*Z>*70=:596H7?RIWPV=;H*/=%G7^C#1:1[0@*%5@TUU>PB]#\*CP9_CR17 M/O>P$EUMA2S>;2;\.=O>K51CI@)<05\9TN`&]#^,&)CI'??8U+&@O*C`4@;JG?`2FQ,CCP7SIWVC8VB(5^;DA>?Y*6+>I/#25/"245 MTI^+>RK]]$6%&Z:T!(MC_JT6WA_55I:1K64Z4KC'6C/F:(;AU?4`L;CB"=(4 MM9C<8*T3-48\!49L\]"C%NT.5AG<%,G=&LF?#,G=Y9'C"RMQVK MF\P3Y3?S(LUU)WYX+6]XMZ=W[QVB=8A^F?6FLG5O7MTL\BHUBE0T?)R5L=9X MLN=X4NIL=F'-W6=-W`--`#UPW">0\:,P'?D''GH3F-YLGCE.U?C1;#3/&LZ& M(F6G>5HU?D#X!BIRNAF?[[K/8^1TW6IP9AQ^W(;[?$GX@2&GZX"?*.26EU]A MHV/,ZS.*GUEY$Q/6HY*I9*JD+3\]SC5M[G%(2\9S)4Y?+KQOUL-^SU MWJ+3?!(:28X_:YJ4GG?"B\S&/QN<*Z0EZ6.[+$Q(/L";.DU*R'L#^^0W%@2- M/T)Q'Y);D)H(F4^NE(J8S%-D.V/?G[%KTM-VG$_9OQ`CYLXS3MJO(HA"<"M# M$%[`I)HD*.UA.\PGY)/(TS$V?'S]1'5NV`"_[Q5V"?[8("J@(^Z9=K3]EN9+ M\33C9!EBR27(LBOD<)(8TYXTSZ?A(Y5=1BX\CP7H$D#\9H(\72,SCI-SP[I< M:BS M!_(S*V!0W,7T@`[S*$ M).L?HTOBN,PS>I[YP"#Y3(>T'3`"LD'KE!%89O+S7,[480)/"25IO2*>(!Y_ M$?KQZ-S@!-DFB4421Y3*S2M5`V)6Y^P4DEMP,2LL6(Y=FD.;.;ML.2]?K&.7 M43\*#*B:+T,B*`PDZV&-Z8X1^]LD\@-^F?K9(?G$-!$=\H4^%.PVFTY9]GV,^```UH-PG/"0>'7!-@XD] MI3T_0\>K\-)V6\T.W:;KOAS=0/'T&R1T$28[SNG9\]/E"`T"X1D5,DZJT:8* M_D9Y@#`HCB3O'_!O-D%X,M(,?(OC\L/B47-1>@XXM$Y.1O>ST*I/N;V3);;G MO'C^LE+;<]/MN8ML[^3TM&+;H;C-.F>%BR\VHJ+;;4%E,U:\8[R``.;1D?(AJ(0DF7? MBCXD>(/4R(-I0DFF^2#D+4R2#1F]@^I1`6BK=>:.[F6Y5O&RM M9=/9M\(5HNYLWF5R.X^(N;6L"(#GJ$L91+ZIN[`F^>IMRHD>T/5 M3DAIS9>=S1'3IF4T%Q]K(6X=04OA3ZEZDW71?;-YCSS7M.H?:A^AZBGE7SM\_$0;,SYI?G)4D M:RZ+EY_XN'7MY5=`[]2!XX5XL=M^F_?;94J;JR3R_$6#UF^W%W3<3R_S(F]< M.6F7P&6OK@//G2WX['6'^-.AHDQZ\20HL'H87PHEF%'164(_RJD%VZCK[(@: M;".'7Q?JERI^=T]/SIYO$]!KO[TVP2U\TKR98X\O`E\U&X_9JBO>IP'>PHOC M*X"XCSEKV5^IES;=7KD66M$HJT0YV.JAUTGSY%5R*F_49@64.MG$C+ MZ.0?;=:MRB3R1=ZAE.I1)^^;/%Z?!)(Z%-P<0#R=Q]]]?U*6URZ6T8^5[S)I0`GRS;7\)&_\&SM;?IML/T"B?J47U6!. MI%BF\G,5W<,*D60%/J"QS?2BDO9>U3=)%RXGE%/8)?+_*VC`EAS_0HHP)=&L MD.&7,6]<32G6\H&&VZC?QWL!1(?<\FYHSD1"3>)O-./GTC\+O(>+37Q#\2U5 M7%UW/DNF8%/F`Y@7L(ULDFR.9(HO(,>W@?#^F/]M[^\#_'W2@ M?Z-#^SP8GI._?.%]\$V?V#VY$7T:_N60F">'1#').Z^(Z:T`W,^)TQSH5P?? M=_6KHAGO&5Y.=T[:(O!MKT\"U-ZQ+0A$RI`$^J1N>DX!U=+(/;#TG^%5?[L7/4DY,L&(N+\B4C=^`LH8` MX#?,$[!)%.?ZMH.@P3O#QU-O2/V-@3%(_`2VB"21,>$=*?ID8*ZM(<`I_-9T MV#TB7WJ,:-Y',>&7T:F!`I1E,D[:#6/08Z9@U.O%$S!<:,`0RZ*!"`DE=U1R MIHTN=*BGA012>>@%D;E9`!"%J`'8*:@(T4SVS?&LF9!V)6/FF_=(!78,J49X M@P[X+Y\%L"&)]JM,%]$&UAFK4D>@@ODI%`$%)&V$QOX@8`^F?Y\"5=+\7RAT M3!0C_2C0'#H1%MBQAB.*Y6?#,7'_0W+/=4]$R,(^MU9]F(X%7MG/D6MA]\JT MMDVXC0$%EQ`+@(<="1RQ;4'^*_31H`%LCOD0BK`A62<*?>.+8JZ3#@,FH&/" M12+%[.PX,4PP+F(BQ9`&)@T%$7D"N`@4#J3P(P](5J#AI#U,)0HS)!+P\A\: M5EI"?Y2(X?Y]R*3J\0$NS0&K@H!!*W[N6XH!DZ`"$BT(9*64\+CA"K+.()ND MMJ]F7B\4@>@.0;[@"\3`:@#>=]A-Q/$QW4A.)!3IL`"#>@FL`!XQRY`/%[=O MQ[77;*$;<1\]X2$Y2*SY(K>4I>^71"'>Y33NZ`"T@JMT!ICVWQ'':S9@.XK[ M>)T)K@!R![6CZ6>;X=]&NUFF!:"9F:[K'M6D1T$*>#$&H($(&=@0!HJ12BS& M*!5:P$@-8R,C\5BEK"(-\Z8'RM+1]EZ>W&2QS0XHA!)>%%!IP,#: M[1BAV(\.4&DD*HF1ES1@D8.@-M/WC(7$7MAF#3*60-X$?H]\<^FE80L(`6!` MX1K)-!PM(!CF$:3"H#L+S\%NZ/G8&I+\#$\BO(QDJ MNUFG]XCF M"A+WC\KJVW`A;!@)4]8<`IB%[`5O,?H`4*3R-MO&(=CKG'Q%QZ!Z$D$QS>)AY3["9`%_/L?[OMQ0- M8T,N)@+-WW24%L4,X"$Q*:[AZ,1$`]A984V4FD`%,K9#_@)?R!7)[*?L.`Q)^>+VD5!X\)@-/!VH0''H#*@/J(GG@KD_FW&E`O M^7<\S3WW=0]5O?D_X[:R"$(/>R!4:*)$" M7A)KI7&992C>HR/"$-QX2D)1HA%O6<=A&KF'$-&X'?C?>P#%4"12F<*=-`NR ME2$37N3D9"\BL3E?AH269PGEIM`%HH"X&?)`5/AX#ZF0D'(;,N70O(`4B.9, M%&U[X+4E-JZ#"-EC69B5#YR,&[&Q9)S*Y-68JM0_`6="[&N"*]'6E..UE-0H M4%XA(8U-;C7&YL)0"W>&V07Z@^0YZB>J[ECP-2/HRB#I.$/58X/P4_Q#[4)J M%[)U%Y+<6!I;^V<;<8U'QS&*8!TG[(JL&C%,0C1E*Q(6JPL]2B[;M!%:W@MQ MK&`85`%PF*AM`%H:X\_=AI*4'F1ZTZIU3$F=P<2!:+`"0&':)NV&+%V6CB2R MC^)(^=\1Y+Y,!D.;P?5Y@X:A63=!1[-^O)8R%53@,)++Y8P=Q;$VERD3"I)R MRR;C5VPFCP\2QV(1=)P,%;45)-2F)F&!V;(%67C?XPB^^5`Y)R!;>`F&R,J8 M[AB#C\B%0G]@G#W@IT;4X_T!BL"X`U.V43%Q-B//U#WPP(;OBC^`;$/= M4P3K'S[Y>P198:MY2/!8)/7X<64GXZZ5$UC3=Z=FGN]:S29J)5H&"#48'II* M)Y76E+]KG::UU047=P\QI,!R%RY3D'9CH"I--@D+V#(H,$OT\29I/Y))I:^H M.$P]:],_8(R92-MMOOK(NGA-K10>8^BN4TUPG5?/CDCF**\F4_[\L4!>?P=X M3C-<0Y0?U_7BX#$O%0,&R5%"4>0?`V@PBL:;B/P-0%8N1AR5[#RM`:I][IL3 M#RR8,@5$AJ8\8[T!#8=9C&_*UD@CLC'+*#H&B5A\9:!DO-^.I(IW[-,^[3*3 M1>%<%AOC0Z0HS&G2>!J0W\A-_H@*;.^>@DB"HKK_B"'1S+UDV4.6\R#NMT

/1]PM//(']S_>,V]KE>EX,G]EY..V`GJF=.FJ0]#(M,[CL$DX)@#S4S[9N] M+P)ZZ=G[V!5>?=X##B'*PRA4/O`F"<#;$JC@HC\]6S2EN.@_-K@1. MINR,L"J.CD04^+FSCORZ/#Y7$@AXW!2(?=P^(IG*WK;M4=^.Y8"9S-_&D<$T MLS@:R8@0-+TD#PYYB[@2KV<:-Q;`"A_KV`)[]C M=1'\1>B!NH)A`&TZ2H\34)F_AMS\!E7C3ZTA92(#^P*6]6C_:>_=G]M&MF9VIL41;4L3BA2RX<=[5__ M`>ANLBE2$JD7*;E3Y^S($MD-H`$T@$8#>'H[XOE;?#H8`LT`*;?O&!HL3GS% M_19_IJU()D_1P8NB+A+176]//G&%!)[F7\(E18,A*$2#YRTX@M/)D'XODS^74VF6`& M-C2]-C+=;Q1?H--R(/#4GLMCJS7+0$8@:1L$&(T84,33$(#'0C]*HCVG*-/WN,R!<6O\2:><0I9%3L%8YG&D M$DS`>!PG1%!R=@0;^+[-)5])TQ",`XISC";EF(Y3P`P<$PN+Q$R#,C.#97,6 M$T5`<3;Y#H?V(\:8`A[.1Q&<@W&)^RP9M3-N/(^8FMI!AO*8?><8(22TT:K2 MBNE?3YP&:9PP@F'ZW]BX&7I-^A3R*+S8\>,DH2D>$DMMIN#.PR9@&7/#^P$T M(WH)*%)(EQQ:+N0H2'APR%V*\:P@'BE,[A0`L>[FPF];*W\K!2;+[TN!YIW' MNP5\;%^>T+SWW(?F>XHH\>[8=8W"W+F<#REV.<*,5M3CPLU=$!,(#]I.$$RT MIH-X.CQRQEN*DR^-SI%,!R+VX0=;:F80,BZ5'^&;!W$:L"EQ1)*CB+#AN,8, MZ2WV'()(9">DO4SQ=>Q>S\!DE;LI#P'907(2A=)GV7-3281"PQDV03N0BH&T M_\3QG@(9YY,N+\=7#<_%\)-\I!SYB4S8(AIQNST68:Z,.'W1/\59%&KSGQ4O M=PFQ)!*#?R51SAQRTJ,!<#,&V)U M,8[R[O)VE0SU`)J%#S*%)6.87LL'7]`1B&O*VQC_BKR0CE%LKEHH/O8H=KB0 MY])RI8;Q*2$"N%DI.^(+>=E#P?1EO`T"]V?G]T:8O$=A`8&E&*2;&D1%D/_> M47\/9/338#8Y6&/0`U;HB%3"Y*_,;+8;8\@#<[#J[B9B%#5@ZV?4I2U\(9C< MZ0BY3@[C8"?Q/YA[IM.@V"6FH'X'3RYDC16L]Z>(`BN/*D_2\8-<)R$F(`8F M#1X$T6PNCN:$*R1=HSR)XF*)J6BV2\LD/;8\!-7\>G4B,1(&XV:$YV(S+&86''$3B:S5:GMAC267NW2R?V[#&&% MXR6O!(L1?4(6_TX/^=;+UT\429D4$!@ MP.#F]SA,8V2[W@Q5=Z)59]Z8.?P&EJJY5UM"_)C`3\7$LY&,.!2Q,F!1(BQ! MZG;IH%W$]_&,4X8.V'<,PP72NL3#]NYE?Y@<1C1X[G9\JJ$\V!Y>#H<-GFW) M<]A]H9K:E[WVC_R/0SLR:L+P^Z/*RB'`+]A%ET2-;IM>4!/`7A\_.!C!"=*2B%@ M9"?(^5Z$`9`86196-!`(2:#<&[7CB\`&;E$/GH^'W_A>.CZ-XV;6>>_1UW1Z MY(BC,OV?3!OF/N==_5Q!K950L MG0:Y-Z#6I'M:'M(;)FGW+E9-R-#_74F*K-6ZO]50$LLJX4V#OL%0MPM4;,)^DLG]+;`V8#,] MV&X31_S94,<*7@4L&-_=`040VL M-XOFQ*B_<=6Z\JM7DNO.IVJ_V*E-Q]``+Y(%K]3?+ M8FPR60F<4`;]SH_[M1EWMAB5"V=K(JZ!$G)=OUB%*:*BQJ^IQ1IS$XW6R,M6 MTZ?NNFV98M=K:3\YICM4<>P(<,R<\S\AFNJ7!AO/O\W=2#NNA M[4=2*C?Z-2=H3CCC4)M>>:T#-"<<+P2T+F>D?L94YVJE,75S<[BPT]K$FF/8 M_YN3*ZKU3\K!5WV4M]UMM#I791EFOQD@%?N/E<.D>7J_/-U[/NR\%H`CA0:W M8=_*";<53Z^#^D0.F4^?Y;4&/W\-CE9)M_#Q^5> M0^6Q`WXDV(P'8`^)7OYI%A+ZZ[:L%HY"[9R+JMW]/QH697:D:S2 MD3Q.@D[E:ZSY3O.=CA7K6+'F2*T)M2:L3;AU&:I>K?,_-L9@;^/Z=U1;NVAM MAUW.4^N!>!(`?.MY&(GRIV=L*RCQG.)^UOL/%9UN#6K'<*K*=K:C\7WM,UM6MP6);;@X5` MT26U3RV44K,XR57CNCLX6IRD'OFTFGG/@WEU.KSF8,W!FH,U!VL#XECW1`K[ M"+I2JJZ4JCE!ZW$J2M3-BTP9HQ0+F]J>-TYU;^$62F6UAF*G?R-).=)),= MKX!*/6BL&:S^1J9F-AME_1D'S1SQ;S[:(CZQ53LN+FBMTZI/JI`QVZ0T]*JM9KN-,(8VG! M.:+@/"]9^:_(@\TI9PNI`IA/OFW!2+9;$WANK-!^S`1-*P+F@^E_8V&`YDA- M(+K%@#;R=$W@N0G`7#MJ#[[#J1NM:\]/U][#+-2:SLVTHZL(HCOP8NJB3>Y& M\,(C>7'U`.C6G4=:G6AUHM5)\;:\GA9B+<0U@&9_J2_U8@X=(7BF'%J=!GWQ MGL+>[9=:B6H6K36+=C2+:A:M-XMV-8MJ%JTIBU+N\"FQY]ZSOO=;LV\O:1KW M\!N\YAA_FKX/GOZ^BF0<_JK%=@DSQ[MJL5?XJL_GJ4,&W-&9J'(`-!=K+M9< M7"_XJN?B3F-P/=#\6U/^T/S[#/BW:&KP2K!BXHY\XZ<5+\?TT&FVSS5$\(S3 M;#.IZN<0.]#"H^-K.M56I]I^R\DDK0@:G?"K$WZUQC]%C5^_##V=\*MS!:L7 M8*U.SD2=Z(3?AD7TW(><[%$YIP"S%A_F2H>AE/#-()H-C/]!19.MJ:F^T#Y M:\N%F.%'+,`L(CAQ(>:%D5N&&8:F`0+[NS$#H*:!P=PQ/):MS)R7X7IXHBRM MZ[K\KYJ::BE]1O*Q+W5Y*MTHA9G"W>*:$2GZ9VR)JX?$!LKE1J&Y:Z M!SGZP.7H+F8[H6 MRW9'VU-<^IBA_[,,[#_GL/TQF6=?=M'>9;=]75IXVUIXM?#F">]@.#P9X=V< MUCBA?^>T&_]NVJ[AN<88WGHTL6Z#E+;]'L05"W5ST>JVXWA M5>%]]FA"?;3K`[U]YAP<_=#)<'>"K7K)UIO.2?)_4/JP%7`MX M`8.\W3\-V3ZRE;ZS/WXN=H*,NI5(?=L+C8YB2:\06(##&'O1R&&GFC^_7[RK MUU2E*HGO[&14SI=G8X3D:8_")RI:>VCML1?$^XW.H/2>52_ML4L?@K^B(+0G MBX2^)>_FR/<%F M$KQWO8%SZX(6=!9D/S7HLM"[F_M7AAT$$1NKJ-Z'ICLV_7%@?)V/S9`9+Z0C MWFG]>R3SP(@E!G:GHM7F4S7^.KZS/(>7`!K M;'PQOQNOF,LF=FC\.66N80(^H7$W9[Y)0%`4][7I^XN)YS\!-`UXY-X&$I@^ MO8T/-`S/AZ_QS]<^&\-8ZAO&V^]V$`:7"KP&@)\"V0[@?11G,\$_$/AC$)DN M9=DN["&VZ?"K5\@`QGP)OTA%+@1X1ARYX-+`ZV`X0SSLW/<>[3&L8#@U0Y@^ MB4[[S*&[7:&'!%LUIO'D10YH#":AP-M@B`>0(+)BBAMC-F&^+]XUL<0T71,S M*?#MQ93&$+AA+5$Z$)3&5^D!>A'_LCBAU1<,>V($D37%6V["Y4?"^NQ?D8WS MP[OL^YQ9(8^[(TW9(SZ$GU"F_!!/XG#TN1?8A`&\/[8#$V_1L7$.$4=`&I0" M\`@9E5PGW"**_/_#=".\7\>/YWMXZRW1:T^VXR#MS/G4R57.)T`(XX;!;!I8*A738GPQX]$3[0*<;*-*G'A>Z'HA M`\6>I$.N!1[46#2+N!99CPA.#*!)/G5L,)!MF)]8##4$?Q14K`O,:$\4NJ5G M5O&%<7^_N?F$>(]8^C'X*AD5T4.)0I*!O"RD6@A@6>&UN>>3:@*!L3V0_G=` M$(Z-Q)VK3EAT($\R?00^A;\2`CZ'[2>SIF!:LX86"'30]%&?,F1F^(J#`RK* M`O48`2'SH4`P)2N.&:@Y)^9"+XCY$%D:=R+)T\:3N:S9;,PDM6=T@W<"LX)L M+9CI!X`E.$(N4LN-9WW[[W__+,/[^?YK-UV8P)9SIPUN@,)C!*/4-5,&TVR/JE-C=;/+7 M)`#X"LR(_U%>O`GE6_02R(>+6NXSF_QZ8:$J:PVZK0M81)M_][75ZES`VEGV MS'2"7R^:W8O?NIWKJVMP.1)D"\U5(5:=(EA=#7O#T\*JW>FV-V#5'@X&[9/" MJET`J]ZP=]TY#%:?2.G"[@:6G@DZZ@5H%/KTLAAZ_'WYNGPY1\[:K7;H%92X M=K?3OBJ`;_[D-4*[$Z-=1"3!1>EWN[OC+>KX@?'*?,L.T`ZS81][`5OBV',< MW$=`M1O!%+;4++ZXA=Y-Q!AW_F=TE=^*D:C_4OQC('X-BJC5KHIM!_3/97^H MX+G%K%OB*X(E/^S^Y MT]!S'-1;.0=_OJ:$/@3M:1@?(S*[X+=[!EX:F0;9F5FR)J\D;\1FZ<9-[+>UT>.M M:]$LCY@3K00OT>@;2L:,H:"2X^'7(B1YYQIW5NC170I^-M-N&$_,H&MSY+%A M)(QB'0[MIN:#S[B+C#X1^BR6YX.WB,&7*3/'_XI,'UX543='[,"S&1.!6Q&F M`>]J>5ZR"D1V:,!+*(';.S<7G'U`JG_H&^BM..2H\J%AJAF&MFR?EW"2@^8= M49]$C/C/+.T]MVEA!,>AVDSI!4B(#S[NS$,7#YQ'I.2,.@^2#Q_!,P$+1.R1 MN_04^6"N<&$I"FIY`44P?N@UP-[!Z`H(.;JBZA)T^BUC:H)+/&+P]MQG"`9P-OPB;)E*(@B#Q#O MIXR%G*U\-C-M\KA'XD<,5D84X_I@^M;4:,O(#N(GPST\Q"O"CQ0$,1]-FY.5 MQRY9`RNOP/N,(LTP MF/)O&4=,%M![9!PV5&H^Q@!DN"4)#7Y)L7H@*6S(D*W/)I$[!J8:R]`S?&:A M=9F.\\(,0>B+V#02"[AIP0/#&(+`$)7#D-H80(4W,2HEHD:`4'/BF\"Y!4(. MZ[5W:E\`0((0OFQ@Y(R"(D@AM%O(5@FRQ@J]=(_OW-,3=\I[!:S=I1WPMSXX M`-UVKYV&?M4,1X0]QZ#*PM[NMSJ]SDZPSTU9O.Z'UB6(?#NQ%(V;*)QZ/D;@ MJ:H;:@3\?X$?\GNVKEWF3FW#N.6A:!+]!![,?VH`\1M`_54C-N@E>`X0;0"F MRG.9>=90>_L04S_M]"T-J4FZ121H*Y**TXPRPB5(=!B=P`<_.+#[40)K@4V8 MM:"WF(S^R?3O_'NJ@TEK]XGY-&'IJ,/MQW<7OW%1R45CU405HK3)W]TS2F:L M-DJQ5:)MMI&#=DO\6\-;R0Q'@[R`4&P/N7)(=\O/R%Y@BL/+!B5&@#WYQ?S> MP)_``*.$%#3K`-N;,/3M4<1+IX+)_M%SR:`#YL/';LF<#\(\/NM2;UEEQ=[IRD-[P^%JE=+.ODQRDL(O/LLQU\(PN76I/3GSSH M\%4F.&',,DM&931\AX]&@U4?;*P\"7,W8I]D".X.@YKRF)(^L.28C\)<1+X-/ M&ZK3/S%C:HXIG"62JBFZ)&);3R"'J`4X..H,QI\,C&T*)8V88S-0@91X\T2Y M=480C?YB5LBS*AO,;?BM^)7]DJ M`M)N]SII0Z7`3)5@4R3X,!A>M79`!K8RY$+*8L1H-P_JTA=9#)*'X;/#1.;5 MC?+.CI9-9ETVSWA$7,J9#MW!+KAD2XQD49#/O!>/X-&E.(+81BXZ@^MED%?/ M<#A0BS!]KWW5V0G46SHWH(#^:F`#2A]Q)Y M)RF<@!QTX#INAEZ3'[T:S,1I^6FK*0P;WFTHI]D0Y3M;>*V.KI(\4&$T7]S\ M6%E*B1\H6GA\!Z8+(K.">/&S^)" MS6LOP/V?XF_-D8D`?I+GRNO209*A[R;JP&)<&I8&?85CRB'KJHGV)IHK[\QA M%LH@E85"<<\FD2>U-*>IC?"`?V%T.O)$*Q;3*="`82K#'"6?<7'[P_9=%OY? MXS_A1RX=L8/$'1Y,X`1)NB7C'*7K$R@9XP6^>X$?7Z**PCG$B9P;T26T9+[_ M,&:,TBR6U00-%%\TD]W!\'R(W\:9&-$<]4RGT4^?`XJV8Y822K\TOGC\,/][ MR&]M8<(&^"HF7?X*IG0=C:?!-&1N0^0V14X@!9;P!D/`\R^>,$T0()HP=$/Y MQ2$QN>*IT7TR/@$E,YBDDW(3)V*L^,6+4*#/DS7R"?&`.A27!-`E'`UOSGUD M5)48[_%MNJ[&?YQ'/JA.`-OGR7,O/M]_?2G5-)O-'6_!Y-X"@\"F8-*MCOO4 MT#1I?#]$@@F:>\&3.B03I`&B'`GW7[#R/",B]>NEPCOIUUYD& MSXC%`&0`?V''84%O,K$MXF07[XC`KA!Z?O#R$N."*X"`N3[27/A*/L$$CBL! M6*9<71/68HXBGN0L#S_+/":Z@&/SZSNQ)A@M"-E7'ETIG1AO)%$O82?D!%PB MSQ*#4$0![R:E;N[PM5=7%#6"7%$4:)ZKA#$.3&7"X5SJT"=SH\C\ M$,8*MT+$?)2C!P_1V-+,L)";X$O@:L3INK_C.``,,&UC-8)B(G@HQ;9NW)GQ MHSEC>,>861')WYV4'(X[CT8MXYX%5F"1)$-D09?FVTHXU56`>7[DH_$]8B4X M[75+D89*W%E,0550NX6+.=8:`/Y[Q#`_)9U-D'Q"9``UBH694HPHT^P2`S0& M:%ENW"HV,K?VY62"7-FVF4)!Y<"->X@9!<3["QF'6R+M)9]Z/>RU55(47AP; M?=C6AXWKWI"(W&M<70T:G4XOV5B4'+"BV3_)A5%GT1"*R>!V(#@?0$O??,CC MTQ^N+J^O:-`?!I?#7GH@6.R"T_,`L='I73>&[3X]U>ZW&X-!'Q:@W[H]"Z!'0G>3O]RT%H"N*XK7SS4+AO!$DVE-$G.X)FZH1>" MM0G4Z%SU&H,.)W?GZ@HM1JD8TLM(_JD@LB&)G%`VUFY<#L>4TTIYW&)>D;XT M7H4%?IN/!C\<^*$]O.STQ+)U+CL#2KWAHR^SW)>LVI`6X#*0_#8NK-.,?$G0 M]DZ23_O*,<&_N;=`V0(VCW&`>>:-F<,Y+^D%G"&."1C/%*J7P3F-T<]@Q+T$ M@PUW<7A@83-G+$,:JC&/F+:0+A83.TO\UR\P!(P1EVH0IAS)\*.'9QSD]\,` MPVYJA#;(HCH&#&+2Z4ESXC/&KRZC`O6%'NY+/-[)A2AM530^52$7G=W^EE+'4E-5'WLM/F^F[#(N8$H'<+`<=1 MZK>FCW>&`KQHS@/1#0-+9%C+Q#FT'\;'(P@%6;%+='GL^()+;, MMN+&E_>]U-4X/@*W,A6_-'M34HI-&;"5>EB;X9*A.`6\#$`X&A7^H-U:7M:D ME+9X'%FR#$^2XB.?E(?(<^?H4">Y:ZO.*XJ!S3T\#K(I0,8/OO$4(JE]@*$: M>I<[#L@_N-XIT3N26/!]'G_,X^KLIK]!S20**Z[1A84"R;_%NR;3R!V#<0YV M9.:^2?P&3TG^8G[_#&^]]O`X*H(ID\/Q36&C/+"P<[Y^"44%MC%>2@=KT3:G^6\`::_'A"'K&MJJ/R5OB[]]RQ M32QYU=;_Z+G<[:'Z*,$7C,:HOZ,3\-$+_YL!ZM*QXA69WGF^^`J?:V^2Z:4" M+(2"P$!45?GM4^>_KS^TAV\40AX5A>T6XW-RI,[7Y237(\&"D(B7I/O?G0_M M0?5+\C7CV!NK'?NJ!:10":(<"=B0-=[O+N6<'@R!+O2@4HGP^KV^X87]\ MVK^5!P3*"461/>^=:?MT__DF.8*18_T1#X4[T@ZV"NUYPVY"C^*S5HF@LJEG MD[Q3"/8(P5Z[OQ.*&&+C=87+X'7K@D<5R'=W7"E"I)4JO;!FHL-#7G()6JVK M3CG(\1E>M+1A?."'";SR,)Y8?G6]$4;ZR9/F@Q@H>RX6,3)%F9_/Z.F1`TJ5 M?AO&^S@U.+<8:@R5,MV?,)LZ&9]K::IX(IHGGF7[VBJ9&Q0'`>WL25WD=DU_ M^;*Y)O56I-[FLHTF]3:D+E1]>3`&E_SOV2-SC*YRIWKE-4;5`F58CI:G2MPM39,$3`KHZ%N3<'1,9MW*!D@MBU,]D^99= M?I;;RGRH,J=7^R'*VKXX<<,VHA7O0T?UC"WF.*+O6OQW,#`679A:[5^ M7`9W:SY)M8?=HG/RSLU@-Y`MW>?NR*V=+0^7P457O'B3Y*>I';(F+A\0F[?? MVYI"%M73+=_@LNC)UCW(T0H"-ID2VP3KO=GL5EQ2PUE8/$D:J)!"A. M2]$B&8<&Z2OV?:P)+$K'MII`I'IN-0%)^/POA!?T\D"*]'"V2YV,$*T>M7K4 MZE&KQZ.KQY1)*:>9"FS:7;!:+Q0P1P^@93S_UXN_619CD\E*0/=E>G(/%ZM$ MN0!/JQ[BR#F-RPQIO%&'1QJ*K68Q4^Q'T M#7,=6,V7F+UZB7S1;O2N!V47\>`B>0!,-W@"93GUI+;I]^NKJVJI/C.I;C>& M5X7WV:,)]?;[[`8C9_G0I[?/G(,C;KY*-M*>S+]#':$6!F";L_3ZPE>]9"L% MCX]F1U?.1.OD^Z3V82W@6L`+&.3M_FG(]I&M])W]\7.Q$V34K43JVUYH=!1+ M>H7``AS&V(M&#MM%HU09J=LOWM5KJDYC<,3(0>5\>39&2)[V*'RBHK6'UAY[ M0;S?Z`Q*[UGUTAZ*/?(37=.(_UI;\6G/EX9RKXWQH>7M,2K3NG0IS/CG%[I9 MLJ8E44%`ZWI]:?_].)9N,&'_!>^)5[L=XVQ4[R((&\:#CP%7+'X*L&`9#&PI M$^1\+WIPXAVDG,X"28&ST<((DNP?PZ8R%G0IT#)#]N#Y"VRFE5N,-9-7D5=. M=OLZ?6=Q/ZGJ-,3R0!5)2&SW=O"*:YJSN/_;/@5]XF-<'-@[;RZ;E9=[\$HO M<_W25>O%T_#:/]=(+%;GZ9ZL5-S([0<+&-5>*O2"[R'Q-C8A"N[FAX8($T'ZL^IZ,[G/C5:TFR]QPJ=UJ[YP$(<\Q.B<4 MBGR-<*)/*YK[C-G<"^P-%LP>"JX MS-*^;/7U78&_3UT/M:D[0 MG%#JLM"^3$:]\J>R\EH'G#,G/,_(IN?//6K5\[FQO$N MT.X5ONJCO.UNH]6Y*LLP-;XN+7=\>C'8V[CH76"8H5&TML,N[M;ARYEN5[W\ M],N9[A?O6GC'W:OKHWG'E3.F%A8M+"<0!J^<)]<"<*2`^59RL1/ESDY8UE'C MN<3]*Y>77RUB-2RWNC14VA4X.5MA4%]L^`L/K8MO/;,'K5\'X+(MM:]8[!=;3 MQ;.?"^_IXMDU.!5;W014U\X^M9A)S0(B5XWK;N'^G97G^EXWTJ0MC)ATP9KQ@#E]J:.TYU;G4>0 MF6YAF:GLB'S%4^DIW M%3S7HH\'$/)^^\2;]VB&KA-\U3-T%5&XRIE(,[9F;,W8M60WZJ#YN<4`KAN#G@Z::R;307/-8*?+8#IHKEGM>!MF_QD%SZ0#=!P,+@`S.#R&?C._F8$=?`'`7SF>]>VW__V_#./O_Z?93-I]8#>)=[9KNI9-;=>#T(_( MQVHV^=.9N>XF\?/*XY_`4[<6A@6K`K-]9I-?+ZQ.J]UMM5OMT*-/@V[KXK>U MJ[YU)\$5CBKV[K(G"_DB/O"S88,S:5L99W5Y[HV3;VZELI*VRPRZ?X+$W1]7 MS[2:4#L0):$`N>:&'1CAE!ESW[88?`*__:;OC5=X/R>;X<`)X?'=N<1#!,%;&R$GAQ'>??22.3SRU0=ZL%^%(-,8>59 M$,K!%SA2Y)JR8]R_(@__0Z@',*.!>#TR@4\`I/,-&Z,GJ"$,DR08"&$XMCFR M'0`6WGHANORIF+X$@HT)`,=[RL[OC6!I'JFUI\!2#-)-#:(BR'_OJ+\#;4(; M>U$9S(:I?&-L^\P*88D0:C?Y*S.;[<88>O0FK+J[B1B7N_'I:8K)7>0;DU@] MV(EZ,$S@Q2`TD6+`Z>;,B_!;$A_VK\AT&K@*YGSN>]_M&3S66,&Y?TY!?IZ8 M^JCR9`-_DLLLI`RDR*3!@R":S5$.Q;SPZ(@Y-HO7+"V07*I!GG!M<95A[R$> MS4.P`9\M)\*M,S61.?*B$*R(X!NQN&`HX&H<"$$V23&$S)JZ]K^64&4T>\Y3 ML`H`$`!MHX(AX;>\&:,I!"I$'].:Q;?AO$%?.9GXUUF M7<8\T&PQ\?7$"B""]?$]&Y0QVRIB- M]2+6'FC9ES::`]IVX[ MJZU`TORP2\.V!-NQ2QM6!BS#@@\VLEL`FL6W'TUB*-6,@[EQF-<>GI8%U$W8 MI:--VN)?F0YLD7PR'^/K8#"TT+PQ>*L7W9:__8 MH*W--!X]QT3C``Q+^&G8_7$%Y1#@3%]PM"U@TOT`W!E>=JYS`6Y=7G56`=S[ M<9U\GH,HXG),/`?<`+*VT.((@'C>$U=LTA&QO`!,K@??"V#%DAZS#]A7..=[ MAYJ^$DVSDJ#H09"U`)"B?166)#F>-7"???#\!4H$O)?B9AHWPRY%-6F>\7'( MM=O33+0T!H^F_7K1NC`LYC@B>!3_'BS>7$UDN]Y#*'ANAW-+G.C?6DD7)= M.1^N!:\_V&&C>'ZL^IZ\@'/C5:TFUYU7UGZUS[>H!&C/5=G/2O`Z4*+7>TKQ M.-EKLC5.FZE73DRW7[B43.5W;S7G:LY]/B4*Y%R7[9[F6,VQ)\"Q6N>>.P>? MDK50FZ9_I8XW=&^A`_<6.HW&WYH3-"=LK;'V9C+JE3^5E=8V[GA_/O\G13=Z5N[JYH3GG>H3:^\U@&:$XX7`CJM#F>=JY7&E.YP=JXE M[`X0Y6UW&ZU.X9+,]2R/IWFZ3O!5S].]Y\/.:P$X4FAP&_:MG'!;\?0ZJ$_D MD/GT65YK\//7X&B5='7?LYKZ'FL"N;Q`[U(X5T=SSZV/2SFOH?+8@.:RD^2R MPG;\23&8#D"?DKU\4JRE=5=M6*VGZTK$KM2%;I2)YPAQ;-=W6" M3_.=CA57S7P[Q8J?"4=J3:@U86W"K:?5(VUC#/8VW22M:&T'W9WC!"\.GEQW M#O".NU>Z^9,6%BTL=0J#5\Z3:P$X4L!\*[G8B7)G)RSKJ/%M`[HT5-L5U#E9U55<"/P+#ZTK@SVS!ZU=>^2PK@6O6.P76TY6]GPOOZ M-3BRR^T$0Z#HPMZG%M"I6;3FJG'='1PM6E./K%[-O.?!O#HI7W.PYF#-P9J# MM0%QK-LJA7T$7:]5UVO5G*`Y07."Y@3-"9H3=#2S0#0SKOXRTL6\#^Z"G4GY M5LT)FA,T)VA.T)R@.:'*@$]]S*A#EO'6'D9%5[D:K>&P[++60_]J)CL5)MOB M.$JSFF8US6J:U6K,:J>U=>X<]UL)TE8F;-I@S1B@W-[4<;IS*T(),M,M+#.5 M.WF:R4Z2R8Y7QJ4>--8,5G\C4[.:9K4M-\S>Z;0UJ'?1YB.&2E_IEH?G6I'R M`$+>;Y]X9R'-T'6"KWJ&KB(*5SD3:<;6C*T9NY:,HQG[[$V0YYC7RNMJ6^GL M5ATT/[<8P'5CT--!<\UD.FBN&>QT&4P'S36K'6_#[#^CH'DY"[NR*^;:9ZS2 M9SSA1DJ:[^H$G^8[S7>:[S3?:;X[-[Y[9@T+-\55[72_P@E6K'W4_0JWE]T# M>'K/MAU.9]#H7?>/YN-6SIA:6+2PG$!LNW*>U'*BY>2D0O256&"TQ.YEA MP^YI"TO9KH3[:,:7AN6@70?%X%^F#)YQ'.\)"&@0G@&\"WZ=YX=38[0`$F.# MLR<[G-JN$>+CL<=G3&WFF[XU730,+_(-QS9'MF.'-HX1FMBO*^4A&B9US?A' MY#*CVZ+.=5W#=,=&II_=989WSH+HI]OJ<1^G9%O,M\NV4J\PG!7WH^S6(3M2 M'>C038U2\KY^4SB-R)\6G",*SO.2E?^*/-@VU^Q$QP3FDV];,)+MU@2>&RNT M'S-QYHJ`^6#ZWU@8H*%4$XAN\0P`>;HF\-P$8$@>M6WAX=2-UK7GIVOO81;J MYN=F.OA5!-$=^%=UT29W(WCAD1S?>@!TZ\XCK4ZT.M'JI"A$7UU/"[$6XAI` ML[]LH7HQAXX0/%,.K4Z#OGA/`?GV2ZU$-8O6FD4[FD4UB]:;1;N:136+UI1% M*=WZE-AS[XGR^RUSN)?,EGOX#5YSC#]-WP=/?U]U10Y_.V6['*/CW4[9*WS5 MIT#5(6GPZ$Q4.0":BS47:RZN%WS5:/ZM*7]H_GT&_%LVFWJ3^;YU M!NS(-W[:,+=.]M4G$CK9=\NH12:5_QPB&%IX=)1/)_SJA-]O.?FL%4&CTXYU MVK'6^*>H\>N7)ZC3CG7&8O4"K-7)F:@3G79\3D)\3!'5*<,ZQJ"W")TRK%GT MF;*H3AG6+%IS%M4IPYI%Z\JB.F58IPS7-8WFW*LQUC9[2.=P:N'0PJ&%0PN' M%HYR>/<:[:L-^5M:++18:+$X.;&HHKBU4RCY>J,3MCQYL=ESZEQCF6LJWQA. M#=,(HMG,]!=8G]J:FNX#I<$MU[N&'['.M0@$Q?6N%T9NM6L8F@8([._&#(": M!@9SQ_!8M@!V7J+LX8FRQ!Y'R(;GHAXGPI]J8GQ);9M9O@W4KS1^%^>N=THH MZ*>I';(F+A\0FZNXV@;)[D$[ MH:`E];0E]9ROM]1IM]NSN*R8I:9R\`YMRC_R>FQ6=16"F4'D,VH"6A.0O@8@ M+C6!1:=D%D[)-`Y]JGXXVZ5.1HA6CUH]:O6HU>/1U6/*I)333`4V[2Y8K1<* MF(5#POLR/8_8'?V5Z9BNQ;*][/84)3_F0<19'C,\YT.$8S+/ONRBOP7!X,L*[.6TSG8M)\*# M.'C&9:'A>$'AI,QBI-J/H&^8Z\!JOL3LU4ODBW:C5[Q&FD3MX")Y`$PW>`)E M.?6DMNGW(*A:JI^/5+<;PZO"^^S1A/IHEQEZ^\PY..+F>\_"T,D/?^G4O#K` M5[UDZ[SK)?D^J7U8"[@6\`(&>;M_&K)]9"M]9W_\7.P$&74KD?JV%QH=Q9)> M(;``AS'VHI'#3C6;?[]X5Z^I2E57W]G)J)POS\8(R=,>A4]4M/;0VF,OB/<; MG4'I/:M>VJ/092#Y^>\_14'SP33G/V/:#67=W$W>V2Z(HFTZMVX0^A$Y!I_` M*K46O_WO_V48?_\_S6:2I-,PWHN8'99%$+DR8PSK?696Y/MX0>>5&=B!\<\O M=&GD"Y#!>.5XUK?_UVSR`3,P*$/*$>_<>#P:#H>A40P+%A+^^,PFOUY8:'.T MVJUVZ-&G0;=U\=M:1MGZVHF@8,Y5I`#O(HFK2*,%K#7F?#S9X31[!6EJ,]_T MK>FB05>1'(64N9>0S`!O+65O'&72%"Z75UQ^7'=)*.9RW>OBN5;8><:]+O9_ M9:>>%P&TX.C25+K/Q3/K.J;8U@48G_.J$7ZWQ3U'C MUR]#3R?\ZES!Z@58JY,S425Q:05GJV_VF'4_7`D9_T`2B>:\'( M,(VW!)B$?8'P8).Z6S'UK?O6]%UX+-A8=-J(7)O_^K75ZEP`2I8],YW@UXMF M]^*W9KMW/0`6SB'P^D]3T0 M?&SP5+1ERB:/W_EO[&#N!:9S-\'7Z"W^$J_(7HO M)TA.4H#\N.9>19Z*_"L*0GNRR$1JEO$MAO"=:YCX?VYD.L:(JMH_,<.F_,;) M@BJQ^\`R/LA-@B#*#J-&EP[BZ1">)N%I/$V9:[!'K+!/;UM3TWV@!%O#LGTK MF@4A=L7`+\:@PT-FA%,SI"KRENG["ZPY;\Z\B-,18<-QC1G2&W:4T!@Q@@CV M`.3J2R-1^)_EUT+B`V,FB_>/%L!-@(!O!P`U#(SSF9C#:<^I*/TD"N%!T@P1 M`!98"`%\;YG!U)@XWE-@A!Z]Y3.'E['GZRJ=J:M?$OBILKT*V>W$"")K*FED MPDS`W`&0&8&#@0$I3E\V;M`L"K7YSXCS@PNK-UY&C%#A%(._GJ8V3+2"G/0H MAX%]AUUZ'-!7<]_[BUF(E(*Y0A&%"$A!'',"UD,R7*8V?W8?W48#)-K&A=5C MQA?SNP'O6L!_"-H_US1>X&_`"\GS=5(L&^.NI:5YE5[ZZ(&(]8RFD="0U58; M8>L)F\,9PEJS[W/F!MB-PB=>"Z<^8\8,WIP"`[NXFZ<;1SR9@?%#M]]K"#'` MOTU@X0=N#8!5RBB]7IW$1QT$LM$WYLS'TXI+8P,8@?V]`!"#;8#H7"I@W.![ M/@LBAX07)=&#'V$8$$"A@\<1]2,A*0;">HE$/X*@@J[SV<2!^5!;.PM0HZX] MBV8TY]Q8^-,2/L3*]=PF+%`$],:+B:IA".2[-/YDQM1\ MS)T+;3383!`I[&,R9A/FD[(&$@@5RDU*?"*[-%S[-H%EGDQ_'.0U+UDG3D4N M71Y='$?,91,[+"J.'2$)C?ZPE9(%=X,,#%9*XC($:R51S-]O7`VZI>:_CN>O MJYZ\Y691$,N?W,6!A1RN+5AP/#F`[D&L?%!YAIFPH-U2V:%YZ//](TY M:%8`H=#@(OLL0"K-/9_/X*.TDM1X10'CRYLW+*I`&R?EPQOK1B51;;<;O0YO__3#H#&\:F6ID-L: MJH$;R9POB;,X35U[LX1I`_TPVISD!HJH4PNMS=L-N4YS,`*^D\P!K_S0[C?Z MG2M.VWZG<=4?I(C6P'W3)L$9L0?;16\?Q:;3$B\!3(-SH//;6/7_PP2G%W0` M,5%K2`0WQ]Z M]%'X*`25>C_ETI$;3JDR8"(%[#\"8R)[UO%%5TTU%EB^/6+<@J(Q2/)P/PZF M8/G38[,D%`1B%,(+49C8L+FCJX,M#X$X*O_A79PO.-B6#(7G)YD$F7V,H!I&'8$ZY/8]!6:5UX M=\1P:0+@*:X1$54PXL*&L"6%L@^9-74QQ@Q$\.TPD%N5G.)8S+\?YY"'>B)N MVZ.13]USD.W[M-!";]`"!1'M;K@V[#M,Z7*U+@(-9-*3WHY@+_4QSH(#/((( M>)%H\9?Z'>2"=@C8=OG$.` M48SD@+M8Z!MYKI#@K%-+7N9R`T:Q]XSCJ>P9;B,^"B4/)@5\M%SX9(!,Q,MB M#9@2VNQJY82,UL1PED-#+S!>_9*SQ&L/]6^$W'(W%^8BFG<35`EO0?4`TWX` ML]<;&[^YS@X_*V@0'[T M"4%Z!P`E\"3@O")H8@Q9\,%V29SDD#?N.#T*!YS#K8"=$\SJE3FW&0RN^JFS MA"/"KA=QU2)VXD4LO^SV]BG5;Q=)'J/W!0*]BW5:QW-ELL].ZZM9& M%O'$Y*T(B+YXQ0V#ERO/2L23XKD==Y9NKD;*S')0B$NJT6X?C]4KAKF)QV#YOYKH@7$YJB@I-G3$^B,S5&>%R M(EM48HMB_#4.BMEH&/!3?^.?XK]%3O53(XCWZG6JKZ,$QXX2Y/"$RGP^,U'( MWC#^Z27&&]_(DPC54LUA.GI#OGGKRM<4@VU'E9*6KUP4+?'X/A8*G+1A5AFNF>^8J)0UQ-K#SAXQN>$G'X'QR5S0,2D*_(W0 M#4KV]&8DY4AB('!^Q##**#NO8[>;V<6W`*/F1"G'$;U6=Q-#[(,FDN7?*IDZ M5(]O5?+P*K:4FD,,!,#0,'R4'1FDT\]8M5L`49(4A3&7I-L-Q][U53$K=&VZ:==0[IB"Y@O1L/SD M^>$$K#*OKDE5JTQ<[\DU.FVPNP/4V70`BAJK%W^%L3N`QY@3HC`+GGV/Q^*4 MW(-)'RF!`[.9T*6+ATB_B!D;#J;$D^&K9%ZB\;\\^]*Z1V,1J.`E4\H9A/E.&.0`#)3"^2UQLC]:T!ASF!U3 M[!WEB#>(1H$]MDU_T3#^L'V7A?^70L67#0[;O65C2I5QHXY.@5!^%`V#O?9\ M3.#BI_^>;]S?W+YN\'25UH`@?>+9!FJFP.O,T,D&9Y239)-V>SJ;C&7DZ6Y`DLX6+.1&;YDBF:/![$P(, MO"+QX%$YC:73^9GY'7-Y^2@;+\W")^GC&>BB7>-WQO`3[90@(J M:8:??S&FWA-R;X,3"WQ/4+<>)JK8H8-9O^Z8)21+7_#@7BK#5!LS21V*;!Z!Q`0:9G"+?%*QINQ-D?)'NZ)CV M+!!\#91Y;<[I-L^_8_8&-1V@Y%(RP@27$,#]MV`PI+MZ?>-NI6Z)W&GGL0`B3,[N)\\FR.(1KN9NX=/.LF^5-\P4?:FZTQ_-1L MMYK==@)-WD@*+`^P(7TPPQ#3J5%>>104U+F%2GN=_4COBE"!"%]7PU'>(IGP"P4A<_#ZHA&T.S!Y*_52V(\=\"B(,O4IS M2B9(SS!)?NZ@9>&3.R]VDZ\@.Z#S[S&YCIR3T+?!!G@-NUER%^*M&:")E/P, M^Q@PD0G`?P$"^/`#OQ+4,.:P"T8FOUHH[D4PS-MF#\EMS$"%@@-/5I*TCKB- M&)M`?^)^S+X98W-F/H@$/MO]*W)YKJV/*?$3,HP=AU_V@?W1P6"M<@W'NB9,9Y$K+%RP\^9)&(>@5LC.T/"AC-:4*%???0NC>M&J]]N MM*_;E\:=:[QC(Y\RG#M7BCMCNJZ'T?8Q-_+=4-PQ1=#&OOE$7^>L`M"5^P#( M/'R=?#8%NT997[+-B-I$;.5R;)`6@7#J>]$#'W@L&=9"?LZ8TSBOA?H>5V[$ M&(@$\RDME8W+IGSN1]Z72DP<*XEWE M$DK@YT&CW^HTVMU^P[@"X;R&_V_AQU[[&G[IT<=AJ]$&T86/PTZ[T6FWN6:! M/Z^O&IVKE)->2->J+WSTC"DS^5U&U'5X0C`C_J5#)H*4:,&5;U\EQ`-%611R%..9(Z`J M(BU\VK0%\30I%61*&]B>0L>9=;Y28*9W'J M"D*X[,E9-%/!ST8.X86:CJDE+L3*ZZSN&,O>E&#-G-2%H!GFE@AS[0)X8?D>Q[\4XKWKL4RQ@O M'&G\`'05O.Z`34H'<`\^$Q>MR-R+`AE#I:?I9XK2C<&?B2UX(K`9A^A2]IVD M"CPW`Q!"$?1C3;[Y"(1YJ9._HO$#HX#`F,\R]X(0LU%XD)3GDXCQ.!/",X`W MZ).>(X^P#>(`F_&/R%_DL_/67&SB92JJB6!@ M#0'CA^X`+/-6BU^*@V_&^'Y:9%6+AM\TC'EV0NIJ21/>$)G2])1H9+%/L58< M9^RT)).DO(6!--+V+^&2<='[_<#`HX&5BV;&W1RV-''I\`XKXX$F?S!]?M:0 MH#GS.+?QLA&I,C2\?L5?N):"OOQ>,H=SS%R\B)Q5*7Q$'JH&_<%9+MY!_,!Z\"/.F4`H%WS!.!@/6'9;:#1)-H(=9!`%;L:#Y#S,UN!$SOF>'#[\33*M M!`B5`7#$I7$_!\'%7EQ+`%"!0Y3GV`''`P80A1YRZ=C$&B!Q:E@TQP$GM!W' M4-!5Y6ZWE3PO)U?D@ZN;W/?5\P0.@/3"U6!^BIH9CD'RI1=L#LZGZ7(J<;O# M?E$2,PGB#'@?K]0'E!<P MXDO&Z4E`*FJ.;X1#98M0`1[;8T&K&8?73;9!GC0)__M`:RH/R*A`R))N3EL? M9%(((Q)U]CRY+(UICG:L<&+PVG$5!3RN$VNA8DCFFB14P$S\L+PB@MGB,6,% M+EA7G@!G&0$L'YN?UY&4X1Y,+D2:`S($0!-`(4)L?`53>S[G"'#"Q-:8G+73 M^H53W?&P?EM2@2.&J]/^A6/&MX"X[IJTYR9"Z$Q4DI?&?\H#RA2OS$#5C!@B MP2G&BP$ANI$OJOL`CO#$`[@-6$R%^RC\/CNP-M"Z'3:7TQ1O\$71!=18.2FU)EBWBWY M2]BL<>^DAY=,NG*'ZN#[WMR^?DF\]^1%SIATMSPR[_1_S)SC>B-QGQZ6/A)V M+["[]$Z7W!,*E?J\T(JP=X!T'KCBBU1%O0D3/AX=SZ+>CBBK%89WQ+$`L3:> MQO/(Z&4J3$)^P)-IKY$`Y/D@#B.AA-(BIO(OP!J/'%$H0MI%7.:D3@)FXG8+ M'DIS)SR.N+@RR)!G>1#J655#&E_XH'VI(;(0=7/UJ2OX/F$L(17\W#D3%D[V M`?$$G2Q+VQIVPD6LZ5883^O4MA#?/-.:>V\`:1!;DN]$L9/7F$I@%PY)I>_T MEXW/IM[^(D4QS_-0]Y>4"Q([.8B_H#L-T$ADVP+J&"/3^L9%,O$$L+B;YS93 M)HTP!F@,OLL%^#I7$NBT@E?@"O.*?,_$.8"!FB1UE#F`59>Y`F0N4-EBO&!0 M'!;H*B%9N<^LLE$3JYS(L3J^C\69LEZ+2+9)BL!Y0K-A3"CQ)//&5K2%\X` M\!.3` M1U)DD$;J?\P/`RX5ETU$098`A;$165VU_$W M)?1U`B8=]V<6=U>:TWZWD42I8!$J[/95=J,H1I\D>"3L&"__\DW="ZH4/1+X M``SEP,#AD^=_"U*&#YT,5!7KCRM2=910;?E@_[V->H4S$D>UV@`_-UM3(7Y> M.G+[Z+[0B().12/:1R,,FD3CL7'S:"Y,SG6D^.+`,.'`;%-%: M,QNO70[7"CT31QQR4B'5T""/SL:@=&393'&M3ZK-17-3$O63 MB/8I!RI*P%%R>T>ZZ')Y#H]O*C2@VO-Q7!WU[-BSOC%^W=WW'(&6V/Z6'1MN M-L@B5?%"JRP0EVB,@P$XB<=#,62R!,P13B7\B%7/D?7NV3P4::&"3CQ`Q'TM M4S5VX,7DZ6%LF&+0CS\`J(AREXDS&EA3<,0U!_E2/B(Z1'RA)>? M`U>EY^-CB/8&/9]VFPLHJRUTM!R;"TVP7;910>N1:Y M%'Q+66&./>&"&H3F(C?8ECH=$8YW.Q>:ZY70J$'&/"BL)`=L!T&T3VBQ)ZC>.\ M\HR>F`G?*3;45+# M+L4'1&#F'\HYHN%E^49XO;"%XF4FC!:X(:Q=-">'3);*W+-1Z>6?(*G,(_BQ[A),:H"+=Q MA>NS9G)&MB+3^"_/)I':_O#"^.?'_[Y_^S,>6?P_?L`_\_A5M`0I//HBBYSL M_D2J52($PK8W`Z&K!9H\OLXO.0JE$N-"V-]9H4>X#]2%VR:9W;+8/,QZM:2P M867#B$NULM*43)%)"8NY`GC$>'L)'A@RY.^V,V8F)=[X#-L"\'-ILDU2(UX: M]ZJV\Q(4.UV)(HXL!I2^E'0(Y=%(-%?T&%=6/4GFT/0?&#^HX.?WB"U+3LFR M(.'^E/BDS8GO\8BJ`@CIZ927\P'LOTY\\OIL4^6KUL-"OR7^QMQ#$J-74.`: MC7!.\*B7#D1&:HL&?J54BD#Z3F\2CWJ:>MSSX"(>`%7%S57NP2?9?>Z"W^85 MIXS&C1-.:5F>F.SW((V0&`<9S_7Q$-4'WB!^H+PWO/N!][PH@B=M$7$DS6LN M\5/G,5WC;N*6&\WH36$I8>)'D#K2EI%X?G"-.@E3,C!\1+>0EZ!*G7LTC)&T M.1-HD*Y@8XF,O/CM5*B:.Y3X),S';0G"=8O9:_-.35;CIN($]KP?,W%F)YY:TJAV[FB1-J M^$*>R\MWGZ@2^40]V^Z@W6UWMX0:>Y$DW`O2^DE(XVO2&`WC8X0&808/>$]Y3;S$W^%O%*'_ ME8K)[<=W%[_U%1PV3K$&BS?"2;[A*:$-@[JM;L!"O"3>H3=VK3PYN.:=HE>B ME3-GC-9'L*Q>8Y6+3]@=3F2VOOA*!KO[4GH^F.J!(8#3V;>I@OO)=7#=VT8<=7J#)<1248_,*QE^R*T M.H->9<"6KRS9Z51(V7+:JC>\RO#S"F#7B.A=7!6JM(C&K^Y-(0TS?%UPWII@ M6WH)>X7VF_4(/\D2EX@6O,HC)I22ET7M*7DV_2@OUUN_!O"KPQYY7>$/41!E M#8%/+3U+MBZE<':2>?'NYOZ5#!8JJ-YC;):2X;_.*1[X0KE#<'/_5;DO\)+B M]+QT3UN]:O#)9P'ZYC*`:+K&5[40-A8CEUT-_L3L?Q,3,-Y^MX,PN%3@-0#\%,AV(,X?E>Z!@1*<( M2<`X">#SXFCB9!R/467S3.(ST<=3A#^%D&'@VO-GXEQFA(.'<:7(0)F>CAHV MS(PV15RO?RF.FTRN:'KA:Q! MF7E$)#Q^6@,\)@S,1&/X]8B(P+OD4\=VX5>LU"$[WLM2=-2^7EPZ%!4V4S.K M^,*XO]_$SNG2+U]NH<.JE\2X. MZTKP_636%$QKUA#+S01-G\D4/DS]YW>-XTJ.03X4 MU!Q5L.*8A7@P(+D0KTX)=)"E<2>2/$T'9VG-1C=V[1DO00NS@FSQKIY)TV!^ MN6LYBZJCR`L;)PI47L.4S5TC7]GH8C6,U^'HSC?/18N;BQ2(K)%&GC;^7@1_/;S_0KJ=*[V0QU1:3SC"<5/R`=V#,H,^M?I,$=F@KT"5[)6:OOJ MJG5$Z$H&F@>]UO51:5\1,D'VZ5*\Y]D M*?PWV;/3A.7I7?ZF>%&^]R;W`+5(7YO6B@UH_60)9OZ#Z<;UX),J[K)FT7*< MZ5ULPM['U1F*-A51YTK-!'I5G>=N$L^23%+_#B1'J!_=3M6/?A4%X%2"++QA M@>7;\WC17IF!3?Z$2M63*H&I7K,0E2W5(.D34V*.#34N"F[6JI^B0`U4@N.E M_+9TT88BKR)+*S"P$BJE5%&&&K.FKN=X#POXWHF2^E-4^Y@J73#3:6)R6[H. M;5Y]OW[Y'>93%6+[$\PH@>]?``C##"'D`W-C.*;HP]O/-GN!@Q M"*C&*$6#WWR\;X!!XGV+YL8,W@6)#F8B`8VY>$X78+4F/^!^/2:<47F?G,+0 MCNU^,R**P(G?E3D%N9YD@!,_.,CL+WJ___3^R]N7&%F@6\XG=YE;Z7LI&@?) M;I(Y>:&!J)P5N>-8">,"CJ3PS[PQ"^OXB0N M2'/T\R2NNI$@KUQE3 M63&0"\`&Y@,E%X,&N?W0,!X]VQ*W`.1`L7:DA_[P;C\U0*9&6"Y.,A!@'`(O M8IJR@6![O)XNUM9W@PE&30%/O(418A`R^!9Z\V5&4:@@VR$%B5:46IY.5TQU M8_HW\[VF!2A^6[UYH09U6/:I$9H!J=`VR%E@SX!BDX4\]QBSN>,M9+46`=$* MP5,6$%:&8?T25Q:JPN,C<0DB-8.M7&W.)RI,-,BW$]G+[J0E[&<,Q%T*80+Y1:+ZS<5,(%W`]`/!` M\7X<+G+Y*<*2J@?HOK'X8B:2A^__I\DW;R)QG8;FY+QRD/C M^06>M+Z4X^<^^)K&%8KQQ\ M&C6;RY+1LG(=$MR+0DMTNA15="D31-3>2G4QQ,/);RXZ"*:X+8X[OKH14?I( M0(-):,;*L2GF;I`AH[+PK0L;`NXBH.\#A$2%E7)#<%XWKS,%S$5_4$[P1$<"3\55,CQ1TQU6")`S^:7-!D4C M3=$'S!PC:6;@+[=X)6.626"CSO@?'' MGEH91):R3K*SXLU:]:]CXV3YRG41`LO-0IIBE-:#NQL9.D"EK+V)F3?@5@!/ MB([#\;8O4<[#K6&,HA`0%-N6BF)NBE`*L^`U5`U]Z4XY;\L]SXR5<+^?[B->9I\:-L@N!6SE_H M(+O.(WCPQ7L,RQO=EX>E6_SQ/VW0 MH+XU7="\1,#X-PX2_=#EP-2?]/@TO^/9$"1M&)RD'641CLND98G=.1BQC\'A MJU>@72\RMT^:S'N@(%TI/P#ZO?959Y_:M+S*/#+=ZJ--]TWZ;<2\4R]B:VUZ M%#+73IO2LQB)4]RT6Y&I3[\UZ,H8ENTSO^>2,/4N?Y6^A]?N)GAI;,>4O.NL MI&Z:LDKL2B8/GQ9RI9,`3PN]LNF#5P=!3UQ[;V#@B=(J>,4?:X$%]-S`M&)' MGOYVN&/_.T:=Y(5YWZ:$&G'0](D"$=N02T`@`5#F!Y]8F1TGQZG%Q'Q>/NV> MB%V`SGL$5J_2=NI,KU(UJU16+^=8OWJICK54I:R?>B\55AN@\[NQ\9^>0\>% MZH)0PX;X['=ORY/,*B:56-VYR72'6Y->H179%UN(^+93Z!DW%L]<^20RUAO&)\=T18/MMS(A<9F2N!:C@^6"K+N"=D;67FZ.?'\9F`Z:E;71ESCM\%,N8=W M%?';N8SFTM6W$G/7`^%RJ]OM]I?*N&V%<)RB2+5N&W'HE(K*9+"33]/#J^J\ MEG(.KH?RGAZZ2=XL0,VV"G"+ M6S]+G+]VCB-CD$/RPV$@:B&5A)[STS:TWP`R'_A(X!8@]([@SDT?FRR#7"'$ M8\]QL"#.'#M>X/L;@/]D^G<^IC>S=2[;ET"P[17X;-JKLIQ MRUFDP^/F16'<_Z4DK]TIK^Y?/I31CP[][N*R`OJY:5,=NQSC@/_X!7_;P[X9 MC[6'V8MLC.W><-!=5M.K@>#=/9AR-TA<0^6U$5?!)ZJ]@#U*?LL-/;M+8X=! MJYT']+IY*L&ET!*T>SO@0IT_1'4-U/7RBFM\KI[!@K_Q#EZ0S]]-XC/WW0SV M%!;KYCD>`B4K%BV5\-D*"W(GL"D09GY30Y6)Z/N46UA8G0,M>ECQ#^+-N\D' MNAJ']O[>O"IP(8?+'%<2@KH@7M)W[G26BM;LA#B_O$\U$:233=0NUNEOV``O!^9@'#A!N1S!_W4I*URY:!EL_#>,K3XN$= M3P2ZU^E3FK5S'0F#_*_TK-JB.5_<\A8EW[-_[)Q$TE<1&3`\XO>_): M-KRB`[`-KP$\P<&TOY M4)TF\FY&CN@X&F`75'6(0/9MM*A7Z7=1+6?!S;A%ZB86B$R(U_0-QNO3\[K\ MZ$$EH^$[XGE>+@+K-&,1D5"4GY/OJG7Z>868N.P]H#$W@U`N0*IMII/DO3:` MD*)C*K_VYF)U::RAA'GQ@NK&1-;B4"XZQ]6/EI?8\+V%Z9"IZ>&%>:`B4QJ' M!Q[OCQT7^4A:?R/YX#M10B7T(ZK+P:G_Y#(_F-KSU16@?)2@`/U.S[*)*G1_ M%?6(;_)GE>(R2FM)@SR1![D<[V-$E"6A(CV\NH$H*\"+:\?%YI>XEU"0-><; MQH64YAME*@[?!\D0;Q2.N[S@A;CCJO7BPAY9[]B@5Q3YX<7%L3F!)?F`N)LE M7&"Z"J_3[75L#4OQ&=`&V+>=1_>BN,(_,165^\:4:%FZ_>.6\H ME:.\-"^#Z^(YCR+.I$".)"0&)5M:-F40%[<%2W%&6JBBUQ#%Q=.#"9G%5INV M%6&[B`GU*,CO"J`HH)&+'RB>]'B>BH*I*P\H(C`7]'X8197 MX'<Y- MC!/A#RDS8\\F`$WTB?/\>Z%R;^+U)K3Q%7SJ9^,K;GQ45H%Z]::TKR)Y5"I' MK1X6[Z#4_(.7%*$6R2RGSB'G'(PIR]TS7;#NSU@;"D'.!R)855`@UFL3+S$8 MS(QNC#?+S&Z\64P"Q`?P=STY)_BV&>['$X159O_;@L*UN;Z:$??QHOSW,= M/YCN+!..U[^3ABU8S$98ZVZ5V0[L&"+32`*%WAQ4'_],FC4%PW5W-0Q9/T-` MA35&,]HE)))AUQU?:I=PO8.1!^FVNJWT[#31ZXQ,?,*M'Z.%@H&E?C/2CZI] MJ&+!294B$7)`85,1086=G4N=LG=CJ1?^*W:=>O!"6[3SEI81KZ>5:$FRE*+0 MYCERJS0DGPKKUVU4R'R&B*K0B&H\O.$\KQ0H.F790?("ZA]_9(>"%LL0QK4] MLQX.]H_![E!4$W\9$-+>2!4JP2D5GK2U8KN,$Y27O)*5]6+]O>QH")1#8:89 M3]2>GFI=42$+UY.KLH(ZL1J)`>(> M5C5S!`[Q(E%94S*9%&V>`PI8$R%^IP]N"I#@AL[QHV`*K*9^:868F8Q[C_)[Y$_ MD767C*\U1E>BDGY*M.I/I.%7[`]Z"]%;R-&W$'$X_%E(N\SI6[*.A1;!.([[ MX"71B(4TT0(>D>"Z.G='4;Q-;J&INQ#V"N-:A2HW+<4V1-TK2SG(EJ&';"^Q M]XD=B`+K@5)8A21'B,,EF[EQRSX2EO*_XL*%Y,'-[*:L5)%O+%R#+H,11*,`'&J*27#%+,K" MV:XH\I4RE94%XH$7A\H_";B%#KXT;GCS2=SL07]2[T=[-L4$HMX@GQFOWE9H@31RNJXEX8R6O(B_`M!PR,,81 MD_3$"`A?;1E!7%Z#N*J4$HK#/Q_MP);;AHMEMA#`1`AZ;//I^LE]'_]WJ MFFNY]V4U<`U#+?HX8,&4!ID=0>(;O!EC?/+;Q*6PM&M8K'L6$ M-)',+/.9/1M%?B`P'ILS\X'Q-L`PEMJ,DQKFQIRT[`:HB'Q6CZAD[V`G+^Z? M$B0SV5X2[R'Q>40_7S7:*UHIB"-39&.L6HF4YD=%(7H.J5.6)*ZJKAA2J2%* MII>4K@)5_38>QB8GNT+)B3'3L:IH^?4T/O":!R"2#=(T!4+J&C MNW0[X$!$*G7[IA"1WLH#'X_W.4`N;U(&L7$G2B"OJDE$*<84#WBM'!E]T2E%G40]K\5#:_4Y,9-QPUO5"PP:QA^PZ0GU'2\/ M;!Y_T%[X]COS+3O@^OQ/2OJ`GV_P;.,!::W#Y[9.](GQ&.R26/,2:N9[MGP&"=)S&/MFO.8-67CR"'ODQ":>@[V MIOD/NG4-)@!V1VPDU0'!BO[,LP#^^84L\35=*>78=Q-U9#XN#BL'O?/YD'5- MY=MWVPJE&'JSBSQD>43=$-`V^9,_&YWY]SA:WOXQ&^KFSVT^#2@.@9AL MN&FRU>MFD5NZA[C^BMS3.]DHJR`?'1J>CQ'5QO; M84W$2.U>5!.0,-BH!5L+]LD(]BMFF;.Z6`V*EM%"I(7H9(1(&M\;?&'-M9IK M:\2U7WB.!QZS_%23#>`UIIOM]CATKST.PM12?GQ2OL9DJ@DAMZEL3 MD/"(ZSQ$>#,7KP6H7V=&!DUKKB@X4DEX`;;&-4RCI)F?_9G@;I/I`Y[SMM;K ML=:[,+%>:[W6>JWU6NNUUFNMUUJO]8D&7/3"UF)A-SK9J^9;Y5*.'BS/\?Q? M+_YF68Q-)H7HLE_=LH9$NT"W77QM+Z4=.HU!>]AH=0?K`T-;8;@)T.;"8<@<4/0.@?#D?H"K52][(_/`W9.9#6JARF MBDZM#@1?]1S=[@\;P\&59FK-U.?#U'&9F,XOFK$U8VO&UHRM&5LS=MT8NW(` M-!<_/DL;N.Y)2#3/!^HOUFFU^VL6)A63E2!-1;)0IP5X7>02:$+_+K#:73`W M@4*=PL3J(;&V)!!??_K&=K%,W\]&O;=BFV.2>$@PWY-FE,>#]R-9AD*Y)>W@$/K,)\T4K'FSH%_G& M/3P.(]W&=9*S/31*\G2VY\;6U9236L_`X\#?#>-WYC+?=*@:^,UX9KMV0#TC M'QD5!W>#3,<'\:IX\<8=IU\3;^W:OZ/3ZK347A#%9JT0OW+M0-KMWG!P6@B6 MZR[2[E]U3FX%R_0J:5_W!MV=$-R]I/]'SVWR>O"R1/NM"]-%HCGU75)#')ZE M,LC-N/IP7(T_H[#6%^I_M;EF_:OEFO4`)P>30ZD`J8`HZC1GV2Y;>%]`*@KN MOW;,(+B;B"^%SN/=00BU6XF8*,2?6M>VNJXMY-LA&'E+=?H/C'/M6*(.ZPY> M8+>];MWU.IZZ:&]<8BW:9RG:&U5ZG=<1#6ZQ/I8R73'"[MJRK=OKI4V.W%D. M!6PY`ZG315A+`'MP"7GG^1-FAY'/`MG]2-0J"BJ1%`4>WLA'0E.R#U$)V=FX M'(=!J+:+7.D.>9#UW^^>>0;\DF42XXX:OX93TTVZHOW.E]]VC4_4%CBG^QD] M8F!!,0.[`QK4'K!DG[-M")C=GA#^+P"^@)[#?NMRR)<:?]&/"'3T8 MUW:":_M(A/(FQN?[K_^1;O/V`GAD[#F.Z0?4:VJ]P3>*EJ5:`E?#:%RF\`?G$J2(+3; M`Q_A5D[;=_!R;[3)M49_][T@&R)8&YQ;EK[.U55_U$=2QK;._$Y09WLS1*'!@6,RLR*]JZ'[7VL:%F$]#H76^0\ED8^9A#>TY?NA,:=VNRM"`GG+Q/OS MYFK*]:YU>W@Y'"ZA38,=%#`2[0T^__"R<[T6L"5SHF$\+8=?DIA+4`;F= ME-K7E\((TAE9091U=EN&/)W+SJ`$N^X/[K.E_UI[,$=N.KUJZ?_Y_FN^+5V# MO3V-SOZ/F;*;_*!W'&,NC=DY+,;.9S/565RK%L,.OC4G/F-@"84,EB$T?(S! MX[I,(W?LLW$XA;4Y<#PC#A;?!$$TX[,@:.\`LEL!V&>$J]R*Y`0Y4LLQ4)?C M]N,[L&LN6^WA/DYABV)T-BM1.MRT>25@2:M8B3?VHSUF[MA8V,P9UV$!,`T> M]8J$[-"BL"<#OR@JIT[Y/;)^5927/QH!T9@[+X^>`Q,ZZ$[78"F6++T_8N`. MO28=5$;#[H&692U:Y[L^>]16Z&-<[L6DW7Y]]G&ZR6-[WH0_%!@W43CU?/O? M;+R_XTN:XV["9T@F*!(/R42%^ZTBN8NZ6]O]+*O+J_WD=Y?#E"]0,6C=(/+89DHR+X7B/8#3^P'R]E4!SI:+'BK M9;V:`2TSO.XM!U[W"57=B93#7,M$ZEU=#3JEHFR[$4G=IR$X:^/8IX M;8C0`]GV8<`,J3(7[XLP1.:23*_3O1JF=Y[,P$<"-V=I,N#VN\/E&TAKP(U& M`?M7A'KQ[2/&<3)`Q0_PW^,R!1N#M+^M+3^T=3F.%04C_HJ"T)XL,C4CEN?9 M.-&J'N58L\$8&DK](R-#O)PR)I7`NKI62V40'7UNU_-!)OCL=V`81`\PCW'5 MP"K473P1,0*8'H]$0!Q#7,/WL(%AS8&;!Y]Q"^)%.&7QBG=:O\2_Q-^U?WEI M/-GA%.P%%_]>8FH%AXM=4 MG,01\UO,#TW8`.`].PR,.4$7X!,T20,/D=EW:XJJ%7#VC5GDA/8<5,N<*U9Z M5LZ!]ZM,&,Q]\'!G\9D9>"XI(M];F`XH&1QB$N$-'R,P':!Y./6]Z&%*4+/X MPH_$0X`YC@&CHBJA8[O\?#N%*R<.[&/H3B)8$CDK\E$'$GAB\MM/3>9:_F*. M]M?<]\:1%0:70%-XP*UA(($#!/C+'FR-"F4HQRQHNC_\VE#JJ2"HV\RG^"7M5B&D)4_.1&;#) M>`JQQW8PLX.`GN,4!@:8^+:TP"W8[8T1,1.9XY+T(P;$9_3:U\O[2^.-S4\R MP):'E::5P=_>F@%`YB8_`X2P_YC`%#>.8WC$$R:Q5@R]F7`>@RE<+T0H+<<# MCLU6^5E?P6?5UA?OGK\CA[V`L8.7!M[%Y2()W\6W"8#"]B,OA.+8YH@<^>4M M]JL+0NF@`XKCO8?1[MPW\7MYV7%EJO0TVYVTV[QANHJ1*U>BIPE&Z/4)85>R M/D_O>G!"R)6[>MYL#Y>LZJ+8O>;H"(%'E/C^9#J.]V2Z62_]#_G(C7P"K[)^ M9J`Q85Q^0@D[-VZ-[`WC_]UQZ?J#83^%W#8PK+Z]Q'W#E,LX,@/;HNUT;#O1 MAB3>)1\^%1!37+%7.":`^4:,6$H3M3,T:;>75GP[,&I/EK4Z+$N6UO55[SF0 MI7A6M^"60?\YD*7XI0#.+5>#P3[)0L\9K]:'4E^)4*IX+A5*!9/,GQEW$_Z7 M)-+CU-H^*(0CWDWXZ!O##)_:K?_^^T_[FB^FRWL6!(P9[T$1(V>H"6,8/"8G M!+['W]'Z)B+`EO0:P/5-*U3IP(<2(ZD#QOW5+?+ZST=SQK!F";,B,J#N)A-X>!M"T$CQ M0'*<'0B"*5YER)$/0`&^^'A_)WEB,]H?`T_RS_:HT:GX=7\==LD\!1;V%C!X M*(K![3XPV+0XMUGP/_F>!;YV8+SSO9F1/F3'74I)8>0']0_1+UAUM7_7W0H#DC#YR*64;]/88F1BT-_!, M0!7#'/"6PL"8V$X:;VD)?*57O^";G^2+K^/WWN%K1#Y\;67K:[&("#)H%00P//CIX]YC^6WI-DAI\]*L!);`R]!XJZ,D3/7 M6C2,-^8,;+F`VU28P<^K.+PQ;0?O&O$LPI2-`4,H(XCWQ>OT,KTK7]U5OGLQ M>Y><.(>UWW@SO+UKB3A\8-P]N?F<+)\4#])S15BWEV'=SA+OYHT<@PJP@T%E M8\PK045!WU9@'@ZW("6.[$Z_^1OB298Z/ M"QR'/;`Q\+&,%8^-:`Z*8+0P;N9SAS7H&"5O_<7JW,@1;N4`7^']5PMZ&][- M(`6LW>YL8HENFB,*SE4O1$%+M]N;$.V=`:(=6-/!T1`%G0U.MKM908D'=]=/ MO27]E#-P$MB(]T0\H3#HB"*U+\H'ZG1VO^Z4_2IURBZA7]4CI+*S;@(8F`B/ MU'@`>N1%H?$DET,-+(TC9#4*6`?V=V,&0TT#@[FP1QK_B%QF=%O\9!IFP0!Q M\'-!;-+=-$H>,A9[F:>M\&8^&+U6Q-X8C5;$WAN@R!BX_6]>0HWM:I"%G:9;&_=NXZO M"8X,P8HF;#"K$7B./3Y0!\2]0',RNE-&;FJB&GB8%N_RUP0@7JFB)L#0";84W$Z`VS*.!I=-N-FH"$@0$MV%JP3T:P7S'+G-7%:E"T MC!8B+40G(T3QL:GF6LVU)\.UF(IENR;F+OQ4DPW@-:8E.TZ-(**C\W,1;"W% MYR?%:VRFBB`RP^1`J28@X;G6>8CP9BY>"U"_SHPLDY1JPC28*[6&:7Y23@+/ M_4QPM\GT`<]Y6^OU6.M=F%BOM5YKO=9ZK?5:Z[76:ZW7^D0#+GIA:[&P&YWL M5?.M/ZO%W^S+,8FDT)TV:]N64.B7:#;+KZVJ\?/8T*-07O8:'4' MZP-#6V&W-^';`VTW3G\`VKYHER5J-8)_`-1?'H"=#FPF'('%#T#H'PY'Z`JU M4O>R/SP-V3F0UJHX/&\/!E69JS=3GP]3*]4#-V)JQ-6-K MQM:,K1F[;HQ=.0":BQ^?I0U<]R0DFB8P3G(J0;&9Z3_8;A/'`U:/ M1UBFX1)6%FI7/>R:P9SF.D!*-8/')/ M284;,,:;7EA>$`:&[5(' M5>JXZMBA_<#;$6&!8&YSFC9SE':.V=*]Q MBELQPZW[/A[_-0Y=I*)UMG5+1W1#V#,P25=`:AUZA[N+\8&-;5Z2F=H.@,Y4 MR4%/TH/Q<_*Q'-0ZG;XHC-WI#"Y^^]3KO^&(K!EFV\8.HB?5%GT=9$>N'=LZ M='$S+M7704P<8[S<&0NK4-K>V+8,;/<+%&;?L3,72W4G6.I2]4F\\IG>>"M> MV+4C8XQ9H=D4OG*17T6SDL]V\*UA*)7A;==T+1OPNG6#T`XC:NV2YC;E?7P] M+NDN7U7?+(=D?ZF]4$=R9IDI.:B.[7[[>>)YH>N%[#W\87RGKWR/3MS"=">^;=Z&;-9L7Y286`Z8GMQG`8BFA=_.')@%30/F-K_>7_Q6:`_X^T\I M:%,H@!(7V0N1-Y*TG-@850)Z!)%D#W@^[__A&#`A_\?4$L# M!!0````(`%V)"4-/=J9:F0D``*AQ```4`!P`=FAC+3(P,3,P-C,P7V-A;"YX M;6Q55`D``^):!5+B6@52=7@+``$$)0X```0Y`0``[5U9<^.X$7Y/5?X#HWV6 MY2.[R;C&V9*O75?98Y?M2?*V!9.0A1H(4`!0EO;7IT&!DGB!H"Y"._LRMLD^ MT-T?NAL@R/G\\W1$@PD6DG!VT3DY.NX$F(4\(NS]HA/++I(A(9V?__77OWS^ M6[?["V98((6CX&T67!,94BYC@8,73F,%$F3P]/QX>W=_$YP>G1Z!M."*CV>" MO`]53Y5)*+SE"I\7FO]_'Q^_T^/BD]]^' M^Y=PB$>H2YA4B(6X$P#]N4PNWO,0J<3D%?;IFZ"I@+/>0E3N@A0$$8OHA=G@O2"8^T]PBI_Q M(-`_OS[?+;@G1#"LID4?\BM#<43@+HPKT:%F8WS1D60TICB]-A1X<-&9#,.N#O_Q3V?'VD<_K*6E MMQM[^&@L\!!HR`3?<[ECNRS:=F/?XUA/7#U%=VI8J9KM672)J(;TRQ!CM7U# MJJ2OCC]$-(QI8N(]_)W1C*<*@]C%>+0=VS$P&4`Z!,K#C%JJY@JF5[1SCGM'I^8Y/6#N?S;/4%OA!)%L.PS"#0/ MOPTYC2!EW_PO)FJ6ZJ3H#=.+CBNY(DI[IIZ\YX'A5[$0`.YJ4W,$1>,6!*V9 M`_65QS!!G]`,O5$,WH8K(L91K9UKF9EDO5%UDE(A*D>^#4SPXHE MT%#T9#P:)=*Z,)M&*?]`\)$UD'P3\U=L.`^*U('B02/A7,#$N.B^+G#IFS MRD&EDK6[#F.ZU%;/VGKI586$5!6/=)AP]*B&6&1:VCM80HZ2QO8+5H^#5S0M MEI5UN)>EI1EW>S/#/AI6YF)8G<['EH5;L&)7=RPR\_?TP2()C*&_0\>*\P\MN+8O% MRJWV)E.YA[EU[)DYDQ%@BL(*HW^EOC]!A.H]LELN7A#%+SB,13+GK_&;6OY5 M@<".G<:R_5LZ&/C?3,?Z@0R4D62M;$MR#3BRRP.!I3$:%J;O]:J"?!QUBHV1-%3,%P]8P:ZU,;7W"QN-63+JJ: MC=2G2#=_$JN1^ M>T_X,`69[_-#DE0_SH]&A!&I1/(LUXPP_]2O$5/Z)-"1J;T)6!TWOJ;-F5E9 M$)]L\SB*]6\!\HPE!J_J;N<:3S#E25XI!XP3[>+)EI764W@TL;`>%372_-L' MA'*R?#*;"W[I/>.*W+W6QK\<&$>/R=[3@^$<4'4 M#!HJ++#4U34K9;YK^X#5D,.="9`DM:S0FNY=\Z+;W:/FUB*[F%^5^+10Y`MV M-5;WF8C:@`QW\5,FL>UQE#IEEH[.),IC?Q+E5R8PHN1W'/V""-.C?&3+HW-Y M:#I2&_?74G]WD&WFOS;A6SM2_VK^BIG)/L+]22O3=X=7)6VW" MM&J`CLN3?8:PO.WD;79?3LW@@;!?2E^?)MBO]C[6YL,^YOZM`<[O]F9RQY3'H MK)/3[=]BJ^KU@>1ZQ5L>C7C2_0$W'N_\<`O=!'EG\\>UX>Q5("91F$"`13FI:[@/\RJG.R`\/,JT MPWYKG?9@UWV8XYAJ`N754K#X#1V_#E'.)P&X&6:/Q-=X_M/I+*6=U7JDLHJU MS969'N*3X!,"T;^/M?) M69)]G:86I>7DE7C,DQ\^\JP.V"K&\IK*WK'O_GF`YF"PM,'YEV90, M=&(M6Q#8B=)7*"J(#@TZ3L9N@)4J^08<_SB`YL@M^5@^GE!'?&B8:63\+IJB M;(*I/%'3RG[W.AN-?(-=N.R.=@/M9C_'6:M_[Z16C/Z6,,3"-;8\+8SV+<]2 MQC9?U0TQCI)#AW=2QOJ+X(^#_R`A4/&=%S?BY>NZ5F+O$IDMHKRA\2Z)K$2? M>?77JF?G[^:O#B#YFM7C.#G%"KGB&4LE2*C,%]UNIEB$1"X?'Y7@I*&$$O`X M2SAD1*WGIBW!S%FYA\?%MUQ#Z]/Z+FIHJ5;_M@0K1C\_H+Y&#;4PVFMH*:,7 M-51_E0H`\8"4/H,Q>QP\(/$-)T'!K7=PXU+?P.RB6RS5NNXW MHE'S-:LMCN63/S.Y3BB(ABQ6*<`#28^?7 M+T"1$@\0!'&0D*R79"PV^_P:1(--X-??7I?!X`4@[,/P_.#D\/A@`$(7>G[X M='X0XZ=\_^.U??__;K_\8#C^!$"`G`MY@]C:X\K$;0!PC,'B`01P1#GAP M/YW'IX>$V^`2/K\A_VD1#4X^?/AI,!R<'I^<#1X7<(EA.)B"."*R M!R/7!4&,#P>C(!@DY'B```;H!7B'PR&5'OCA'Q_I?V8.!@.B=8@_OF+__&`1 M1<\?CXZ^?_]^^/WL$**GH]/CXY.C_WZ^?7`78.D,_1!'3NB"@P&A_XB3'V^A MZT2)R;G;7V,'F`A+.$1OS^#\`/O+YP!DORT0 MF)\?O"S<(<7`\<]GQ]11/S!X',GH\LU!R`DC+*])A8.4'@\1=).8>I=P^0Q" MK.B?!GY2.A).2S]:`B5WL9A(:3,F`\X2/#JO0$$;%A,I;>[)^!9&]Q!%]3>8/_E/HSWV7`)6,FC`.(S)4WQ,!KJ_BOI;\I6RXB+$? M`DRX8!?YSQ3&H]"[<+"/)_-[.MZ'D6*RM!>A--8\.K,`J`PU&0.#F)#6L1U[ MU,EH@L"`T_@NXA=BP M71QI9NR;/--U"+KB8-0PIAA]%ETX`:W0'Q8`1!L)]PXBTA<@(OD;Z+)*2)1I MR\P:(ZG_%71C&FXRX%R3<3)Z&X=SB):R0QF?75Y#![F9DND_\WJNUVC\,#KR M_.512G/D!`*@J%D5RA9[Z&+53XFZ"3<-6I%_T_2'X=`#>@>':$1KU97+/:TU`XH<^ MS;=;\F=!,'@E\S=O,Q!1=65'!B,BI8>[/C3@/#W,JM/J$=V=*J+3H`XU:IAP M:M-$<@*O3;Y,Y:--.+:"E]?F`26,[0)8Z_A:&-?MSRE$=.\ M-;B.4\=P"C4NX79L+FM56SLPC0I1>Q/2L;LS'1(-,AT"Z!8$!_2=/43,:6,R M99P[>);,&V,\?'*<9S)_/#D]`D&$LU]HJ78Z/#Y)7]+_D/[\^XWCHZ].$(/\ M1.<3@O$S4?+&#\EOOA.LGZR73N)/3'P#QN2G]5I=X,Q`<'Z@BQV94J8K6;:`[0D4[27V2L4Q+%&2EE[.J6LDO8-QH!8[FC6^LT M]T[MR#VC*6ETM@WIE%CQ)80SVOE*BX/DN4PN0^*XP$^F MZY=.X,9!\L\I#((;B+X[R)/+,'5Y[9).1=[[R4-M4>DI-57T3[/U1SNR-36. M.N2;'RTJ-N&B4;CH@LQ+;PFON@PU(:.S3JW.:<3]M9<;5 MF/:)8(B^?QF';A![P!N'UPX*"5GM0DU7T]HQNN0AJDN/NE5]R-7AP_H-E#*KP')P`/-&$$$2AU M;^KQEO?N`"I5O*4;GRUU29'ZH5>D7@8.QI-Y^FY^@J;T*_3K5X!<'X-[Y+M@ M?1&G5\O3$!46:23D6.P`?#7X3C>*Y53*7IT>]XKFAX6#5CJ6,%J]D'HO?V$' M\%1KIVZ4Y`5EL;?DO?EJQDI'6MIN,R56\/LN6)3LWHLBY0[`1=P3AGLPBI(S M0%GR,GB$<;QKU9?S`PR>Z#_L`.CZG__V`2*!7;S=@A<0C%[] M^@92D9NJ(.7>9!*FG$^_RK`5@!J4]`0;G/4"2P#D"K*K-3*W7HFK:E\5/FSD M+)8WWLM9_^;<:_317//Y9@5F(K"I6;L6=4L-WCB2ZQ:=.1+?%_!^/]T*Z!6_ M=>X$>Q7/=(`^*M.NOM15M918=/*Y,#UGU[8L2G9M6Z3LN[IH-1I5"UF.V4S8 MB(AC5*U%,7:-5#D-3X61;-B\TZ)E[6A)U_$PO[J38B.V*,%ALZT5H(JW%&O"EJ+M&MB8 MBO+GZ`*WE&'(O<6*4E`./U#*+2WP5JM"`8-%$Z[59]C!G-BIL$A=+\>B[ZF@R'@&M?B'"4V. M>`I#.;&*8V%E1S_RP^]?0@2

+3K&C-!Q*5)O5!#LR4P$+%0)LXU?!5' MEX9`TM9YT!1)%E$EE$6BK8LEQT:U8!896U'!K4<4^4>$_)-A%Q\(W3X'6@S_ M_7Y".@Y?`$ZV4GLDHAAK`/4$J9]8!%M5MS=:*%.1LYA:,;`4%;MT(O`$D?]7 M\I4(ZS"!NL>E@5 M'-PZ5Q8>UM2OEX`\W>C.>!'`D_D5>(;8CYC($*#,OB/@4?8TQV@Q",`VMM:# M@24CZ>SG\391/EY"]`SIP8E78!9MOH:AC92>X[!CW>*6+.A"MVQ']-M;+P$# M(2$FJE">Y`U`P[Q-`1NF^K8<'SP]Z,5*2I#@/Y0/E`H;>2NJL:<#@ MD);AP"3=+@0T6ZL0="9S*PK,@HH;7#8CHXZ6!8TJ[?9AH\%>17!4N=NUG\[% MVWI3@N1S1GXW0CUMM>6`1;M5ZQ-M[%9L'F#QMV(46>NHOJ-;V4K^ZU[3\O3O M2U@GSXK&!@Z`]>X[*.3UFFRI*JEY4\$ZY:Q8!MJY5*MOR]CZ9&OHZ>@YVT2[ M/GK*-PWK:LQ2Z`$@HNHXVW&!.=/ETF0;';!I^G[Q9GQLAF+N88+)E'+)!@IL MI:J#]J]'I=#YJM]>6L/.FEQ M1[9)F,@=_6V35JN=L.'"]O8VY+0)&FQA:G[D$)"1;&3&X6W%K*U>P>O79W]U M\.`5?8T@C(^:^QKA4KEOV]'#=X16,%5$6?'>KUY?UJX5@M2-..ICKPIMF&G: MB4(9*<5])LZV9YN)]31B%$<+B,@TB]ETQ"-:]Q*PB7I=W!.%!!0T4@PTN;8C M-D\KGE%5Y9@+`DUDM>'O?Z6K(:3,H#>N3+&9LJ-MU4J28KP9S4,]1YS=,B0; M\H9FH;9!MZ9-:!PFIQL%4_`"PAB0LOG%=\%X^E#31"9$O89``W5O[_T:TAJV MM90/ALVJ1"-7*X:"9$\M>O0<$1'\)T8^]GRWMK%0D#I;)VNBMA@3[2P5Q40C MU^HXT=F:5>[L;L,'^C*/\.Y[Z2K9A?6BK-6(+BD^)7/TB[<-R;WS1G\:T3E> MWU'RU)/-Y#N!P99>T8^O9@5,]#BSI=ZUPTZ5 MG(N=N_>!G5JO=(6=NRIV9#L>6V!GLMI@.I7\".^<)?`(C1O3LZ$G\SFA0N49 MOPY67,R)LMIA/$IYLRNLBBJGV.&M@..3X\2X!0P\6?RR6;3";9G%.\(KUWM] MX;2LE!5G?TH[(/G/5X#I"[E[@'SHG>@JA#BL50LB)NN=2`R#WK:H0&(J:\7) MG=(FI,6RU!*(KFYKXJZ94/?_WG5>"?KHUMN*,4HUV?0/T M%$#@C5X`MM)U,_W,'D"V'@Z7V2RLI5S>GV?),9#-;WCZ))>)B>>ZR+'8\+^]?-_<9Y>T>6%B^>+>A:DYDRI69_ M3=ZSCT)O/5V"]*?TE0#=R*SDBBF@H/;#ITL81LAQH]@)M!8$QA13+2`,*+8[ MHX\E#K6U0#%@:O8]?K^M=:,@80X\MH.IG2$NSTO:W91&4_2FG<@I*0_IQ[NH M&AD6^VW"NEX^!_`-9+NNL75>]Y8EUN)'&#E!_OHEQ-$=C/X'DIWHGT+&MD/& MY:3Q-"AG)Y*DJSCHSRN#FF>IV&^+EC$#5]/S&XC2GRA=>>K9CW#325LC?)_) MJA';HO2N,2?+^9X[MMP%\.(`I)NE2;6KL;:PU\XW*P3U\>UT6WS-U9LA[QHH MOO1IFB7,C]NS4_]*_?2H^G(]Q;J6E4W%:[UNQZ\?:Y!O?`&$NH0GA5%1J!V[ M.DN;M;$F].X#)Z1;&#$WASBOT,(V/!4ZD\7]F4>_@4]U'K*>?+W MF2`OHG($P5;G`NMXADZ3@7NB0R?I8,TA$,GNZ^D:=,T>_W4$ZVW]JP2VEIXJ M`R<4\$6KJ:V$,JM#`ZI*6#&V3DG-BGSZ[B)1D8DF+DWJQ!J:'<64B$>Z@%6- M'E8,4E-J&Z.ZJ?R>(6CS^^Y5-75&&ZMH<@+M00-[=*E>R2.BDY&$.^6OQ@[R MM,Z'='WK.B1V#?XB0:G,N_H("VOVV107[H2Q+C+6S/'275^9T6%>*^[>V_,# MF)4>D*]X)3HKJMP.N%;ESF?GM3X^K&M9?(K7+(L/1W%>?(JW]7@`UC<')8U_ M?9]$E9QN/YFGZDS0E+8!51;L4[B($:=A:"+N+2&8BJW/VP%NC$B``;YT@@!X M%V]9I%)"(9^TY\9S6AMN/:6I(#*@;G_E[4[WM3VWQ(BE0_C:R/2^L3HP?/M M$JD;!15/E++]NZ]5HWCG7W.RQ1K_:JLL=G>34"T"'25B:R45C^BR]BF8/?[U MG3LK+LK<4R\G:G<3K;VG>W_*Y113/"O,VH2Z@6@._"BF1^DF'T'Y*&&J;;-; M!='F$HXC^CTFH&@D>D](CJ**AZ4Q#_/;"$B^-(8H*S=+R=%(EWV)4$]G/>Q$ M;6R'$0Y7*P[M8EK`:HEO)N2M#O71M*ZX\M/482ZYOE-L!_]EWPW>9=^$0*!; MM'?7<]OW:^_[M??]VOM^[7V_]KY?>TOZM=.G&+-7A'DM]5CIVHXVT_(\T$43 M;4F^%4,H<_K#F!PVTO$*AZV9-(I:*3Z!Y'"T8L1@ZL=\$@I0\C#0_PRM.;AU M"&B<=-6RKH6`5?,H+2"H/(9M@`%K339%9=/8M"#(^")+P+#&X.6^K6*SJZ9P9UVHMX3)TVIA,NU#331(Y=/_ MS,@4A?SR?U!+`P04````"`!=B0E#G&+BE<%5```3Z@0`%``<`'9H8RTR,#$S M,#8S,%]L86(N>&UL550)``/B6@52XEH%4G5X"P`!!"4.```$.0$``.U]:V_< M.+KF]P7V/W![=]$)4$G'SID%NG&F%H[MS/@<)_;&SLPV@L6!7&+9.JT2:R25 M8\^O7Y*ZE"Z\BJ1(V_DPTT[IO5#B\[Q\>?_7__VP2<$]S(L$97_^Z>#MNY\` MS%8H3K+;/_^T*]Y$Q2I)?OK?R__Z7_[UO[UY\Q>8P3PJ80QN'L%)4JQ25.QR M"*Y0NBNQA0)'9^"@[?'K[%UL`QVC[FR>U="0Y^_?5/X`TX?'?P'ES? MH4V!,O`%[DKL&QRM5C#=%6_!49H"*EZ`'!8POX?QVS=OB/[@)GJ3 M9$4992OX$\#ROQ7TQW.TBDKZRAWUAYL\;0R\_Z7UQ94@_WK3B+TA/[TY.'SS M_N#M0Q'_5!>1/%9PTH@_C.3K=\)?[]=?Z--6%!M*!*;;U\9?#X#J^^4HA5_@ M&I#_?OURQM7^]1V-RSIR8U[HS[8^K:C(GVU^ M9S,_`7RDKFFPI99;VVC5LYJ25@3ES->A!@NX>GN+[G^)88(- M'QR2/]Z0/]Z\.Z@;BO^.?_J/HPTN'?Y?^3&-;AMS]$W^_!/S69F4Y`4&SW[I MEY;H]\J+FU2TRU=PX&%4@O](;U*M+]6KZ*IH/*.;%+LER07,WGR]^@DD,4]V MV?X$R&__^LN^S./W/,K[51/EJZ9`^$_)2]02OZP0;B^WY9O>^ZQSM.'5`I)\ MO/I;4'N_@9X8*!'@Z/XR#^B.=WE._.(T+DI_AU&.@]<)9M4`'3*Q^AWY8@:H MY!FU!5")?1Y6A6K+^BFH'@/R'&`!0"3\@EA:E4C]L_>AS=-H4"ZV.!/@3]!J M1YC6-M4,M`MEZG?FR!C@G&G1%LA%QGD(Y^LLFT>@>A8(M,7UAA0_/'),5]3"8_.#(]7HQDC/DPL&B7!VSC8ORS=!KA8!M=E4AI6_+0G)/N`]@AIU9ATJ!W_PB09R'`EU-A2.T#LP#3..2G(.ATR8;U3-` M'P+\-`0H\^H-*7YF9E[1%Q\D%"Q;\\(9;38HNRK1ZH^KNPAC[&)7DDEULCJ" MC6T%A3[0A0KFJ!>8MTP!N2<)'V0&6G)004`E%Z"2!1WA(+BB@@,TI::8+!+H M#B@E]3+S4/Q^0N`C_F78@95(#8;C1U(6!N0'-FT/R;/-RP;E65K[8?GNM!-] M'L;`/*\.D?('9P_.#Q2&P_-,>UY`7DT4R&'.D&,"O2=G#>H=JV[`/G:@!O>A MW@CP]714<)!GU2<3])Q/+X)]1X4-_)'-F:%_C]\?B;\;&X-$:@B[O:8ATM91<4/?:U>\N8VB;04WF)9% M\\L0=_7/_W'T/G11F+9-X>*R^@QNDGA41;C7_(=C,^3Z"9)DQ(7M9Z. M8I-*1[//,C5-.[13\:7+PWN8WZ#A0GXF'36\*_!3V=JR40#;2@-$60RB2@>D M>Z4@.*H%I#%I=6N8R6(5(PQ:J_N>%\T'EIL5';\6@7S00?)E!\FU$NAH+9K5 M!2\)T@<^,7W@M_':;78IV;YR4=[!_!AMMCF\@UF1W,.S;(4V\!P5Q6=87JRO MHX=Q`S9%>]^(Z6F;4U_'GVYC5H[WI(U"P`3_DBB@;7'940*(:(%55PTD5`^\ M2K'F:^]!8!*^D)5*'\4"'4.#>*!?AOG!;K.MF^+;,M(/^E"G:J"G!\YJJ!/5 MUPN`M4G/#.N_1-CSV\`9<>^U+8SCA&S#C]++*(G/LN-HFY11.FSSQ%)-V\:3 M,J4UVZ[5`1"A"R%)!9K+_4/D$!-US]IK=!P5=Y0QB;4F`51:_BRCF-A^%(WM*0KWMZ0 M@Y9BVO5NA`"LI#Q'&3V<()-:'$0")?T>MS4\S@91>]UH+9=VT$DZS8UPM9RU M!FI7'IR^%*#R^L0.D>JU!UP4L&R&IGEYNTBF:3;8,J849%FUFOH*'`CIQ=5K MCU^)J(CO!%)8=4CC2P_HP!+OH9]OSS/6A2`7HMLRK*?B63[KP#(O1_.@#W5U M=7I]%0)ZY;!5Q2L?J$*$FE>OO02!:5JO;DF#3W\,9\'1A'KFM=,:%1U,NRMJ M;T7MK-WV53L.C<\]%32NNHUJ%87HH:=@U6M20\"J:!T"[YL*6E!NRVDQ'CE9 MXL*RK%7%;3`*91&*=O4*`Y%*_?H/0\SXPPP\EK#H*-0HQYAN<`DGJ/#A)@LC M8WQ9#!P.(H9ZJ.C%B/`K21@,V+7DE?[W49*2!6L?47X5I?`*XJ:6CGN?P)MR M_R].GC)-NPDHNMJF8-;SYV+H>5()A!R98'%YEMW#9G8L:@R`-=`&(:N^','). M+Z#G-56SHC[,QN]CE.1_B](=W%\QH]ST"72E#1]3UUE88'BS.K0^P?&T@,"S M]T1;.A&"E"@OJ5A5OC/,J+&=Z]\;U3]$15)??CK*XLQ]SO-7P M&CZ4'W"1_ACPRH:IN@;,3!G&!1/G-L.$A7*(HH:Q>8T-O'X#BA5@(OL`Z8<; M$ZO=Z&->.F_!B*P\PV4E_SG]QRZYQ[$3-U!'Y7&4YX^XO#1T#EBKI5-_<44= MPSBBY,5!9UK'KRA`J-M9$AFZAY(N&X5[:<^WJFAA`QE479_*2NI=SFKXFPN4 M6CW@+>]"M(G(E'6!-0SQL;D`-_`VR3+24.$FK'J'YPY83M_6'6+'_5AGD#W4 MA^SH`L*)@#VT!=A#(6`A_O7%0/5P;J@>S@?5][8Z"5H>K2#T?0>A](_3+D*C M$C0:@*H\=Y2^GQNE[X-+T*NC#,^R50ZC`I[`ZK]*>;I859BN\U2=4)CMS/ID M_03G^IP6F%N27=^ODOK1:Q#7#ZL-JD\HQY?@2DIT>7VKT)UM19X6UM M(FR*8YO8/A`V6_41M8TB>-6H>C[T8VYT:W4/[,/;YZ37,<-"IPD?Z.$]4H*R_R+\GM77E-YK^&O)$*-K01")JR MAFO:*FED7H2<$2LOZP<%^$9_]$T1>:4BW<\_(`A7I\6PZ'&>9/"LA)OA M`F,U81%-.L(NJ-*:=TZ7H2=MRO0-=&A#'@#Z)$3NC&M;QA]FG2APJ-63\FC@ M(2PNG:!-E&0J1.I+BEC42+J@4&7;.7]Z;K3)T]%>7JWN8+S#X1;G9]\;%MT\ MDB,:DKS:!!^3^]>_54HADFI0\S)&C:M(@4Z5DI1+7=MA$8EQ*X-43D0B*[8KY("7N;) M"K8/B_JI$H,438C()37A@G<2I\XIJ>9?FZTJ9ALB8Q)7PF!+I,EH.8A1FD9Y M0>9E04'.-/$]:FB".1G=-3"@$`DDUJ1!0JDTGJB@-78N/;O"I!0N&''PT_*T M3X5M=7PVN0.4LN`'-T2@"(,<7D?<667^O"-#FA?KSJ:8*$W)2813&EI]:Z(V M5\>:BYBC[M_ZR3EVRJ,=AS0]+"_RY#8AQRIG5+'78TV*@ESO08(2#42^#_2W M!5A94)J&&H7PI&Y8&JETR^B?7?8FQNV4Q3&UR/0YL4(8U63"*`=48`$^MVS; M6P.5.=+O;?O`C8;O-2-!,D\G,_!&/:_Y`LXMDVK3XG[_'&\WFIIPT]I+A$W# MC="\BRT@*@Z%$4-N8-F1\4QGM:I&4RIDP$6A7H]J"AZ&Z7DR@Q0!SU$ M@<[6VF]$#E!!WX.E#I#&"_L6H19(T"8KP1#=>`@SLNUP7UK.R:.3=,A7!;+S7!(K>K?*\511D_RIR=Z M%Q>[LBBC+,9%9C!:)MHA,%_4`E]YQFW34^)'QD:A^O*X'F\E(@N`]H\#&N=0 MJ7.D7S=CIO&TAL026P^!1\R=[IS'8[Y8VK\^,.B(%\K;T5DJ`_QOHQSO5N\J_Y7[\X^)<#GL4%5<)R!W]Z MMSC\E\..W,A/,(SE;Y`3H(/+S/&N-Z:5$!A8!8>JMF6-6%^*UWXU4K:;KLJN MTU:KYT*KP>IH#K@:W'"\I%9%+=2X"B2-4QU%1.U2UV8(A+B,\HO\JB3WME"J M7L*<%I1/#IG&F"A\#7NDX?EP1"").T4R":UP&\$@Y]\U\,&FG$H%PK!%I6P6*?W,C:JK$DK[WJ2MINL_:VG;9;(S=:;==`>T"SJ'T:?KTY/`/[KZN+\[.3H&O_CZAK_Y]/IY^LK7TKUCN[&^G MX/SBZ@J\^II%NSC!`?MU2*.1ROA!DRMX1%.9\H"N:KY"I"W^5[J+Z8&&.3WO ML"SSY&97DMU_U^@SKAB4E;B2<)ENS[(28F)I4-S$NCP<3+/N+G1,*8_](RUN3K`1=EFINO! MD*^56?"*W(K^>@'(T4AH#;"'!6A]@-H)Z'HA6.K[`8VC'_PWP.E3#@!^EV!@ M1.!2T9V'7Y+BC^,`'E,7[U;/L(Z-49%MJ"66-R26P;I=>^-2B=P#7/,:S+:0*__(X/MU=4%:8J^1]D(SAH:]?=2TC`D MEX(/ZSNSU'V*V*9J9=G^#J+F`5A%>9Z011&WN/7"J52&4^6X-@C*Z"&(FT1U M$(,F5VF?G`K*78HJ^YH'IM8ZB!K^+&`4=^0:2=);`\TMRGODMN+/&9&<;I,; M2/KLWIQ`W%E;);10^.\4UE?>'&U(%^V?]/=1ZZ&NTC8?*BK&Q)0[L9FC:?@3 M$U/1S+(K23L]44?$-QLU,(&FU]F0CG+M/A]5O7GD8Y[J25RF62 M'6L-W4RMF7+2S+^#;>AV2B0DN04/2[I([0V5`%TCGF.!)7`B)P@91!4SP[W0 M8Z.,_IED;^S$3EDPW[)/)KHX=4!L"U-("4%MO;BC?&FL!;?(/DWB\ MX9R@F.=U&$BU^#?=XG-6_-HQIIL8<(S-%ON#4KSH9:X>+?8%;:9H3#@\&UU=LB*:A:,HY95=6Z:?K5O9'Z,TV18\07L'\ M/EG!_=!2MX/W&67WL,`M^M'W*(\+NN*W^YST_#ZC\G=8?H$K=)N1_>75_<(? M45[_1.0.AD'!B_,FL,SLW#0XS5IT7ZN-B`YY#KAY0H!*@/0O^LY>@U'QZ^P/-K@N9J;>9J6,)M0YY$ M<^&S9:@:@:]9WOY2G6`$J@G857>*`SZ0OWWWCIV398Z`[R&VSQ+&/4?LCU&2 MTY/8CHIBM]G2?LPI1NV*G-"&4EQLLN25]'@&@4A?L:XU'47#(*GNRF;4T_8J M"F.:QI;-,W#?/@QP+&`">)!IM?:#AKJ-;A30]>R?UA\>VS__FN#N2KZZ>SR' M][B*QY=3ZRD-Z2Q1LD5EH1LG-%;QJ$1AN:$E$:`;Z^`"M#)!W&NM"0X6796K MCD-5H3Z3I@H>0Z!HLW?BD5XH)F8F7W9,2):L/1Z.K3NB']>1(NLX^LOV]^I. MN-!H)JAI-KO$%<(EU5B-PR6>??\4.LNVN^JV)K3+2E&VRI<O4\P(JL" MXXOL"SG2)$^R6RR`.[9Y\T^R,J0X2DN89W1'$V?%KV,OC,ZD52\6>YX6RV5] M>:#;O9O0`1NRN!5@OL%;E#\& MLR[9-8,X/6I'<.5WORTZY/75K;]3N.'!VJI-QV7T%!L.^GWLR@%H;`*ZN:HV M0Q>-=NW2M:0%5MJ;_A$LW(#W.44+G^MFV]>J7X&T=']/RKNO&;HI8'Y/CEFM M$E0R(Y&M\`M7:YF^]-ZL[?FQ[M%SZF.8Y]GU82N,VRR5;HY7+30YQ8!5">8. M2JH4R:W[79Y65U%^B%+_)X^YI0`K]KI"'"?PVG3'#+OVWR=4;FLE:!6YK\HH M+[W06SE3L^]X^0'>)EGV@^/VD?=<2&Z^%-=9T0ZM=\-?`= MVP==!Z#R``8N%IU>6MTIVT_F4+L_8H4E_#Z76''X!'MAG'>Z@B6N$[HCWU)7 M3-V187],Q9&GD"XOFG+/[-%IAF,-6EB( MR7H`M!.7Y3YM!&?5-PN:^?8'UIT5TQ_I#XQS.U%JMP`_0HI+9#^_F!+$V+O3 MY15.5U4$MI@B\#44LR^=<+9B(MT;#F^&T_W$YER+']S-8@:XU"'@%0[S+VQP MM9ZA8_\\!=^(#J!*H:1J MII!EGCAB#AO>H233++//+3$II?_0)0[$AGF=8>(V>V8V.?72/0A!M0`6$JQ! M!K6?B%^`B"H&$D%TD:2?&=E+?4QR&[M7GTYQZFH+O[)SVZC6V71/M<&W:[I" M,)@[3'VQ0&U#O',:!#$C?+%NF^U.LE5=JL-K_E1TAFV>6,=6/!!Y<9)8*SA4 MXKW4CDJ*'`B;E>#!HK!J[7%H*U)G*D@3Z:$...Y,LNE!0&;)3 MJ&*+G`(G3K@I]Z=$39F97BOO-/ MSP^/K)XPS;.XXUQRE?&ALP(5>V?/- M?)T;A\)/%8RPCZM5JD/NJ;5<;<[AM1)OH?*3&5C$)T1/,J/&8X$9M]SF.IZ1 M[[(R&,0`L6FUN"!HT<,ZUWH:/M5CB!)6M.(*UZ)&K)&4RG_\45A5*!UMGF)C MPL)H!^/..EY][2";/@*M;;5+LI>Y M]R7M+G7OVG:XW)WA1F/)^TA[>97<9LDZ6459R3Q\XE6]8NTU^%:IA4):0=WS MU\+S*DFX'KZK)%@3/[8=%)4.E*ETH$RE`X=4.IA&)?57_V2%R MN^!EGJQPAT;!^Y"7#%V4=Q@R%[R$Z##D6#T$@815C-J2D^I0C52'CF/U MX4RQ^M`L5A\JQNK#9XDJC5BM#ZL@8K6=P]G^$B79.2J*LVR5[F(8GV6G44Y. M>'=\CJW7)?G;+4[HS# MW:A*B?2G,EB"%!L*)#[.1D!WIUVJ8=OIV9?\(C@\"E/VWOY;%?.#3(ZC=+5+ MJZ^`TO0CRK]'>6PP/6GDS_X93SQ_X9SQQ"ZAURE2DQ+/=-"3H`S+XSM<@&IP M;1UU3^5L-E?W3N5:9-:2\84V:CX]H[3G]$HWGQ_]S#D<^AC[\@%']/TO0HPXESBTM+Z.2W$MQB?)RC=($!7,6 MWC3X(`NUV@\H6F:ZP6&"?V\\/]ML<2@C7>V+'!=NBXHHO5B?H^SV/+F'<57J M:J,=;_FKB8GZBT\S84C^*4YMQ@`#_Z)0,-GL,^3,J4VVZY5]@I="`DJT%P> M7WP^.?U\=7H"\%]7%^=G)T?7^!]7U_@_GTX_7U^!BX_@XO+TR]'U&18`K[YF MT2Y.2AB_#J8!E]4]TJJH`>'8"CU.B6QZILUU]+!/`;@-JH)HCT`\42LL8AO7 MI=(]S&^0>(Q3P9V<5@+U924!L(COG1Q*-3RBB;PF6%QA:XT)([+N&$C61K14 M')E@Z*`+HNZ&PV_!;'NP#2W.:(LM;/DN2NF01@OOE.5SHR3-IP+`8$`.8!SS)Q+@LL'20 M$\^P6R8H']@D5.6P(8A3F:3U*F2$[/0EGH:8%4&JYQ]Z9/%L)"+.457OI$RJC5#XL,&?9Y;%KOM(LB1"XH39!&+=C[ M;<)290U4YD#'W@)T._L+8 M\T"=EQCG@AB!/'W8PJR`'V`&UPEW])$M->Q-#J5L=2;[=I7SO%^KB)O!VZB$ ML=($$-.34H^2H=F$,YP\@5>P>OX:ARXJ$4*4X5EK":5B,HRHD!>ON]Y4>NZ71#YM0A92?NQ M8/>E7A*H]9H?RZ@.HIGZBFLB+Z,D(_M&F%?XJ(@.&R*FJ"T.,XR[:VKXSI2( MRE/O-B:[KDP@[!/5-8MNDCKAT(NAQ>03U[IC2-EO!P2.3/#4C_0]H06H/^RW M^K_AK0^S!#99,#=$F^=PG<.H@">P^N]9=@+7,,]AW!EZ&L=M=9U]`%?1,:>= MW(N;41UEOQ(V*MI9?H8E6-%C!,@I`G$M%LCTF08\D$'MC>@H5Q_P4M7?7+BT MV2ZH>[0"R:JEH#+@52/]FH"S4>C-E#QWC/+;#$<@#:L5N:#)Y M,H,4/[8W4`LRIIM#33F*3\=:6''[:+6BUU9=1H_D+(^C+,:_Y#LRPI3;2/8SK!UN4V]3YZ!)6&UQ/ MYF2WQ]$V*:.4OV%34Y';UO(5K8<1GBO+^W;TO.H%"Z&Q[MF>474W#HD$G?;R MM]!"@!0V0MJK5*B,Z3P;8G:+/0=$Z#KE;P9NZDE<'(WH#1W5`3BJ@R1*1F2# M)Q(CKCJ_0K`-+5YH(5&ENZV,"\5>N-">4N]2.)^Y$BI"&X8(A]I:E8;$;I4 M-QP%<71;`"S1':R:@29A)=9UJ>O2JK:X`W%9V]J*NPH0M8,Y)R?Z+B M"2.J1*3SR4>L8,@/B,"UZ!?Z691^@?B=)<,(FD; MK.#;MTX/J2LI3R06EA]A#/,H#>229-7:'K)&K4H8].$KCG@D\^&14,WA&M?8 MU3'.8&]1GOR3[K_C<$I5H:657,&863(7=LFEZ$W,+R4CR[T<((*@+QG,.8O* MF$!3:VW(/YENGX)JG@)A(?.47IX`DV663N<=FG3'(N53>9E*(Y:$<1@OM\JX M))`=PCN4Y8,\@,-WS\F`VNG#-JEV#%P0"_CE\QC53M+,^3,KFE./+-)1TP((.Z M&I)-0;W//F5_&M7Y@2S]4M0=4CU M8P\X,)+M`9YCR0D:[,5;KGE]*)!(NG^P`/6CIPL#7BR<@(.PHAQGSY!GW$H]+RK1Z%BA620[]KAZXBY$+< MY`ZE,)3D6AR4\OSLZ,/9^=GUV>G5^#H M,[DQ^N+XW_]Z<7YR^N7J9W#Z?[Z>7?\>#`W5X,(FI7)5#Z\1% MET/HS!1]_>X(!=[I,X::O+-B!6M>.S*H*/8#28^7,(O)_NXT2C;%YQUC:8VZ M0A/J%11,N29UX6)87]6ID'1J1I;5WV0#*2;)T3 M&W1U01I]+S"V"K"MS'DFISI@T-0J'?!3JMMCJ**G63!JKT50=F<.SX/Z0LF. MY`+4LJ`27H!*_/E"D==6.,!B0.W%2;2);G'3]CW*8QC_+4IW0_RK*[#;"Z:" M72XR7-A?9Z/J4H../"/+HPTYA(FT%G$E`J)*ANRZW%8;P'HMQBKRO?U2`R9\ M:DHJ4LA,AJZ`F5Q/LR#352LA<&<.2V8K4&9(IIXUF^.Q+,,B@HSEE_5/@>Q*8=<)4OB4?1SWQ+J0 M9>C[`V>2\<')>M:`L__,%)Q=:U;!R3`L!.=(?EG_%`HXF76"%#[E`)Q=L1XX MQ_K>P/D9EL=1<7>9H_L$1_,/CU\+K,KFOAI/8\V?3#=1? M:XH!0R[HN[1)F,G>1:R::'1)E,`Z1=^+ZH[T=:,`HE;#\\RW`<*0K3KO,UO? M5I?^4TL26HRH]M;T"JP6&P2*XIC`5'03"QBNK$_A:;N>$`!XQJKKI0CYM[4& MN'D$KW8%[;23XY)JO4X<"#(,B,`DI[^DFI5HS["A0'>NYUGQ;*UGK^_6'I@/ M*C33INRRB^:O#9I;17#T`M',&028`\X^!P74V]G)*>WD5';&%':N9HOOVD[> M*FBV6$EKD/0606A2KFHC1YV6F[ILK#CN7#=6`K?V("QOK%K%T!LK)VC6:ZRL MPCG`QHK1K.J-PR@8T.YSN1Z'$;B<81Q&[MU.YBH>AV'UO\(9J"I_A?WMG"J!"D\!U'&-^+#>`[U+==LUJ=,I6QA;%YK;H]>+J5R^_Z*-:N M^1E@(Y.'%EO2L66MFCVL:K8^E/<5^?DU."K+/+G9E?1&3OQM+B/_^]7U:_[0 MM.8/GT1:.CD=G9R&SIA^SC7.RG=M)^=4FAYDI9[>2:<+IDD9IXU,/.]8BKP*T],,M'7%O%T$=JS^GW?NX%3UM@G353;'[Y.(J])EB\2N?UK0W3]1GC^N44ZV_!3]0X.'G3IMO2%M MY'JV:"3SY(16BDZ5:*9DJT,[,BB&>W4=A<7PA'3/K:`^>E@4U:E8#F5E)I@4 M5O/KG])-J)&U<+*6S7Z+9GT0A>=!JQGK'H2$AHU8((09U9FH[=)HLX1ME94A M":95:R,/7.O:"#CHAM+FP5.M?4ZG7[_Z?7;A^8'WFLP'*&LFH=01ER2I^NATD>/.5-(H\:74*C"78(CD!B2P^)R'(9-)W306I7# MTZI.;>DN<$-9*,`73^M+/C,'ZNP9?JXM_^`>L>X\R>!9"3?J#<)(0]HR=#2< M-1&MCWG:BJ&[:8U&WXHD"2/"@$H'FXF-H:'4IC#K3K5Q:9756IF!KP`82>YR M*S[NRET.Z\-%+J-'.N-R,CH@3U-KQ$R)EC5V"OU87U.JYU>-JG)+]7V$.,)O M$GI+:;$@"VXVB#1Z44H//-Y$^1^0V`N%L6JP8;)6N4YYS!4:8+-7P>=\F+4_ MK*7FTQ)@>T-@E?@"5`K-<4>@40$GO@_6FP>RLI$T)YCU.NJ6WT99?5'X,<[- M49K$]!]'67R)J8*+2?]YL:[W64;I%?ZE6@'`FURW:;-ILNS8-`T.-DIA-2&U M6"!A6+'F9_EA5^"4"Z>S)[!8YV:Q!\:[1])[E608T< M8FH0NFR8[P4V>^5]FE'O)"E6*2IP..WUF1P5;FY&DUY8Q^P" M]`Q39O?R(4SPUCC86P=[\P%=C_U4`P"O&_C$(H#7CF5Y!_/.!58?HR2GQ\OO MRSK,FM0UFD1(1<,T",I]6.W0*;L3!BI%*\LKF),]/P?@[U&>1][W3>A``$VN MHP&IYK*^C!Q;W5'6Z[)/KV."? MS(O]E:8:7J5$5+*SI#^!GFQ_>_P"8-D`^*D,DR%#=6J1P5&9^HBE:O[FPJ>] MS%?'HQ5P'HC0N:AJ9T'VF)+L]`6`E)<>.D.I]T2.4! MQF(9K2>RLQ1W2HBS70J5UKOV"1JGH..5]O,[?@%QW!Z+4SD'E7=0N0\_WKJ@ MJT*T=L0'M5!OT;E*0V']78-K94BIFR)6!<:_YV1*_016_^5-0ELS*&DC=`PZ M:@+4BS!'A-DP06PKQDN99K\$\9_12FYD+F)Q1?9%5SA0$S/&S7.C6VYD00[.0J!I MP5Q,.;LMZI2H:<7U\O@.^R7A$^Q:>^"6)JPTE`*K8+,J4RU#S52M MD4]GBX.''N' M3[7?^]2BB>9HYE,))S['3)L%WM?H:/6/79+#RYQL?RP?+S$W2]PW/\6_;HG( M()3I*]:5IJ-H&&;572DG5;]6<3.#MU$)8U%2I>U<%`\UC2TO\5>Y(WM\58`6VOY]=W:PRYNG=NM//C#URJ@ MT5D`JK6@8#Y]>6#F-(%SH#FH9NKH/DI2)M5YCU>F-!T9J!=R(6*U6H1)6\XT(:2WS/2]XW353C^)(@K=I2.<&TU[8*Y71>LVP77#)67GZ"FQN8#]LJ M?$P#O`E&IJS)$Q9 M/+9I_1`CO@\A$3E:R_8!*,B3!=A&.;BG+>__>/?VW;MW!V"+\5+<123=WI5W M*"?C[[^!@W?O%N^J_U5/"Q"5X-]V&03OWRT`KKGW=-CH!*XJR+T_6)#J7("S MHMAA?^0AVI5%B?](LMO?0(8RSX?)B%"#E*MY0,^Q<(]]/%MNH&BO.\BW/P&' M!UT@7E5`I`\;M#QE7/#Z9I.`X;6OU2O2%27]/B0((S!/F!F,Q\)6R3`T;S6/ M4O&D3A"F@7',CEH!\"K)ZG#\.B3.<.N?2Q]1+8F(--3CFQ&027\DJJWANW#%,XE&=;4)#HCX'(5^,TC3* MBWV_(R@>2A'#Y:1*?8KXR=/G5@'E8M\35&CN&-*"-J\G[:#AZ]AW MW?J-7>DV@4,+8S9V.N5A-X8L%$A:1$Y5R9O%CJ*L;1SY\$FT;93$U]'#>*4& MX]&>0IU'YGQIC5DFQ]"NA`E]\67]"]E]X'VJF%472/X-1ZAMI080'6C[QF-] MM=A1%M,AYZ.B@&51;58=+7Q5U^BC5ZQA!]0B'PZPKN!.@0)2*RTSZKL/JX': M:I]D)08BJA0$:920,>:2:M4Q*2929C!/[LLC(=$*PKCXB#\IZ=)%^'-?K)M# MOT9<5!%N:2@6-F:@R+R#21<%=V+R20TL&YGJ7B3X`/-54JW3^Q[$*6R*]8^F MU-*09R*]/L7D'IQ#S>*DBHHK,YP=#('6B!&@A7';6C.L5=Z30<:ANG:]\\FO9(H7#S3*X3-"L'>;?(;C3I=<=,][@:@Y MQ;G&+;-9YD="7+'Z\I*Y*9`>@."=D?*:1OHU,N(95VM`*8EU;^SY0HZV.'I( MANWFZ/?ZS3N_&Y*@M603\4.C(GCW99?TG^`;^<'S2S]:'92O2Q>!` MSR_@F$N<&4^ZH+.T(+ECRSKPE)Y@B&H_K$:TA,%5D&ZB*94W!*[+NX$@G%7]"G$OUEXT( M32'BO9!G#BA5.9I0,P.>B-1ZS)';=XTM:Z-!2IZ,8'4PP%5'"M1BSPU?G'$@ M>P#S.0J$"U?FR:JLIZ/9Z8-(9A^=63+FS!E;M9I<"!Q(>,+16^X?5KU6ZS2\FJIQ.X3E;)<'Q# M7:'E@US!F!PR%W:9HNA-3!LE(\O.[SASH0]\LT>Y_M'4&AKR2J;;)YF:)X^, MNX?9#GZ!*W2;)73W(/NT;;E@RS"^H#&S>*;M,DKB1GT22.V'!!9+E&:K!YYMP0KRW.I,Y*WSJ"!![=$8CO3XQ/+!HM6 MH7&)5_5"2@EJ1\:L@:J88$P__GB6%'\4N%OV%7_>G#2@]#!03KND(MOP2RQK MRBV1=:N\4G`DY)14?WE,D)WA'YH;:8]S&./4AJC2\06Z_JV@_R[H#SUCX31I M2NA`$RIQ0#^16H]ZH[1\K*/#D&?,APVQ!@]-F=0SYV*4E^5`2)FQ M0M/F>`8XNUJ0RL<<0+@GU\,LPX+U&K8WULHTK5>Y9#2U^A$\V5KF#8]J5+// M`5"Z`>=R>='-4%+O-EF@5 M9%"7C'1=PWQS,("D>T=U!;AT9$A'=T6SF?S4G M[9*;PBZ),ME9O:77M9"A@WP_\5J=/;?+$M_KU\/Y:E;;0J?4"M&`+4!=M`:K" M5;?"-#T0S"?R\P)TBK@`32%!74K0%A-TR@FNGVZ_Y07&=LX@43B%##>X>QT< M6]W!>)?"BS5=NW6'TA@GM6233?GX&96PV#$2AOE]A[.'<4;W$LKZ&JU>\C>T:JGU`0]1273B*;DQL$R*"W'PI"D M;FA9"RU`42G1L:>H)^\Y>.A!!9E4Y(#V2OH]3FMXG`VE]KH*6B[M`)1T`BKA M!:C%*4+["F'LJ9T#J;SLW2%4O2\[$S6-O);Q,\JJ8<:J\W&6X1?;T;:TR,H(=SS/RL MM!I.\,P(6\;,C6/OHSF96=[VB403K>2G"B=79927(004I9GP6#FTLH0&.WU3>6WF MACI^%Z#C&!EQZC"X3K)2MU:I(^HH!%O?B\3SH!_DZJD8,H=9 M1YM5YVF(@4.=ZKJ=%3F;?$]`V*?X1Y2O85+NR"VV='U:4FV]'QY2[,.UNS$C M@>OP+B+,D:RR0CAV3]LB*7) ME1+&G>=7W%(XSK,D;__$0I+=W1HS%SRD>&1GQX6DN]@I0;,9HRG#CRCGA38O M,\P]R;G7<8^9G$YU?1?5GZ#X"UT$>I9=TO'VP2X/^O`$9QOM?GM;2;>K3RCM[,2.^3G5T*"AQX?;;T*OR`1RYJQ(RMIM3$4"*"4@Y`2WHCZC^ M-**Z[5[5BPGKS[,_ACNG]W0S?CA=,?TB.>^%Z10IV,9?_27<3\]Z>1\_#;YF M,;4[6YUS`UY8AVM"H)BE59Y&M+G:8_72S=,4ZWZMI]<(\P>`Z[6U,':_N&#D MRMUB@HZK\&;JVL*%,\"H7MB9)^/Z[I?M/Y_US/^8*&[GP)B`=#[EM:]+MU-< M@[<+/![X'^S2**C/8##+3'SK\4>,<0+RYQEDGN0X#?V_^L#F:DR*>9*Z9=.F M*2#3M*\0SRA,$.,8_'(Y">`\=X/CP)]H2!6!V48(E8#(4L1D>+$2(;FE?WH! MD3E._Y<<%=;6X!9"3?60NK(H&D$[1CT%3#;(K@X]Y(?>W'/ MT^YU3F;7-VBUPQ%SI86L]TZSXJ';H-MH?H%?4(Y,;/@?IHH1E&6'^`J MVD``G]41UU/9-DL3PD?R7`U(OP3SM!^LMWY"P>8)9,/L0H<2:6;-A>M;G]OM MMC_"V*P<>5EQS'L:?)DGHQ@Y?M!-)>L'-N(O-65]E4O7JC2"[867N+8WJ,Y> MP);\'N[NO7[M##D[^JX,4E&9$>P[FN%VS[@W\*EL)6]6)G.!/Z]GU4Z:3<^N M4R=[99UU!9SU8ANE3Y9+,UPQMP#?A[N:]UN9BW`#W\SLU,F&W,!>,Q^R5PBM ME,CVNX?;^%@ZX&2VL4&VVYE/20RXN]XO:!!+KJ>5.83#L]J)\N>T,GLJQ3R< M-^7_D$`?AT4]U2:C/4;CJ"AVF^K-OB3%'Q]S",\P>3!GRB]1:>V<)UU_IHV$ MNC]?K8-J"8-H%C0+ZZ0]T"K#DCQYL\:/0%(_`SDY-(FT"7>[+,YA7-X]V79! MFTXV&H0IB+74$JBZMM($Z+WG\XC]Y)KO%7P1CE(,/?(7:7/8#)` M2@,KQP8J(,_648$<5W;.!Q2^1XB\]K]45U:ZV4EMZ6#1:KL16H,Z1.R=_(@$ MAEA]ZJ'`^R+8*2]4ST1>[+>#VUQH:->KI6/SE+UZ/DI/L9PA'1\UJ>0N3][3 M*XZ?8@%LGNVG]H$V49-8V+T2B2MJ@T4?CT_!U5]/3Z][?`R1 MCG+(L&FI5*5<>G*U.325>/-(5[3ZHQYIX*26/(&6BF,!8^(-3=JE&<>ZF%1, MI7JTKCF))I0,D5ME2/4C#X$_E.W#G&W)+ZCO4!K#O*@VWG-;'IE@%^0<01M@ M9YJV#GJ1%RGX^FHC%+A>B:>"ST"5,"_)MZJ73X#^(>&?C74ZZ!=C'([RU>89NVM-.&: MU\?"P3`*UA_IJ"SSY&97TI/$\1>[C'*<#SY==/`6,DR`A]?E`;N;`A,55\7I M/1D?OH8/Y0?L[X]A$)3)-;&0+V?*`9YEJ]F!Q(F0#T+=Y?XQJ)Y[QKZT0I'F MMQ\0@:?2XX/8;C"LX&7-$C$.)^QES!S#+AFADRV+5,=\"&=,15:M`F8HI,L< M#1$O`DF5OV8YC%*RM>,O49*=HZ*XR$Y@GMQ'97(/AQ=;*TK77T911"`5"\OC.S*Y2^XTH.?[DFU8<2L#TB2ZH?N?_5)* M%0MH4H7U"291[/),R8=[X%E+Y!5]&6(.I_CD&7B5XJ>O`I=WD'*]VI@1-8;\,MP(9\A>O?=#P11KW?@P MO33>8L;?([+DK&3.HS&?U5]L\,R0OCUK-GG),BPBW%A^6?\4RDP9NU*0PK?L M8[TGU@4Q0]\W.BF+R,:=XC,JX4E2K'`^L\LAI[.OJ=5'M%S+#M9E?ARP0-&E M`C^4+'68$\AP@2XPQJS2J34FWV0&&$Q4\^F/H_TM=;TC)CH;03Y$1;+";W*2 MI+MR=""6F9&&P1.-F!)ZDENK_#8I@9#NTPTOVRV\S/]N__U_AT-'?B'Z7O,KF&^ MN5C3/X>#_!9-FNYI[9F<&&!L?2;=4!.C%;WP@[H:?!#+96(%'ZLNEO6%*+@C M7*URJ$\A6'5/*XB(>$%NH"W!'0Y7`+>JNR@%*`=;W.1F98+_D6RVI'W>;;$" MZ5,3"U'V^',!ULU"25`TJR>+MX%ORM*A`G(#14L;6CO628RS6](`F&L\Y&R[ M,*XYVYPK`CZ(SQ7Y4)\K4LOUSA4!Q":X6%?_^L%%*;C")^-X9-T'&P^U5O;Q MSIRU72+7E#S\:4D)A5M1LN7T!Y^D\`B?3X?VUH+,1?]\F?V>?'_R,\CA%E<)78M$'.!_HIQT40;!(XQR;(',:V]PT>Z*!1UI M*.\2+`HS$$>/OM-T0\PC6PCL1ZMI]IKX9%(:+S2TDF";N;=/0)Q$5\J@UNZF MSN2TO<8`J"PL0$/8QLK+9@8G,?9%#;/D=[I?>^FN61GL$^20$(3.W^-'+QOK MG*35%]8M)J:?DBS9[#:]8QXOUMWKBV%\C0[>T82YWNTQX(^)B?I[3C-AP/@W?_DQR4O2(OUTQ;5=9P!AL5 MW6?8P#I*SIU#^4F0RW-J<*U/K@NJ)3U\;+90(GI_1!!;-\]FD M20EL$^)P0OM2=.LRJ+L5?1*$DXCZ(,CL22@YQC'&,JL=V4MPL5YCJ8G)J-B4 M5E+*,^4\>+`=^TE2A64QBR8"TWI!)2.&B&AE"4M5IIYUPBH!NE8TD@-N2E!B M6]4+3J*2>>3AC(FMN!"N&'B@24%J";2F0&/K!Y-&D`F/2G,DQ'SO^#P)[LB? M'N,'Z@)2?[ZZZ!(ZRAX!W&Q3]`CALTI,&6`2,II=X2JDW6N*B3GTX!BS#I/! ML2,3M`I'+PE<:]GGAS*MY&L:S%PD47T/KA.EL3<3L`D3GFYL?`()C1GXM!*3 M:>!SGF"\<^Z8.F1,.4UV4$<%7<@R=8I^HZ3E0*M$G)0)?B>E'5 M((*$Z6&5[F)85-G3PPH6!2BC!W`#,[A.R@7X?I>LJA*1K=#E(\ZA'JM] MTLUQ>+6[>A-&`;=1CE\E??2<2YF0!%E!;3\:33#6!*C)Y9B?L592-0/?EKF* M$[I&$Q!5T+\_AR#_RX!H[="2YRS/'_XYN>#\!##+&"2O$WP:0G=!UUX[Z@.*"E>MXW6"/4O!;Z=B5(FL/A".LY1Q#S%6$>E_C)J*@:D5'%@N\71\,DCH[*))1$` M12L!<$NQP_BY>00QVN#$)5F1P]76*(?);8896=L%-[LBR6!1+,!-E/U1]:X0 M;I#R:NB!F*)M5(3YC#9U[IG#;77,B>>62`MI:!H2^MQ5T6Y(J^YI!F!;:69T MG)E"&C$N8`YQ*Y>JW%L@9,(1KU7;B(7/$(X-8 M;TE^I'W5[]7/.,<@=0Z)%J2G2AT?__[[FT^?WIR# MW<#R.SD%D;2@1_%_[HJ2GHI>E,VAC4EVCSOJ]$CEJ*S63M:+)G&?_./^GR-Q MSZVL&`E(L>)$=P06_0Q38,L%M*RTJ$+KVJ#"+>G^&:`/`^FU5FK5E175B#R)OM60>[)>DWY/ M=>3N;90"W.?!UA;U(G=L'3^NS(-ZR'1OJ&=EMR66R<46:2N)O3?"=2E\GYX[ M$VD@>(*`2R5DI8[4BO>MBK25A:P^4C?,L. M465U@9/(R50\]98P-4*@E@)4[/F`2+(FR01%9IF$S+K-)=XJOJ:BZ;"+IJ]O MK][VX]'S01*G(;>!)(M--&[Y<2TF-RD\RN(+LK#IJ"C@:&98)E:_(U_,`/D\ MH[:;9(D?'N"%:LNK77OIT"K*\T=ZV1!-B0LZ?I&F)"^N#9!-=Y!_U)V M=MR!N+H?'!>H'@D:&,)=7`S[#1;.DR@EN_DP08LDAM5,#B[CYY$+!I-Z!%;=,1B*RF0S,$4_N+49_^8<`50`5!)/'V, M<+(=$Y"893DBR_8&1F1>ID#EL`>5_3+AZ)E`A9/.F$#%R8P\&?&`LBEYEM!H M3KXO9&7FM&O2W:P\PXM\!G6D](+FY9EP&,W%\BJ/-Q?;E1]/QHZM.4&8Y#Q46Y^BO<'X-B[-F210S0@IEZC?BR)APYVX;I%B50RND6:) MM_="\VVY`(N52">TK@T3'.=&*`@DSIFA@1/EIL'!K,?`-6NONR!TH0V*P^<* M"MY5\Y-`X6`6LAY%/4I3>`MC,NFYSLF\:/QUB[(/CT?;;0K/LM4`8Q.U!W.5 MRMH69@@4?;F:T=1S+YM&T+'6F5AHYA2B1H\<:U8I@AW6)!M_J>X"]V!7@4R" MZD(,&=<[>VI"T=!PMD++_[PXMSK'JNG7(L(/?D!O2.!K+_0/PK7GD.<,25!12^K2# M56$CX7;A%\^,[:SJ8W5DAL+2+H'D(%MB2EIH,1AV765!?%>R]H"GR5[5U9Q8 M$N*B+E&%(ZV:8<=PAM(P7G/MND.3U5Q#X&,BCGHY1"T3XF(N<_!(,H#IZ+&S MD(MCW,4Z+H&KB2CJK>)BQJ#G@B+),J[I*!J/<%A$T7MK@U\*CB9BZ/V+P=![ M5QAZ;R^?:X;@KN%#^0&K_3$`'?=Y_4Z,YP;P'EFSG:?Q'/"PS):GI^:3@^!R MV*QSV^5TIKN=%$(YR)/;N[(YEJO=L4N2LFY^O_8)>7CZ^JL M9#H53TJ4DUG["!1;N$K69'L`O:Z#'&J79/CW%K>+=7-2^C7Z`"^C)#XB:Y%/8+Q; MD27''R$D9Z8?HZ(LSJKES?%9UHS:9+?':91L!KAR9+VY?L>V=9-K#NR6Q7;R MX*9XW-L1''A;[HW2N83F&H5J+?T66Z[7SL>-;9PE8`YD\+'X&:PAK+(7L@P0 M)S:U*[+`/VV=57L>B$??*U]<\08Y!^O@V@:[CMHK'5R4/RSRV[D!R$VY9J3] MP13>:Y+]!]4G0O.I7

!^EHYQ(*MEF00))(R9Q[=K/=&2N^'01 M:RZI`$Y8R$*%+BN\9_T-,W5N3Y6]"4BGC_^3+[/?N4G5QG?\7_ MN?JYOHMG017A0[2A>R9^OCSX_4^?#MZ?_$RRI&;A+5UL`3%X29NT)OD^SJ*: M\X6P!;(V8X.R\@[G820#*^\2+`K)U1R/OJ=!5#"-M,`W#`-B3U,9$J!PU7J`AH95KD/A?L<),:4_"8)BY"XS97;BBXF@BBPW[`W;0@2IX9 MB+B)B"F(+"8;BD3=\'CSKC'[MV'4 MPS%[`R0GJ8RVVSOIZ.S(\'.Z(&,(:[W3U!E@FW26>FU'\RCUGO=9F37GW1@# MM_8XI7\S1JW\LH!M=BV&,;)GN12CXV_V.S$&ONWANW;"= M]^DXY5%7W4:'L-M:"N14K"5K3K;6Y%6^AW^KAH!PVU0F:5KG>V13#KT*&O\* M\XWG1$P/3&AB7?=YJJ3>T%/#UQSHM9);:7DSQBW.I%I94`F/\`MK^><,1DZJ MY`:-9HF1LAM[^9"62V-,'G8G>N]@%/]C%^6D?(L]-)O8^8(@RDELW$#4ZGQ: M1A8;5AF*;>S;GK*1B/#.J[LS\U- M\,X?/M8VUMVBWPCA#LM>BFY#WD_`;;91]OAS`591<5?M&B!_D/3H/DJA_U-P M)Z(.F6)A.%"M8V<_=JWO?5;@6YICF^+6'N3I3%Q'"1"M!>@FC^:ORR`)OIJB-%80,P\Z6>/-]21<*\E1?^$)N$8*&2P\E-Z@]71`D]3 MP83SB>>)&]E:9P/2GKJ36_+6 M<>*V7+9[)O=IBA8A"1F*T("DV[J_/@`7222Q$Q0`V2^S6`=GPX>#[?#@KW][ M7B4G3P!G$*6_O/GX[L.;$Y#.4`S3Q2]OBNQME,T@?/.W__SG?_KKO[Q]^Q6D M`$-R?G,)LE*"LP.+E'29$3#MG)[=WT\NKZXN33NT_O"+>3,[3>8+A8 MYB5BB58;2DSM0Y$3VR60V`TF1O3N9),E)29Z=8)`! M_`3B=V_?4ND)3/_XF?[C,D MA!$4L-Z:3;QW^*LJ7\?1[A`T"E M+VRX`>-KK:'J$\0DZ#R_FZ%5Q?D:YG!13@+G((]@DLDU?5K.WM+YZ\-/GS^4 M:C!X&.GR6X1QE.:9N28]#D9ZW.=H5LY'\1E:K4&:#?2/A)^1CH33"N8K,,A= M+"9&VER1Q=(*/$3/8(`V+"9&VMR209'FMPCG M+E(XAS,"5++B0T6:DV7F+1$P@T/:'0VTK/+8N#Z8-#"8.`H'3`^K:X!K$W^PV?]8=/]\-$^ M;)3;F=F'3^FC1IG1HLO8L_>8T[8Q\M.8#!XZBM*,N"&F&Q^R4?I_"S* MEI<)^I%]3Z,BAN17HQ%B(&4D>TBTP&!):.`3N$;9R'8)I(UCWW1-SU#I:>FH MAC'%V+/H-$KHZ>+]$H!\)^$VPD3Z$N1D_"IL_=6L4A(UMF7C&F.H_SF:%;2[ M2<"Y('$RWURE7+LF?VC)`L]DIHEW+J.J&MI0BFR$)FC6 MDI/00WR$)4:1/_PNDC%YS'(HA&^/)C!XB&T<@H\>YQH@'WT'R%F!J8\O84;FUK^#"%^D\3F9 MO3H8D9'5+N23!8,414O-P,)G7N/ED^]XJ',)$X`S)H`X-"W@]&@" M`XS8QB%`Z7&N`?)O80"DCIAW8(TP/1ZB^]Z"C1,Q:7LAPR$-##5*%@]:UG`$ MU!CZ2Q@8*I%_1J;9!<+LQ2^3HH68#D5@0!'9-P0?';XU+'X*`Q;TJ@"EY=W% M_9(X/)L6.4VDHQF1[`"CT*`=9H0-`L.0AO6#0HY03(VP?_<=88W-NY7^)?E+ M=]Z24'4.FWI4P0!(S4XSU'!YUU#YC["@4F7GR<'"H&/"I447*&#XMMJ`3(M[ M#9HOH8#F@;#EX&3_IPXTJI^"0P/#HF$`J!@V1W7>'^9.B,YQ"=PDZJY0F+_5 M3NK\%DR_BVPRZ_@.QZ;GO3^E;>S;IIXSCFB%-)T`T*$)!A$J-@X+"1W.#4*& MGLO^]7W/M=?D#^/ZK?U%XC!'*&)26XAY(H`GZ+S%8!W!N)40 M74./]5/MSO9/_H)&8((B(MH<7-_C#^[GBV>:P`](W)WF2X!;9K.[7Z5%&Q7B M%MZ#1<-@/0R)&;N^V;>T2!0M#D6+0I^!80$"[,XVN*7/>]4+G'E,ZBK.9H#E M,JZO=CQ<)V4.B;UH#7"^N4VBZJB"+'?7=-]Z`_I!5TZZC;8B4@^QH6&;#")B M5BZR,YGIZE?$A'0!R7JR'?0[G2XCJYW")_.PLQ5MDG4TGXWY4BSOE29Q-FDR M9TOF-.EE)QMU::<##18\7LR!6N>52'+@U_:9"NN=)VW,D%X,B6L8/<*DW%^3 MP5[FB"Q10DS*:'C/-YSS1]UFMMMUXJ=^R":HZ+9W%&(5^14.\T`X[?&EEL-&1$ORA[3G`\(GXY0E( M0:A"VES0"DD]AYF&G3JX$K-U_:&5S>`M#=K28.T]1JPB0X`'DU6_#XM&[;4* MTZ=*BTA546Q/'\.QB_(*4GG-Z.4J\;;IE%([ULVU@&)W$4IHN,[.^* M59'0],)S,(3E*; M=!##8F;^27FP^W;E7:7YOETD(MP%J\P#FO<_FO<^@:%,TWHK9T0<08&?S>E> MZ!K>.YI=]:H+LS3N??VDJ5TM]/7[)J]62B_@?)7@;XK+CHG+DZ%;@,M"%L(C M5UDCYBDLOY'GBTDCV\W/:OD"PKVZ:%M854J9%/D28?B/75!E8HU'S,18GS@H M;$EL-<=4GW&XRVF6964Y014U)`YS!O+@,$0[28U3GIN`257Z+7"O92 MYA1HM]ER0EIGHT'>5TC/T/;PX+*O,N2$;(,?+_<@(3P77T%*G)#0C^SB%4S+ MQ\GH)U)L4.DU:N[:%!OY#3,CTS7PILH_^#I@/2_(`K0L,/N.')E!&B!AL`H\ M%T9AP:,Z8RNO?00,P[U\VQJURY3E#:P^17=H[5,$`0VN2?J@V&<5[IW:]Q2# M**''I%\CF%)KINGN`^@N-!2I:Y]*J7V&C)ZIRO"1L@WW-NTJS0%Q0][41:J\ MT#LS$!'MZDHQB7S&BY)ARC#A<0OW&FP7+B^)2\]02F)H0<+H[MCK%,P1KC_@ M**N;?H,IPF4)_:TSVERJ<\%O(%\B\@L9/GEYEL8\ICJHY-;1UX$D^STX7'6! MQH@[H(IC?'QR\+%,?%`OC$_)9G3>^QA30M4:(PPJ__$L,TT3>PQV!O>17RJ< MI&!!+QA<(^4&Y-Q]!O.WVG6=WWS&@L@,901TF)C?(GH1'YJOA9OTG=,H@S-Z M0`J3(N]E+RA2-R]=RJA]QHJ>J#IO+1U[_9=#+-A3.HN,67B,RBM.$89JZ;2++V4Z->=?^O3=1KZW5_],[ZF M;[ZDY]R4:K38I17)6[RN60R'O$Y_:*U?%!CSUS*AEJQ2*3%1/>)'_HY!E(%S M4/V;EUA@C6%S&F^!H7?NO21;;;A(J^)_L\T#CM*,:$I'3QJ7_Y>4J&Q.42<8 M9F3:."\P^6=E+:=LRP$E2CK(JD1W=YOV\(Q<]$[G6G6P->4ET2&L"/=C4IY[ M=IRA@8UZU&H\6Z M2C;??_+LG#'*EI<)^N'!^>+>]U];K>0%JKBD_<)4#%*71XE4G5N,GB#IS=/- M=]))5^DVAW!"]GY/U5J1[0)S!KM#26T&KR>OAC%U0&]I'<3JRSF^<]E)_']% MG4_S@.X`">@SF("6C0]HV.`;4\2V?/T8(AP^4D60-(,E3,E_)Z`^VIJLZ#S\ MC_+O'2?K--D^6J72Q-WKE&/"!AEYK!T^QE"P>CA+1;%PCRV;W`JZSEK11"T6 MGL5$S7*%0W2TF%7RRF%0RE,EW&.=[E'5%1E]E?I[R:K]Y$SU-KM4394V1PMB M$Y\=!M.*FAD<'/F53OHROU8:&]=#/G4:"]%C?">E@.5@-HL'V)O8V'..H^8Q M3=5;0^OWNOBU=C0;V] MG%Q%@>P515N0P2[.KZ4$UT!V11-5 M"DD=)ER@JC$)'KX&OK(+:C4%!MSUV+U>L!Z25M_(DA5[V!`CH," M`W%$$3)P]XA)M*F/0R:S/PN(`5&;`"/?W"912DM(T*(190W)CIOT&S9/FV@T M]"W@JH``#?"-4L`5*%$^D*(A//AM<\_8R5,$$[J`O43X/DK`+OU=AE]Y2QZ` M12V/!<'*WAD%PB+IP>^^B7-F`,1EB1YJ'!FBWZ*9SK]%^`]0)HKRD6S: M?OO6E';[4%$]T%-6L*VOP]%MYQ@N,EZ$&2^^@D6QL6]LP%='^,O>SJEO&*QL MYX3BPKVAY%A;O]5BOIU38"".*$(&!NYZ6LZH#SY_^.GSA](#Y`_MI0%]@6:Z M+FO_D4GCCO0VAK.\?@CQXAG@&$(/FWJ"QMC,.H?FA(Q.C#=D();O M6RMADM-&",9>FT!1*+;=!OQZ$LR?6%B72"9JX/QHT??[IY>,OY[U8R+0X'6` M"H$7:?N*Y:"U*$Z+#*8@R\Y!-L-P77\"2LOY9M/Y[9X<9Q4HIG@1I?7GJ+N" M&96>^PKN/5"\JZ7!*^IIDV=31T>`1XT3-\7JU6$-]/Y/5RD<`YG M-%6ERD@NRR8E<$9WZ_14X=7HD!(VE38$A,Y")&-:)&`4=@DO'-I@5;MJ M&"MWG\G*H8"L^JGS)2Q7/`T^P\1:R@X]:(2Y):$SS6D!MCDQ"#D+)5\1BG_` M)"E?Y\JC=`'IUQ99!O:#.B>Z&+6MT:'9UN6SC1SE>*%&H\7N04=Y"V>!PZR7 MD8DCVB%#2W#]+*1<8,"KDOUJ%_]83?\% M*;?NK1Y=:Q2Z`PG](N$,97E6%H8K56X^A^"$##O,FF*6`YFYJ_6IJOCION*\ MJ&.)FZY3>=R!S]IYJK0#-;Z6O<68W M*`?2E9)FJ^;%5-56ME*X&X&\2,/]O:.P#]%`U^5(;EY[("L**!]N[3,.>`Q> MPQPN3-YJEC>TM-HT1JNU<38$ M!;V&S"QNC\`^?SK8%/D&/`#OB\<,_%D0;A=/3@\/NHKP'B.1D#65O;ED[LJ6 M=U3BC5XI'<=$'T:IM'>0NGV=G"X.Y[*4.)]CB#=V:CD!K[D!AS'S#A!,%8`6 MS26]0;NW5&[#&[[*]+71"O2>7^7K6JQS7Z_`.]R231<13HG=-/6^W&.+@:5( M73M92NTYJ/2LU8&4E'.X'XV3]>F,N`%71S@P^^.,:`YS^E^]VP4IY?9J04#I M.8C4K=0!D)!KN!]Q[97U%P'V@2@^H>?(4;91!S@BIN:?6;G&S=5J'4%< M?FZ!SV&V1EF43.?7*%U<$TOC*D-&C*@A+)IT!R,6GJ/0@E]T\&DFSOQ#+=?( MO236EM_Z[*6:7Z7$'T5YRU%9VH&J5INZ#Q3;>`Y&$\MUT*?(W_RK+-=PNP$_ M]CR`44K^G.YUYQX5TJZM3-)@LC_EAIIE?S+YVGR)V<,#XP=:7O/UN/A0 M:\IJM?P-1!2$\32]HX5-,5&V_`2)-\F;-N^N-)6;>S[)#_2'T?I3653@3[=O M#=Y[Z<88KR8\NJ#5XQ$*<@=XQ@B^>O("KUVG.&B_I^@Q`_B)3H%7Z;K(FS

YZP5J=>R@C8A1OCA#JU36Q=.KO)/W5\;KP6))@+24)S98@+A)` MUO+TRXTE2@BP,EJE*-]091L+IK@R@)M$-)1/DV1DSB>D;%U;[C+.ZAV@0+#; M5N425>>`;-43=R'JM5*5S,_,3.R;8O4(\'1^CE:T0O^LJD2137^DO6KM*J3- M.;:0]'B*.VFX9*1"36(-'-9=%Z+M$F$`%ZD"V`24':PQ*8\/:G*'C(PTI@+F M.U0/DNM5#F9=3V\OY&2VGTK*,5-.R$W=]<%,M(F2?%/KUC6-^6-C3N='9P%. MH0.0Q)9VH.(S+'.,.XPL)Q1[=PZCC.]AB=J]PO8!9FC3G$ZZ?6O=%_+"A@IM M,]3$M+;61+U,U>U$NY]@`_."_MY]W<.L,2]K6-+87:Q1ZC56+K&..SKA2"23 MF6$LD37&191_84MC?&E%+C'?<+\&V)YRGVY.HX0^6G2_!"#_BE&Q)KXHSWUY M%QX*3;JW&,(F/CAA^Y__!0$FJ%QNKLFDE4R>83?TZ37J.T+8R+TKZON.M-I&-X M.P)K"6S=T+$$'4O>Q9YMGY1Q]DD99Y^."V=LPT?`V:<.SH+/C=BS[;,RSCXK MX^SS<>&,;?@(./OU8D\<3NWO\J!ZO)BNY(,_'>PXB-VK9,P,:]`YG*B;P:%Z.-F+A/NZIP`!9\1`G"@H4 M*%^2-A+L(B8RSY._IQA$"?P'B+\2@S(F^H0TM?,X-,'@1\5&,X!P.+LXA)0@ MX!IE&9!!@$74PT";*$`0"*P?<=>@I2V.FLE7% MQ)^MDWS9C8Q6HUJ;*:X2K0V64/B+W-L.V4<-WNUJ"@_WNO$J?0)9^8K&`Q'% MV-GR";8?K?<)/#'G+,K!`N$ZV9$Y4:DW8)K+;N"NE!P@89]F+.8@F\[/P1IE M,&?:K4#9)(6(*!W6)%#N-Z1C;;L(VPCBSSW>JH,#M%:5SI^R@+5@+2+IB8I*'A1V[O(,@PV9MO&;VX M9&\9MQL/=ON32E,S=W#QJTMQHBWS8'""I,7\[Q M@72S:G8PP&(;[JGNGM5-U9G-61)EDGMM/FW_\II%Z]Y>A1H[DN(A7!.=\*:9H"%VP:]W%J]"Y':@[BQ+FQU"N+8;#5 M"OPK%[4`J%DYS,:HY\YD?35U"XT9JO=READZL^+@JPB6A'#?'=@9QC"_7W#@ M+"HKS&37,"UO7?CKDV'L>DL84W;N'5OE*G,^=Y50L?/%/?@^OL3^=%Y/+G4] MI8MG@&X^?@"+9GMOQ,)]6.-T-K+B%$Z`:\LLM_U&LL)- M+:[>J:)V=5>XO1^:9>W>#SZCAFN`,A;V.81[>=XQD"8(T*0`>E@JCKLL2G;L M;5/Z#`IU$Y51(F1Y!`Z)4*30S'9A9GD5&#THBSD&V]CZ6,P:@SV*@3 M5^CS5?FUXIX1\EE*HT53O%JEA?L`97TBTO>4T8V?=%&-W M9CE\AJ=WZ1QG43(KDJI>(TH2LE[[$>%NX?&#R;.?SL&3Y[[O]FJZ_`;S9<^. MK&U(UC9[>R5:\N+UUQ@R!,7Q+,AP'UU'QSBGF)#M#AHM_X5M'J]>D06SS*?L M-<`0Q61NP;DW,5O3-QS7T"H+]!O[JW26%#&(K]*+"*>$C)L><"BY`^.#@=S7 MF#%F1P841PQ,/8*;5SM.N@ZRPMRX$80A:)R0T1+T&B.L=E7X0:%EF\%^ M\$L5!5*PH-^%A;JZ<+ZK^/W3Z[["_?C7ZZ*`!K_:SL(@?:':65RD[)%_W*>" MULYYG!T4#K%@C.]^@TCTMY)>/O1;`%,EPOVB5O.-FE%C'^)KXM6; MC;18W)S8C5R_:?@5H?@'3)))2K:I>90N(/%L=;$N?5O/7T[F#H:/[1*XQOXJ?>KE/PG>(B>W;]VNU5% M.@\H4&XK^0DHG1UFT(5&-:B2!/V@BPV:5'8'Z&(=9+?ESHMHCLFZ'IR#ZM\= M%PQA4?O&C(7#PBOR3D=6'-.MR<*52\."F;QP\]>W[J!?3*09.`4IF,/\#-&E M=4&6RM,UJ)['[%<9U6[9'<4J+7T'J+D;M'"I)2;P1-2+^1S,:`+4UFCZ\8X" M)/4;UEVAT]!W0!H[00N/.E+"_>SOO%:6F%>M)?O30P>"&BUJMRNU\!UT^F9K MH4V)?>`%#NL1DR[HU?]9A/%F7AWA9JP'A!6IFYQO&;7[]<>DR)<(PWS#+&@N M(NJN*CI$'IG&K#TF(^.:Y_P)+;+1IJG*R1UX`FD![LD2&<[`U=T]IVR[$O76 M7`FU^XC(ZR^D:RLG%';X5ZM`"=]P-R+E90C]%HN(2/Z[P#"+X8QZA%UQ3HVZ M*=(AH_8:3'JVJH-)RM=RKIE3M_8KNRI%79DW=S5=>>S"_7Y'=8G!]*:TK)J$ M.]NIH3]=RC?ZFE,M3:.%=*UW[4'-,[YVRH8KV^OEV.EW&](P5G4,7>\GF8BX M'^-8NGA>P^KPX9R^[Z(,+$X[*#:E=U2B=2XE96TIC>N@=\AG:+6"9>E\YW?(>ZJ0C4IUNKP`*S!1,'8@JM@2_WI.[!ED& M`-64EK*@18`7U?=)G2'Q`/!J.J=&,Z+T,"9;7)DQ"1%Y%MPU&)MF.@1>Q*1C MW661T_>X80I7Q>HVVE3KI=Y':)JMV!,TOU5X"#9SB-U)FB\T\#OD;F;:57J+ MP3J"<7.!7B](B-?*XE/597K_0G(`D]UUI1&3\`!MQ5T#\6VJ@_GVU'&>\WV. M9G\\$DN)=U;4M&J9Y'B[NNL<.N_M]+H#"?WH^@QE>5:6T2\U;P(/9_]JAUF3 M9#20F;MKX=D2Q$5"U"[5.^UV^?[ZXW2SHZE-F-##&%;^C'6^S56S/;[NJB:7 M2G1>8VRJ(K-^:ZH>MW]S^XJ'D>=W%J3Q;1*E-]$*,)-VQA2Q_[*(=1$.\SM( MQ)Y6W[ER4CIX!-LLCCZ!L^7"J`!`"MYHKQC&4*?*$>FK$>Z5X1T@\QFD[T*4 M=C%A**2I?<^A.5HPJOCD,'CD:!+N'19[/D4'F6$Z']3O:[)]\,FZ!N'F0]E? M,B+Q>JHSI&R)+Q\\:(L-.*13FQGKU-[?F]"]^[M;G=F33_^7?;W9$\T!-:^/ MS)BZ,W^KM>_\YFP(L_R+Q*JW!^$>`SJ,.@W#'4;?HF=^Q[)^:SJV_9MW'2M0 M7=RQ[8;AKB_Z<1")P@S#*=@;?$QEN35BI'WANN.:D2]MC MJ'H*H\`P//JKO2 M?E)?9V=95,E$YLLAPZJ%LN7/H[X_O5JZ+34]"M]K-X[=5Z3 MO\K05_J"8$V_C(%.N0K.4K\TD'>CA[P^N1!Y-R\%>5R_ M'`YY-WWD'3ZA2P-Y]?U:K?,#HL?E,:&9%;3`SG0^)U2XN].QP4J(6%561XUF M(W\>#NFJZMG,\SK4*/CXH73+$B6Q*?K9++10WV7QHM`N])\[E'?5JM']ET"3 M=HU=5_[C5UKW.%U4WQUUO\D9@_70;223]9$,JQ'][=6VDJEN/0Q_>D''T'5D MFA9YED=I3+Q1G579&H8R_D/'(I__2Q^0BI[W:E3R=:Z'YK^_Z*'Y&X"+)5E` M3)X`CA:@M<@8;\"J2+4_C,527P?W@%[R?,B++:D#P7\X>!'#<3RX^+.`^>8J MS7)E1X6!/>557-"WI8X, M7U[:)EK=4YW(6AY'T,(,V[?&#A\RE%4Z7#114.DUT(S5OX'&(`4SF[OK`'-K MAR[N2G=D5VEUT/(5H\Q:UIM<@J6M"5/"2X\#RM[W:EB+M&Y&Z3&FHG)3[N$F619L:I\1HNQT$]8 MS^$3C$$:TY>3;,WHNO*&SN_J\E[*^+?<,U[-_>HV-&/=(/'JJ,9Z)R+^BA+" M+2'[HK$'O9+@,4:_1/!K&!C65]['`XDQ36`86A([],!P![,_+C$`Y9-.(,O' MC@6.$`;:\U]%OU#/>#WJV#2?EF(+^DW#[I]47[Z.-@EW]LL:-?\'7%'M.0/WP_>36A M:YO2A(.7E$^HZ21_D@4,]3IP0'E-&W#=TR&')(T$`H/41W\2G$R6=[7#?BTS M+29IO%W:(?JG^HJ&5A7J./$.T(*-,%TT+W@446)U`S.:8D,W/",H=DRQRQ.7 M^KNA&L'8)GJ%FIXY24KF(&9W3?T\12>RZ#5JBM`K-CJ2$6GDHS%&BZHB32D0 M@T0^3SY!N%BM$[0!X![@)S@#;'NWN8VEI[('E$?)_N_TQ8T;E/\=Y'=@AA8I MH[K:Z')J-(PHYT@&V:%Z8HQQ.:+NS5`.,-MO-*]4^Y%+A.L_4;KNBMF-\+%' M.T?X:P@8WF=!Q06.04VPL)7\%WK)8(OP'+W6L`U=S4O`B99]!T2!I??8T'AO MC[41,$S?LMOMZ6FI7OA!WQC\+<+E(:/K5P4;/29I?$?/"S(2<0'_3S),JRZ;Q6=(I+-5DO_,D):YM%A*]O\+V^P6==A+-.J2'.?.6# M^5L[*CA_Y6/4'D=B'QSF?;..!N$^L\&.4:_OFGG850H3I=9#97Q^1_7R&--, MQFPMI1,M0QS/XDR=F).Q`J7(S@%3(_LI!H`AR*Z:Y2S[P5D13;,`8-/X-589 MK\@64S'./]#=?>[$Y8ZLA6\&@S!PF9'OM4HAH1=:85`<]PG\=B M&M4[_Q-%8-YAH8S8+Y.W#P"!68%A3B+1690D(#[=-`&I)E3RB3XWD=-TN/DU M+IGW''8]IC""6Y<2@Z4[>Q!J1/1WJJ&;0%Z1A0CG4A:A@EO/-U80+17I[*4F MU^\.HCJ_MY__.U:);0.1@U\GU!$9P+!RX'O=87@8%//N MGJAC'J;ZOO9@GMU3S=DS9MX.QTN$YP#F!7T7N?S0!.*2J;4*L0-$CS=]WM>WO>]V`(\W>^!O5AJIWO11I;?F1T M%UG*#\$1;D[9NA]CR.B:[R;X=`%`5=5*770)^)J_.>;OW;#:52;OTFWP?>:U MC71ZUW?$NHG)/"_+,^`5)7'='7#N^C7,X:(:E\;9Z\RPNF/,R3OG$]1]Q")P MMF:[1EE&O[8G4QE(9YM;4,YJ!`UPE3%77.H-&G,5&C@;BX+.0@:VMH=?GSD= M:2I,S4?"6V@-G(*.K*J(\W=G`I';!-09,.?1*EJ0O3-=HH.854I,O0$[1#$;>(HP;5L-0A23 MJ?GZ:^!9A3!`W9)%.%WP)`E8@#@AF[8YIE;$W];73^9!B[WJDXZ(<[+(W#35G[4#$K.UA#;-@X;86P?6`385H"S`WTFOLY0@W`9B3N=6=8 MY^XI/,?UH@JDK6M@\RBEZY`%2,4$ MOZLT:XT*`6X)F_'97<575:HLQBJ_?_KG/S[^JUK]#!PDU6"3R8ITF+(OTNN:E2;#;7I'ES\XY4R56C>4W&<^$JPA+=:NL.;B4:"IGH)^H"\JC%MQ5 MYEI[M_7Z@DD.>EFSA%LWHS3>7QMK''"!ZP_HN\K?/G78E(%=(6@^ M5[=+M9;R^OI:>[VN"3E#(8UF_3^/_5$P;DR[F%LY0X9TZ#R]\F`C>4K5))`; M]QB6JVJC6;UNQDP.XU]3JBPGTHF5N:Z;[@E5L-9[ASY2'9U]4P]ZUZ0HB&6( M9EQIRBU(TMMZS9`D?E@MD@56+696-3#OCV6Q_A41"W89GQ[ M&^/Q#%,2>/O6:'%74?(7YZ$&JH74TCA0`8VIKON MF07!0\7ZFW%C$51:.U)V)@,*$1Y(S7#R;>92_5M995&GJ%7(8OG.)1MEP[2H M4KA MVI1N,(TJA-EWE4R*];CQR!O`/C4PZ#<:N%'%$I*/E-LD%$<2\C[6MX5LR_<5 MV`/^*7C>7L<1=T22Q;FU5HYG3,_'_7Q1:XS!R=#<"VX#1]GXH(3#;),NM*EC M]I;1'$"K%TY]FVFS^QJDBC!D`H>P!<"-T+<0(7<_>.ITGT;=CGD:#?J]3FN, M+^U6O_5TWR6C+]WN>$3>K$?X=XGE:5@.J41'S$$SM*PPL&GN')2;YZ-,WJ1& M+%'/17WM;C68#CQS"##I_C%+.8\S$^VKX]?T:(Q_'KM/B/3@@0R&W>?6N(<$ MY>H^%>=[X:(+YDC#%M`7JC#<&0(R4;\^%?7[P>/PN?L%Z7I_=$E_,"K1/QU] MJN8/CG@MCOHN8R;:;T]&NS7Z0A[Z@S]+E`^AW/85XZ!4!Y0EF6<&Q8RX315# MH(8)VT-LCR?/1/1]G$)O;HBJ))9-$L*#A#H03\24)`EZMJ_?Z1D_>Q$_E\?I`HIG&;E]'#D`YB6<)P3DK:TPG3K%U%7%D@O;AW%45 M#E("NB_'2D*VU98#2D:^5;K\K%O"#FC*'%7PLC#FRH3MYOP[0_(F&JE$MWB$ M3$%;C"4'US-C9(EI_JUB"KP#?3DH'7''6&*1EP2F<-C3GH-!;@I8^C_[%C+E M_SWM.?[/OI,LW5_@=C*]G622Y(!2X*ZR1"@SHTYALMV8@T)F3EUZ/?,V,^7W MW>8;?Y?^/YC?>L#_+`A_9F^^4B?N1[F*H3OE(8D2R]FE'JI>H2PK*0O MK$!8NE9@+V,='*WBENI&5&VI[/BKYDQULLH0,M79YC$/9RNPIT3C&!T2;-'S MV9H$V;]<%58ER1>_G*^,+R5PZP1MDHSKM[/U@:4U+ZS+FBEX.EL'3ID5E"TU MBRBQX0H?JQL!IZFAF%58B9C'/)RBP'99Q$T8Y3G,:/!IW`$=4FR.E"FNJI%3 M14B:[\_70Q?609\R?MJIVI/%D8B9@J=O@46R>NT8'P0LYJT:\QE/7!M/G*'% MV[HT93%'*A!0FV'?5AL?JLU&,0!V*O&.'#5F,`._.\W2_;5VQXR?Y'P*&<]> M`;O5@L4T.5V-['+.TY.*0-8ID7HW,D2U6:BJI:NP]!S*J19R]8#OQT>+I)3N M1DB&SZ*:VT!'"'L,*HT^-KG532 MRF)\H=V1-5S##.0WL'M*'76BX5$%!Y_U`8_?:A@P,^O9'"82 M)\UT!>Y,5*Y^C)UAWR2L2L(.F#!]V'I3PX`0&H-,3M>A+IV!:KU2:8/]!W5\ MZ.!A;#6D*\.T<4-1OE_%'_?"EWJ`1LA'L%D@HH>S5"[B&K!PSF<0)2V-M?BY M,WP=B#HPT2/`_)V9NM4@(HT00`<.QZY\EDL+9%EULJU(_L;0XZB3F&(;.N"G MFHA!Q\1<7''F9TEA`=AJ+-HPI,QN37$B=L#V+;,V'P`7);?OA=*JQX.3F]WC M\6T+G]T[E+D;;WQSP='DP)GAA:*_YTH(4]^,Q;W^T1V6NNT(Z^O&\CU=J8FM MX_:?NY37FZN0P&8\_#U+#5YY7,MD;,DD^L'[;RXFFYN_W<6YK^_"EF+LZ\C) M+<=!C]J."2-&-[!?/,';JY;G.8#K9!>DHQDO#;@1$H/JQ0MG>P@VRANCJ1N!ZF^-&YV7IJ%4O- MXA73$7A.U,S*#G[[J2YM$1V91@?9)9I3./_>,/XJ"?AFP7W&-96Q'E/=E[8< M\2#(0IH.SC_^($_T$*-_C^8!!\C6C2^FB1<>;Z;JSY$*W!`U%/B<]F@2;=D$_Y0T]`^=-\O\)/1YOV M]*N9%LW+2.FQ,/]ET48:"W5;8/\4J:3*,_M8*;^D2YJ-T9Q*F`O'/L$5V]P7 MYH(^8)8+YK(6M]&6V6%GT;_U2%_DCD&ZYO^[\.TSZ(G\EW<-&,#4WOYF+6%2 M>[4AB2YN@X0R-"UX3)SOOHFTG^NEX*N;\$`L``00E#@``!#D!``!02P$"'@,4````"`!=B0E#3W:F M6ID)``"H<0``%``8```````!````I($ZE0``=FAC+3(P,3,P-C,P7V-A;"YX M;6Q55`4``^):!5)U>`L``00E#@``!#D!``!02P$"'@,4````"`!=B0E#0;\< M?WP2``!Y+0$`%``8```````!````I($AGP``=FAC+3(P,3,P-C,P7V1E9BYX M;6Q55`4``^):!5)U>`L``00E#@``!#D!``!02P$"'@,4````"`!=B0E#G&+B ME<%5```3Z@0`%``8```````!````I('KL0``=FAC+3(P,3,P-C,P7VQA8BYX M;6Q55`4``^):!5)U>`L``00E#@``!#D!``!02P$"'@,4````"`!=B0E#*I.% MF$@H``"4H`(`%``8```````!````I('Z!P$`=FAC+3(P,3,P-C,P7W!R92YX M;6Q55`4``^):!5)U>`L``00E#@``!#D!``!02P$"'@,4````"`!=B0E#&@2` M_+T)```Z5@``$``8```````!````I(&0,`$`=FAC+3(P,3,P-C,P+GAS9%54 L!0`#XEH%4G5X"P`!!"4.```$.0$``%!+!08`````!@`&`!0"``"7.@$````` ` end XML 60 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 61 R13.xml IDEA: Warrants 2.4.0.8060700 - Disclosure - Warrantstruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_WarrantsAndRightsNoteDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2vhc_WarrantsTextBlockvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-weight: bold;">Note 7 &#8212; Warrants</div><div>&#160;</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Information about warrants outstanding during the six months ended June 30, 2013 follows:</div><div style="text-align: left;"><br /></div><div style="text-align: left;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Original </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Number of</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Warrants </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Issued</div></td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercise</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Price per </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Common</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Share</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable at</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">December 31,</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">2012</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Became</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercised</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Terminated /</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Cancelled /</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Expired</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Exercisable</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">at June 30, </div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; padding-bottom: 2px; width: 15%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Expiration</div><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt; font-weight: bold;">Date</div></td></tr><tr><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; width: 15%; vertical-align: bottom;">&#160;</td></tr><tr><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">2,619,036</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">(1</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">)</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">$</div></td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">3.59</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">159,967</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="text-align: right; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom;"><div>159,967</div></td><td bgcolor="#cceeff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#cceeff" valign="bottom" style="padding-bottom: 2px; width: 15%; vertical-align: bottom;"><div style="text-align: center; font-family: ''times new roman'', times, serif; font-size: 10pt;">March 2015</div></td></tr><tr style="height: 20px;"><td bgcolor="#ffffff" colspan="2" valign="bottom" style="padding-bottom: 4px; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; font-family: ''times new roman'', times, serif; margin-left: 9pt; font-size: 10pt;">Total</div></td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">159,967</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="text-align: right; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''times new roman'', times, serif; font-size: 10pt;">&#8212;</div></td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="border-bottom: #000000 4px double; text-align: right; padding-bottom: 4px; width: 9%; vertical-align: bottom;">159,967</td><td bgcolor="#ffffff" nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; width: 1%; vertical-align: bottom;">&#160;</td><td bgcolor="#ffffff" valign="bottom" style="padding-bottom: 4px; width: 15%; vertical-align: bottom;"><div style="text-align: left;">&#160;&#160;&#160;</div></td></tr></table><div><br /></div><div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr style="vertical-align: top;"><td style="width: 18pt;">&#160;</td><td style="width: 18pt; vertical-align: top; align: right;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">(1)</div></td><td style="width: auto; vertical-align: top; align: left;"><div style="text-align: left; font-family: ''times new roman'', times, serif; font-size: 10pt;">Referred to as our Series I Warrants.</div></td></tr></table></div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame.No definition available.false0falseWarrantsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/Warrants12 XML 62 R23.xml IDEA: Income Taxes (Details) 2.4.0.8090400 - Disclosure - Income Taxes (Details)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$c20130401to20130630http://www.sec.gov/CIK0001082324duration2013-04-01T00:00:002013-06-30T00:00:00U006Standardhttp://www.xbrl.org/2003/instancepurexbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$c20120401to20120630http://www.sec.gov/CIK0001082324duration2012-04-01T00:00:002012-06-30T00:00:00U006Standardhttp://www.xbrl.org/2003/instancepurexbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$c20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00U006Standardhttp://www.xbrl.org/2003/instancepurexbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$c20120101to20120630http://www.sec.gov/CIK0001082324duration2012-01-01T00:00:002012-06-30T00:00:00U006Standardhttp://www.xbrl.org/2003/instancepurexbrli0U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$c20121231http://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00U002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_IncomeTaxDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecreaseus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse56950005695USD$falsetruefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryTotal increases or decreases in allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e24092-122690 false23false 2us-gaap_IncomeTaxExpenseBenefitContinuingOperationsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse354000354USD$falsefalsefalse2truefalsefalse35900003590USD$falsefalsefalse3truefalsefalse356000356USD$falsefalsefalse4truefalsefalse57630005763USD$falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to pretax Income or Loss from continuing operations; income tax expense or benefit may include interest and penalties on tax uncertainties based on the entity's accounting policy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e32247-109318 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45, 46 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 48 -Paragraph 15, 16, 19 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false24false 2us-gaap_EffectiveIncomeTaxRateContinuingOperationsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truetruefalse-0.05-0.05falsefalsefalse2truetruefalse0.260.26falsefalsefalse3truetruefalse-0.025-0.025falsefalsefalse4truetruefalse0.280.28falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepureA ratio calculated by dividing the reported amount of income tax expense attributable to continuing operations for the period by GAAP-basis pretax income from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(2)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Subparagraph 2 -Article 4 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 47 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false05false 2us-gaap_DeferredTaxAssetsValuationAllowanceus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1142300011423USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1142300011423USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse69700006970USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 43-49 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 17 -Subparagraph e -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false26false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6false USDtruefalsec20130101to20130630_IncomeTaxAuthorityAxis_InternalRevenueServiceIRSMemberhttp://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseFederal [Member]us-gaap_IncomeTaxAuthorityAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_InternalRevenueServiceIRSMemberus-gaap_IncomeTaxAuthorityAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse07true 3us-gaap_OperatingLossCarryforwardsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse08false 4us-gaap_OperatingLossCarryforwardsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1552700015527USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1552700015527USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of domestic, foreign and state and local operating loss carryforwards, before tax effects, available to reduce future taxable income under enacted tax laws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 48 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false29false 4us-gaap_OperatingLossCarryforwardsExpirationDatesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00December 31, 2027falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringThe expiration date of each operating loss carryforward included in total operating loss carryforwards, or the applicable range of such expiration dates.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 48 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false010false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse7false USDtruefalsec20130101to20130630_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMemberhttp://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseState [Member]us-gaap_IncomeTaxAuthorityAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_StateAndLocalJurisdictionMemberus-gaap_IncomeTaxAuthorityAxisexplicitMemberU002Standardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse011true 3us-gaap_OperatingLossCarryforwardsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse012false 4us-gaap_OperatingLossCarryforwardsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse5275600052756USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse5275600052756USD$falsetruefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of domestic, foreign and state and local operating loss carryforwards, before tax effects, available to reduce future taxable income under enacted tax laws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 48 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false213false 4us-gaap_OperatingLossCarryforwardsExpirationDatesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00December 31, 2016falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringThe expiration date of each operating loss carryforward included in total operating loss carryforwards, or the applicable range of such expiration dates.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 48 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false0falseIncome Taxes (Details) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/IncomeTaxesDetails513 XML 63 R26.xml IDEA: Warrants (Details) 2.4.0.8090700 - Disclosure - Warrants (Details)truefalsefalse1false USDfalsefalse$c20130630http://www.sec.gov/CIK0001082324instant2013-06-30T00:00:000001-01-01T00:00:00U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$c20121231http://www.sec.gov/CIK0001082324instant2012-12-31T00:00:000001-01-01T00:00:00U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3false truefalsec20130101to20130630_AwardTypeAxis_WarrantMemberhttp://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseWarrants [Member]us-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_AwardTypeAxisexplicitMemberU001Standardhttp://www.xbrl.org/2003/instancesharesxbrli04false USDtruefalsec20130101to20130630_AwardTypeAxis_WarrantMember_ClassOfWarrantOrRightAxis_SeriesIWarrantsMemberhttp://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseWarrants [Member]us-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_AwardTypeAxisexplicitMemberfalsefalseSeries I Warrants [Member]us-gaap_ClassOfWarrantOrRightAxisxbrldihttp://xbrl.org/2006/xbrldivhc_SeriesIWarrantsMemberus-gaap_ClassOfWarrantOrRightAxisexplicitMemberU001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0U003Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0$1true 3us-gaap_ClassOfWarrantOrRightLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 4us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse26190362619036[1]falsefalsefalsexbrli:sharesItemTypesharesThe specified number of securities that each class of warrants or rights outstanding give the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 2 -Article 4 false13false 4us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3.593.59USD$falsetruefalse2truefalsefalse3.593.59USD$falsetruefalse3falsefalsefalse00falsefalsefalse4truefalsefalse3.593.59USD$falsetruefalseus-types:perUnitItemTypedecimalThe exercise price of each class of warrants or rights outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 4 -Article 4 false34false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse159967159967falsefalsefalse4truefalsefalse159967159967falsefalsefalsexbrli:sharesItemTypesharesNumber of shares reserved for issuance under non-option equity instrument agreements awarded that validly exist and are outstanding, including vested instruments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false15false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThe number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph b(2)(d) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. false16false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of non-option equity instruments exercised by participants.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false17false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of shares under non-option equity instrument agreements that were either cancelled or expired.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3)-(4) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false18false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse159967159967falsefalsefalse4truefalsefalse159967159967falsefalsefalsexbrli:sharesItemTypesharesNumber of shares reserved for issuance under non-option equity instrument agreements awarded that validly exist and are outstanding, including vested instruments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false19false 4vhc_ExpirationDateForWarrantsvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00March 2015falsefalsefalsexbrli:stringItemTypestringDate the warrant is to expire, in CCYY-MM-DD format.No definition available.false01Referred to as our Series I Warrants.falseWarrants (Details) (USD $)UnKnownNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://virnetx.com/role/WarrantsDetails49 XML 64 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Tables)
6 Months Ended
Jun. 30, 2013
Warrants [Abstract]  
Information about warrants outstanding
Information about warrants outstanding during the six months ended June 30, 2013 follows:


 
Original
Number of
Warrants
Issued
     
Exercise
Price per
Common
Share
   
Exercisable at
December 31,
2012
   
Became
Exercisable
   
Exercised
   
Terminated /
Cancelled /
Expired
   
Exercisable
at June 30,
2013
 
Expiration
Date
                              
  
2,619,036
 
(1
)
 
$
3.59
   
159,967
   
   
   
   
159,967
 
March 2015
Total
         
159,967
       
   
   159,967 
   

 
(1)
Referred to as our Series I Warrants.

XML 65 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
6 Months Ended
Jun. 30, 2013
Subsequent Events [Abstract]  
Subsequent Events
Note 9 — Subsequent Events
 
On August 7, 2013, we signed a Patent License Agreement (the “Agreement”) with Avaya Inc. Under the terms of the Agreement, VirnetX has agreed to license certain of its patents to Avaya, in exchange for multiple payments to VirnetX and an ongoing reasonable royalty for future sales through the expiration of the licensed patents as outlined in the Agreement with respect to certain current and future IP-encrypted products. In further consideration, Avaya has agreed to license certain of its patents to VirnetX for its ongoing Gabriel technology product development.

Under the terms of the Agreement, the Parties have also agreed to dismiss the patent infringement case brought by VirnetX before the U.S. District Court for the Eastern District of Texas. All other aspects of the agreement were not disclosed.
XML 66 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Patent Portfolio (Details)
Jun. 30, 2013
Patent
Patent Portfolio [Abstract]  
Number of U.S. patents owned 21
Number of foreign patents owned 41
XML 67 R15.xml IDEA: Subsequent Events 2.4.0.8060900 - Disclosure - Subsequent Eventstruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_SubsequentEventsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_SubsequentEventsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">Note 9 &#8212; Subsequent Events</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: bold;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: normal;">On August 7, 2013, we signed a Patent License Agreement (the &#8220;Agreement&#8221;) with Avaya Inc. Under the terms of the Agreement, VirnetX has agreed to license certain of its patents to Avaya, in exchange for multiple payments to VirnetX and an ongoing reasonable royalty for future sales through the expiration of the licensed patents as outlined in the Agreement with respect to certain current and future IP-encrypted products. In further consideration, Avaya has agreed to license certain of its patents to VirnetX for its ongoing Gabriel technology product development.</div><div style="font-weight: normal;"><br /></div><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; font-size: 10pt; font-weight: normal;">Under the terms of the Agreement, the Parties have also agreed to dismiss the patent infringement case brought by VirnetX before the U.S. District Court for the Eastern District of Texas. All other aspects of the agreement were not disclosed.</div></div></div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.No definition available.false0falseSubsequent EventsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/SubsequentEvents12 XML 68 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Basis of Presentation (Details)
Jun. 30, 2013
Patent
Business Description and Basis of Presentation [Abstract]  
Number of U.S. patents owned 21
Number of foreign patents owned 41
XML 69 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
6 Months Ended
Jun. 30, 2013
Aug. 03, 2013
Document and Entity Information [Abstract]    
Entity Registrant Name VirnetX Holding Corp  
Entity Central Index Key 0001082324  
Current Fiscal Year End Date --12-31  
Entity Well-known Seasoned Issuer Yes  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   51,203,141
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q2  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2013  
XML 70 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
FinancialInstitution
Jun. 30, 2012
Dec. 31, 2012
Revenue Recognition [Abstract]          
Royalty Revenue $ 6 $ 36 $ 300 $ 36  
Concentration of Credit Risk and Others Risks and Uncertainties [Abstract]          
Number of financial institutions holding company's cash     2    
Fair Value Assumptions [Abstract]          
Warrant exercise price (in dollars per share) $ 3.59   $ 3.59   $ 3.59
Common share price (in dollars per share) $ 19.99   $ 19.99   $ 29.28
Discount rate (in hundredths)     1.41%   0.72%
Expected volatility rate (in hundredths)     93.00%   94.15%
Changes in fair value of Level 3 liabilities [Roll Forward]          
Beginning Balance     4,172 4,699 4,699
Gain on derivative liability included in net loss     (1,486) 1,979  
Settlements     0 (1,415)  
Ending Balance 2,686 5,263 2,686 5,263 4,172
Series I Warrants [Member]
         
Fair value of liabilities [Abstract]          
Series 1 Warrants 2,686   2,686   4,172
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Series I Warrants [Member]
         
Fair value of liabilities [Abstract]          
Series 1 Warrants 0   0   0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Adjusted Cost [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 13,378   13,378   26,485
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Adjusted Cost [Member] | Certificates of Deposit [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 351   351   17,836
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Adjusted Cost [Member] | AA [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 13,027   13,027   4,099
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Adjusted Cost [Member] | A [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale         4,039
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Adjusted Cost [Member] | BAA [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale         511
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Adjusted Cost [Member] | Total Corporate Bonds [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 13,027   13,027   8,649
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Gains [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 4   4   8
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Gains [Member] | Certificates of Deposit [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 0   0   0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Gains [Member] | AA [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 4   4   0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Gains [Member] | A [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale         8
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Gains [Member] | BAA [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale         0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Gains [Member] | Total Corporate Bonds [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 4   4   8
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Losses [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 0   0   0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Losses [Member] | Certificates of Deposit [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 0   0   0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Losses [Member] | AA [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 0   0   0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Losses [Member] | A [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale         0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Losses [Member] | BAA [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale         0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Unrealized Losses [Member] | Total Corporate Bonds [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 0   0   0
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fair Value [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 13,382   13,382   26,493
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fair Value [Member] | Certificates of Deposit [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 351   351   17,836
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fair Value [Member] | AA [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 13,031   13,031   4,099
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fair Value [Member] | A [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale         4,047
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fair Value [Member] | BAA [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale         511
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Fair Value [Member] | Total Corporate Bonds [Member]
         
Fair value of securities on the basis of investment category [Abstract]          
Investments available for sale 13,031   13,031   8,657
Significant Other Observable Inputs (Level 2) [Member] | Series I Warrants [Member]
         
Fair value of liabilities [Abstract]          
Series 1 Warrants 0   0   0
Significant Unobservable Inputs (Level 3) [Member] | Series I Warrants [Member]
         
Fair value of liabilities [Abstract]          
Series 1 Warrants $ 2,686   $ 2,686   $ 4,172
XML 71 R1.xml IDEA: Document and Entity Information 2.4.0.8000100 - Document - Document and Entity Informationtruefalsefalse1false falsefalsec20130101to20130630http://www.sec.gov/CIK0001082324duration2013-01-01T00:00:002013-06-30T00:00:002false falsefalsec20130803http://www.sec.gov/CIK0001082324instant2013-08-03T00:00:000001-01-01T00:00:00U001Standardhttp://www.xbrl.org/2003/instancesharesxbrli01true 1vhc_DocumentAndEntityInformationAbstractvhc_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2dei_EntityRegistrantNamedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00VirnetX Holding Corpfalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false03false 2dei_EntityCentralIndexKeydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse000001082324falsefalsefalse2falsefalsefalse00falsefalsefalsedei:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false04false 2dei_CurrentFiscalYearEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00--12-31falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No definition available.false05false 2dei_EntityWellKnownSeasonedIssuerdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00Yesfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.No definition available.false06false 2dei_EntityVoluntaryFilersdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.No definition available.false07false 2dei_EntityCurrentReportingStatusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00Yesfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false08false 2dei_EntityFilerCategorydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00Large Accelerated Filerfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:filerCategoryItemTypestringIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false09false 2dei_EntityCommonStockSharesOutstandingdei_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2truefalsefalse5120314151203141falsefalsefalsexbrli:sharesItemTypesharesIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.No definition available.false110false 2dei_DocumentFiscalYearFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse002013falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No definition available.false011false 2dei_DocumentFiscalPeriodFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00Q2falsefalsefalse2falsefalsefalse00falsefalsefalsedei:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No definition available.false012false 2dei_DocumentTypedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse0010-Qfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:submissionTypeItemTypestringThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".No definition available.false013false 2dei_AmendmentFlagdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:booleanItemTypenaIf the value is true, then the document is an amendment to previously-filed/accepted document.No definition available.false014false 2dei_DocumentPeriodEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse002013-06-30falsefalsetrue2falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.No definition available.false0falseDocument and Entity InformationUnKnownNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://virnetx.com/role/DocumentAndEntityInformation214